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Preface 
I had wanted to pursue a career in Radiology since my time as a house officer when I 
came to appreciate, as never before, the pivotal role of modern imaging in both the diagnosis 
and treatment of many common conditions. During my general radiology training I had 
developed an interest in cross sectional imaging modalities but was aware how limited the 
data on their efficacy was in many areas of radiological practice and how rapid was the pace 
of technological advance. Perhaps unusually among radiology trainees, I had always had a 
strong interest in research and I relished an opportunity to get to grips with some of these 
technological advances such as power Doppler, MR Angiography and spiral CT 
Angiography. I was therefore fortunate to be appointed as the British Brain and Spine 
Foundation Research Fellow to the Davie Cooper Study in July 1997, which gave me the 
opportunity to do just that. 
On 23rd March 1995, Davie Cooper collapsed and died within hours of a 
subarachnoid haemorrhage (SAH). He was a previously very fit man of forty whose 
footballing skills had helped Scotland to reach two World Cup Final Competitions. The 
subsequent extensive press coverage drew considerable attention to SAH as a disease, which 
could strike without warning even in the fittest. The question was asked whether anything 
could be done to prevent it occurring? The Daily Record and the British Brain and Spine 
Foundation (BBSF) set up an appeal in conjunction with the Cooper family to raise funds for 
research into the condition, particularly as it impacts upon the Scottish population. The BBSF 
awarded a grant to the Institute of Neurosciences in Glasgow and the Dept. of Clinical 
Neurosciences in Edinburgh to pursue a combined research effort into the potential of non- 
invasive imaging tests to be used to detect aneurysms before they ruptured and the 
epidemiology of the disease within the Scottish population. 
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Abstract of Thesis: The aims of the research project, which led to the writing of this thesis were to: 
Examine whether non -invasive imaging methods could replace intra- arterial angiography (IADSA) in 
the detection of intracranial aneurysms by: a) systematically reviewing the literature; b) prospectively 
determining the accuracy of the non -invasive imaging methods currently available in Scotland, including 
the effect of observer experience on diagnostic performance and the patient acceptability of the 
alternative imaging modalities. To establish the incidence of aneurysmal subarachnoid haemorrhage 
(SAH) in families by a national retrospective study of occurrences of SAH in a one year period in 
Scotland, in parallel with a follow -up study of the families of patients who were admitted to the Institute 
of Neurosciences with aneurysmal SAH a decade earlier. The thesis is divided into three parts: 
Part One: a) summarises the current understanding of the epidemiology and pathophysiology of 
intracranial aneurysms; b) an overview of cerebrovascular anatomy with reference to aneurysm 
formation; c) the modalities available for imaging intracranial aneurysms and the current knowledge 
about their diagnostic performance are considered; d) an overview of the methods available for the 
treatment of intracranial aneurysms; e) the concept of screening for unruptured intracranial aneurysms is 
discussed and placed in context by comparison to other screening programmes. 
Part Two: a) describes a systematic review of the non -invasive imaging of intracranial aneurysms. CT 
and MR angiography had similar accuracy compared to IADSA of -90 %. Data on Transcranial Doppler 
Sonography (TCDS) were scanty but indicated poorer performance. Detection of very small aneurysms 
(<3mm diameter) was significantly poorer for the non -invasive tests; b) describes a prospective study of 
200 patients examining CTA, MRA and TCDS vs IADSA in the detection of intracranial aneurysms. 
CTA and MRA had an accuracy (per subject) of 0.85. TCDS had similar accuracy per subject but poorer 
accuracy per aneurysm than CTA or MRA. Detection of aneurysms <_5mm was significantly poorer than 
for those >5mm. Interobserver agreement was good for all modalities; c) combining TCDS with CTA or 
MRA improved the detection of aneurysms on a per subject basis. Non -invasive imaging tests, especially 
when used in combination, are reliable at detecting aneurysms >5mm; d) examines the effect of observer 
experience. Neuroradiologists were more consistent and had better agreement with IADSA than non - 
neuroradiologists. Small aneurysms and cavernous /terminal internal carotid aneurysms were poorly 
detected by all observers; e) assessment of patient preferences indicated that TCDS was preferred to the 
other non -invasive tests and CTA to MRA, with the differences being statistically significant. 
Part Three describes: a) the rationale behind the epidemiological studies; b) the methodology used; c) 
describes the results: Comparative risk for 1st vs 2nd degree relatives suffering a SAH was 2.29 for the 
Scotland wide study (SWS) and 2.43 for the West of Scotland study (WOS). Absolute lifetime SAH risk 
was 4.7% for 1st degree and 1.9% for 2nd degree relatives in the SWS compared to 4.2% and 2.3% 
respectively in the WOS. Prospective 10 -year SAH risk was 1.2% for a 1' degree and 0.5% for a 2nd 
degree relative compared to background population risk of -0.1%. The hierarchy of risk was greatest for 
a member of a family with >_ 2 other 1St degree relatives affected by SAH, with a more than 20 -fold 
increased risk over the background population risk; d) discusses the implications of the findings and 
examines the strengths and weaknesses of the study. Routine screening of families of patients who have 
had a SAH is not supported by these data; e) reviews the implications for i) clinical practice and ii) 
future research arising from the imaging and epidemiological studies. 
Publications arising so far from the work in the Thesis are included. 
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The aims of this thesis 
The purpose of the project which led to the writing of this thesis was to: 
Examine whether non -invasive imaging methods could reliably replace cerebral 
angiography in the detection of intracranial aneurysms and to determine whether more 
data were required by systematically reviewing the literature. 
Assess prospectively the accuracy and reproducibility of the non -invasive imaging 
methods currently available for the detection of intracranial aneurysms in Scotland. 
Examine the effect of observer experience on diagnostic performance. 
Determine the patient acceptability of the alternative imaging modalities. 
To establish a firm understanding of the incidence and nature of aneurysmal SAH amongst 
families where at least one individual has had a SAH in Scotland by a national 
retrospective study of admissions and deaths with SAH in a one year period and a 
longitudinal follow -up study of the families of patients who were admitted to the Institute 
of Neurosciences with aneurysmal SAH over a decade earlier. 
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My contribution to this work 
I co -wrote the ethics applications for a prospective study of non -invasive imaging of 
intracranial aneurysms (Study of Aneurysms in Glasgow and Edinburgh, SAGE) and helped 
obtain ethical approval for it in both Glasgow and Edinburgh. 
I developed the imaging protocols to be used by review of the relevant literature with 
assistance from Drs Wardlaw, Teasdale and Collie. I recruited nearly all the 200 patients for 
this study. I performed half of the more than 170 transcranial ultrasound examinations and 
personally supervised most of the CTA and MRA examinations in Glasgow and many of 
those in Edinburgh (over 325 examinations in total). I performed all the computer 
workstation image post processing and prepared all images for blinded review. I constructed 
Access databases for this study and punched all the data obtained on DSA, TCD, CTA and 
MRA studies, over 1580 datasheets in all. I also distributed patient questionnaires and 
punched the data returned from these. In conjunction with Val Easton, medical statistician, I 
analysed the results of the imaging studies. I performed a systematic review of the literature 
on the non -invasive imaging of intracranial aneurysms, obtained translations of foreign 
language papers, and in conjunction with Dr Wardlaw, analysed all the available published 
data using the methodology of the Cochrane Collaboration. I was the main author for the 
systematic review and the four other papers generated from this imaging research and 
subsequently published in peer- reviewed journals. 
I wrote the ethics applications to the Multicentre Ethics Research Committee for 
Scotland and all fifteen LRECs in Scotland to obtain ethical approval for the epidemiological 
research and prepared the questionnaire booklet and letters to be used for these studies. In 
conjunction with Professors Teasdale, Murray and Dr Wardlaw, I developed the strategy to 
be used for obtaining data for this study. In conjunction with Dr Wardlaw, I obtained 
iv 
permission from the information and statistics division (isd) of the General Registry Office to 
access their database to obtain information on all cases of subarachnoid haemorrhage in 
Scotland hospitalised in a specified 12 -month period. From the GRO I obtained permission to 
access death certification records on all cases of SAH occurring in the same period. With my 
co- researchers advice and support I organised the distribution of questionnaires and 
supervised the ongoing process of database maintenance, data collection and punching. I 
assisted in the preparation of data, its subsequent analysis and writing up. Throughout the 
project I was responsible for liaison on a day -to -day basis between the research teams in 
Glasgow and Edinburgh, liaison with the funding body, with patient groups, the media and 
the Cooper family themselves. 
I confirm that the work comprising this Thesis is either my own or undertaken as part of the 
Davie Cooper research group and my contribution to this research effort is clearly indicated 
above. A very substantial proportion ( >75 %) of the work contributing to this Thesis was 
undertaken whilst in post in South -East Scotland and that the Thesis has not been submitted 
in candidature for any other degree, postgraduate diploma or professional qualification. 
Signed 
Dr Philip M White 
. 
I. 
.. Date .Z.9Z.läK... 
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A general introduction and a description of the development of an appreciation of the 
link between aneurysms and SAH. Overview of the current state of knowledge 
regarding the epidemiology and pathophysiology of intracranial aneurysms. 
1.1.1 General Introduction 
1.1.2 Development of knowledge of the link between SAH and intracranial aneurysms 
1.1.3 Pathology, aetiology and clinical features of aneurysmal SAH 
1.1.4 The epidemiology of intracranial aneurysms and subarachnoid haemorrhage 
Prevalence and rupture rates of intracranial aneurysms 
Familial SAH and intracranial aneurysms 
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1.1.1 General Introduction 
This introductory section sets the scene for the rest of the thesis by examining the 
nature of intracranial aneurysms, the clinical problems they pose and what can be done to 
diagnose and treat them. Subarachnoid haemorrhage (SAH), due to rupture of an intracranial 
aneurysm, is a serious disorder with a high mortality and morbidity. SAH accounts for about 
one -quarter of cerebrovascular deaths and despite improvements in the management of 
patients with SAH,1 the case -fatality rate is still reported as between 25% and 50 %; with most 
patients dying as a result of the initial bleed or its immediate complications.2 Of the 
survivors, about 50% will be left disabled and dependent on others in activities of daily 
living.3 Spontaneous (i.e. non -traumatic) SAH is due to rupture of a saccular aneurysm in 
about 75% of cases, which usually arise from the Circle of Willis or a branch artery arising 
therefrom.4 
In recent years, there has been increasing interest in the possibility of detection and 
treatment of intracranial aneurysms prior to rupture. Patients are increasingly being referred 
to neurological and neurosurgical clinics, concerned that they may have an aneurysm 
themselves following a SAH in a relative. In order to offer asymptomatic subjects reasonable 
advice, it is necessary to know what their risk of having an aneurysm is, and should they have 
one what the likely risk of rupture is. How one might go about detecting such an aneurysm 
without exposing the patient to unnecessary stress or risk, and having identified an 
asymptomatic aneurysm what treatment, if any, should be offered. The risk at each stage 
must be weighed against the risk of not doing anything in that individual. This thesis 
summarises the current state of knowledge, presents original data adding significantly to the 
knowledge base and highlights where more information is needed. 
2 
1.1.2 Historical Background 
The concept that subarachnoid haemorrhage (SAH) was due to the rupture of an 
intracranial aneurysm emerged rather slowly into the medical consciousness. Apoplexy 
(stroke) has been described in the medical literature since the time of Hippocrates (400 B.C.) 
and the ancients distinguished between different forms of stroke.5 The German physician 
Johann Wepfer (1620 -1695) described a number of pathological causes of apoplexy including 
SAH. From ancient times aneurysms elsewhere in the body had been described, but it was not 
until 1778 that the first description of an intracranial aneurysm appears by Biumi (of an 
aneurysm of the intracavernous carotid).6 Morgagni was the first to describe the connection 
between intracranial aneurysms and subarachnoid haemorrhage in 1820.7 In 1861 Hutchinson 
made the first reported ante -mortem diagnosis of an intracranial aneurysm in a 40- year -old 
woman with a painful third cranial nerve palsy. When she died eleven years later of an 
unrelated illness, a post mortem examination confirmed the presence of a large 
intracavernous ICA aneurysm.8 However, it was not until the advent of cerebral angiography 
pioneered by Egas Moniz in Lisbon that the possibility of accurate diagnosis and thus the 
treatment of intracranial aneurysms became a reality. 
The development of cerebral angiography is discussed further in Chapter Three. 
Aneurysm treatment was pioneered in Edinburgh by Professor Norman Dott- see Figure 
1.1.1. Dott had treated aneurysms successfully by surgical exposure and packing of muscle 
around a ruptured aneurysm as early as 1931.9 The first reported treatment for an aneurysm 
was Hunterian ligation of the carotid by Magnus in 1927 10 and Dott also reported success 
with this technique in his seminal 1933 monograph.9 These classic cases are described in a 
poster on display in the Department of Clinical Neurosciences in the Western General 
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Hospital. Soon afterwards another step forward in aneurysm treatment was made by two 
other great pioneers of neurosurgery, Walter Dandy and Harvey Cushing when Dandy 
successfully obliterated a posterior communicating artery aneurysm by using a vascular clip 
across the aneurysm neck, a device invented by his mentor Harvey Cushing» 
4 
Figure 1.1.1 
Portrait of Professor Norman Dott hanging in the Department of Clinical 
Neurosciences Building, Western General Hospital, Edinburgh 
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1.1.3 Pathology, aetiology & clinical features of intracranial aneurysms 
Subarachnoid haemorrhage refers to the extravasation of blood into the subarachnoid 
space, which is the space between the arachnoid and pia mater meningeal layers that envelop 
the cranial contents. SAH is a condition that can be produced by a wide number of 
aetiologies. These can be divided into two broad categories, traumatic and spontaneous. The 
post -traumatic cases will not be explored further in this thesis. The most common causes of 
spontaneous SAH are: 
1. rupture of an intracranial aneurysm: causes 70 -80% of cases (nearly always due to 
saccular aneurysms) 
2. haemorrhage from an intracranial vascular malformation: 10% 
3. hypertensive intracranial haemorrhage 
4. haemorrhage from a tumour (including pituitary adenomas) 
5. bleeding diatheses: either pathological or iatrogenic 
6. cryptogenic: 6 -10 %, most of which fall into the category of non -aneurysmal 
perimesencephalic SAH. This is a syndrome of focal SAH in the prepontine, 
interpeduncular or ambient cisterns. It is probably caused by rupture of small 
perimesencephalic veins. Cerebral angiography is negative and it invariably has a benign 
course with an excellent prognosis and rarely recurs.12 
SAH from rupture of an intracranial aneurysm is not only by far the most common 
cause of a SAH but it also carries a relatively poor prognosis, particularly compared to the 
perimesencephalic subgroup. Saccular aneurysms are rounded outpouchings caused by 
dilatation of the vascular lumen due to weakness of the vessel wall- see Figure 1.1.2, and 
account for the majority of intracranial aneurysms. Microscopically, deficient collagenised 
6 
tunica muscularis protrudes through a defect in the internal elastic lamina, which together 
with the vessel wall media terminates at the neck of a saccular aneurysm. The wall of a 
saccular aneurysm therefore consists only of intima and adventitia. The aneurysm lumen 
contains varying amounts of thrombus. In longstanding aneurysms, calcification can arise in 
the wall. Fusiform aneurysms are produced by symmetrical stretching of the whole vessel 
wall- see Figure 1.1.3. The term dissecting aneurysm refers to a condition in which the wall 
of an artery splits, with blood tracking between the media and intima, but as the lumen is not 
dilated, the application of the term aneurysm is really a misnomer.13 
It was at first thought that saccular aneurysms were congenital in origin but it is now 
well recognised that they usually arise from chronic haemodynamically induced degenerative 
vascular injury.14 Saccular aneurysms are also known by the term "berry aneurysms ". Like 
many other vascular diseases, aneurysm development is a complex multifactorial process not 
completely understood. Presumably, environmental factors act upon an individual with a 
particular genetic predisposition to aneurysm formation. Repair processes within the vessel 
wall at a particular site fails and aneurysm formation results.15 In some people these stabilise 
and in others they rupture.16 Mechanical shear stresses are greatest at vessel bifurcations, 
therefore it is unsurprising that most aneurysms are found at such sites. Aneurysms are 
recognised to have an "inflow zone" at the distal aspect of the ostium and an "outflow zone" 
at the proximal ostium. Centrally there is a "slowflow zone" -see Figure 1.1.4. 
Haemodynamic forces govern the growth and progression of aneurysms and the 
haemodynamics within aneurysms and at vessel bifurcations are very complex." 
Investigators have attempted to describe them using a number of methods, including 
mathematical modelling with computerised flow simulations,]$' 
19 in vivo and in vitro animal 
models20 and elastic computer models.21' 
22 Blood flow in the body is actually non- 
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Newtonian (i.e. flow does not simply equal pressure divided by resistance) but is generally 
laminar in nature and can be adequately described by the Hagen -Poiseulle Law.23 This states 
that flow is dependent on the pressure gradient across a tube, the tube radius and the tube 
length multiplied by the fluid viscosity:- 
Flow = dP. Tr. r4 
8. n. 1 
where: dP= pressure gradient across a tube of length, 1, and of radius, r 
n= viscosity of fluid flowing through the tube 
However, at vessel bifurcations and in vessels smaller than 10011m in diameter, the 
approximation to laminar flow breaks down, flow is turbulent and the haemodynamics 
become extremely complex. In this situation none of the flow models referenced above are 
entirely satisfactory. 
There are a number of less common causes of intracranial aneurysm formation: 
1. High flow states such as arteriovenous malformations (AVM) or arteriovenous fistulae 
(AVF), which account for up to 5% of intracranial aneurysms. Most of these are 
intranidal aneurysms but they can be on the supplying vascular pedicle or at sites remote 
from the AVM- see Figure 1.1.5. These more proximal flow aneurysms occasionally 
rupture (as happened in the case depicted). 
2. Mycotic aneurysms (2.5- 4.5 %), which are usually located quite peripherally in the 
vascular tree (typically MCA branches) and not on the circle of Willis. They are actually 
pseudoaneurysms. 
3. Post -traumatic aneurysms (0.2 -1 %)- particularly affecting the intracavernous ICA and 
distal ACA adjacent to the faix cerebri. 
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4. Oncotic aneurysms (tumour related) (rare, <0.1 %), either due to tumour emboli (e.g. 
cardiac myxoma) or direct invasion. 
Approximately 90% of aneurysms are located on the anterior circulation and 10% on 
the posterior circulation usually on, or in close proximity to, the circle of Willis. An 
aneurysm in any other site should arouse the suspicion that the cause is infective or post - 
traumatic rather than the typical degenerative saccular aneurysm. 
Aneurysms are multiple in 20 -45% of patients24' 25 and some of these are bilaterally 
symmetrical, known as mirror image aneurysms. The MCA bifurcation is the commonest site 
described for mirror image aneurysms 26 - see Figure 1.1.6. Saccular aneurysms are also 
associated with a number of vascular anatomical variants that may occur around the circle of 
Willis, probably due to the alterations in flow that occur with such anomalies and these are 
detailed in chapter two. 
Several systemic disorders are also associated with an increased incidence of saccular 
intracranial aneurysms. Genetic conditions associated with SAH and intracranial aneurysms 
include adult polycystic kidney disease ( ADPKD) 27 - aneurysms occur in 10 -15% of 
ADPKD patients and recur frequently in ADPKD patients with known aneurysms, 
particularly if there is a positive family history.28 -30 Less common hereditary conditions 
associated with intracranial aneurysms include type IV Ehlers -Danlos syndrome,30 possibly 
pseudoxanthoma elasticum 31 - although a recent report refutes any association,32 hereditary 
haemorrhagic telangiectsaia,33 neurofibromatosis type I 
34' 35 and alpha 1- antitrypsin 
deficiency.36 Marfan's syndrome was thought to be associated with aneurysms but a detailed 
study of 135 patients with Marfan's syndrome (classified as such using the standard criteria) 
found no evidence of a relationship.37 The authors suggested that previous case reports 
indicating an association might have been based on a doubtful or inconclusive diagnosis of 
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Marfan's. However the average age in this large series was 21.3 years, whereas the median 
age of case reports linking Marfan's to aneurysmal SAH in the literature was 41.3 years. 
Even in association with genetic disorders, aneurysms are rare below 20 years of age. 
Predilection to aneurysm formation has also been reported sporadically in other conditions 
including Klinefelter syndrome, tuberous sclerosis, Noonan's syndrome and alpha - 
glucosidase deficiency.38 While some studies have shown a relationship between aneurysms 
and HLA -B27, HLA -DR2 39 HLA -A28 and HLA- B40,40 other studies have failed to confirm 
these associations.41' 42 
Clinical features of intracranial aneurysms and aneurysmal SAH 
Aneurysmal SAH is a disease that still has a high morbidity and mortality and it 
typically strikes people without warning in the prime of life, peak rupture rates being in the 
fifth and sixth decades. It is useful to consider the clinical presentation and management of 
the condition to set the research underlying this thesis in context. It is particularly helpful to 
define the type of aneurysm in any given clinical situation: 
1. Symptomatic aneurysms: are those causing SAH following rupture, or exerting symptoms 
by a space occupying effect (most commonly oculomotor nerve palsy produced by a 
posterior communicating artery aneurysm). 
2. Asymptomatic aneurysms: may be defined as additional aneurysms found in patients with 
a symptomatic aneurysm, which are not responsible for the clinical presentation, or those 
aneurysms found in patients investigated because they are at risk (of harbouring an 
aneurysm). 
3. Incidental aneurysms: may be defined as those found unexpectedly in patients_ undergoing 
investigation for other suspected pathology. 
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Most aneurysms do not cause symptoms unless they rupture but in certain anatomical 
locations they can present with distinctive clinical patterns. For example, posterior 
communicating artery aneurysms that are rapidly expanding may present with a painful 
oculomotor palsy, which usually does not spare the pupil (unlike an oculomotor palsy due to 
small vessel disease in diabetics). Less commonly unruptured aneurysms of the carotid 
bifurcation, posterior cerebral artery and superior cerebellar arteries may present with cranial 
nerve palsies. Large aneurysms in the cavernous sinus can present with ophthalmoplegia due 
to compression of cranial nerves within the sinus. Giant aneurysms (defined as those >2.5 cm 
in diameter) may present as mass lesions related to their anatomical location (see Figure 
1.1.7). Abducens nerve palsies can occur as a false localising sign following aneurysmal SAH 
due to raised intracranial pressure pushing the brainstem caudally, thus causing traction on 
the nerves against the petrous ridges, but abducens palsy can also be caused by direct 
compression from a posterior circulation aneurysm.43 
SAH is a medical emergency. Ruptured intracranial aneurysms present with a typical 
clinical response to meningeal irritation caused by blood in the subarachnoid space. This 
includes the sudden onset of a very severe headache (usually becoming localised with time to 
the occiput), photophobia, neck stiffness, with early nausea and vomiting. Headache occurs in 
85 -100% of patients with SAH.44 Confusion, depressed level of consciousness, restlessness 
and seizures are also common.45 Loss of consciousness occurred in 50% of patients with 
aneurysmal SAH in one study.46 Nuchal rigidity develops some 3 to 12 hours after the onset 
of a SAH but may not occur at all in patients with small amounts of blood in the 
subarachnoid space.47 Aneurysmal SAH may occur at any age but the peak is at 40 -60 years. 
Patients with SAH are graded according to clinical status using the World Federation 
of Neurosurgeons Scale.48 Grade 0 is an unruptured aneurysm; Grade 1 is a patient with mild 
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headache and unimpaired consciousness. Grade 2 is moderate to severe headache with no 
focal neurological deficit (except cranial nerve palsy) and GCS 14 or better. Grade 3 is 
drowsy, confused or with mild focal neurological deficit. Grade 4 is severe focal deficit and 
or stupor. Grade 5 is comatose, decerebrate posturing. GCS refers to the Glasgow Coma 
Score developed by Teasdale and Jennett in Glasgow.49 The main differential diagnosis of a 
severe headache with nuchal rigidity is meningitis, but in meningitis the onset of the 
headache is usually insidious rather than explosive. Aneurysmal SAH may cause sudden 
death as a result of rapid elevation of the intracranial pressure or as a result of cardiac 
arrhythmias.50 Data from community based studies indicate that 10 -15% of patients with 
aneurysmal SAH may not reach hospital alive.51' 52 Sudden death is more common with 
aneurysms in the posterior fossa whose rupture can exert direct pressure on the brain stem.53 
Headache of more gradual onset is more typically a feature of patients with non -aneurysmal 
perimesencephalic SAH.54 The suddenness rather than the severity of the headache is the 
most characteristic feature of that caused by rupture of an aneurysm. 
The altered level of consciousness that may occur in patients with SAH has a number 
of possible causes including raised intracranial pressure (frpm hydrocephalus or a large 
intracerebral haematoma), intracranial vasospasm, systemic hypotension or neurogenic 
pulmonary oedema with reduced arterial oxygenation. Up to 10% of SAH patients have a fit 
at some time following the SAH, most commonly at the onset of the SAH or soon after.55 
Strokes can occur due to vasospasm or to embolic debris. It is vasopsam with resulting 
cerebral ischaemia or infarction that is the leading cause of death or disability beyond the first 
72 hours following an aneurysmal SAH. Almost 50% of patients develop angiographic 
vasospasm with symptomatic vasospasm occurring in 32% overal1.56 Onset of cerebral 
vasospasm is typically at 3 to 5 days after the SAH, with maximal angiographic narrowing 
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seen from 5 -14 days and gradual resolution over 2 -4 weeks. Progression to cerebral infarction 
occurs in approximately 50% of symptomatic cases.57 
Up to 20% of patients with a ruptured aneurysm develop an intraocular haemorrhage 
as a result of raised pressure within the optic nerve sheath causing central retinal vein 
occlusion.58 The finding of subhyaloid intraocular haemorrhage is reported to be associated 
with a poorer outcome.59 Aneurysmal SAH is associated with a wide variety of systemic 
findings including pyrexia, hypertension, cardiac arrythmias and pulmonary oedema. The 
natural history for untreated ruptured aneurysms is that there is a 3 -4% re- bleeding risk in the 




Diagrammatic cross section of a saccular aneurysm arising at a vessel bifurcation 
Adventitia 




CT angiographie image of a fusiform aneurysm of the basilar artery 
MRA targeted MIP image of a normal basilar artery for comparison 
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Figure 1.1.4 Anatomical diagram depicting intra -aneurysmal flow dynamics 
The inflow zone is typically at the distal wall of the ostium and the outflow zone at 
the proximal aspect. A slower flow zone is often found in the central part of an 













,1it11111111N1ndpunll IpinlflAf l IIIIWl1111111III10111nirll llUl llll 
16 
Figure 1.1.5 
Flow aneurysms at basilar tip and right P1 PCA segment secondary to a high 
flow arteriovenous malformation 
One GDC coil is present in the basilar tip flow aneurysm 
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Figure 1.1.6 
Mirror image MCA bifurcation aneurysms 
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Figure 1.1.7 
CT and IADSA images demonstrating an acutely ruptured, partly thrombosed 
giant anterior communicating artery aneurysm with a heavily calcified wall 
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1.1.4 The epidemiology of intracranial aneurysms and SAH 
The epidemiology will be considered in some detail in order to place the 
epidemiological studies presented in part three in a proper context. In a recent systematic 
review incorporating eighteen studies from all regions of the globe, the overall incidence of 
SAH was 10.5 per 100,000 person years, but 6 -8 per 100,000 person years in those more 
recent studies when CT has been in common use to confirm the diagnosis.27 SAH is 
associated with physical activity but the formation of aneurysms per se is not.60 Spontaneous 
SAH occurs most commonly in subjects aged between 40 and 60 years, but can occur from 
childhood to old age. It is 1.6 times commoner in women than in men.27' 50 The risk factors 
for SAH and for having an unruptured intracranial aneurysm are very similar (see Table 
1.1.1). Smoking, hypertension, alcohol consumption (particularly binge drinking),61 cocaine 
and amphetamine abuse,62 oral contraceptive use 63 and plasma cholesterol concentration in 
the highest tertile ( >6.3 mmolll) 64 are all associated with an increased risk of aneurysm 
formation and/or SAH. 
What is the population incidence & prevalence of intracranial aneurysms? 
Incidental aneurysms are commonly found at autopsy in patients dying of unrelated 
conditions. The answer to the question "How common are unruptured aneurysms ?" depends 
on the method of case ascertainment (e.g. autopsy or angiography), whether the study is 
retro- or prospective, the population studied, and - perhaps most importantly - how hard you 
look! 
Prior to the 1970's, several autopsy studies suggested that the overall prevalence of 
unruptured aneurysms in adults was as low as 0.3 %, but was as high as 9% in studies which 
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specifically looked for aneurysms.65 Studies using angiography are confounded by the 
underlying disease for which the angiogram was done (e.g. tumour, stroke, intracranial 
haemorrhage), and the images may be suboptimal for detection of aneurysms, thereby 
underestimating frequency. Rinkel et al's systematic review of all studies (published between 
1955 and 1996) of the frequency of aneurysms, identified 23 studies including a total of 
56,304 patients.27 The majority of these (78 %) were in retrospective autopsy studies, 5% 
were in retrospective angiography studies, and 11% and 7% were in prospective autopsy and 
angiography studies respectively. The prevalence of unruptured aneurysms varied 
considerably: 0.4% and 3.6% (for retro- and prospective autopsy studies respectively), and 
3.7% and 6% (for retro- and prospective angiography studies). 
Subsequent data support the figures derived from earlier prospective studies. A recent 
prospective Japanese study of 8680 "normal" people investigated with MRA, found that 5.6% 
of men and 8.5% of women had intracranial aneurysms.66 Another Japanese study found 
that 3.4% of men and 15.4% of women (out a total of 120 patients) with ischaemic heart 
disease (but no neurological symptoms) had one or more asymptomatic aneurysms, compared 
with 2.6% and 3.6% respectively in a control group.67 A prospective autopsy study of 
unruptured intracranial aneurysms performed in East Finland found 33 incidental unruptured 
aneurysms in 29/532 patients (4.7 %) aged 30 to 70 years, of which 21 aneurysms in 18 
patients (2.9 %) were 3mm or greater in diameter. In this study only a quarter of subjects were 
female, so it may have underestimated the true prevalence of unruptured aneurysms.68 An 
important technical point to note is that the size of an aneurysm at autopsy is significantly 
less than its size in life when it is distended by transmural (arterial minus intracranial) 
pressure. Perfusion of aneurysms identified at autopsy with saline at 70mmHg increased 
aneurysm diameter by 30 to 60% and volume by up to 400 %.69 
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As mentioned earlier, 20 -25% of patients undergoing angiography following SAH are 
found to have at least one unruptured aneurysm in addition to the one which has ruptured. 
Additional aneurysms occur more commonly in females.27 Both smoking and female gender 
were important factors in the development of multiple aneurysms in the International Study 
of Unruptured Intracranial Aneurysms (ISUTA).70 Therefore it seems that 3.6% to 6.0 %, of 
the population aged over 30 harbour an unruptured aneurysm, these are commoner in females 
than in males, and increase in frequency with age; they are associated with smoking and 
alcohol consumption, possibly with hypertension, oral contraceptive use and 
hypercholesterolaemia. Clearly only a modest proportion of these aneurysms actually rupture, 
so is it possible to identify a) those at greatest risk of harbouring an aneurysm and b) which of 
those aneurysms are at greatest risk of rupture? 
What is the frequency of aneurysm rupture? 
Rinkel et al's review of the literature on the risk of rupture of aneurysms identified 
nine studies with a total of 3907 patient years of follow up,27 over half of these were 
contributed by one study from Finland.71 During follow -up, 75/495 (15.2 %) patients suffered 
a SAH, giving an annual rupture rate of 1.9% (95% CI 1.5 -2.4) - Table 1.1.2. Aneurysms 
were significantly more likely to rupture in women than in men (RR 2.1, 95% CI 1.1 -3.9). 
The risk of rupture increased with age - in the group of patients aged 60 to 79 years, RR of 
rupture was 1.7 (95% CI 0.7 - 4.0) compared with those aged 40 to 59 years, but note that the 
95% confidence intervals overlap unity (i.e. the trend to higher rupture risk in older people is 
not significant at the 5% level). Symptomatic aneurysms were significantly more likely to 
rupture than asymptomatic or incidental aneurysms (6.5% vs 0.8% vs 1.4% respectively), RR 
of 8.2. Posterior circulation and large ( >10mm) aneurysms were significantly more likely to 
rupture, RR of 4.4 and 4.0 respectively. The median time from diagnosis to rupture in the 
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study by Juvela et al was 9.6 years (mean 9.4 years, range 1.2 to 23.1 years).71 But this was 
the only study of the nine included in the systematic review to have a mean or median follow - 
up of more than nine years.27 
The initial size of the aneurysm and subsequent rupture rate is a complex issue. In 
Juvela's study, there was no disparity in the size of the aneurysm on IADSA at the start of 
follow -up between patients who later had a SAH and those who did not (median 4mm, range 
2 -25mm in those with later SAH versus median 4mm, range 2 -26mm in those without). 67% 
of the aneurysms which later ruptured were less than six mm in diameter, although the 
proportion of aneurysm ruptures increased almost constantly according to size (p= 0.03). 
Aneurysm size was not associated with the interval to rupture. In a logistic regression model, 
the only factor significantly related to aneurysm rupture was the size of the aneurysm- 7mm 
or larger aneurysms had a relative risk of rupture of 2.24 compared with smaller aneurysms.71 
Although the threshold size critical for SAH is not certain, most studies indicate minimal risk 
of rupture for asymptomatic or incidental aneurysms measuring 3mm or less.16' 72 A 
proportion of the patients in the study by Juvela et al. had a repeat angiogram during follow - 
up: in patients with later SAH, the size of the aneurysms had increased from the start of 
follow -up, whereas in those without later SAH the size did not change. In addition, in 
patients undergoing angiography during follow -up, new aneurysms were found which had 
formed during the study in 19 %, giving an approximate rate of formation of 2.2% per year. 
Some patients later suffered a SAH from these de novo aneurysms! 
The largest ever study to follow up unruptured aneurysms is the International Study of 
Unruptured Intracranial Aneurysms (ISUTA) with 2621 patients.73 This studied two groups 
of patients retrospectively: 1) patients with asymptomatic or incidental aneurysms with no 
prior SAH and 2) those with multiple aneurysms who had previously sustained an 
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aneurysmal SAH. The investigators also prospectively studied the risks of treatment of 
asymptomatic unruptured aneurysms. 
The results of the ISUTA indicate a tiny rupture risk, compared with previous 
estimates of 0.05% per annum for small aneurysms ( <10mm diameter) in patients who have 
not had a SAH previously, and of 0.5% per annum for large aneurysms and all aneurysms in 
patients who have previously sustained a SAH from another aneurysm. Of the 1449 included 
patients with 1937 unruptured saccular aneurysms >_2mm diameter, 32/1449 patients had 
confirmed aneurysm rupture during follow -up; mean duration of follow -up 8.3 years (12,023 
patient -years in total). In the cohort that had not previously had a SAH, only 1/12 aneurysmal 
ruptures occurred in an aneurysm <10mm in diameter, compared with 17/20 patients in the 
cohort who had previously had a SAH. The ISUTA also found that the only significant 
predictors of rupture were the size and location of the aneurysm: aneurysms >_10mm diameter 
had a RR of rupture of 11.6; for posterior circulation aneurysms the RR were 13.8 and 13.6 
for basilar tip and other vertebrobasilar locations respectively, and RR of 8.0 for posterior 
communicating artery aneurysms. The follow up of patients in ISUTA continued until 2001. 
There is clearly a discrepancy between the size of unruptured aneurysms in people 
with no prior history of SAH which subsequently rupture compared with the mean size of 
aneurysms discovered only after rupture in other studies ( >10mm vs 7.5- 9mm).16 It has been 
postulated that this may be explained by a propensity for aneurysms that are going to rupture 
to do so soon after they form, possibly before collagen can form in their walls in significant 
amounts (D.O. Wiebers, personal communication). However it may simply be that small 
aneurysms are so much more frequent than large aneurysms, that despite a much lower 
rupture risk, ruptures occurring in small aneurysms outnumber those from large aneurysms. 
The discrepancy in aneurysmal rupture rates between the systematic review and the ISUTA 
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requires explanation. The annual rupture rate was 0.5% (ISUTA) versus 1.4% per annum 
(Rinkel et al.) for unruptured additional aneurysms in patients with a prior history of 
aneurysmal SAH; and 0.05% (ISUTA <10mm) versus 0.8% (Rinkel et al., all sizes) per 
annum for incidental aneurysms. Although the mean follow -up in the nine studies in the 
systematic review ranged from 2.1 to 13.7 years, compared to 8.3 for the ISUTA, ISUTA 
follow -up was significantly shorter than that of Juvela et al.- 13.7 years- (which contributed 
substantially to the systematic review data). Crucially, Juvela at al found a median time to 
aneurysm rupture of 9.4 years. The ISUTA data from 1999 -2001, when published, should 
clarify whether the duration of follow -up is a significant factor in explaining this discrepancy. 
Recruitment bias may also have influenced the results. The majority of ISUTA 
patients were identified retrospectively from hospital records (1981 onwards, with the 
identification process commencing in 1992) and only survivors with persistently 
asymptomatic aneurysms, in whom a complete set of angiograms could be traced, were 
eligible for inclusion. These patients might not be entirely representative of the natural 
history of all aneurysms: e.g. subjects who had suffered a fatal episode of SAH, or where an 
asymptomatic aneurysm had been treated since 1981, or who had incomplete angiograms 
could not be included in the ISUTA. The included patients are therefore (self) selected 
survivors of SAH and the outcome of follow up of additional unruptured aneurysms in this 
group might not be completely generalizable. The patients with asymptomatic aneurysms 
identified and followed up prospectively from 1992 to 1998 provide less biased data but there 
were fewer of them and six years of follow -up is too short. Finally, one also needs to bear in 
mind the relatively small numbers of ruptured aneurysms in the studies from which the 
rupture rates were calculated (only 32 in the ISUTA and 75 in the systematic review by Rinkel 
et al.) and therefore the greater potential for the influence of chance. 
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Can we identify specific groups at higher risk of intracranial aneurysms? 
The association of SAH and aneurysms with specific genetic diseases and risk factors 
like smoking has been detailed earlier in section 1.1.3 on aetiology. SAH may affect several 
members of a family without any specific genetic "disease ". The first report of intracranial 
aneurysms affecting several members of the same family was made in 1942,74 and the 
association is now well described. Familial SAH has been defined inconsistently, including as 
"families in which two or more members have had a SAH ", which does not take account of 
the degree of relationship. Some studies of the familial incidence of SAH, included first to 
third degree relatives, and others only first and /or second degree, leading to potentially 
confusing results. Therefore it would be preferable to use a more precise definition of familial 
SAH as given below:75 
Familial SAH definition 
"Families in which two or more close blood relatives (first or second degree) have a history 
of aneurysmal SAH without any other known predisposing heritable disease." 
Note: 
First degree relatives = parents, siblings, children, half brothers and sisters 
Second degree relatives = grandparents, grandchildren, aunts & uncles, nieces & nephews 
Third degree relatives = cousins, great grandparents, great grandchildren, etc. 
Several examples of families in which numerous members are affected by SAH have 
been described in detail, and it may be that several of these badly affected families are raising 
the apparent prevalence of SAH in relatives of index patients with SAH in incidence 
studies.76 Though there is concern about the possibility of increased risk of intracranial 
26 
aneurysms in families where only one member has had a SAH, it has been suggested that 
many cases of seeming "familial intracranial aneurysms" might simply represent accidental 
aggregation.77 
ter Berg et al. calculated that if each SAH patient had on average a rather conservative 
17.5 relatives (first to third degree), and the prevalence of intracranial aneurysms in the 
general population was 1% (also probably an underestimate) and the annual rupture rate of 
aneurysms was 1 %, then each SAH patient had on the basis of chance alone, a 5.6% 
possibility of having a first- to third- degree relative also affected by SAH.77 This is 
consistent with data from a case -control study by de Braekeleer et al. in Quebec, in which 
each SAH patient was matched with controls from the same geographical population.78 The 
proportion of SAH patients with third degree relatives who had had a SAH was the same as 
the proportion in the control population (14 %). The difference occurred in the proportion of 
second degree (9.6% vs 4.6 %, SAH vs control) and first degree relatives (9.0% vs 1.9 %) also 
affected by SAH. 
So is the risk of SAH in relatives of SAH patients truly increased in all cases or just in 
occasional families? Eight studies since 1987 (Table 1.1.3) have examined the prevalence of 
unruptured aneurysms and/or SAH amongst relatives of patients with SAH. 40, 78-84 A further 
Japanese study sought family histories of SAH amongst patients self -presenting for cranial 
MRI (including MRA) though they did not sample a defined population.66 Other studies have 
described small groups of families affected by SAH but were not truly population- based.76, 85 
In the population -based studies, five were retrospective (studying families of patients who 
had had their SAH in a defined prior time period) and three prospective (studying families of 
patients presenting with SAH during the study period). Three were case -controlled and the 
others primary observational studies. Three were Scandinavian, two American, two Dutch 
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and one Canadian. Six used a hospital- admitted population of SAH patients, and two were 
community based. Three excluded patients known to have ADPKD. Five used a 
questionnaire or interview to determine the family history (which was validated only in the 
study by Bromberg et al.79) and three used centralised health data alone without contacting 
the patient or relatives at all. The studies did not include similar groups of relatives, i.e. some 
only included first, some first and second degree, some first to third degree relatives, and 
furthermore not all the studies analysed the results obtained by relationship to the index case. 
The studies where it was possible to calculate a relative risk (RR) for SAH in relatives 
compared with the background population were broadly in agreement. Schievink et al. found 
a RR for SAH of 4.14 for first degree and 1.6 for second degree;82 Bromberg et al. found a 
RR of 6.6 for first and second degree combined;79 de Braekeleer et al. found a RR of 4.7 for 
first and 2.1 for second degree 78 and Gaist et al. a RR of 2.9 overall for first degree relatives 
(4.5 for relatives of patients admitted to neurosurgical units).83 Whilst the relative risks 
appear large, it is important to bear in mind the small absolute number of relatives affected. 
Norrgard et al. found 22/1352 (1.6 %) siblings had had a SAH;40 Schievink et al. found 
11/608 (1.8 %) first degree relatives had had a SAH; and Bromberg et al. found 17/1290 (1%) 
first degree relatives had had a definite or probable SAH, Gaist et al. found 19/14781 (0.1%) 
first degree relatives had had a SAH. Therefore only 69/18031 (0.4 %) first- degree relatives 
were themselves affected by SAH in the studies from which it was possible to extract these 
data. 
Some of the differences between studies in the number of relatives with SAH per 
index case may be due to case ascertainment bias. For example in the study by Ronkainen et 
al. only two thirds of those invited to participate actually did so.81 Those who did may have 
been motivated by a positive family history, whereas the third that declined may have been 
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less interested in a disease which did not appear to affect their family. Other possible sources 
of bias include recall bias, patients missed from hospital -based studies, lack of knowledge 
about family history, failure to recognise SAH, etc. In addition, some of the studies are 
relatively small and geographically localised, so that a few families with many affected 
members amongst a large number of families with no affected relatives could raise the overall 
average considerably. Despite these methodological problems, on the evidence available so 
far, somewhere between 1% 79 and 11.4% ß0 of SAH patients will have at least one first 
degree relative with SAH and between 16% 81 and 29.8% 78 will have at least one first to third 
degree relative with SAH. Nevertheless, the very great majority of relatives of SAH patients 
will not have had an aneurysmal SAH, which implies that the prevalence of aneurysms likely 
to become symptomatic is also small. Therefore screening all relatives for aneurysms would 
necessitate examination of a very large proportion of people never likely to be affected by 
aneurysmal SAH. 
Are any particular relations more frequently affected by SAH and aneurysms? 
Most of the above studies reported detailed family trees of the families in which two 
or more subjects were affected (including the index SAH case) - Table 1.1.4. The most 
frequent relationship was index patient to sibling only (44 %), followed by index patient to 
second or third degree relative only (25 %), followed by index patient to parent (18 %). 
Overall, a parent was affected in 24% of cases i.e. in only a quarter of affected families was 
there a clear warning of the potential for SAH from a previous generation. The quarter of 
cases in which only a second or third degree relative has been affected offers an even more 
difficult target for screening as it would be difficult to know whom to screen. As siblings are 
the most frequently affected relatives (affected in 52% of cases overall), these would be the 
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obvious group of relatives to target any screening effort towards. 
Familial intracranial aneurysms are reported to have distinguishing biological 
features, including rupture on average at a younger age than non -familial (most frequently in 
the fifth decade compared to the sixth decade for sporadic SAH86), worse clinical outcome 
(after matching for age and sex with non -familial cases) and an increased prevalence of 
middle cerebral artery aneurysms.66' 79 From published case series of familial aneurysms it 
appears there may be a younger age of rupture in subsequent generations, implying possible 
anticipation.79 Familial aneurysms are also reported to have a predilection towards rupture in 
the same decade in individuals of the same family, particularly in siblings.75 Familial 
asymptomatic aneurysms are more likely to rupture in families having members with a 
history of SAH than in those without 66 - though this finding might be due at least in part to 
case ascertainment bias. 
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Summary of Part One Chapter One 
The historical background to the clinical entity of subarachnoid haemorrhage and the 
appreciation of its link to intracranial aneurysms is described. 
The pathology, aetiology, clinical features and prognosis of intracranial aneurysms and 
aneurysmal SAH are considered. 
The epidemiology of aneurysmal SAH is considered in some detail. To summarise: 
o Incidence of SAH varies between countries but is around 6 -8 per 100,000 person 
years in more recent European and North American studies. 
o Peak age is 40 -60 years. 
o Rupture risk of an aneurysm in a subject with no prior history of SAH is between 
0.05 and 0.8% per annum and the risk is cumulative. In subjects with a prior history 
of aneurysmal SAH, the rupture risk of an additional unruptured aneurysm is 
between 0.5 and 1.4 %. 
o Risk factors for SAH include smoking, female sex, hypertension, binge drinking, 
atherosclerosis /hypercholesterolaemia, oral contraceptive and several inherited 
disorders. 
o The risk of aneurysmal SAH is raised for first and second degree relatives of 
patients who have sustained an aneurysmal SAH 
o The risk is concentrated in first degree relatives, particularly siblings (Relative Risk 
in range 4 -7) 
o The absolute risk of a relative (of a SAH patient) having an aneurysmal SAH 
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ables 2 and 3 for references) 
Table 1.1.2 Summary of data on risk of aneurysmal rupture 
Rinkel et al.* ISUTA 
No. of subjects 495 1449 
No. of aneurysms - 1937 
Duration of follow -up 
(patient years) 
3907 
(mean of mean follow -ups 5.5, 
range 2.1 to 13.7 years) 
12023 
(mean follow -up 8.3 years) 
No. ruptured 75 32 
Overall rupture rate 
(expressed as % pa) 
1.9 (1.5 -2.4) 0.27 (32 in 12023 years) 
Rupture rate: <10mm 
>10mm 
0.7 (0.5 -1.0) 
4.0 (2.7 -5.8) 
0.05 
0.5 
Cumulative aneurysm rupture 
rate 
10% per decade 
(from Juvela et al) 
0.5 -5% per decade 
Symptomatic aneurysm rupture 
rate 
6.5 (4.4 -9.1) data not extractable 
Asymptomatic aneurysm 
rupture rate 
0.8 (0.4 -1.5) data not extractable 
Additional aneurysm rupture 
rate 
1.4 (0.9 -2.0) data not extractable 
Posterior circulation aneurysm 
rupture rate 
4.4 (2.7 -6.8) data not extractable 
Age: 20 -39 
40 -59 
60 -79 
0 (0 -13) 
3.5 (1.4 -7.0) 
5.7 (3.4 -9.0) 
data not extractable 
Note: *additional data to that published in the systematic review were kindly supplied by Dr Gabriel 
Rinkel to allow calculation of duration of follow -up 
The paper by Juvela et al. (1993) contributed 28% of the patients to the systematic review but almost half 
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An overview of cerebrovascular anatomy with particular reference to sites and normal 
variants predisposed to aneurysm formation 
1.2.1 Carotid artery 
1.2.2 Anterior cerebral artery 
1.2.3 Middle cerebral artery 
1.2.4 Vertebrobasilar system 
1.2.5 Typical aneurysm sites, important collateral pathways and normal variants that 
predispose to aneurysm formation or impact on their treatment 
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1.2.1 Carotid Arteries 
The arterial supply of the brain is provided by paired carotid and vertebral arteries. 
The supply can be divided into anterior (carotid) and posterior (vertebrobasilar) circulations. 
The right common carotid artery (CCA) arises from the brachiocephalic trunk, which is the 
first branch of the aortic arch, usually arising behind the centre of the manubrium sterni. The 
brachiocephalic trunk bifurcates shortly after its origin, posterior to the right sternoclavicular 
joint, into the right common carotid and right subclavian arteries. In 0.5 -1% of persons the 
right subclavian artery is aberrant, arising as the last brachiocephalic branch from the aortic 
arch. In this situation, the right CCA has a separate origin as the first vessel to arise from the 
aortic arch. The left common carotid artery is the second branch to arise from the aortic arch, 
usually behind the left sternoclavicular joint. In up to 25% of people the left CCA arises with 
or from the brachiocephalic trunk.87 The normal anatomy of the aortic arch and great vessels 
is depicted in Figure 1.2.1. The common carotid arteries ascend in a cephalic direction 
through the anterior triangle of the neck to the level of the thyroid cartilage (the cervical 
vertebrae C3 -05 level) where they bifurcate into internal (ICA) and external (ECA) carotid 
arteries. Directly caudal to the bifurcation is a dilatation of the CCA, the carotid bulb or 
sinus. The left CCA is approximately 2cm longer than the right (12cm versus 10cm). 
The internal carotid arteries 
The ICA initially lies posterolateral to the ECA then courses medially as they proceed 
cephalad. The common and internal carotid arteries are enveloped in the carotid sheath and 
give off no collateral branches in the neck. At the superior apex of the anterior triangle of the 
neck, both the ICA and ECA pass deep to the posterior belly of the digastric muscle. The 
jugular vein lies posterolaterally to them here. There are a number of important potential or 
actual anastamotic sites between the extracranial and intracranial vasculature and these are 
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discussed in section 1.2.5. Any of these may be of importance in disease states or to the 
surgeon or neurointerventionalist attempting treatment of cerebrovascular lesions. The ICA 
then courses deep to the parotid gland and styloid process to reach the base of the skull where 
it enters the petrous temporal bone just anterior to the jugular foramen. The ICA passes 
through the petrous temporal bone via the carotid canal. 
The intracalvarial ICA can be subdivided into petrous, cavernous and supraclinoid 
portions (or the intradural intracranial portion). Initially the carotid canal runs directly 
cephalad (vertically) just posterior to the Eustachian tube then curves anteriorly in front of the 
middle ear cavity becoming horizontal in orientation. Several small branches arise from the 
intracanalicular petrous ICA including the carotico -tympanic artery, the vidian artery and 
tympanic branches but these are not routinely identified on angiography. The ICA emerges 
from the carotid canal at the apex of the petrous bone and immediately crosses over foramen 
lacerum to enter the cavernous sinus. 
The cavernous portion of the ICA is further subdivided into 5 segments- see Figure 
1.2.2. In the cavernous sinus the ICA courses medially towards the posterior clinoid process 
and on reaching the posterolateral wall of the sella turcica it angles antero -inferiorly lying 
lateral to the sphenoid air sinus. On reaching the anterior sella turcica, the ICA curves sharply 
cephalad adjacent to the anterior clinoid process to pierce the dura, leaving the cavernous 
sinus and entering the subarachnoid space. The two sharp bends of the ICA within the 
cavernous sinus along with the intervening horizontal segment are also collectively known as 
the carotid siphon. The ICA runs within the floor and anterior wall of the cavernous sinus and 
is intimately related to a number of other important structures also coursing through the 
sinus:- namely the Oculomotor (III), Trochlear (IV) and Abducent (VI) cranial nerves and 
the ophthalmic (V1) and maxillary (V2) divisions of the trigeminal (V) nerve. Knowledge of 
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this segmental anatomy is important in the management of unruptured intracranial 
aneurysms, particularly whether or not they lie or may rupture intradurally. 
On entering the intradural space the ICA courses superolaterally, gives off the 
ophthalmic artery then arcs gently posteriorly as well to reach the chiasmatic cistern where it 
bifurcates into anterior (ACA) and middle cerebral (MCA) arteries. Major branches of the 
ICA occur in the cavernous and intradural segments in the following order: 
1. Meningohypophyseal trunk (not always seen at angiography) 
2. Inferolateral trunk (or lateral mainstem artery)- arises from the inferolateral aspect of the 
C3 or C4 segments of intracavernous ICA. 
3. Ophthalmic artery 
4. Superior hypohyseal trunk (usually not seen at angiography) 
5. Posterior communicating artery (PComA) 
6. Anterior choroidal artery 
Branches 3 -6 are usually intradural in origin 
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1.2.2 The anterior cerebral arteries 
The first part of the anterior cerebral artery (the Al segment) runs medially from the 
ICA bifurcation over the optic nerve toward the midline to reach the anterior communicating 
artery just superior to the optic chiasm and inferior to the interhemispheric fissure. It gives off 
many small perforating branches during its course, which are collectively known as the 
medial lenticulostriate arteries. The most important of these is the recurrent artery of Huebner 
(although in 50% of cases this arises from the A2 segment), which curves sharply back from 
its origin to supply the head of the caudate nucleus and the superomedial portion of the 
lentiform nucleus. The location of this artery is of particular importance to neurosurgeons 
attempting to clip an anterior communicating artery ( AComA) aneurysm. 
At the interhemispheric fissure, the paired ACAs approach closely and are connected 
by the anterior communicating artery. The AComA is the anterior anastamosis of the Circle 
of Willis and itself gives off multiple deep perforating arteries to the brain parenchyma. 
Willis (1621 -1675) was the first person to realise the importance of the anastamoses between 
arteries at the base of the brain as a potential collateral blood supply. The Circle of Willis is a 
potential arterial circle produced by three anastamoses between the anterior and posterior 
circulations (AComA and the paired posterior communicating arteries)- see Figure 1.2.3. 
From the anterior communicating artery complex, the paired A2 segments of the 
anterior cerebral arteries arise and course anterosuperiorly toward the genu of the corpus 
callosum. In the interhemispheric fissure the A2 segment gives off several cortical branches, 
the orbitofrontal and frontopolar arteries before bifurcating at the genu into callosomarginal 
and pericallosal arteries- see Figure 1.2.4. Figure 1.2.5 indicates the typical vascular 
territories of the ACA, MCA and PCA. 
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1.2.3 The middle cerebral arteries 
The MCA is the larger of the two terminal branches of the ICA. The first part (Ml 
segment) courses laterally from the ICA bifurcation towards the insula, paralleling the 
sphenoid wing. The M1 segment extends for 18 -26mm and gives off the lateral 
lenticulostriate arteries. These end arteries penetrate postero -superiorly deep into the brain 
substance to supply the basal ganglia and thalamus. Just distal to the origin of the lateral 
lenticulostriate arteries the MCA gives off the anterior temporal artery and makes a sharp 
curve up over the insula, known as the genu of the MCA, to enter the sylvian fissure. At the 
genu it bifurcates into its insular (M2) branches- see Figure 1.2.6. In 12% of persons the 
MCA trifurcates and it remains a single branch in 4 %.87 The M2 segments ramify into 
multiple (M3) branches as they emerge from the sylvian fissure to supply the hemispheric 
surface as the terminal cortical (M4) branches. The typical vascular territory of the MCA is 
shown in Figure 1.2.5. 
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1.2.4 The posterior circulation 
The vertebral arteries usually arise from the subclavian arteries, although the left 
vertebral artery arises directly from the aortic arch in 5% of persons. They course 
superomedially to enter the foramina tranversariae, usually of the sixth cervical vertebra. 
They then course cephalad to emerge at Cl, where they make a sharp posteromedial curve - 
grooving the posterolateral osseous ring of Cl - before turning sharply superiorly to enter the 
cranial cavity at the anterolateral margins of the foramen magnum. Anterior to the 
pontomedullary junction the paired vertebral arteries merge to form the single basilar artery 
(see Figure 1.2.3). The left vertebral artery is dominant in approximately 50% of persons, the 
right in 25% and they are of equal size in 25 %.87 There are a number of potential anastamotic 
sites between the carotid and vertebrobasilar systems (apart from the communicating arteries) 
which may help supply the posterior circulation- see section 1.2.5. 
The only major vertebral artery branch is the posterior inferior cerebellar artery 
(PICA), which usually arises from the intracranial portion of the vertebral artery (82 %), about 
13 -16mm proximal to the basilar artery; although multiple small branches including 
anastamotic vessels to the ECA circulation are given off in the neck. The size and course of 
the PICA is quite variable as it loops around the lateral medulla oblongata, superiorly over 
the cerebellar tonsils then under the medial cerebellar hemispheres. Up to 1% of vertebral 
arteries terminate as the PICA. 
The basilar artery is formed anteriorly to the pontomedullary junction by the union of 
the vertebral arteries, then it courses superiorly through the prepontine cistern to the level of 
the interpeduncular cistern where it bifurcates into the paired posterior cerebral arteries 
(PCA) -see figure 1.1.3. The basilar artery can be quite ectatic and even demonstrate fusiform 
dilatation (dolichoectasia). The major branches (all paired) of the basilar artery are: 
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1. Anterior inferior cerebellar arteries (AICA)- closely related to the sixth, seventh and 
eighth cranial nerves during its course. 
2. Multiple deep perforating branches to the brainstem 
3. Superior cerebellar arteries (SCA)- arise just proximal to the bifurcation of the basilar 
artery and run just below the third and fourth cranial nerves and just above the fifth 
cranial nerve. 
The terminal division of the basilar artery forms the posterior cerebral arteries. The 
segment of the PCA proximal to the junction with the PComA at the tentorial incisura is the 
Pl (or peduncular) segment. Multiple perforating vessels supplying the basal ganglia and 
brainstem are given off the top of the basilar artery and the Pl segments. These are also of 
great importance to the neurosurgeon or neurointerventionalist attempting to treat an 
aneurysm of the basilar tip. After the junction with the PComA, the P2 segment courses 
posteriorly in the ambient cistern between the midbrain (medial) and hippocampus (lateral). 
If a foetal type PCA is present (see section 1.2.5), the ipsilateral Pl segment is usually 
hypoplastic. Thalamo -geniculate, posterior choroidal and inferior temporal branches are 
given off the P2 segment. Distal to the ambient cistern is the P3 segment of the PCA, which 
runs through the quadrigeminal cistern and gives off branches to the posterior corpus 
callosum before dividing into its terminal cortical branches supplying the parieto- occipital 
and calcarine regions of the cerebrum- see Figure 1.2.5. 
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1.2.5 Distribution of cerebral aneurysms and anatomical variants predisposing to 
aneurysm formation plus important collateral connections between circulations 
The distribution of saccular aneurysms is as follows: anterior communicating artery 
aneurysms account for 30 -35 %, posterior communicating artery aneurysms for 25 -33 %, 
middle cerebral artery bifurcation aneurysms for 20 -25 %, terminal ICA aneurysms for 10- 
15%, basilar tip aneurysms for 5% and other vertebrobasilar aneurysms for 1 -5 %.88 Fusiform 
aneurysms most commonly involve the basilar and internal carotid arteries, they are thought 
to be atherosclerotic in origin and rarely cause SAH.88 
A number of anatomical variants are recognised to be associated with aneurysm 
formation. These include: 
1. Hypoplastic segments of the circle of Willis. Less than 20% of persons have a complete 
anastamotic circle of Willis. The most common variants are hypoplasia of one or both 
PComAs- 33 %; foetal type PCA (where the PCA arises from the ICA with associated 
hypoplasia of the ipsilateral P1 segment of the PCA) in 20 -25 %; hypoplasia of the 
AComA -15% (it is duplicated in 30 %); hypoplasia of an Al ACA segment- 10% (this 
variant is associated with an increased incidence of intracranial aneurysms.89' 9° 
2. Vascular fenestrations and duplications. The vertebral artery or basilar artery may be 
fenestrated or duplicated, which are both associated with an increased incidence of 
aneurysms.87' 91 AComA fenestration also predisposes to aneurysm formation 
3. Persistent trigeminal artery 87 
4. Azygous anterior cerebral artery 92 
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Potential anastamoses between anterior and posterior circulations: 
There are a number of these (other than the Circle of Willis) and they are relevant 
because they can influence the management of a particular intracranial aneurysm and they 
also may predispose to aneurysm formation. 
a) Embryonic Vertebral artery to ICA (from caudal to cranial): 
Proatlantal intersegmental artery 
Hypoglossal artery 
Otic artery 
Persistent trigeminal artery 
b) Vertebral artery to External Carotid Artery branches: 
Occipital artery (via muscular and radicular branches) 
Ascending pharyngeal artery (via musculospinous branches) 
Thyrocervical and costocervical branches 
c) There are also a number of anastamoses between ECA and ICA: 
Maxillary artery to ICA via 
-middle meningeal artery and temporal arteries to ophthalmic artery 
-artery of foramen rotundum and accessory meningeal artery to inferolateral trunk 
-vidian artery to petrous ICA 
Facial artery via angular branch to ophthalmic artery 
Posterior auricular artery via stylomastoid artery to ICA 
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Summary of Part One Chapter Two 
The anatomy of the cerebral arterial vasculature is described in turn for: 
o The carotid artery 
o The anterior cerebral artery 
o The middle cerebral artery 
o The vertebrobasilar system 
Aneurysm morphology and typical sites of aneurysm formation are discussed with 
particular reference to predisposing normal anatomical variants 
Potential anastamotic pathways are described for the cerebral arterial vasculature. 
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Figure 1.2.1 






VA = vertebral artery 
CCA = common carotid artery 
ECA = external carotid artery 
ICA = internal carotid artery 
RIMA = Rt internal mammary artery 
LIMA = Lt internal mammary artery 
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Rt = right 
Lt = left 
Figure 1.2.2 
Segmental anatomy of the ICA 
1= Remaining intracavernous segment 
2= Anterior genu 
3= Horizontal cavernous segment 
4= Posterior genu 
5= Ascending cavernous segment 
Ophthalmic artery 
Anterior choroidal artery 
Posterior Communicating artery 
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Figure 1.2.3 
Circle of Willis 
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ACA = anterior cerebral artery 
AcoA= anterior communicating a. 
Opth.= ophthalmic a. 
MCA= middle cerebral a. 
ICA= internal carotid a. 
PcoA= posterior communicating a. 
PCA= posterior cerebral a. 
SCA= superior cerebellar a. 
BA= basilar artery 
AICA= anterior inferior cerebellar a. 
PICA= posterior inferior cerebellar a. 
VA= vertebral a. 
ASA = anterior spinal a. 
IIIn= oculomotor nerve 
IVn= trochlear nerve 
VIn= abducens nerve 
Figure 1.2.4 
Anatomy of Anterior Cerebral Artery (lateral projection) 
A2 = A2 segment of ACA (beyond midline anterior communicating artery) 
OF = Orbitofrontal artery 
FP = Frontopolar artery 
CM = Callosomarginal artery 













































Describes the modalities available for the imaging of intracranial aneurysms, details 
how they work and summarises the current state of knowledge about their diagnostic 
performance 
1.3.1 Preface to the detection of intracranial aneurysms 
1.3.2 Intra- arterial digital subtraction angiography 
1.3.3 Computed Tomographic angiography 
1.3.4 Magnetic Resonance angiography 
1.3.5 Transcranial Doppler Sonography 
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1.3.1 Preface to the detection of intracranial aneurysms 
Doctors have been imaging aneurysms in vivo for over 70 years and there are now 
several imaging modalities that can potentially be used to detect intracranial aneurysms. 
Detailed information about the development of these imaging modalities and how each of the 
methods works is given in the sections below. The current mainstay and "reference standard" 
investigation for intracranial aneurysms is selective intra- arterial digital subtraction 
angiography (IADSA). IADSA allows not only aneurysm identification but also delineation 
of the relationship of the aneurysm to the parent vessel and penetrating branches, definition 
of the collateral circulation and identification of complications following SAH such as 
vasospasm. Due to the relatively high incidence of multiple aneurysms, pan- angiography of 
the cerebral vasculature is required when an aneurysm is suspected. Approximately 10 -15% 
of complete cerebral angiogram studies post SAH are negative but in 10 -20% of these 
patients a second angiogram will be positive (i.e. reveal a cause for the SAH). This initial 
false negative result can be due to vasospasm, thrombosis of the aneurysm, "microaneurysm" 
rupture or interpretative error. 95 So although IADSA is regarded as the reference standard, 
like all tests, it is not perfect. Due to the invasive nature of the test and its attendant risks, 
IADSA is unsuitable for use as a screening test for intracranial aneurysms on a population 
basis. 
An offshoot of digital subtraction technology was intravenous digital subtraction 
angiography (IVDSA). This utilises a bolus injection of contrast usually into a large central 
vein and then images the bolus as it passes through the arterial bed of interest. It avoids the 
risks of a direct arterial puncture and distal arterial emboli, and when the technique was first 
introduced it was hailed by enthusiasts as a major advance that would replace diagnostic 
intra- arterial angiography.94 However, in order to achieve adequate contrast in the arterial 
bed of interest from a systemic intravenous injection, a large volume of contrast is required, 
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which is a problem if multiple projections are required. The technique requires the patient to 
keep very still throughout a run, which takes considerably longer than a direct arterial 
injection as the contrast needs to first reach the heart and then the arterial bed of interest. In 
addition, the technique is unsuitable in patients with a compromised cardiac output because 
of significant dilution of the contrast bolus. Non - selective injections (arterial or venous) are 
also troubled by the problem of vessel superimposition. These problems combined with the 
poorer contrast resolution of IVDSA compared to IADSA and the limited spatial resolution 
mean that it has no real role in the diagnosis of intracranial aneurysms.95 
Hence there has been increasing interest in using non -invasive tests to detect 
aneurysms, particularly in asymptomatic individuals thought to be at an increased risk of an 
aneurysm. The non -invasive tests are safer and can be performed on an outpatient basis. 
Although larger aneurysms may be seen on standard MRI or CT imaging, special 
modifications of these techniques are necessary to reliably attempt to image intracranial 
aneurysms. At the present time the available non -invasive methods are computed 
tomographic angiography (CTA), magnetic resonance angiography (MRA) and transcranial 
Doppler ultrasound (TCDS). Examples of the type of image obtained with these techniques 
compared to IADSA are provided in Figure 1.3.1. 
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Figure 1.3.1 
Example of a large aneurysm arising from the terminal supraclinoid portion of the 
right ICA as demonstrated by DSA (a), CTA (b), MRA (c) and TCDS (d). 
56 
1.3.2 Intra- Arterial Digital Subtraction Angiography 
The reference standard for identification of an intracranial aneurysm is an intra- 
arterial digital subtraction angiogram (IADSA) performed with selective cerebral arterial 
injections and multiple projections 45 - see Figure 1.3.2. X -rays were discovered by Rontgen 
in 1895 96 and as early one month after Rontgen's historic report on his discovery, in January 
1896, an attempt at angiography had been made by Haschek and Lindethal who injected 
chalk into the arteries of an amputated hand.97 
Cerebral angiography in vivo was first performed by Egas Moniz in 1927 using the 
direct injection of strontium bromide into a surgically exposed common carotid artery under 
general anaesthesia.98 Moniz soon stopped using bromides and used iodides instead due to 
the toxicity, although sodium iodide is itself very toxic. Arteriography ideally requires a 
medium that gives good contrast, is of low viscosity (to facilitate its injection) and is of low 
toxicity. There have been considerable developments in iodine based contrast agents since the 
days of Moniz, but a detailed consideration of them is beyond the scope of this thesis. Low - 
osmolar non -ionic compounds have been developed that can be given intra- arterially without 
the need for a general anaesthetic. These compounds also contain more iodine per molecule 
so adequate radio -density can be achieved with smaller volumes of contrast. Allergic 
reactions are also much rarer with modern non -ionic agents. 
Moniz first reported visualisation of an intracranial aneurysm using this technique in 
1933.99 That same year Norman Dott in Edinburgh also described visualisation of an 
intracranial aneurysm in a 23 year old nurse with an oculomotor palsy (secondary to a 
posterior communicating artery aneurysm) using the Moniz technique.9 This angiogram is 
illustrated in Figure 1.3.3. Having confirmed the aneurysm at angiography, Dott successfully 
treated it by carotid ligation- a treatment technique first described in 1927 by Magnus.'° 
Moniz in fact included the angiograms from this pioneering case of Dott's in his seminal 
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monograph on the subject of cerebral angiography.98 Percutaneous puncture of the cerebral 
vessels was described by Lindgren in 1947,100 and the Lindgren technique was applied to the 
vertebral arteries two years later. However, cerebral angiography was an invasive and risky 
technique requiring a general anaesthetic and it was not until technical advances in catheters, 
guidewires and above all non -toxic contrast agents in the 1950s and 60s that cerebral 
angiography became a routine part of the radiologist's armamentarium. This in turn meant 
accurate localisation of an aneurysm, revealed its morphology, and greatly facilitated 
neurosurgical treatment. 
There have also been considerable advances in catheterisation techniques since 
Moniz's day. In the 1950's a Swedish radiologist, Seldinger, developed a percutaneous 
technique of femoral catheterisation which uses a long flexible catheter inserted over a 
guidewire introduced into the artery through a hollow needle ioi -see Figure 1.3.3. 
Radiologists worldwide rapidly and almost universally adopted this technique. 
Considerable improvements in catheters and guidewires have continued throughout 
the succeeding decades. Combined with other advances such as rapid cut film changers for 
angiographie equipment these meant that it became possible to obtain high quality images of 
all the principal vascular beds in the body, including the cerebral. Digital subtraction 
angiography (DSA) is a further advance and has replaced the technique of obtaining a mask 
film and manually subtracting it from the post contrast image (photographic subtraction). 
This was an effective but time consuming technique. In DSA the radiographic image is 
acquired digitally by an image intensifier rather than as an exposure onto cut film. The 
computer of the angiographie equipment can rapidly subtract a pre contrast image from the 
post contrast images, giving a real time subtracted angiographic image. Although DSA has 
slightly poorer spatial resolution than cut film angiography, this minor disadvantage is far 
outweighed in most circumstances by the advantages of subtraction. It is faster, safer and 
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more comfortable for the patient as a result. Smaller volumes of contrast and smaller 
catheters can be used due to the greater contrast resolution. The operator can see at once if the 
images obtained are satisfactory, "road- mapping" facilities are available and as with all 
digitised data, a variety of post -processing facilities are available to improve the images 
obtained and to allow quantitative and or qualitative analysis of the acquired data.94 
The cerebral angiographer must possess a good knowledge of the cerebrovascular 
anatomy and common anatomical variants in the different radiographic projections that are 
necessary for an adequate pan -angiographic study to confirm/exclude and adequately 
characterise an intracranial aneurysm (see Part One, Chapter Two). Depending on the age of 
the patient one of two main catheter types is now used for diagnostic cerebral angiography by 
most neuroradiologists, the headhunter and the sidewinder catheter- see Figure 1.3.5. In non- 
smoking patients under the age of 45 -50 a headhunter can usually be used, above this age, use 
of a sidewinder catheter - although it requires somewhat more manipulation - is more likely 
to be successful. Catheter size is usually 4 or 5 French in younger patients but typically 6 or 7 
French catheters are required in older patients to negotiate the more tortuous vessels that 
develop with increasing age. As the French size increase, the stiffness and torque of the 
catheter also increase, making it easier to negotiate tortuous vessels, but potentially 
increasing the risks of the procedure- both local at femoral artery puncture site and of 
dislodging atheromatous plaque, potentially causing a stroke or transient ischaemic attack. 
In vessels arising off a normal aortic arch, the shape of the headhunter or 
multipurpose catheters pictured in Figure 1.3.5 are suited to enter the vessel origins. But in a 
dilated unfolded arch, their shape is generally unsuitable, particularly for selecting the left 
carotid origin and the shepherds crook shape formed by the end of the sidewinder catheter is 
much better. The angiographer forms this crook after positioning the distal 15cm or so of the 
catheter in the aortic arch, then withdrawing the guidewire, followed by pushing and twisting 
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the catheter simultaneously. The tip of the crook can be manipulated into the vessel origin 
desired and then gently straightening out the crook by pulling back the catheter slowly will 
cause the tip to advance into the selected vessel in a stable position for angiography. A 
variety of guidewires may be employed for cerebral angiography but usually a standard .035 
or .038 gauge "safety J" wire suffices. Using modern IADSA equipment only 3 -4 mls of non- 
ionic low osmolar contrast are required per injection.94 
At least three radiographic projections (AP, AP oblique and lateral) are required to 
adequately examine each intracranial carotid artery, although further projections may be 
required to adequately delineate any abnormality. Two to three views (Towne's or half -axial 
and lateral ± Water's or occipitomental projections) are required for the vertebro -basilar 
system. In general, if contrast refluxes down the opposite vertebral artery (to the one being 
injected) beyond the origin of the PICA, only one vertebral artery need be catheterised and 
injected. A frame rate of 2 -3 per second and filming through to the venous phase (typically 5- 
8 seconds) are adequate in the detection and assessment of aneurysms (arteriovenous 
malformations require a faster frame rate for proper angiographic assessment). 
IADSA is still an invasive test, it requires a stay in hospital, is relatively costly for a 
diagnostic test, and carries a risk of complications including a small risk of aneurysm re- 
rupture. Other potential complications include: 
those due to the femoral arterial puncture, which are usually mild but can be serious 
(haematoma, dissection, pseudoaneurysm formation, local vascular occlusion or distal 
embolus) 
damage to a vessel wall by the catheter or guidewire tip (dissection or embolus) 
embolic stroke due to thrombus or air bubble (always serious in the cerebral circulation). 
The underlying disease, the age of the patient, the experience of the angiographer and the 
duration of the procedure influence this risk.94 
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 adverse reaction to the contrast agent (these range from mild to severe anaphylactic 
reaction and death). A particular complication of (usually hyperosmolar) contrast injected 
into the vertebral arteries is that it may induce transient cortical blindness in a small 
proportion of subjects, particularly if they are dehydrated. 
In patients with suspected atherosclerotic cerebrovascular disease, modern IADSA 
carries a risk of neurological complication between 2.5102 and 5 %.169 However, a recent 
meta -analysis of the literature indicated that the risk of a permanent neurological 
complication in SAH patients and patients with a suspected aneurysm or arteriovenous 
malformation is much lower than this at only 0.07% overall.103 The transient neurological 
deficit risk at 0.8% is identical to that described by Warnock et al. Even though the risks in 
patients who have not had a stroke /TIA are small, nevertheless cerebral angiography should 
only be performed if it is clear that the results will influence the management of a patient. 
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Figure 1.3.2 
The importance of multiple projections in cerebral angiography is 
demonstrated: a PCom artery aneurysm* is only clearly seen on the lateral and 
not on the AP and per- orbital oblique projections 
Per orbital 
LLeft lateral CCA 
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Figure 1.3.3 
Professor Norman Dott's first cerebral angiogram demonstrating a posterior 
communicating artery aneurysm in 1933 
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Figure 1.3.4 
Illustration of the double -wall puncture technique for percutaneous arterial catheterisation 
originally described by Seldinger. 
The artery is transfixed using a two -part needle. The trochar is removed and then the 
needle is re -angled and slowly withdrawn until good arterial flow is returned. A 
guidewire is passed through the needle into the vessel. The needle is then removed and a 
catheter or sheath is inserted over the wire into the artery. Most neuroradiologists now 
use a single part needle and only puncture the anterior wall of the artery. 
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Figure 1.3.5 
Examples of catheter types commonly used in diagnostic neuroangiography: 





1.3.3 Computed Tomographic Angiography 
CT Angiography as its name implies is a CT examination designed to look 
specifically at blood vessels. It requires an injection of iodine -based contrast to delineate 
blood vessels from the surrounding soft tissue. CTA is a more widely available and a more 
rapid examination technique than MRA, but has been less extensively studied than MRA in 
the detection of aneurysms. The advent of helical (or spiral) CT technology led to a renewed 
interest in its use for this purpose. Helical technology allows the acquisition of a volumetric 
data set, which markedly improves image data reconstruction techniques, and allows the 
whole area of interest to be rapidly examined during peak arterial contrast concentration. The 
published data of CTA versus IADSA indicate that helical CTA is as accurate as MRA.75 
Computed Axial Tomography was invented by Godfrey Hounsfield whilst working in 
the Central Research Laboratories of EMI Ltd. in 1972.104 He subsequently received the 
Nobel Prize for Medicine in 1979 for this discovery. It is almost impossible to overstate the 
impact that CT has had upon the neurological sciences and neurosurgery in particular. It 
completely revolutionised the diagnosis of intracranial disease and thus patient management. 
Computed tomography (CT) produces an image of a patient in cross - section, so 
internal structures can be seen unobscured by overlying tissue, of obvious and vital 
importance for imaging the brain surrounded by the bone of the skull. A CT scanner consists 
of a moveable X -ray table and a tilting scanner gantry containing an X -ray source and a 
detector array. The detectors record the attenuation values of the X -ray beam emerging from 
the patient. The image is divided into a large number of picture elements (called pixels)- the 
matrix, and the CT number for each pixel represents the average linear attenuation coefficient 
in a block of tissue (the volume element or voxel). These data are stored as digital raw data 
and turned into an image by a computer using a Fourier transfer based interpolation 
algorithm. 
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The different CT units are displayed as a grey scale image. Since the human eye can 
only detect a limited number of shades of grey, only a limited range of CT values can be 
displayed. For this reason a system of windowing is used, where the CT number range of 
interest is spread to cover the full grey scale available on the display monitor. The total range 
of values selected is the window width and the window level represents the CT numbers 
selected for the centre of the displayed range. Windowing is varied according to the structure 
being analysed. A narrow window enhances the contrast but produces a grainier image than a 
wide window. Such a window is typically used for imaging the brain whereas a wide window 
is used for imaging bony structures. 
The X -ray beam used in a CT scanner has optimised collimation, which reduces 
scatter thereby improving the ability to detect differences in X -ray linear attenuation between 
structures and hence greatly increasing contrast resolution compared to conventional 
radiography. However, spatial resolution is inferior to conventional radiography. Early CT 
scanners used a so- called translate /rotate system- see Figure 1.3.6. In this, the X -ray tube and 
detectors traverse an arc around the patient (rotate) and are then angled through a certain 
amount (translate) e.g. 1 -10° and a further traverse is made. The first EMI scanner used a 
single detector per slice and 180 steps of 1° to produce a single image taking 4 minutes to do 
so. Later scanners used a fan beam of X -rays and multiple detectors to reduce the scan time 
per image. Rapid technological advances have continued ever since and this can be 
appreciated clearly in Figure 1.3.7 comparing an early CT scanner image with a modern 
machine. The most significant advance has been the development of helical CT and as this is 
so important to the development of CT Angiography, it will be considered in greater detail. A 
typical helical CT scanner (used in the SAGE study) is illustrated in Figure 1.3.8. 
In helical or spiral CT there is continuous tube rotation (using slip -ring technology) 
with continuous movement of patient through X -ray beam. This results in the acquisition of a 
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volume of data.105 Slip ring refers to multiple sets of parallel detector rings and electrical 
components that rotate without the constraint of cables. Fixed brushes make contact with 
these multiple rings- see Figure 1.3.9. However continuous scanning requires a very high heat 
capacity tube and this was a major limiting factor until very recently. During helical CT the 
tube anode target is continually bombarded with electrons to generate X -rays. This causes an 
extreme amount of heat build up in the anode. Continuous scanning also requires massive 
computing power. Only the section sensitivity profile (SSP) and image noise of helical CT 
are any different from conventional CT (CCT), the spatial resolution in plane, uniformity, 
linearity, contrast in plane and radiation dose of helical CT are identical to CCT (at a pitch of 
1). Beam collimation can be varied as in conventional CT, however the slice width set for an 
helical acquisition is nominal rather than actual (the true slice width is a little wider than that 
set). As in CCT, beam collimation is tailored to feature of interest, image quality required and 
volume to be examined. Helical scanning inherently broadens the SSP. Put simply SSP is the 
"nominal (or effective) slice width ", or how much of the data in a "slice" actually comes from 
the slice. SSP determines spatial resolution along z -axis, it affects partial volume averaging 
and therefore image contrast. S SP is degraded as pitch increases- see Figure 1.3.10. 
Pitch is the table feed (or increment) per 360° gantry rotation divided by the nominal 
slice width (collimation) e.g.- if nominal slice width is 10mm and table feed is lOmm/s then 
pitch = 1; if nominal slice width is 5mm and table feed is lOmm/s then pitch = 2. The pitch of 
scanning can be varied by altering the table speed. Increasing the pitch does not affect image 
noise because the quantum flux at the detector array remains the same (even if the flux per 
unit area of patient is decreased by increasing the pitch!). However, beyond a pitch of 2, on a 
single slice CT scanner the SSP is too severely affected for routine clinical use.106 At a pitch 
of 1.5, there is an approximate 15% widening of the SSP. During helical acquisition an helix 
rather than a complete cylinder of data is actually obtained. The missing data from an helical 
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acquisition is "made up" by the scanner by an averaging process using adjacent acquired data 
i.e. data are interpolated. The algorithm that performs this process can use either 180° or 
360° worth of data. Most scanners now use a 180° interpolation algorithm because this has 
less effect on SSP (i.e. the nominal slice width is nearer the value actually set) than a 360° 
algorithm. A 360° algorithm slightly reduces image noise compared to CCT whereas the 180° 
algorithm slightly increases it (by factor of 1.15).107 
By using overlapping slice reconstruction in helical CT, one can retrospectively 
improve both contrast and spatial resolution, particularly along the z -axis because 
overlapping reconstruction increases data sampling along the z -axis (and hence spatial 
resolution) and maximises in -plane contrast (by decreasing partial volume averaging).107 This 
is an all too rare example of being able to have your cake and eat it! The only downside is the 
increased number of images generated and the increased time these take to reconstruct. 
Experimentally the best results are obtained using around 80% overlap but this produces too 
many images for clinical use. 30 -50% overlap is a good compromise in practice (e.g. lmm 
"slice width ", with images reconstructed at 0.5mm intervals = 50% overlap). Volumetric 
scanning guarantees the contiguity of "slices" within an acquired volume of tissue with the 
abolition of slice misregistration (as can occur with single breath hold scans). It also allows 
much improved 3- dimensional surface shaded display (S SD), Maximum Intensity Projection 
(MIP) and multiplanar reconstructions (MPR) and enables advanced post processing 
techniques such as virtual endoscopy /angioscopy and volume rendering. The dataset 
generated by all volumetric imaging methods has the advantage that it can be manipulated on 
a computer workstation to view an aneurysm from any angle and establish its relationship to 
the parent vessel. This can be a great help in the planning of surgical or endovascular 
treatment. A detailed description of these complex reconstruction methods is contained in the 
articles referenced and a brief description is given in Part Two of this thesis. 
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The advantages of helical CT outlined improve the quality of an helical CT 
angiogram compared to a CTA study performed using a conventional CT scanner. Helical CT 
allows the whole area of interest to be rapidly examined during peak arterial contrast 
concentration. To image small vessels such as the intracranial vasculature the best possible 
spatial resolution is required. Therefore a volume of data is acquired using very thin beam 
collimation (e.g. 1mm) following the rapid injection of a bolus of contrast medium 
intravenously. Typically 80 -120 mls of contrast are injected at 3 -4 ml /s into an antecubital 
vein. A sub -millimetre reconstruction interval is used to maximise the z -axis spatial 
resolution such as 0.5mm, i.e. a 50% overlap of reconstructed slices if 1mm beam collimation 
is used. 
To enable anatomical coverage of all the sites of aneurysm formation a considerable 
volume of tissue needs to be examined- some 7 -8 cm typically. This is too large a volume for 
most current single slice CT machines to examine in a single helix, which typically might be 
a 40 -60 second scan time or 4 -6cm at lmm beam collimation and a pitch of 1. To facilitate 
examination of this relatively large volume at a very narrow beam collimation on a single 
slice helical CT scanner, the pitch of the helix can be increased, typically to 1.5. Angulation 
of the gantry (and therefore the slices) along the orbitomeatal baseline (see Figure 1.3.11) can 
also help by reducing the volume that needs to be examined compared to using a straight 
gantry, typically down to 5.8- 6.4cm. Using these aids, the scan duration can be reduced to 39- 
43 seconds, within the limits of most modern helical CT scanners. 
CTA does have some disadvantages compared to MRA: it requires an injection of 
iodine based contrast. Contrast may cause allergic reactions and can cause deterioration in 
renal function in vulnerable groups. CTA is associated with radiation exposure (typically 
about 2 mSv, which is equivalent to about one years background radiation in the UK). The 
radiation dose would be a significant drawback in using CTA for community screening for 
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aneurysms, particularly if this needed to be repeated several times during an individual's 
lifetime. However, CTA is more rapid than MRA, and some patients have a contraindication 
to MRI or suffer from claustrophobia and cannot tolerate a MR examination.108 CTA has 
been less extensively studied than MRA but published data of CTA versus IADSA indicate 
that helical CTA is at least as good, if not more accurate than MRA, with overall aneurysm 
detection rates of 85 -98 %.108, 
109 Accuracy on a per patient basis (i.e. the ability to detect at 
least on aneurysm in a patient who harbours intracranial aneurysm(s)), which is more 
applicable to the screening situation, is also reported as excellent at between 0.90 and 0.95.110 
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Figure 1.3.6 
Translate/Rotate configuration of first generation CT csanners: the X -ray tube 
and detector array traverse the patient. They are then angled through 10° and 
another traverse made. This process is repeated through an 180° arc. 
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Figure 1.3.7 
Comparison of image quality from an early CT scanner (left) and a modern 
machine - both images are at the level of the midbrain 
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Figure 1.3.8 
A modern helical CT scanner as used in the SAGE study 
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Figure 1.3.9 
Helical (spiral) CT scanning- the X -ray tube moves around the patient 
continuously in a helical path 
X -ray tube 










-10 -5 0 5 10 
Slice position (mm) 
Conventional scan 
Opposed -beam interpolation (180 °) 
360- degree interpolation 
Scanning parameters 
for conventional scanning 
slice (fan beam) thickness: 5 mm 
Scanning parameters 
for helical scan 
slice (fan beam) thickness: 5 mm 
couchtop movement speed: 5 mm /rotation 
FHWM = full width (of a slice) at half maximum (tube output) 
In simple terms the SSP may be regarded as the effective slice width. The SSP is inherently 
broadened by helical scanning, even at a pitch of 1. The SSP is wider with a 360° as opposed to 
an 180° interpolation algorithm. 
The SSP is broadened further as the pitch is increased. 
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Figure 1.3.11 
Image of cerebral vasculature imposed on lateral scout view of CT angiogram 
demonstrating the advantage of an angled over a straight gantry: 
to minimise acquisition volume 
to avoid lens irradiation. 
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1.3.4 Magnetic Resonance Angiography 
The advent of MRI has meant that a more complete evaluation of intracranial 
aneurysms is possible because MRI has superb tissue contrast resolution, is multiplanar and 
can provide a direct evaluation of intra- aneurysmal thrombus and provide some information 
on its age, which IADSA and CT cannot. MRA is an evolving group of MR imaging methods 
that permit non -invasive imaging of vascular structures and are based on detecting 
differences between flowing blood and stationary background structures. Conventional MRA 
techniques do not require an injection of contrast. 
Nuclear Magnetic Resonance was discovered independently in 1946 by two groups of 
physicists, led by Bloch and Purcell respectively for which they were jointly awarded the 
Noble Prize for Physics in 1952.111' 112 Ever since then, nuclear magnetic resonance (NMR) 
has been used as a tool for the analysis of the molecular structure and properties of matter. 
However, although it was realised that NMR could be used to study the properties of human 
tissues in the laboratory it was not possible to localise the signal obtained in three - 
dimensional space and therefore to utilise NMR as an imaging tool. 
In 1973 a method for localising the NMR signal in 3- Dimensional space was 
developed 113 but it was not until 1977 that several groups produced the first images of the 
human body in vivo.114 -116 It was soon realised that NMR offered a true non -invasive 
multiplanar imaging facility of the human body without exposure to ionising radiation and 
the rest is history.117 
All MR scanners are constructed around the bore of a large magnet - see Figure 
1.3.12. The magnet can be a permanent magnet, or an electromagnet. Permanent magnets 
have to be very large to produce even a low strength magnetic field and are not a practical 
proposition for clinical imaging. High field strength is desirable to maximise the MR signal 
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obtained within a reasonable imaging time period. Electromagnets can be used to generate 
large magnetic fields (B0) by passing current along a solenoid: Bo = 2n kNI /R where N is the 
number of loops, R is the radius of the loops, I is the current and k is a constant. When the 
current is switched off so is the magnetic field. However, as Ohm's law states, current equals 
voltage /resistance and so an electromagnet can also be described as a resistive magnet. Large 
quantities of power are required to maintain the magnetic field and field inhomogeneity tends 
to be greater than in permanent magnets. Due to this power requirement, the maximum 
practicable field strength achievable is about 0.3T. However, if resistance can be decreased, a 
greater current (and hence magnetic field) can be produced for a given voltage supplied. 
Resistance depends on the material a solenoid is made of, the length and cross 
sectional area of the wire and the temperature. Some materials, called superconductors, 
exhibit virtually zero resistance below a very low temperature (usually a few Kelvin) e.g. a 
titanium niobium alloy, and hence after the initial current is supplied, power requirements are 
extremely low. Such a superconducting material is used to make the wire coils of a 
superconducting MRI scanner. A vacuum insulated cryogen bath of liquid helium surrounds 
the coils of wire and keeps them at a superconducting temperature. Using such a system, 
magnetic field strengths of 0.5 -4T can be produced in scanners suitable for clinical imaging. 
Solenoid electromagnets produce a significant stray magnetic field outside of the bore of the 
magnet (fringe field) and require shielding to prevent them interfering with a variety of 
devices. This is usually done by passive shielding using steel lining in the walls of the 
scanner room and necessitates a dedicated MRI suite separated from the rest of the hospital. 
Unsurprisingly, this type of technology is very expensive to produce, install and maintain. A 
typical modern superconducting MRI machine costs around £1,000,000 to buy and install and 
almost £400,000 per annum to staff, service and run (including capital depreciation but 
excluding the costs of employing radiologists). 
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The bore of the magnet not only incorporates the solenoid with its cooling system but 
also the gradient coils and a combined transmit receive coil, generally known as the body 
coil. This produces images over a wide field of view. In addition for images of greater spatial 
resolution, a variety of local coils may be used to image smaller parts of the body. These are 
generally receiver only coils and are closely applied to or surround the anatomy of interest 
e.g. a knee coil or a head coil. The disadvantage is that they have a much smaller field of 
view than the body coil. 
Modern MR scanners can be of an open design, which is less likely to be 
claustrophobic for the patient and can facilitate MR guided biopsy, although most open 
systems are resistive type magnets with field strengths typically in the range 0.2 -0.3T. 
Superconducting magnets with an open section in the middle allowing access to the patient 
for interventional procedures have been developed, although these are not yet in widespread 
clinical use. 
How the MRI signal is generated- the basics 
The physics surrounding MRI (as NMR was soon renamed when applied to imaging 
people!) are much more complex than those relating to CT and this is illustrated graphically 
in Figure 1.3.13. In order to appreciate how MRI and MRA work and how they can be 
manipulated in practice to improve the images obtained, it is necessary to appreciate the basic 
principles underlying MRI. 
The atom consists of a central nucleus and orbiting electrons. The nucleus consists of 
positively charged protons (the number of which equals the atomic number of an element) 
and neutrons. The sum of protons and neutrons is the atomic mass number. Simplified, it is 
only atomic nuclei with an odd number of protons that exhibit the phenomenon of nuclear 
magnetic resonance. The laws of quantum mechanics explain why only certain nuclei are MR 
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active i.e. they can interact with an applied magnetic field. As a result of having an odd 
number of protons, these atoms have a net charge and possess angular momentum due to the 
spinning of the nucleus on its own axis. We have known since the time of Michael Farraday 
about the laws of electro- magnetism, i.e. that the movement of a net charge generates a 
magnetic field or net magnetic moment (and vice versa). Therefore MR active nuclei behave 
as magnetic dipoles or small magnets (see Figure 1.3.14) and can interact with an external 
applied magnetic field. Whilst there are many MR active nuclei, it is extremely convenient 
that all biological material (including the human body) contains abundant quantities of 
hydrogen. The hydrogen nucleus consists of a single proton and because the proton is solitary 
it possesses a very large magnetic moment. 
In the absence of an applied magnetic field the magnetic moments of hydrogen nuclei 
within the body are randomly orientated, but when placed in a uniform strong magnetic field, 
the magnetic moments of the nuclei align with the applied field- see Figure 1.3.14. The 
direction of the external magnetic field conventionally defines the z -axis. The x and y axes 
are perpendicular to the z -axis as well as to each other. Some nuclei align parallel with the 
external field and a slightly smaller number align in the opposite direction (anti -parallel), this 
excess in one direction produces a net magnetic moment called the Net Magnetisation Vector 
(NMV). The relative proportions which align parallel and anti -parallel depend upon the 
strength of the external field (Bo) and the thermal energy of the nuclei (in clinical MRI, the 
temperature of the patient determines this). As field strength increases, more nuclei align 
parallel with the external field. The interaction of Bo with NMV forms the basis of MRI. The 
SI unit of magnetic flux density (field strength) is the Tesla replacing the older unit of the 
Gauss. The strength of the earths own magnetic field is 0.6 Gauss and 1 Tesla equals 10,000 
Gauss, so a 1.5T superconducting magnet generates a magnetic field 25,000 times greater 
than the Earth's. Each hydrogen nucleus that contributes to the NMV is spinning on its axis 
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but the external magnetic field produces an additional spin of the NMV around B°. This 
secondary spin is called precession- see Figure 1.3.15. The precessional spin is a circular path 
around the external field known as the precessional path and the speed at which precession 
occurs is called the precessional frequency (coo). This is determined by the Larmor equation: 
(°= k x B° where a, is the gyro magnetic ratio, which is a constant of proportionality. For 
hydrogen, k= 42.57 MHz /T. 
Resonance is the phenomenon whereby an object exposed to an external perturbation 
oscillating at, or close to, its own natural frequency can gain energy from this external force. 
If energy is delivered to hydrogen nuclei at their precise precessional frequency and at 90° to 
B°, nuclear magnetic resonance occurs. This is achieved by the application of a 
radiofrequency (RF) pulse. The energy absorption induced by NMR causes the NMV to 
change direction and move out of alignment away from B° by a certain amount, called the 
flip angle. The magnitude of the flip angle depends upon the amplitude and duration of the 
RF pulse. Typically a flip angle of 90° is employed, so that the NMV along the z -axis 
(longitudinal plane) is completely transformed into a NMV in the transverse plane at 90° to 
B°. A second result of NMR is that the magnetic moments of the hydrogen nuclei move into 
phase with each other. Phase is the position of each magnetic moment on its precessional path 
around the external field. When resonance occurs all the magnetic moments move to the 
same position on the precessional path and are then in phase- see Figure 1.3.16. Therefore as 
a result of resonance, the NMV of the hydrogen nuclei is precessing in phase at 90° to B°. If a 
receiver coil is placed in the transverse plane, as a result of electro- magnetism, a voltage is 
induced in this receiver coil when a coherent (in phase) magnetic vector cuts across the coil 
producing magnetic field fluctuations within it. This voltage constitutes the MR signal. 
The electrical signal picked up following a RF pulse is called the free induction 
decay. The magnitude and length of this depend upon the nuclear relaxation times. When a 
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RF pulse is switched off, the NMV tries to re -align with the external magnetic field but in 
order to do so the hydrogen nuclei must lose the energy given to them by NMR. The process 
by which the energy is lost is called relaxation. The amount of NMV in the longitudinal plane 
gradually increases to what it was before the RF pulse (recovery) and the transverse plane 
NMV gradually decreases (decay). As the transverse NMV decreases so obviously does the 
voltage induced in the receiver coil. It is this decrease which is called the free induction 
decay signal. Longitudinal recovery occurs by nuclei giving up their energy to the 
surrounding environment (lattice) at an exponential rate with a time constant Tl. This process 
is also known as spin lattice relaxation. Ti is the time taken for 63% of the longitudinal 
NMV to recover. 
The decay of the transverse NMV is also an exponential process governed by the time 
constant T2. This decay is caused by the magnetic fields of nuclei interacting with their 
neighbours and energy exchange results. This process is also known a spin -spin relaxation. 
T2 is the time taken for 63% of the transverse NMV to be lost- see Figure 1.3.17. As 
indicated in Figure 1.3.13, there are multiple parameters that determine the MRI signal from 
a tissue. Mobile proton density, T1 and T2 times can all differ greatly between tissues 
producing contrast between them depending upon the pulse sequences used for a MR 
examination. Images obtain contrast through the mechanisms of T1 recovery, T2 decay and 
proton density. In order to produce a detectable signal at all there must be an adequate proton 
density; hence cortical bone returns a very much lower MR signal than soft tissues. Ti 
(longitudinal magnetisation) recovery occurs more efficiently and hence more rapidly in 
tissues with less molecular mobility because the molecular spin is slower. Therefore fat has a 
much shorter Ti time than water. Again, as energy exchange is much more efficient in fat 
than water, fat has a much shorter T2 time than water. 
83 
MRI Pulse Sequences- the basics 
A sequence of RF pulses is used to generate the MR signal. This consists of one 
radiofrequency pulse followed after a predetermined time period, the Repetition Time (TR), 
by another. The TR determines the amount of longitudinal (T1) relaxation that can occur 
before the next RF excitation. The time from the application of the RF pulse to the time the 
signal in the receiver coil is sampled is known as the Echo Time (TE). The TE determines 
how much transverse (T2) relaxation has occurred before the MR signal is read. Variations in 
the timing of pulse sequences produces marked differences in tissue contrast. 
For example, tissues with a short T1 undergo longitudinal relaxation faster and so 
have a greater longitudinal NMV than long T1 tissues. Therefore short T1 tissues have more 
transverse magnetisation after a RF pulse, which determines the size of the MR signal. Image 
contrast can be altered by adjusting the TR. Short TR sequences produce T1 weighting, 
which means that tissues with a short T1 time such as fat appear bright (high MR signal). 
They do this because if the TR is short, the tissues have not fully relaxed before the next RF 
pulse and differences in the T1 times between tissues produce contrast in MR signal 
intensity- see Figure 1.3.18. This process is known as T1 weighting. 
T2 weighting is also possible and is produced by utilising a short TE. The contrast 
predominantly depends on the differences in T2 times between tissues and TE controls the 
amount of T2 decay that occurs before the signal is read. If TE is short, then the tissues have 
not had time to undergo T2 decay (dephasing) and therefore the differences in signal intensity 
between them are small; but if TE is long, full dephasing can occur and the differences 
between the tissues become much more pronounced- see Figure 1.3.18. Proton density 
weighting is always present to some extent but in order to maximise it, it is necessary to 
minimise the T1 and T2 weighting. Using a long TR to minimise T1 contrast and a short TE 
to minimise T2 contrast achieves this. 
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There is a problem with a single 90° RF pulse in that only an in phase transverse 
magnetic moment can produce a signal in the receiver coil. When the RF pulse is removed a 
free induction decay signal is produced, but dephasing due to a combination of T2 decay and 
magnetic field inhomogeneity occurs immediately, called T2* decay. This very rapid 
dephasing quickly reduces the MR signal intensity. This T2* dephasing effect can be 
compensated for by the application of an 180° RF pulse (i.e. it has sufficient energy to move 
the NMV through 180 °) to produce in phase transverse magnetisation. It works by flipping 
the individual nuclear magnetic moments so that although they are still in the transverse 
plane, the magnetic moments are rephased at a specific time after the 180° pulse. At this 
instant there is transverse magnetisation in phase and so a maximum signal is induced in the 
coil. As T2* dephasing has been reduced, the signal is greater and contains more Ti and T2 
information. The time taken to rephase after the 180° pulse equals the time taken to dephase 
when the 90° pulse was withdrawn and it is called the TAU time. The TR is the time between 
successive 90° RF pulses and the TE is twice the TAU time- see Figure 1.3.18. This 90° pulse 
followed by an 180° rephasing pulse is called a spin echo sequence and it remains the basic 
pulse sequence underlying many clinical MR examinations. 
The other basic pulse sequence in clinical MRI is the gradient echo sequence. This 
utilises a RF excitation that is variable and can flip the NMV through any angle, so not all the 
longitudinal NMV is transformed into transverse NMV. As in spin echo imaging, as soon as 
the initial RF pulse is switched off, T2* dephasing occurs. In order to generate a signal in the 
receiver coil, the magnetic moments must be rephased and this is done using a magnetic 
gradient rather than an 180° rephasing RF pulse. A coil situated within the bore of the scanner 
magnet generates this gradient, hence the eponym gradient echo. As the flip angle can be less 
than 90° and a 180° spin rephasing sequence are not required, the TR can be significantly 
reduced, hence the imaging time is much shorter. However, with this technique T2* 
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dephasing is not compensated for, so gradient echo (GE) sequences are very susceptible to 
magnetic field inhomogeneities and T2 weighted imaging can not be performed, only T2* 
weighting. T1 weighting can be achieved by increasing the flip angle and minimising TR so 
that no tissue has fully relaxed before the next RF pulse is applied and T2* effects are 
minimised by keeping TE short. 
Localisation of the MRI signal 
Gradients are alterations to Bo generated by coils of wire located within the bore of 
the magnet through which current is passed to induce a magnetic field around it. Gradient 
coils alter Bo in a linear fashion. Gradients within the main magnetic field are used to localise 
the MR signal in 3- dimensional space. First a small linear magnetic gradient is applied along 
the z -axis of the main magnetic field (Bo). This alters the precessional frequency slightly 
along Bo and enables positions along the z -axis to be related to precessional frequency, a 
process known as spatial encoding. By applying a given frequency RF pulse an axial slice of 
tissue along the z -axis can be selected, as only tissue at a particular distance along the z -axis 
magnetic gradient will resonate in response to application of that particular radiofrequency. 
This process is called slice selection- see Figure 1.3.19. Once a slice has been selected the 
signal coming from it must be located along the two remaining axes. By also applying a 
gradient along the long axis of the anatomy being imaged, a particular point along it can be 
determined from all the others by the resulting precessional frequency- see Figure 1.3.20. 
This process is called frequency encoding. The frequency encoding gradient is switched on 
when the MR signal is received. A signal must now be located along the remaining axis of 
the image, which is done by a process called phase encoding. A gradient alters the phase of 
the magnetic moments along their precessional path as well as their precessional frequency. 
This difference in phase (phase shift) along the remaining axis is used to locate their position 
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along the phase encoding gradient. However, as any of the z, x and y axis gradients can be 
used as the slice selecting gradient, slices can be selected in any anatomical plane so MR is 
truly multiplanar. As in CT, there has been rapid technological progress in the image quality 
obtained- see Figure 3.1.21. 
MR Angiography 
In order to generate a MR signal a nucleus must receive an excitation at its resonant 
frequency and rephasing must be employed to ensure that the resultant transverse NMV is 
coherent (in phase). Nuclei that are moving through a selected slice of tissue e.g. in flowing 
blood, may have exited the slice before rephasing, or have entered it after the excitatory pulse 
and therefore do not produce a signal. This is known as the time of flight (TOF) phenomenon. 
As a result of TOF, in conventional SE imaging many of the hydrogen nuclei within blood do 
not produce a signal and so blood vessels appear dark. Time of flight effects depend upon the 
velocity of flow, the slice thickness and the TE. As velocity increases the TOF effect is more 
marked because a smaller proportion of the nuclei will remain within the excited volume for 
both the excitation (90 °) and the rephasing (180 °) RF pulses. The reverse happens as velocity 
of flow decreases. These effects are known as high velocity signal loss ( +TOF effect with 
+flow velocity) and flow related enhancement (+TOF effect with +flow velocity). As the 
TE increases at a given flow velocity obviously a greater proportion of nuclei will leave the 
excited volume before the rephasing pulse and the vessel signal void is more pronounced. For 
similar reasons TOF effects are more pronounced in thin than in thick slices. 
The situation with respect to TOF effects is very different in GE imaging. In GE 
rephasing is by a gradient field applied to the whole body, i.e. the excitation pulse is slice 
specific but unlike SE imaging the rephasing component is not. Therefore any flowing 
nucleus that is excited is also rephased and produces a signal. In addition GE imaging uses a 
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very short TR and this causes saturation in tissues repeatedly exposed to RF excitatory 
pulses. So in GE imaging flowing nuclei appear to produce a greater signal than stationary 
nuclei and hence blood vessels appear bright. MRA produces a flow sensitive image rather 
than a conventional morphological image. In MRA vascular contrast is maximised by 
enhancing the signal from moving spins (i.e. flowing blood) and suppressing the signal from 
stationary spins (i.e. the background tissue). The NMV of nuclei that receive repeated RF 
pulses eventually reach an equilibrium position and are said to be saturated. Nuclei flowing 
into the slice are said to be "fresh ", as repeated RF pulses have not saturated their NMV and 
the signal they produce is different from that of the saturated stationary nuclei. This effect is 
called the in -flow effect or entry slice phenomenon because it is most prominent in the first of 
a stack of slices. Entry slice phenomena decreases if nuclei receive repeated excitations, 
which is more likely to happen as TR decreases, slice thickness increases or velocity of flow 
decreases. However, the direction of flow also has an important influence on entry slice 
phenomenon. Nuclei flowing in the same direction as the slice selection gradient (co- current 
flow) are more likely to receive repeated excitations as they move from one slice to the next 
and rapidly become saturated, so that the entry slice phenomenon declines quickly. 
The MRA method most commonly employed in clinical MR imaging at present is 
TOF MRA but alternative methods are available including Phase Contrast MRA, velocity 
encoding techniques and newer methods such as contrast enhanced MRA ± subtraction have 
increasingly been advocated in the last couple of years. As it is the standard MRA sequence, 
TOF -MRA was used in the SAGE study. The technical aspects of TOF -MRA are considered 
in more detail below. 
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TOF -MRA 
This produces vascular contrast by manipulating the longitudinal NMV of stationary 
nuclei. It utilises a GE pulse sequence with gradient moment rephasing to enhance the signal 
from flowing nuclei. Gradient moment rephasing is a velocity compensation technique and 
uses additional gradients to compensate for the alterations in phase induced by the gradient 
fields in nuclei flowing along a magnetic gradient. Due to the extra gradient tasks that 
gradient moment rephasing engenders, the minimum TE is increased. Another of the 
weakness of the technique is that it assumes a constant flow velocity across the gradient at all 
times and in areas of pulsatile or turbulent flow this does not hold true. 
A GE pulse with a short TR is used for TOF -MRA so that Ti recovery is prevented 
and thus the signal from stationary spins is saturated. TOF -MRA can be acquired either slice 
by slice (2D) or as a volume (3D). Thus in a TOF -MRA sequence the TR, TE and flip angle 
are chosen to maximise signal from flowing nuclei and minimise that from stationary nuclei 
and therefore TOF -MRA depicts flowing tissue as bright and stationary tissue as dark on a 
grey scale image. It is most sensitive to nuclei flowing perpendicularly to the slice because 
flow in this direction exhibits the maximum flow related enhancement and entry slice 
phenomenon. For similar reasons fast flow is detected better than slow flow. To more clearly 
depict signals from arterial flow it is advisable to use pre- saturation pulses in the direction of 
venous flow, which saturate the NMV in the nuclei in venous blood before they enter the 
slice and therefore the signal from veins is suppressed. 
If the TR is too short the signal from the flowing nuclei will also be suppressed, so 
despite trying to saturate all the nuclei in stationary tissues, those with very short Ti 
relaxation times may relax completely and thus produce a signal on a TOF -MRA image. 
Such tissues include fat, methaemoglobin and tissues with Gadolinium present. However if 
the TR is too short the signal from the flowing nuclei will also be suppressed. This short Tl 
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effect can be compensated for by various methods. One of the most commonly employed by 
MR equipment manufacturers is to add a further background suppression technique to the 
TOF -MRA pulse sequence- such as fat suppression pulses. These pulses selectively saturate 
bound protons, found particularly in macro -molecules (e.g. in long chain fatty acids), and 
increase the Ti contrast between flowing and stationary tissue. A further development is 
magnetisation transfer suppression (MTS) which not only suppresses the background signal 
but also suppresses the saturation occurring in small blood vessels where the flow tends to be 
slower, and therefore enhances the signal obtained from small vessels. Whilst MTS and 
similar techniques work mainly by suppressing unwanted background signal thereby 
maximising contrast, a different kind of pulse can also be employed to maximise the signal 
from flowing blood. A ramped pulse is applied to compensate for the progressive saturation 
occurring as nuclei move through a 3D- imaging slab. An example of this type of pulse is the 
tilted optimised non -saturating excitation (TONE). Both MTS and TONE were incorporated 
into the 3D TOF -MRA sequence utilised for the SAGE study. 
3D TOF was used instead of 2D because it offers a high signal to noise ratio (SNR) 
and thin contiguous slices maximise the spatial resolution. In 3D there is more chance of 
saturating the signal from nuclei within the volume but this is more of a problem in areas of 
slower flow velocity such as the carotid arteries and the venous system. The intra- cranial 
arterial vasculature is a high velocity bed where due to the small size of the vessels, high 
spatial resolution and SNR are desirable. 
Although one can compensate for some of the problems inherent in the TOF -MRA 
sequence as outlined, it is difficult to compensate for turbulent flow. The gradient moment 
rephasing technique ceases to work as effectively in areas where there is loss of laminar flow 
such as at branching points or other causes of turbulence such as vascular stenoses or other 
abnormalities, including aneurysms. Apart from good spatial resolution, 3D TOF -MRA has 
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the advantages of reduced sensitivity to involuntary motion and an acceptable imaging time 
of approximately 6 -12 minutes. 
A MIP reconstruction technique was used to display the 3D -TOF MRA data as an 
angiographic image. This reformatting method was considered earlier in the section on CTA. 
For the SAGE study, base axial images from the 3D TOF slab were reviewed as well as MIP 
images. Whenever practicable fast spin echo images were also obtained. 
Safety issues in MRI 
There are a number of potential hazards associated with MRI. Firstly there are the 
risks associated with the main magnetic field. Secondly there are the effects of rapidly 
fluctuating gradient magnetic fields to consider and there are also potential effects from 
repeated electromagnetic radiofrequency pulses. Finally there are a number of additional 
safety considerations including MR examination during pregnancy, examining patients with 
prosthetic or other implants and the impact of acoustic noise. 
The main magnetic field: reassuringly, there are no data suggesting any significant 
biological effect in humans in vivo exposed to magnetic field strengths of <2T. The main 
safety concern regarding the static magnetic field is that of the fringe field. This needs to be 
calculated in advance of installation, with shielding employed as necessary and warning signs 
posted. These precautions are mandatory to prevent persons with ferromagnetic or other 
susceptible implants coming so close to a significant static field that they may suffer harm as 
a consequence and to prevent ferromagnetic objects coming so close to the field that they are 
converted into potentially dangerous projectiles. Cells undergoing division are more 
susceptible to interaction with electromagnetic fields and therefore there is a theoretical risk 
from exposing a foetus to MRI, particularly during the first trimester of pregnancy. The 
National Radiological Protection Board (NRPB) therefore advises that MRI should not be 
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performed during the first trimester unless alternative imaging methods using ionising 
radiation (with a known and quantifiable risk) would be employed instead. 
Gradient magnetic fields: these produce time varying magnetic fields as they are 
switched on and off These can induce currents within the body. Fortunately in practice these 
effects, if any occur, tend to be mild and self -limiting. Advisory limits have been set by the 
US Food and Drug Administration limiting the gradient field to 6T /s for all gradients, the 
axial gradient field to 20T /s and gradient rise times to 120ms. 
Radiofrequency fields: these electromagnetic fields are much lower in energy than 
X -rays, microwaves or even visible light. They therefore do not cause ionisation. The main 
concern is the potential heating of tissues during a lengthy MR examination. The ability of a 
patient to dissipate this heat is described in terms of the Specific Absorption Rate (SAR). 
Recommended SAR limits have been set to keep thermal effects to a safe level, in the UK it 
is recommended that core temperature should not increase by >1°C during the MR 
examination. 
Acoustic Noise: as currents pass through the gradient coils a significant amount of 
noise is generated. Whilst most commercial systems operate within recommended noise 
levels, it is good practice to employ ear plugs or other ear defenders to prevent transient 
effects or even irreversible effects in patients who are particularly susceptible. 
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Figure 1.3.12 
Siemens Magnetom SP 1.5T MR1 scanner used in the SAGE study 
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Figure 1.3.13 
Comparison of parameters influencing increased complexity of physics of MRI 
compared to CT 
CT 




C.T. Image depends only on X -ray absorption 
IMAGE PARAMETERS PULSE SEQUENCE 
Tissue ' - anatomy p PS & SR - signal 
physiology T, SE intensity 
biochemistry T, IR 
pathology b other sequences 
MRI 
Symbol legend 







At least 10 parameters can influence production of the MR: 
p = proton density 
8 = chemical shift 
x = susceptibility 
T1 = T1 in rotating frame 
rf = radiofrequency (absorption) 
diffusion 
perfusion 
T1 and T2 
flow 
As well as the image parameters, the pulse sequence selected also has an important effect on 
the final MR image 
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Figure 1.3.14 
Diagram illustrating that the nuclei of atoms behave as magnetic dipoles and 
align with an applied external magnetic field 
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Illustration of the phenomenon of "precession" in an hydrogen atom exposed to 














of the nucleus 
Figure 1.3.16 
Effect of resonance resulting from an applied radiofrequency pulse on the 
precessional paths of hydrogen nuclei 
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Proton Relaxation in MR: a) T1 recovery (of longitudinal magnetisation) 
b) T2 decay (of transverse magnetisation) 
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a) Selection of appropriate pulse sequence to obtain T1 weighting: the repetition 
time (TR) controls the amount of T1 weighting- the TR needs to be short to 
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b) Selection of appropriate pulse sequence to obtain T2 weighting: the echo time 
(TE) controls the amount of T2 weighting- the TE needs to be long to 
demonstrate differences in the transverse relaxation time (T2) between tissues. 
signal 
intensity 
small contrast difference 
between fat and water / 
I 




short T2 (fat) 
TE (ms) short TE 
I large contrast 
I difference 
between fat 





Slice selection: the application of a gradient field in combination with a specific 
frequency RF pulse to select a slice of tissue 
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RF at 63.76MHz 









RF at 63.86MHz 




Spatial encoding of the MR! signal 
a) Frequency encoding: a further gradient is applied along the long axis of the 
slice. This produces a linear shift in the precessional frequency along the axis of 
















b) Phase encoding: this is used to locate the signal returned along the remaining 
(third) axis of the image. The phase encoding gradient applied along the 
remaining axis alters the precessional frequency and hence the accumulated 
phase of the magnetic moments- 
14,998G 
63.852 MHz lose phase 









If the slice selection is along the x axis (e.g. for an axial slice), by using the frequency 
encoding gradient along the long (z) axis of that slice and the phase encoding gradient 
along the y axis, the location of any signal returned from that slice can be localised in 
three- dimensional space i.e. spatially encoded. 
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Figure 1.3.21 
Comparison of image quality between an early MRI scanner (1989) and a modern 
machine (1999): T1 sagittal midline images 
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1.3.5 Transcranial Doppler Ultrasound 
Since its invention as a clinical imaging tool,118' 119 ultrasound has become well 
established as a method of imaging soft tissues and more recently vascular structures using 
imaging methods based on the Doppler principle. It is relatively cheap by comparison with 
CT and MRI and readily acceptable to patients. It can be brought to the bedside if necessary. 
However, ultrasound is limited by its inability to cross soft tissue -gas or soft tissue -bone 
interfaces and bony structures cannot be imaged. Unlike CT or MRI, ultrasound is very 
operator dependent in the results obtained. 
Principles of Diagnostic Ultrasound 
A sound wave can be produced by placing a vibrating source in contact with a 
medium, causing particles in the medium to vibrate, and propagating the pressure (sound) 
wave away from the source. Ultrasound for clinical imaging is generated using the 
piezoelectric effect and ultrasound is defined as sound waves with a frequency of >20 KHz. 
The piezoelectric effect is the change in physical dimensions of a substance produced by an 
electric field (and vice versa). If the electric field is applied in an intermittent or pulsed 
manner, vibration of the substance results, which produces an ultrasound wave. The 
piezoelectric effect is dependent upon a geometric alignment of atoms within a substance and 
it is the disturbance of this alignment by an electric field that produces the piezoelectric 
effect. Certain substances exhibit the piezoelectric effect much more strongly e.g. lead 
zirconate titanate or barium titanate and many plastics. Each substance has a resonant 
frequency and if it is made to vibrate at this frequency, the generated sound wave is much 
greater. The velocity of transmission of sound through a medium depends upon the 
compressibility and density of the medium. 
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A piezoelectric crystal housed in a transducer generates the ultrasound beam. This 
comprises a thin crystal layer with electrodes plated onto either side, the voltage produced 
between them produces an electric field that causes the crystal to vibrate and produce the 
ultrasound beam. The number of oscillations per second determines the frequency of the 
sound wave. The shape of the transducer is chosen so that the sound beam is formed with a 
well- defined direction and can be focused- see Figure 1.3.22. 
Unlike electromagnetic radiation, sound is a longitudinal waveform requiring a 
medium for its transmission. Therefore a coupling agent (ultrasound gel) must be used 
between the transducer surface and the skin of the patient to ensure adequate transmission of 
the ultrasound beam into the patient. By transmitting pulses of ultrasound into the body, and 
detecting the echoes returned to the transducer, an ultrasound image can be generated. Echoes 
arise because whenever an ultrasound beam is incident upon an interface of two tissues with a 
different acoustic property, part of the beam is transmitted but part is reflected back. The 
amplitude of the reflected wave is proportional to the degree of difference in acoustic 
properties between the tissues forming the interface, which is described by the acoustic 
impedance (Z). 
The echo signals are amplified and converted into a series of dots on a display screen. 
The brightness of the dot is proportional to the echo strength and the position on the display 
corresponds to its anatomical location. This is calculated from the beam angle and the precise 
time between the ultrasound pulse and the return of the echo. As the sound beam is swept 
rapidly through the area of interest by the transducer, a 2- dimensional image is produced in 
real -time, called a B -mode image - see Figure 1.3.23. 
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Doppler Sonography 
Doppler sonography is the standard technique used to image vascular structures with 
ultrasound. It is based upon the Doppler effect, first described by Christian Doppler in Prague 
in 1842 from his observations on the colour shifts observed in relation to light from the 
stars.120 The Doppler effect is the change in frequency of a waveform whenever there is 
relative motion between the source and the detector. This frequency shift is described by the 
Doppler equation: 
Af= fr-fo =2fo.v. cosa.2 
c 
Where: Af = frequency shift (Hz) 
fo = transmitted frequency 
fr = reflected frequency 
v = velocity of moving object (m/s) 
a = insonation angle (angle between source and detector) 
c = propagation velocity in the medium (m/s) 
If the source is moving towards the detector, then fr is greater than fo and the Doppler 
shift is positive. In clinical imaging the Doppler shift is employed to detect objects that are 
moving relative to the stationary transducer, in practice that is the red blood cells in the 
arteries and veins. Fortuitously, for the typical operating parameters found in the examination 
of blood flow in vivo, the Doppler shift frequency is in the audible range of the human ear. 
Ultrasound can be emitted continuously or as a series of pulsed emissions producing 
continuous wave (CW) and pulsed wave (PW) Doppler sonography respectively. In PW 
Doppler sonography the transducer acts as both a transmitter and receiver and the time 
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between sending and receiving the ultrasound signal indicates the depth of the received echo 
signal. In order to maximise the Doppler shift it is necessary for the insonation angle to be 
much less than 90° (because cos 90 °= 0). In practice 300-45° is an ideal compromise between 
the need to detect reflected echoes to produce a B -mode image and the need to maximise the 
Doppler shift. 
The combination of a real -time B -mode ultrasound machine with integral Doppler 
capability is known as Duplex ultrasound and it allows areas where flow is to be examined to 
be accurately localised on the B -mode image.12' Using the Doppler equation, if the angle of 
insonation is known and assuming the velocity of sound in soft tissue to be constant at 1540 
m/s, the velocity of flowing blood can be readily calculated. The transmission rate of 
ultrasound pulses is known as the pulse repetition frequency (PRF). The information from 
PW Doppler is presented as a Doppler spectrum where the temporal distribution of velocities 
is directly visible as the waveform and the amplitudes of the Doppler frequencies are 
displayed within this on a colour or gray scale- see Figure 1.3.24. The disadvantage of PW 
Doppler is that the PRF limits the highest measurable Doppler shift and therefore the 
maximum measurable flow velocity. This frequency is half the PRF and is known as the 
Nyquist frequency. If the Doppler frequency exceeds the Nyquist frequency then the peaks of 
the spectral curves of the Doppler spectrum are cut off and displayed beneath the baseline. 
This misleadingly indicates apparently reversed flow direction. This phenomenon is termed 
aliasing. 
The ability of Duplex Doppler to accurately locate a vascular structure, delineate the 
direction of flow (from the Doppler shift) and determine the flow velocity in real -time, 
completely non -invasively, has proven to be a very powerful clinical tool. Colour coded 
duplex is a more recent development of Duplex sonography. This technique allows flow to be 
sampled in an entire vessel section rather than from a small pre -defined sample volume. The 
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information obtained is displayed as a colour image superimposed on the gray scale B -mode 
image and contains information on flow direction and velocity. By convention, flow towards 
the transducer is depicted as shades of red and flow away from the transducer as blue. The 
colour shade is related to the mean flow velocity. The lighter the shade depicted the higher 
the mean flow velocity- see Figure 1.3.25. In order that data can be processed from many 
sample volumes to produce real -time colour coded images, most ultrasound systems use 
fewer scan lines for colour coding than for production of a B -mode image. The intervening 
values are extrapolated. The usual method of colour coding employed is based on an analysis 
of the phase of the Doppler shift of echoes backscattered from the moving erythrocytes called 
autocorrelation.122 
A further derivation of this technique is power Doppler or colour Doppler energy 
(CDE). In CDE blood flow is imaged by the colour coding of the Doppler spectrum 
amplitudes rather than the Doppler shift. This is much less dependent upon the angle of 
insonation so CDE detects flow, particularly at lower velocities more readily than colour flow 
imaging. However, CDE does not provide information on the direction of flow. Colour shade 
relates to the energy of the reflected echo- see Figure 1.3.26. CDE was used as the Doppler 
imaging method for the SAGE prospective study of non -invasive imaging methods for 
intracranial aneurysms. 
Transcranial Ultrasound (TCUS) 
B -mode imaging of the cerebral parenchyma was developed in the late1970s but was 
only possible in infants with open fontanelles to provide an acoustic window.123 Attenuation 
of an ultrasound beam increases as frequency increases and this combined with the high 
acoustic impedance of bone prevented the use of TCUS in adults at frequencies providing 
adequate spatial resolution (due to a shorter wavelength, higher frequency US has greater 
107 
spatial resolution). The use of ultrasound to assess the extracranial cerebral vessels was first 
reported in 1965 by Miyazaki and Kato.124 However, it was not until 1982 that Rune Aaslid 
developed a system for Transcranial Doppler Sonography that allowed accurate measurement 
of flow velocities in the basal vessels comprising the Circle of Willis.125 This system utilised 
a 2MHz pulsed wave transducer and the temporal bone window. The relatively low frequency 
allowed the beam to penetrate the thinner skull of the squamous temporal bone and insonate 
the basal cerebral vessels successfully. Alternative acoustic windows include the transorbital, 
submandibular and suboccipital approaches. 
One of the major problems encountered with Transcranial Doppler Ultrasound (TCD) 
was that of differentiating between individual vessels. Due to the lack of orientating 
structures usually only the middle cerebral artery could be determined with any 
confidence.126 However, the introduction of newer, higher resolution ultrasound systems 
combined with colour- coding techniques has enabled the flow in intracranial vessels to be 
visualised and also their anatomical location and course.127 With direct visualisation of the 
vessels, more accurate angle -corrected measurements of flow velocities can be performed. 
This significantly expanded the clinical applications of TCD.126 
Once colour transcranial Doppler ultrasound became available in the early 1990s, 
with apparent success quickly reported in the identification of aneurysms.128' 
129 In adults, the 
thin part of the squamous temporal bone, the foramen magnum and the orbits are the potential 
acoustic windows for insonation of the intracranial contents, including the cerebral 
vasculature. Ultrasound has the advantage of significantly lower capital cost and greater 
mobility compared to IADSA, CTA and MRA. The recent technological development of 
Colour Doppler Energy (CDE), also known as Power Doppler, offers significantly greater 
sensitivity to flowing blood than standard colour flow imaging.l3° Using this technique, 
overall sensitivity for detection of aneurysms of 80% has been reported in patients harbouring 
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aneurysm(s) who had an adequate temporal bone window and specificity in this study was 
87.5 %.13° Unfortunately about 10% of patients will not have an adequate temporal bone 
window and the technique is very operator dependent. Recently developed ultrasonic 
contrast agents and 3 -D ultrasound imaging may improve accuracy further.131 
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Figure 1.3.22 
Orthogonal ultrasound beam focusing to reduce beam width in the focal region, 
thus improving contrast and spatial resolution and reducing slice thickness 
L = cylindrical lens along the face of a linear array used to focus ultrasound beam 
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Figure 1.3.23 
Transcranial Ultrasound anatomy in B -mode (top) at the level of the midbrain 
with T2 axial MRI (bottom) at the same level for comparison 
Figure 1.3.24 




Colour flow Doppler image of the carotid bifurcation 
Flow away from the transducer is conventionally depicted as red. The small blue area 
in the external carotid artery is a normal finding. It represents either a boundary -layer 
separation phenomenon or normally occurring flow reversal around the bulb. 
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Figure 1.3.26 
Colour Doppler Energy image of a terminal carotid a eurysm (a) and 
turbulent waveform in an aneurysm on Pulsed . ve Doppler (b) 
a) 
b) 
ACA ICA MCA 
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Summary of Part One Chapter Three 
The development of cerebral angiography of the cerebral vasculature is described along 
with the attendant risks. 
The technique of modern IADSA is described 
The development of computed tomography (CT) and CTA are considered and the 
technique used for CTA is described. 
The development of magnetic resonance imaging and thence MR angiography is 
described including a brief consideration of the physics behind MRI and MRA to place 
the subsequent research in context. 
Safety issues in MRI are briefly discussed 
The development and principles of diagnostic ultrasound including Doppler, colour flow 
and power ultrasound imaging are described. 




Provides an overview of the methods available for the treatment of intracranial 
aneurysms, helping to place the research in parts two and three in a clinical context 
1.4.1 Introduction to treatment options 
1.4.2 Neurosurgical treatment and outcomes 
1.4.3 Endovascular treatment and outcomes 
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1.4.1 Treatment options for intracranial aneurysms 
Aneurysms may be treated by neurosurgical clipping (or wrapping) or by 
interventional endovascular techniques. The most compelling indication for the treatment of 
an intracranial aneurysm is when it has recently ruptured due to the devastating natural 
history of aneurysmal SAH, with up to 60% mortality at 6 months reported.132 The main 
exclusions from surgery are patients in a poor clinical grade (WFNS Grade 4 or 5) or a 
patient who is too high an anaesthetic risk.133 The aim of surgical intervention is optimal 
exposure of the aneurysm with minimal trauma to the surrounding structures, followed by 
exclusion of the aneurysm from the circulation by application of a clip across the neck of the 
aneurysm- see Figure 1.4.1. Once the operator is satisfied that the aneurysm sac is fully 
excluded from the circulation, the dome of the aneurysm may be punctured. An operating 
microscope is used for the surgical dissection following craniotomy. The precise surgical 
approach used depends upon the site, size and orientation of the aneurysm. In such 
technically demanding microsurgical cases there are a host of pitfalls that may adversely 
affect outcome,133 and a full consideration of them is beyond the scope of this thesis. 
In the past decade neuroendovascular techniques have emerged as a viable alternative 
treatment to microsurgical clipping of intracranial aneurysms. Endovascular techniques offer 
a less invasive means of early intervention with the potential for further treatments or 
aggressive treatment of vasospasm as necessary. Currently interventional endovascular 
treatment would usually be with Guigliemi detachable coils (GDC), which were introduced in 
1991 and revolutionised the endovascular treatment of intracranial aneurysms 134 see Figure 
1.4.2. Prior to this advance neuroradiologists had attempted treatment with deconstructive 
techniques such as permanent balloon or coil occlusion of the parent vessel from which an 
aneurysm arises, which in selected patients can be highly effective.136 Detachable microcoils 
dramatically improved the accuracy of coil positioning, allowed retrieval as necessary and 
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thus greatly increased the safety of this approach. An electrolytic connection (of Teflon 
laminated solder) between the fine platinum coil strand and the delivering microguidewire 
allows detachment only when the operator is satisfied with the position of the coil. 
Detachment is achieved by passage of a direct electric current of 1 -2 mA for Y2 -2 minutes. 
Are there other worthwhile interventions? 
Apart from direct treatment of an unruptured aneurysm, it is likely that there are other 
ways of reducing the risk of rupture, which collectively could have a useful effect. Cessation 
of smoking, careful control of blood pressure, avoidance of risk factors for atherosclerosis 
(careful diet, regular exercise etc.), while unproven, may help reduce both the risk of 
formation of aneurysms and the risk of rupture, as well as improving general health.75 
Avoidance of anticoagulant (and possibly antithrombotic) drugs in patients known to harbour 
an unruptured aneurysm may reduce the risk of a poor outcome should the aneurysm rupture. 
There is evidence for a worse outcome of aneurysmal SAH in patients on anticoagulants (at 
least a doubling of the mortality rate),136 but less evidence for patients on aspirin. With the 
widespread use of aspirin, there must be a reasonable proportion of patients who happen to 
rupture an aneurysm while on aspirin and the prolonged bleeding time in patients on aspirin 
or other NSAID might theoretically result in a similar poor outcome to that found with 
anticoagulant drugs. However a study on this subject has not confirmed the hypothesis. In 
fact Juvela found that the use of NSAIDs preceding aneurysmal SAH did not significantly 
affect outcome, and that NSAIDs taken after the SAH might actually reduce the risk of 
secondary ischaemic events.137 
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1.4.2 Neurosurgical treatment and outcomes 
The timing of microsurgical clipping has remained a controversial area for many 
years and in fact there are even no randomised data comparing surgical clipping with 
controls. There are a number of theoretical benefits from early neurosurgical treatment. 
Firstly, the risk of rebleeding is eliminated; secondly the subarachnoid cisterns can be cleared 
of clot, which may reduce the incidence of symptomatic vasospasm and thirdly, aggressive 
therapy for vasospasm can be given (if it should occur) with hypervolaemia, hypertension and 
haemodilution (`triple H" therapy).133,138 A large -scale non -randomised observational study, 
the International Cooperative Study on the Timing of Aneurysm Surgery, failed to fully 
resolve the controversy regarding the timing of surgery. Overall, in a series of 3521 patients, 
there was no difference in the surgical results between the group that underwent early surgery 
(days 0 -3) and those that underwent late surgery (11- 14).86 However, in good grade patients 
(Grades 1 -3) significantly better results were seen in the early surgery group. Due to the 
unacceptable risks of vasospasm, most surgeons do not operate between days 4 and 11 post 
SAH. 
Surgical treatment, having been in use routinely for over 40 years, has fairly clearly 
defined risks and morbidity. Overall, 69% of the survivors of aneurysmal SAH who have 
undergone surgical clipping return to their approximate pre -morbid functional status by 6 
months.86 However, it is clear that many studies have not fully assessed higher mental 
function or psychomotor status when claiming this result. Many have not had an independent 
assessment of outcome but have relied upon the surgeon's own assessment. There are clear 
and important differences in risk between surgery for ruptured and unruptured aneurysms, the 
risks being higher in patients who have sustained an aneurysmal SAH. Whilst it is clear that 
the risks of treatment following aneurysmal SAH are outweighed by its benefits, the situation 
regarding unruptured aneurysms is far less certain. 
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A systematic review of surgical treatment for unruptured aneurysms was performed 
by Raaymakers et al (1998) who identified 61 studies including 2460 patients and at least 
2568 aneurysms published between 1966 and June 1996.139 Unfortunately only eight of the 
studies were prospective, the rest being retrospective, and in virtually all studies, the 
neurosurgeon performing the operation was also the observer of outcome. Median follow -up 
was at 24 weeks (range 2 - 234 weeks) in the 21/61 studies that reported the time of outcome 
assessment. Overall permanent morbidity occurred in 10.9% (95% CI 9.6 - 12.2 %) of 
patients and mortality was 2.6% (95% CI 2.0 - 3.3 %). The lowest morbidity and mortality 
was found with small anterior circulation aneurysms (mortality 0.8 %, morbidity 1.9 %), and 
the worst with large posterior fossa aneurysms (mortality 9.6 %, morbidity 37.9 %). To some 
extent, the higher mortality of posterior fossa (than anterior fossa) operations was due to 
confounding by aneurysm size. In the interpretation of these results, it is important to bear in 
mind the effect of publication bias. Studies which found higher mortality rates than the 
published literature of the time are less likely to have been published because, as Raaymakers 
et al. point out, public awareness of these results might be disadvantageous to the 
neurosurgeon or the hospital. 
The prospective arm of the ISUTA also addressed the issue of risks of surgical 
intervention in unruptured aneurysms. This study enrolled 1172 patients (211 of whom had a 
history of previous SAH) and 996 underwent surgery. The surgery -related mortality at 1 year 
was 3.8% (95% CI 2.4 -5.4) in patients with no prior SAH and 2% (0 -2.6) in patients who had 
previously suffered a SAH from a different aneurysm, already treated. Morbidity was 12.0% 
and 12.1% respectively. These figures are based on current surgical practice and indicate 
higher mortality and morbidity than the overall figures quoted in the systematic review by 
Raaymakers et al, although it must be noted that the 95% confidence intervals for these two 
papers overlap. The increased morbidity was largely ascribed to impaired mental status which 
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was not assessed in most previous studies.73 The mortality figures at 1 month in the ISUTA 
study were similar to those in the systematic review at a median of 24 weeks, 2.3% versus 
2.6% respectively. Age was the only independent predictor of outcome in the ISUTA study: 
the RR of surgery -related morbidity and mortality at one year was approximately 5 in the 
group >64 years of age compared with patients <45 years of age. Surgical risk data are 
summarised in Table 1.4.1. 
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1.4.3 Endovascular treatment and outcomes 
The great advantage of the GDC system relates to its controlled detachment, the 
intrinsic compliance of a coil helix, which can adapt to a variety of aneurysm shapes, the low 
thrombogenicity of platinum coils and the rapid development of a large number of coil sizes 
by the manufacturers.75' 140 However, the endovascular treatment of intracranial aneurysms is 
critically dependent upon the anatomical location and morphology of the aneurysm. The 
width of the aneurysm neck in relation to the aneurysm fundus (neck -to- fundus ratio) is one 
of the most important factors. A wide necked aneurysm is not readily amenable to coil 
embolisation, unless refinements of the technique such as balloon remodelling are employed, 
but these even when technically possible do increase the duration and risks of the 
procedure.140 
The effectiveness and risks of aneurysm coiling are less certain than for surgery 
because the technique is newer and still developing. The USA Multicentre Study Group 
identified a 1% mortality and a 4% morbidity for unruptured aneurysm treatment, with 78% 
of aneurysms being completely occluded. The rupture rate of partially coiled aneurysms was 
0.5% per annum from the limited follow -up data available.141 There is some evidence that 
even partial treatment by GDC confers benefit in the early post rupture period; post GDC 
treatment haemorrhage occurring in only 9/403 patients, although the length of follow -up was 
very limited in many patients.141 A systematic review of aneurysm coiling identified 48 
studies (all observational studies) including 1383 patients.142 Permanent complications of 
coiling occurred in 3.7% (95% CI 2.7 -4.9 %) but only 54% (95% CI 50 -57 %) of aneurysms 
were completely occluded at time of primary coiling. Many studies were retrospective and 
there was no indication of whether the outcome assessment was independent or not. There is 
only one randomised trial - the International Subarachnoid Haemorrhage Trial (ISAT) - 
which is comparing coiling with clipping (in ruptured aneurysms) and that is ongoing. 
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Coiling has not been utilised for long enough to know what the long term success rate will be 
in preventing SAH or what other long term complications might develop. It is difficult to 
make much sense of the morbidity and mortality data in observational case series (and hence 
in the systematic review) because the type of patients treated may be "worse" than those in 
surgically treated observational series. Patients treated by coiling may get more (or less) 
intensive after -care, and there are numerous other sources of bias and confounding which 
make it impossible to be definitive. 
One study has attempted to overcome the biases inherent in retrospective case series, 
particularly case selection bias by comparing institutional outcomes.143 This study found that 
patients treated at institutions that more frequently used coil embolisation were less likely to 
die in hospital. However, hospital treatment volume was not independently associated with 
in- hospital death, implying that much of the risk reduction was due to the coiling technique 
rather than the relative experience of the operators in high versus low volume centres. The 
relative risk reduction for every 10% of aneurysms treated by coiling was 0.91 (p= 0.001) for 
ruptured aneurysms and 0.84 for unruptured aneurysms (p= 0.03). 
Although the coiling technique appears very promising it needs to be evaluated 
further against surgery in randomised trials. The ISAT trial comparing coiling versus clipping 
in ruptured aneurysms is due to report in early 2003. In the case of an unruptured aneurysm, 
should one decide treatment was necessary, the long -term results of coiling are particularly 
relevant because coiling could provide a much less invasive alternative to surgery. It is worth 
noting that the published rupture rate of partially coiled aneurysms is the same as that 
reported from the ISUTA study for untreated unruptured aneurysms >10mm diameter or any 
unruptured aneurysm in a patient with a previous SAH! The regrowth rate of partially coiled 
aneurysms is still being defined, thus there are considerable uncertainties about the long and 
short term effectiveness of coiling. Current evidence suggesting an overall rupture rate of 
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asymptomatic untreated unruptured aneurysms in the range 0.27% (ISUTA 1998)73 to 1.9% 
(Rinkel et al. 1998).27 This means that the cost effectiveness of GDC treatment or surgery are 
decidedly uncertain. If the ISUTA rupture rate of 0.05% pa (for aneurysms <10mm in 
diameter) is correct (and it is the most rigorous large study to address this issue to date), then 
neither coiling nor surgery seems sufficiently safe to justify intervention in most patients with 
unruptured aneurysms. A randomised trial of best medical therapy versus intervention with 
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Figure 1.4.2 
Aneurysm of the right MCA pre- and post endovascular coiling 
An anatomical variant of a proximal anterior temporal artery origin with short M1 
segment is present. Aneurysm arises beyond bifurcation. 
126 
Table 1.4.1 Risks associated with treatment of unruptured aneurysms 
Outcome 
Management 
Conservative Clipping GDC Coiling* 
Mortality 0.5'- 5.02 
(% per decade) 
2.63- 3.8' % 1.04 -1.15 % 
Morbidity 1.0' -102 
(% per decade) 
10.93 -12.1' % 3.74- 4.05 % 
(224 -485% partially coiled) 
*no long term follow -up, procedure related mortality rate quoted 
1. = ISUTA 1998 
2. = Rinkel et al 1998 
3. = Raaymakers et al 1997 
4. = Vinuela et al 1997 (unruptured aneurysms) 
5 = Brilstra et al 1999 (mainly ruptured aneurysms) 
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Summary of Part One Chapter Four 
The development of aneurysm treatment and the options currently available are described. 
The technique of neurosurgical aneurysm clipping is briefly described and the reported 
outcomes considered in greater detail. 
Endovascular treatment and outcomes are described with reference to the literature. 
The International Study of Unruptured Intracranial Aneurysms (ISUTA) is described and 




Discusses the concept of screening for cerebral aneurysms with reference to the 
epidemiology of SAH, the imaging methods available to detect aneurysms and the risks 
of treatment with reference to established screening programmes 
1.5.1 Screening for unruptured asymptomatic intracranial aneurysms 
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1.5.1 Screening for unruptured asymptomatic intracranial aneurysms 
The drive behind the fundraising appeal following the death of Davie Cooper was to 
try and reduce the morbidity of SAH within the Scottish population. The obvious way to do 
this is some form of population screening to detect and treat intracranial aneurysms before 
they rupture. Some authors (including Ronkainen et al in 1997, Levey in 1990 and 
Obuchowski et al in 1995) have advocated screening for aneurysms in at risk groups.144 -146 
But it is not clear from the literature whether to screen at all, who might benefit from 
screening and what method to use. 
There are national variations in aneurysmal SAH rates; Finland for example has a 
significantly higher rate than other European countries such as the Netherlands or Denmark.68' 
83, 84 More information directly relevant to the Scottish population was required to make 
informed clinical decisions and thus the Davie Cooper Scottish Aneurysm Study was 
developed. It is worth examining the concept of population based screening in some detail and 
considering both the potential advantages and disadvantages. 
Definition of screening (Oxford English Dictionary): 
"A test or check for the presence or absence of disease" 
NB. The implication is clear from the definition that a screening test must not only reliably 
detect the presence of a disease or condition (i.e. be highly sensitive) but must be able to 
reliably exclude it as well (i.e. be highly specific). 
There is a popular belief that screening to detect and so prevent disease "must" be 
beneficial as well as straightforward, effective and cost effective; but screening is not a 
universal panacea, in fact it is often complex, may be of arguable effectiveness and very 
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expensive.147 To be effective, a screening test must discriminate between those with and 
without the disease, and not identify any self -limiting forms of disease which would not 
otherwise require treatment. A large administration infrastructure is required to deliver and 
maintain a national quality assured screening programme. The considerable difficulties 
inherent in implementing and maintaining such programmes have caused considerable 
controversy in the UK in recent years, most notably with cervical screening in Leicestershire 
(2001) and breast screening in Kent (1999). Here services operating within the false negative 
and positive rates accepted as satisfactory when the screening programmes were instituted 
have been heavily criticised by patients, the media, the judiciary and politicians when errors of 
interpretation of screening examinations have come to light. Nevertheless there is reasonable if 
not absolutely conclusive evidence to support these screening programmes.148 
Other problems with screening highlighted by the Lancet editorial are illustrated by 
examination of two other screening programmes. Screening for congenital dislocation of the 
hip (CDH) by clinical examination on two occasions in the neonatal period has been 
widespread in the UK for over twenty years. However, screening fails to detect the condition 
in 70% of those children who subsequently require corrective surgery for it ;149 i.e. in routine 
clinical practice the sensitivity of the test is extremely poor. In Japan, a screening programme 
of children for neuroblastoma was set up using urinary catecholamine levels as the screening 
test. These are performed at six months of age. However, it was realised that screening at this 
age detects numerous cases that would have otherwise regressed spontaneously, and misses 
the more aggressive cases, in whom neuroblastoma develops later.15'D Therefore this particular 
screening concept is fatally flawed. 
The resources required for screening may be very considerable and a proper analysis of 
the cost per life year gained becomes of crucial importance. For example with regard to 
screening for colorectal cancer, one trial randomised 61,933 subjects to screening or no 
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screening with faecal occult blood tests twice yearly for 10 years to demonstrate only a 0.1% 
absolute reduction in deaths from colorectal cancer.151 The calculated cost for each colorectal 
cancer death prevented in a UK study of 152,580 patients152 was £200,000.153 This is an 
enormous cost compared to many proven medical interventions such as aspirin in stroke, 
thrombolysis in myocardial infarction and hip replacement (hemiarthroplasty usually) 
following fractured neck of femur.147 Despite this cost, the UK government recently began to 
introduce pilot schemes with the intention to lead on to a national programme of screening for 
colonic cancer. 
Unless a screening test is very highly sensitive and specific, inexpensive, easy to 
administer and can be delivered in practice to the appropriate population successfully, it is 
unlikely to produce worthwhile results in real everyday clinical practice. In fact it is more 
likely to increase health -care costs and stress amongst the population and health -care staff 
alike. Furthermore, unless one can differentiate between disease likely to remain sub -clinical 
and that likely to cause significant symptoms, the treatment of disease following on from a 
screening programme may have less impact than expected on cumulative mortality rates 
(witness the Japanese neuroblastoma debacle). 
In the case of intracranial aneurysms, we cannot yet tell when aneurysms are going to 
rupture or form de novo. Even if we could identify and successfully target an at risk group for 
screening it would be difficult to know which aneurysms to treat, which to leave alone, how 
often to screen, what treatment to recommend etc. 
It is interesting but also worrying to note that although the stress of being screened is 
difficult to quantify, it may actually be significant. It probably depends in part upon the 
seriousness (in the mind of the screened population) of the disease being sought. McDonald et 
al. assessed patient reassurance after a normal test result in patients undergoing 
echocardiography for symptoms or an asymptomatic murmur.154 All the people presenting 
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with symptoms remained anxious despite the normal test result, and 39/52 people (75 %) 
presenting with an asymptomatic murmur became anxious after detection of the murmur. Over 
half of these (21/39) remained anxious despite the normal echocardiogram result. Thus a 
normal echocardiographic screening result had not reassured any of the symptomatic patients 
and being screened had actually made 54% of the asymptomatic patients persistently anxious 
about their heart! 
As already alluded to, several groups have recommended screening for intracranial 
aneurysms in high -risk groups, namely ADPKD patients and those with a strong family 
history of aneurysmal SAH.66° 144-146, 155, 156 The efficacy of screening for aneurysms depends 
crucially on certain parameters relating to the natural history of aneurysms, particularly the 
prevalence and the annual risk of rupture. Analysis of rupture risk is further complicated by 
the pattern of aneurysm rupture- some aneurysms appear to develop and rupture rapidly whilst 
others stabilise.71, 73, 157, 158 Screening will tend to detect the latter low -risk stable type rather 
than the former group of high -risk aneurysms. 
The other critical considerations are the accuracy of screening test(s) and the safety and 
effectiveness of treatment. Several groups have applied detailed models to the screening 
decision -analysis process for aneurysms.146, 159 -163 The two most recent of these papers came 
out against screening, the others suggesting it was justified in the at risk populations identified. 
This may be because the four earlier studies all assumed much higher aneurysm rupture rates 
(of 2% per annum), higher MRA accuracy ( >90 %) and a lower morbidity rate from treatment 
(variable but all <10 %) than are apparent with the more recent and rigorous evidence now 
available» 
To recap, the data from this study indicate a 0.05% per annum rupture rate in 
aneurysms <10mm in diameter and 0.5% per annum in larger aneurysms or posterior 
circulation aneurysms. Furthermore the risks of neurosurgical treatment were overall 15.8 %, 
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although lower in patients <45 years of age. The risk benefit ratio is therefore against 
treatment in most patients with incidental small aneurysms. Even taking the overall rupture 
rate of 0.8% per annum in Rinkel et al's systematic review, surgical treatment would not be 
indicated in patients over the age of 65. Treatment would have to be considered on an 
individual basis in the age group 45 -65 taking into account other factors such as smoking, 
family history, hypertension etc. Coiling appears to be a lower risk treatment option but with 
an unproven long term outcome it should be employed cautiously in unruptured aneurysms.'TM 
All of the above factors mean that there remains considerable uncertainty that any screening 
for intracranial aneurysms can be justified and it is certainly not appropriate on a population 
basis. 
Apart from the effectiveness and costs of a screening programme, are there any other 
considerations regarding screening for aneurysms? As with any screening exercise, multiple 
factors need to be considered such as raising anxieties in the patient or their family, 
confidentiality issues, "the right not to know ", the problems raised by false positive and 
negative diagnoses, what age to start investigating patients, how often to repeat the 
investigations, etc. For intracranial aneurysms, many of these factors remain uncertain. There 
may be financial costs for the individuals who are screened (e.g. through insurance costs and 
employment implications). If conservative management is advised, the knowledge of the 
presence of an aneurysm may be worrying to the individual concerned (and to their family and 
employer). 
Another very difficult issue is the question of whether any genetic test results should 
be used for actuarial purposes by insurance companies. This is a highly controversial and 
unresolved problem.165, 166 Even defining a "genetic test" is fraught with difficulty,167 and this 
may well prevent legislative attempts to prevent discrimination on the grounds of genetic 
heritage from succeeding in Europe and the USA.165' 
168 UK financial institutions will not (at 
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present) charge higher premiums for life assurance simply because investigations have been 
done, provided the results are negative. It is worth bearing in mind, however, that they did 
penalise any person who had ever had a HIV test when the "AIDS epidemic" began in the UK 
in the mid 1980s. 
Bearing all these factors in mind, ignorance (of the presence or absence of an 
aneurysm) may actually be the best course of action for an individual at present. For example, 
as regards driving, the presence of an unruptured asymptomatic aneurysm is considered to be 
incidental by the UK Driver and Vehicle Licensing Authority for ordinary group I licences, 
and there are no restrictions imposed. However, for group II licences (i.e. for Heavy Goods 
Vehicle & Public Service Vehicle licences), the licence will be refused or revoked pending a 
specialist assessment for the DVLA of the risks on an individual patient basis. This might 
have considerable financial implications for some patients. 
135 
Summary of Part One Chapter five 
The concept and definition of screening are described. 
Problems with screening with particular reference to certain screening programmes and 
resource implications are considered. 
The special problems relating to screening for intracranial aneurysms are described in 
detail. 
Current UK situation is summarised with reference to the most up to date and robust 
evidence available. 
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Summary of Part One 
The history of subarachnoid haemorrhage and its link to intracranial aneurysms has 
been described. The aetiology, pathology, clinical epidemiology, clinical presentation and 
prognosis of aneurysmal haemorrhage have been reviewed and considered in detail. Particular 
consideration was given to reviewing the literature on familial aneurysmal SAH risk and 
identifying areas of uncertainty or where there is conflicting evidence. The incidence of 
aneurysmal SAH is round 6 -8 per 100,000 person years based on European and North 
American data with a peak age of 40 -60 years. The risk of SAH is raised for first and second - 
degree relatives of patients who have sustained an aneurysmal SAH, though the absolute 
lifetime risk is small (mean 0.4 %) but with a very wide range reported from different studies 
of 0.1- 11.4 %. Other risk factors for SAH were also considered. 
The anatomy of the cerebral arterial vasculature has been described with particular 
reference to the typical sites of aneurysm formation and the anatomical variants that 
predispose to aneurysm formation. The imaging techniques available for the cerebral 
vasculature, namely cerebral angiography, CTA, MRA and Transcranial Doppler sonography 
are described and discussed in detail, including the historical background to their development 
and clinical application. The physics underlying the non -invasive modalities was also 
discussed. The attendant risks of each technique were also considered. 
The treatment options available for intracranial aneurysms were described and the 
development of each was discussed. The risks associated with neurosurgical clipping and 
endovascular coiling were also reviewed. The concept of screening was then detailed and the 
advantages and disadvantages discussed in general and then the particular problems of 
screening for intracranial aneurysm were considered and the current situation summarised on 




Describes why a systematic review of the non -invasive imaging of intracranial aneurysms 
was performed, the methodology used (according to Cochrane Collaboration guidelines) 
and the results obtained 
2.1.1 Preface to Part Two- the Study of Aneurysms in Glasgow and Edinburgh (SAGE) 
2.1.2 Background to and rationale behind performing a systematic review 




2.1.1 Preface to the SAGE study 
As discussed in section 1.3.2, IADSA is the reference standard imaging investigation 
of the cerebral vasculature but it carries some important attendant risks (detailed earlier) 
including the risk of stroke and even death. These are obviously extremely serious 
complications of a diagnostic test, even if uncommon in expert hands in younger patientslos 
However, the risks of cerebral angiography rise markedly with age and the risk of a 
neurological complication may be as high as 3 -5% in cerebral angiography performed in 
elderly subjects with a prior history of ischaemic vascular events.192, 169 Furthermore, cerebral 
angiography has to be performed as a day case inpatient procedure, a minimum of three staff 
members is required in the angiography room (joint RCR/RCN guidelines 2001) and both 
nursing and medical resources are consumed before and after as well as during the procedure. 
This means the procedure is expensive and time consuming as well as invasive for the patient. 
This combination of risk, invasive nature of the procedure and heavy resource usage mean that 
non -invasive alternatives to cerebral angiography are potentially very attractive to both 
clinicians and patients alike. 
The Study of Aneurysms in Glasgow and Edinburgh (SAGE) presented in part two of 
this thesis was designed to provide more information on the non -invasive imaging of 
intracranial aneurysms. 
Any test aiming to replace IADSA in the detection of asymptomatic aneurysms has to 
be extremely sensitive because an undetected ( "missed ") aneurysm is a potentially life - 
threatening circumstance. Yet one does not want to perform confirmatory IADSA (or even 
worse surgery) unnecessarily, therefore specificity also has to be excellent. 
It is clear from the systematic review of the literature that follows that data on the 
performance of non -invasive tests in the detection of intracranial aneurysms are very limited in 
some important areas. In particular data are lacking on the accuracy of the non -invasive 
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imaging tests in subjects with an expected low prevalence of aneurysms. Most previous 
studies have concentrated largely or exclusively on subjects with a recent aneurysmal SAH. 
This introduces selection bias and observer expectation bias (observers expect to find an 
aneurysm so look very hard for it) plus the information on distribution of blood provided by 
plain CT (reviewed in many studies along with the IADSA and non -invasive examination) 
might also influence the outcome. These and other factors, including the effect of prevalence 
of a disease on sensitivity and specificity of tests used to detect it (discussed subsequently), 
mean that the results of studies performed in an high aneurysm prevalence population are 
unlikely to be readily generalizable to non -SAH, low aneurysm prevalence subjects, such as 
might be examined in a screening programme of relatives of SAH patients. 
Where low aneurysm prevalence populations have been examined on any scale, it has 
been without comparison to IADSA in the great majority of patients, so that no, or only very 
limited, information on comparative diagnostic performance to the reference standard 
(IADSA) was provided.27' 66, 84 
To eliminate the systematic bias in the assessment of CTA/MRA/TCD introduced by a 
preponderance of recent SAH patients, prospective, large blinded studies of non -invasive 
imaging versus IADSA in patients at risk of an aneurysm but without recent acute SAH are 
needed. Furthermore, to truly compare non -invasive imaging tests with each other and with 
IADSA, it is necessary to perform all the tests in the same patient. 
The aims of the SAGE study were: 
to directly compare CTA and MRA in a large, prospectively recruited cohort 
to provide good quality data on TCDS from a large, prospective study 
to examine a range of patients, not just those with acute SAH 
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 to examine whether adding TCDS to CT or MR angiography significantly 
improved the diagnostic performance (no information at all was available on this 
interesting and potentially useful screening strategy) 
to examine the effect of observer experience on diagnostic performance 
The first three aims are covered in sections 2.2.3 and 2.2.4, the next two in chapters 
three and four respectively. 
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2.1.2 Background to and rationale behind performing a systematic review 
In a systematic literature review evidence from scientific studies is located, critically 
appraised and finally combined using a strict pre -defined scientific protocol. This strategy 
must itself be reported in the review.170 The aim is to ensure a review that is both 
comprehensive and unbiased and which may therefore be used with confidence for decision - 
making on patient management and the most appropriate direction for future research. 
The growth in evidence based medicine has been a major stimulus for systematic 
reviews of published research to be undertaken. The Cochrane Collaboration has been 
responsible for the development, dissemination and encouragement of the whole concept of 
systematic reviews underpinning evidence based medicine. In 1972, a British epidemiologist, 
Archie Cochrane, drew attention to our collective ignorance about the effects of health care 
and suggested that we should have ready access to reliable reviews of the available 
evidence.171 In 1987 a systematic review of randomised trials of care during pregnancy and 
childbirth was published and hailed by Cochrane as a milestone and a method for other 
specialties to copy.172 In response to Cochrane's call for systematic up -to -date reviews of all 
relevant randomised controlled trials of health care, the NHS Research and Development 
Programme established a Cochrane Centre to collaborate with others in the UK and elsewhere, 
to facilitate systematic reviews. This first centre was opened in Oxford in 1992 and in the 
following year the Cochrane Collaboration was founded at a meeting in New York to enable a 
collaborative international response to Cochrane's agenda. This Collaboration will enable 
important effects of healthcare to be identified promptly, new research to be well informed and 
directed and not to ask questions that have already been answered. 
Systematic reviews of diagnostic accuracy of tests for a specified condition can 
identify the number, quality and scope of studies, provide an overall summary of diagnostic 
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accuracy and compare the diagnostic accuracy of different tests. They can go further than this 
and also determine whether estimates of diagnostic accuracy depend on dimensions of study 
quality of the primary (included) studies, whether accuracy differs in subgroups defined by the 
characteristics of the patients and test (applicability or generalizability) and identify areas 
where information is deficient and direct future studies.173 
When considering performing a systematic review there are a number of key steps to 
be considered first: 
1. A definitive strategy for searching the literature has to be developed and then validated. 
2. A checklist for assessing the validity, quality and applicability (relevance) of studies 
identified by the search has to be prepared in advance. Criteria need to be clearly defined 
to minimise selection bias. 
3. The statistical methods to be used for meta analyses and any subgroup analyses to be 
performed should be pre -determined. 
A systematic review on a diagnostic test(s) should first present simple descriptive data 
summarising the quality and applicability of included (and excluded) studies. It should then 
present summary tables of descriptive statistics such as sensitivity, specificity, predictive 
values and likelihood ratio. However, the preferred method of pooling dichotomous data (the 
type usually extractable from studies of diagnostic tests) from a number of studies is the 
Summary Receiver Operating Characteristic Curve (SROC).173, 
174 This method also provides 
a valuable graphical representation of the data, readily appreciated by the reader.175 Of 
particular relevance to comparing imaging tests is that a comparison of the accuracy of two or 
more tests WITHIN each primary study is more valid than the comparison of the accuracy of 
two or more tests BETWEEN primary studies. The same applies to subgroup analysis of the 
accuracy of a single test. 1 76 
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Criteria for study validity include: 
Was the test compared with a valid reference standard? 
Were the test(s) and reference standard measured independently? (MOST VALID) 
Was the choice of patients assessed by the reference standard independent of the test's 
results? (avoidance of verification bias) 
Was the test measured independently of all other clinical information? 
Was the reference standard measured before any interventions were started with 
knowledge of the test results? (avoidance of treatment paradox) 
Additional validity criteria for studies comparing tests: 
Were all tests done independently on each person? (MOST VALID) 
Are the criteria relevant to the applicability of the results? 
Were the setting, demographic information, case -mix (prevalence and or severity of 
disease) typical of the clinical problem? 
All these factors were carefully considered when determining the inclusion criteria and 
critical appraisal methods to be used in a systematic review of the non -invasive imaging of 
intracranial aneurysms. Studies meeting all the criteria laid down above are likely to have 
minimised potential biases. There are a large number of biases that can occur in studies 
assessing diagnostic performance. An understanding of the biases applicable to diagnostic 
imaging is necessary for undertaking a systematic review. Therefore potential biases that 
might arise are considered in detail below. This also helps to explain how and why appraisal 
criteria were employed to decide on inclusion or exclusion in the systematic review (as 
described in section 2.1.3). 
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Bias in diagnostic imaging studies 
There may be referral or patient sampling bias. These may be difficult to avoid but a 
well reported study will include information on how patients were recruited and the baseline 
characteristics of the study group. This type of bias will tend to affect disease prevalence and 
hence predictive values and maybe sensitivity and specificity as we11.177' 178 Following 
referral, patient filtering bias can occur. Therefore inclusion and exclusion criteria should be 
clearly stated and be regarded as generally acceptable (editorial and peer review should deal 
with whether this standard is met) so that a judgement on filtering bias can be made. Due to 
these patient selection processes, a particular range of patients will form the study cohort. It is 
important that this cohort includes a range of pathological, clinical and co- morbid conditions 
to prevent the introduction of spectrum bias (limited range of disease type or severity in study 
group) and population bias (generalisibility of study group to the general population). The 
appropriateness of the patient spectrum depends crucially upon the clinical question being 
asked. This is of great relevance with regard to the imaging of intracranial aneurysms and is 
considered in some detail in the discussion section (2.1.5) 
Co- intervention bias may occur if additional diagnostic or therapeutic interventions are 
performed on the study group. In practice the key point here is that any such co- interventions 
should be detailed and the results reported in sufficient detail to allow assessment of the effect 
of the intervention. Verification bias occurs when not all of the study group receive the same 
reference standard examination and is not uncommon in diagnostic performance studies.179 
Incorporation bias occurs when the test under evaluation is itself used as the reference (gold) 
standard. Any abnormally long period between the test and the reference standard being 
performed or variations in this delay between subgroups can lead to the apparently poorer or 
better performance of a test, so- called disease progression bias.178 Non -random exclusions of 
subjects after the study has started introduces withdrawal bias. Similarly patients lost to 
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follow -up must be carefully described as they may differ systematically and importantly from 
those that remain in the study. Any indeterminate results due to technical faults, poor image 
quality etc. must be reported so the size of any effect can be ascertained. As long as such 
problems are random and the test is repeatable they will not bias the results. 
Observer variability effects are very important and can make a considerable difference 
to results obtained. Therefore test reproducibility should be assessed and the number and 
experience of observers reported. It is helpful to quantify the interobserver variability within 
the results presented e.g. by using the kappa statistic or presenting receiver operating curves. 
In literature reviews temporal effects may become relevant where owing to technological 
improvements or operator /observer experience, results improve with time. When performing 
systematic review studies from similar time periods or using similar protocols should be 
grouped together (see section 2.1.4). 
The final groups of biases to consider when appraising studies relate to the 
independence of interpretation. Test review bias occurs if the reader of the test under 
evaluation is not blinded to the reference standard result. Diagnostic review bias is the 
opposite of this and occurs if the result of the test under evaluation is known when the 
reference standard test is performed or interpreted. The results of any of the tests should not be 
known when the results are interpreted to prevent comparator review bias. Finally clinical 
review bias occurs if observers are aware of clinical data such as age, sex, symptoms as these 
may influence the interpretation of the result. For example an observer knows that an eighteen 
year old asymptomatic male is much less likely to harbour an aneurysm than a 43 year old 
female smoker with a family history of SAH and if in doubt about the interpretation of the 
examination, the former case is much more likely to be called "normal than the latter. 
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Why a systematic review of non -invasive imaging of intracranial aneurysms? 
Intracranial aneurysms are most reliably imaged using selective intra- arterial digital 
subtraction angiography.45 Although the risks of this are low, an even safer diagnostic test 
would be useful (were it sufficiently accurate). Screening has been advocated in certain 
subgroups at risk of an aneurysm such as those with a strong family history of aneurysmal 
subarachnoid haemorrhage or autosomal dominant polycystic kidney disease (see Part One 
Chapter Five for a detailed consideration). 146, 148, 157 -161 For reasons already described, invasive 
IADSA is not very suitable as a screening test. This has led to increasing interest in the use of 
non -invasive imaging methods in the diagnosis of intracranial aneurysms.75' 146, 155 
Each of the non -invasive techniques has advanced substantially in the last decade, and 
they have been advocated as a replacement for angiography in some circumstances180 -182 
Nevertheless, although numerous individual studies have suggested high sensitivity and 
specificity for these non -invasive techniques, a systematic overview of their performance 
against the reference standard of selective intra- arterial angiography was lacking. Therefore as 
part of the SAGE Study, we undertook a systematic review of the literature on the diagnostic 
performance of the three non -invasive methods compared to intra- arterial digital subtraction 
angiography. 
In addition the systematic review aimed to examine if accuracy was influenced by the 
prevalence of aneurysms in the population studied, or by sample size, or aneurysm site or size. 
The purpose was also to determine if the information already available was sufficient to be 
confident of the accuracy of non -invasive tests or whether more information was needed in 
certain areas and thus help to direct future research. 
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2.1.2 Materials and Methods 
Eligibility 
The primary criteria for inclusion in the systematic review were studies which: 
a) Were published between January 1St 1988 and 31st December 1998. 
b) Compared the diagnostic accuracy of a non -invasive imaging test with intra- arterial 
angiography (the reference standard). 
c) Comprised at least 10 subjects who had both the non -invasive test and angiography 
performed contemporaneously. Ten subjects was used as a practical cut off level (after 
review of the literature) to try and sift good quality studies from small unselected 
observational series or case reports.173' 175,176 
Studies before 1988 were excluded, as MRA was very early in its development, and 
neither spiral CT or Power Doppler ultrasound were available. Studies on aneurysms of any 
size were eligible but studies on children were excluded. All papers, including non -English 
language publications, were sought. If studies met the primary criteria, they were then 
formally assessed independently by two investigators (PMW and JMW) for eligibility against 
pre -determined secondary quality criteria using standardised critical appraisal forms- see 
Figures 2.1.1- 2.1.3. This checklist method has been described previously and enables an 
objective and reproducible assessment of each paper to be made.183 The form contained a 
checklist of 26 -27 items relevant to studies of diagnostic performance, grouped into 3 main 
categories, which are summarised in Table 2.1.1. 
For each category a score was assigned by the reviewer on a scale of 0 -3 (0 =very poor 
or not done, 1 =poor, 2= acceptable, 3 =good) with an additional mark available for overall 
impression of the paper, therefore the possible range of scores was 0 -10. The scoring system 
was intrinsically weighted so that some items on the checklist e.g. blinding of reviewers to the 
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results of other tests, carried more weight than other items- see Table 2.1.1. This is because 
some of these items relate strongly to the minimisation of particular bias(es) in a study. 
Possible biases in studies of diagnostic imaging tests and their effects were considered earlier 
(section 2.1.2). 
To score full marks (three) in a category, a study had to meet virtually all of the highly 
weighted criteria and some of the medium weighted ones as well but did not have to meet all 
of the low weighted criteria. To score two in a category, a study had to meet many of the 
highly weighted criteria, many of the medium weighted and some of the low weighted criteria 
and so on. 
A critical appraisal score of greater than 5 was deemed necessary for a study to be 
included in the systematic review. Differences between the assessors occurred in 7/103 cases 
(5 CTA, 2 MRA studies) and all were resolved by consensus review. 
Search Strategy 
Following advice from the Cochrane Database of Systematic Reviews Stroke Review 
Group Search Co- ordinator (B.Thomas, personal communication), MEDLINE and EMBASE 
electronic databases were searched for relevant papers using exploded headings on the terms 
Tomography, x -ray computed/, Magnetic Resonance Angiography /, Ultrasonography /, from 
January 1988 to December 1998 inclusive. In addition searching was performed using free text 
terms including all possible variations on CTA, MRA and Transcranial Doppler Ultrasound. 
Both strategies were combined using the Boolean operator OR. This search was then 
combined with a second on subarachnoid haemorrhage and intracranial aneurysms (again 
derived from both exploded headings and free text terms) using the Boolean operator AND, 
then the search was limited to studies of human adults. These search strategies are reproduced 
in Figures 2.1.4 to 2.1.6. 
149 
EMBASE and MEDLINE are the main electronic databases in which clinical medical 
journals are indexed. Powerful search engines have been developed in tandem with these 
databases that allow them to be rapidly and reproducibly searched to find references by 
journal, author, keywords, subject headings or even free text terms. MEDLINE has references 
from 1966 onwards and EMBASE from 1980 onwards. MEDLINE is current to within 60 
days and EMBASE to within 15 days. MEDLINE indexes more than 3800 journals from 74 
countries but with a focus on North America. EMBASE indexes more than 3600 journals from 
110 countries with a more European focus. Between them, the two databases index over 5000 
journals from more than 120 countries and can be searched using similar search strategies. In 
particular with reference to the subject of this systematic review, at the time of searching, 
EMBASE indexed 288 clinical neuroscience and 125 Radiology journals and MEDLINE 220 
neuroscience and 107 Radiology journals with approximately 60% overlap between the 
databases. There is good evidence that the major electronic databases are a very reliable and 
comprehensive source of good quality articles relevant to inclusion in a systematic review.'84 
For all the studies identified by this search, I cross checked the reference lists for 
additional papers and also checked the reference lists of relevant review articles. This method 
of cross checking was continued until no further studies were identified. I also hand searched 
journals not indexed in either of the above electronic databases in which relevant articles were 
identified from reference lists. We did not specifically search meeting abstracts, as only papers 
published in full could provide sufficient detail to meet our inclusion criteria, but we did check 
for subsequent publication of potentially relevant work originally presented as an abstract. 
In keeping with Cochrane Collaboration guidelines, the search strategy was validated. 
This was done by performing an hand search of the "RSNA Index to the Imaging literature" 
(Radiological Society of North America) over the period 1988 -1997. This was supplemented 
by an hand search of the journals Neurosurgery, Journal of Neurosurgery and Stroke for the 
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same period as these were by far the three commonest journals to be quoted in relevant article 
reference lists that were not covered by the RSNA Index. The RSNA Index covers 42 major 
peer- reviewed journals dealing with diagnostic imaging of all modalities but with an emphasis 
on current cross sectional imaging modalities. The hand search of the RSNA index identified 
32 articles that met the primary inclusion criteria. The electronic search strategy had detected 
31/32 (97 %) of these. The hand search of Neurosurgery, Stroke and the Journal of 
Neurosurgery identified a further 11 articles that met the primary inclusion criteria. All eleven 
were detected by the electronic search. Therefore the validation process indicated that the 
electronic search strategy was highly sensitive in detecting relevant studies in the literature at 
98% (42/43). 
Data Extraction 
Two authors independently extracted data from identified studies by means of the 
standardised data extraction form. For non -English publications, where either JMW or PMW 
was not able to adequately translate, a translator with a medical science background extracted 
data. I am indebted to Dr U Koehler (Research Fellow, Dept. of Medical Physics, University 
of Edinburgh) and Dr M Sasaki (Visiting Fellow, Dept. of Neurosurgery, University of 
Glasgow) for undertaking this for German and Japanese papers respectively. Table 2.1.1 
summarises the data extracted from each paper. 
From the extracted data, the prevalence and distribution of intracranial aneurysms on 
intra- arterial angiography were determined. From the actual numbers of aneurysms and 
patients correctly or incorrectly diagnosed by the non -invasive test, the true positive rate (for 
the non -invasive test versus angiography), the true negative rate, false positive and negative 
rates were calculated on both a "per patient" and a "per aneurysm" basis. Where patients were 
included in more than one publication, we extracted data from the most recent publication only 
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to avoid inclusion of the same patients twice. This applied to two studies only.180, 185 Where a 
second angiogram was performed and showed an aneurysm when the first angiogram had been 
negative, the result of the second angiogram was used for the meta -analysis. This emphasises 
the point made earlier in part one that not even the acknowledged reference standard, IADSA, 
is perfect. 
Data Analysis 
Baseline descriptive characteristics were extracted from each publication to allow 
calculation of the mean numbers of patients and aneurysms, and aneurysm prevalence per 
study for each modality. The eligibility criteria permitted the inclusion of studies that did not 
provide results from which data on true /false positive and negative rates could be extracted, 
provided that their overall weighted assessment score was >5, but these are effectively 
excluded from further analysis because one cannot extract the necessary data. However, in all 
but two of the thirty -eight studies included in the systematic review, true /false positive and 
negative rates could be derived at least on a per patient or a per aneurysm basis. 
The true and false positive and negative rates per aneurysm and per patient were 
tabulated into 2x2 tables for each modality and sensitivity, specificity, predictive values and 
accuracy rates were calculated. Exact 95% confidence intervals based on binominal 
probabilities were calculated. In order to combine independent studies of the same diagnostic 
test for a meta -analysis the method of Moses et al. was used.174 This method utilises a logistic 
transformation of data in simple 2x2 tables, then linear regression curves are fitted for the true 
and false positive rates using the least square method. The results of these regression curves 
were used to plot each study into summary receiver operating characteristic (SROC) curves 
using a S -Plus version 4.5 (STATSCI, Seattle, Washington, USA) statistical software package. 
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Using a ROC analysis, which jointly considers the sensitivity and specificity of a test, 
provides greater insight into the difference in performance between tests than examining 
accuracy alone. ' 74 With the summary ROC method the area under the ROC curve is not 
available, but two tests can be contrasted by comparing the proportion of data points lying 
above and below the best -fit line using a standard x2 test. Moses et al provide a detailed 
description of this statistical methodology in their paper. 
Subgroup analyses examining the effect of the prevalence of aneurysms in the study 
population, the study sample size, the aneurysm size, recent versus older studies, and 
aneurysm site (anterior versus posterior circulation) on the accuracy of non -invasive 
modalities in the detection of intracranial aneurysms were also performed. 
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2.1.3 Results of the systematic review 
Studies identified 
1473 publications were identified by the combined electronic database and hand search 
of which 103 (7 %) met the primary inclusion criteria. Following formal critical appraisal of 
these 103 studies against the criteria described, 38 studies published in 4 languages (32 were 
English, 3 German, 2 French and one Italian) were included. Several papers published first in 
Japanese subsequently appeared in English language journals but we counted them as "English 
language" as these were the more recent. 
Study Characteristics 
The baseline characteristics indicate that the studies of CTA and MRA are very similar 
(see table 2.1.2). There are fewer reports on the use of TCDS in the detection of aneurysms 
compared to angiography. 
Of the 38 studies, which included 1765 patients: 
-Fourteen compared CTA with angiography.los, 
109, 182, 185 -195 
-Eighteen compared MRA with angiography.laa,lso, 
181, 196 -210 
-In two studies, both MRA and CTA were compared with angiography.211' 
212 
-Four studies compared TCDS with angiography.130, 
213 -215 
The median sample size for CT angiography was 30 subjects, for MR angiography it 
was 29 and for TCDS it was 38. The median aneurysm prevalence was 79.5% in included 
CTA studies (Interquartile range (IQR) 74.0- 100.0, range 53 -100 %) and 95.5% in excluded 
studies (IQR 68.0 -100.0, range 28- 100 %). Median aneurysm prevalence was 76% in included 
MRA studies (IQR 52.0 -97.0, range 10 -100 %) and 100% in excluded studies (IQR 84.0 -100.0, 
range 3- 100 %). Median aneurysm prevalence was 89.5% in included TCDS studies (IQR 
79.0- 100.0, range 78 -100 %) and 100% in excluded studies (IQR 79.0- 100.0, range 4.4- 100 %). 
154 
The similarities in the interquartile ranges indicated that there was no substantial difference 
between the included and excluded studies with regard to aneurysm prevalence. 
In cases where a second IADSA study was required (usually due to technical failure in 
an elderly /restless patient or to vasospasm), the result of the second angiogram was used for 
the systematic review analysis. Only 7/1765 patients (0.4 %) had a second angiogram that 
demonstrated an aneurysm, after the first angiogram had been negative. In other words, the 
overall accuracy of the initial IADSA was 99.6 %. The more important descriptive data are 
summarised in Table 2.1.2. 
Quality assessment of studies 
The median critical appraisal score for the CT angiography studies included in the 
meta -analysis was 6.5 (interquartile range [IQR], 6.0 -8.0); that for the excluded studies was 
4.0 (IQR 3.0 -4.0). The median appraisal score for the MR angiography studies was 6.0 (IQR 
6.0 -7.0) for the included and 4.0 (IQR 4.0 -4.5) for the excluded studies. For TCDS, the 
median appraisal score was 6.0 (IQR 6.0 -6.3) for the included and 4.0 (IQR 4.0 -4.5) for the 
excluded studies. The distribution of appraisal ( "quality ") scores for studies included and 
excluded from the systematic review is given as a bar chart in Figure 2.1.7. 
Other descriptive characteristics and assessments made 
Radiologists were included in the authorship of 35 of the 38 studies (92 %). In just over 
half, (22 [58 %] of the studies) the anatomical assessment for intracranial aneurysms was 
confined to the circle of Willis, and excluded the pericallosal, distal vertebral and posterior 
inferior cerebellar arteries. Complications were specifically mentioned in only 3/28 (11 %) 
studies (2 CTA and 1 MRA). The blinding of reviewers was explicitly stated in 35 of the 38 
(92 %) studies and implied in the other three. As a non -blinded study was discriminated against 
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by the weighted appraisal criteria, most of the non -blinded studies were excluded. Forty -nine 
out of 65 [75 %] excluded studies did not explicitly state that reviewers were "blinded ". 
Patient exclusion criteria- for example, the number of examinations excluded from 
analysis because the images were poor, were not clearly stated in 23 (61 %) of the 38 studies. 
Two or more readers read the non -invasive images in 26 (68 %) of the 38 studies, but a formal 
analysis of interobserver variability was only reported in 10 (38 %) of 26 studies (or 26% of 
the 38 total studies). 
In 14 (88 %) of 16 CT angiography studies, spiral technology was used. In all the MR 
angiography studies, a 3D Time -of- Flight (TOF) technique was used. In one study, two - 
dimensional time -of -flight imaging was also used.196 In three studies time -of -flight and phase 
contrast MR angiography were used.200, 203, 21° Two TCDS studies used Colour Flow Imaging 
213, 214 and two used Power Doppler.l3 °' 215 Only one study utilised an ultrasound contrast 
agent.215 
The subject (patient) characteristics of included studies 
Three CT angiography studies were performed on patients not known to have an 
aneurysm or recent SAH, but who had symptoms which could be attributed to an underlying 
aneurysm,1 °8' 182, 187 seven of the sixteen studies were on patients who were all (or 
predominately all) known to have an intracranial aneurysm or recent SAH;185,188-190, 
193, 195, 212 
and the remaining six studies were performed on a population comprising a mixture of these 
groups.109,186,191, 192, 
194,211 
The corresponding figures for MR angiography studies were three studies performed 
on patients not known to have an aneurysm or recent SAH, but who had symptoms which 
could be attributed to an underlying aneurysm,206 
-208 eleven of twenty were on patients who 
were all (or predominately all) known to have an intracranial aneurysm or recent SAH 
180, 196, 
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197, 199 -201, 204, 205, 209, 210, 212 and five of twenty were performed on a population comprising a 
mixture of these groups.181° 198, 202, 203, 211 One MRA study was performed on an asymptomatic 
population at increased risk of an aneurysm.'44 
All included TCDS studies were on patients with a known aneurysm or recent SAH. 
Thus only one of the thirty -eight studies examined non -invasive imaging exclusively in 
asymptomatic at risk subjects, which is of course the group relevant to the use of the non- 
invasive tests in screening for intracranial aneurysms. 
Image review characteristics 
Several authors have prospectively examined the importance of reviewing base as well 
as reconstructed images from MR and CT angiograms and concluded it was very useful.180, 206, 
210 In three of the CT angiographic studies the material reviewed was not explicitly stated and 
may or may not have included base images. 186, 187, 212 In all the others it was stated that review 
included both base and reconstructed images. A subgroup analysis comparing studies with 
base image review to those without was therefore not possible. 
In only three small MR angiography studies were the base images not reviewed.181, 
196, 
207 Accuracy for this small subgroup was similar to that in which both the base and 
reconstructed images were explicitly reviewed at 97% per patient (77/79) and 95% per 
aneurysm (55/58) versus 88% (681/772) and 89% (699/784) respectively with widely 
overlapping confidence intervals. In only one MR angiography study was the material 
reviewed not explicitly stated.212 
Results per subject (per patient) could be extracted from 11 of 16 CT angiography and 
18 of 20 MR angiography studies. Results per aneurysm could be extracted from all 16 CT 
angiography, 18 of 20 MR angiography and two of four TCDS studies. Complete result data - 
that is, true -positive, false -positive, and corresponding negative rates- could be extracted both 
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per subject and per aneurysm from 11 of 16 CT angiography, from 16 of 20 MR angiography 
studies but for none of the TCDS studies. 
It is important to remember that any patients in a study who did not have corroborative 
DSA were excluded from further analysis. This means that the figures presented in the meta - 
analysis results may not match the total number of subjects in a study. For example, in the 
study by Korogi et a1,206 nine of 202 subjects did not have DSA and, therefore, 193 subjects 
were included in the meta -analysis. 
Overall diagnostic performance: 
The full results of the meta -analysis of the performance of CTA and MRA on both a 
per patient and per aneurysm basis are presented as summary receiver operating characteristic 
(SROC) curves- see Figures 2.1.8 and 9. These indicate that both modalities performed well as 
the curves are concentrated towards the upper left hand corner of ROC -space and the 
scattering of the results is close to the fitted lines for CTA and MRA. CTA performs 
marginally better, but the difference did not reach statistical significance, per patient p= 0.411. 
The SROC curves on a per aneurysm basis were again very similar with no significant 
difference between CTA and MRA with p =0.09. There were inadequate data to obtain a 
meaningful SROC curve for TCDS. 
A comparison of sensitivity and specificity, with 95% confidence intervals is presented 
per subject in Figures 2.1.10 and 11 and per aneurysm in Figures 2.1.12 and 13 for both 
individual studies and the meta -analyses. These illustrate very clearly the similarity of the 
sensitivity and specificity of CTA and MRA, whereas TCD is poorer (and with much wider 
confidence intervals due to the paucity of data). The actual values for sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV) and accuracy with 95% exact 
confidence intervals are given in Table 2.1.3. Per patient, the results for CTA and MRA show 
158 
overlap of 95% CI for all parameters except PPV where CTA is better and CTA also has a 
greater likelihood ratio. Per aneurysm, MRA has a greater likelihood ratio than CTA at 16.62 
versus 6.32. The likelihood ratio (LR) of a positive test result was determined. If the LR is 0 
disease is excluded, a LR of cc excludes normality, a LR >10 or <0.1 implies a large change in 
likelihood, a LR of 5 -10 or 0.1 -0.2 a moderate change, a LR of 2 -5 or 0.2 -0.5 a small change 
and LR of 1 implies no change in likelihood. 
However, most importantly, the vast majority of the subjects studied by CTA were not 
the ones studied by MRA, so that direct comparisons between the two techniques should be 
interpreted with caution. 
Diagnostic performance: subgroup analyses 
a) Related to subject population characteristics 
We were unable to contrast accuracy in populations with high as opposed to low 
prevalence of an aneurysm because in only two studies was the prevalence less than 40% 202, 
208 and only one of these concerned a population with a realistically low prevalence (of 
10 %).208 It also was not possible to compare symptomatic patients (acute SAH, cranial nerve 
palsy etc.) with asymptomatic subjects, because the latter comprised a significant part of the 
population examined in only one study. This study yielded data for the meta -analysis from 
only the small proportion of subjects who had angiography as well as MRA (32/400).144 
b) Related to the timing of imaging examinations 
We were unable to analyse performance versus time of the noninvasive examinations - 
for example, before a subarachnoid haemorrhage, in which extensive blood might interfere 
with aneurysm visualisation on either CTA or MRA, because the precise time of the 
examination relative to the onset of a subarachnoid haemorrhage was unclear in most studies. 
c) Related to date of publication (surrogate for technological advancement) 
159 
The CT angiography studies published before 1995 (two of sixteen) had an accuracy of 
84% (27/32) per subject compared with the fourteen studies published after 1994, which had 
an accuracy per subject of 93% (424 of 454). The corresponding accuracy rates per aneurysm 
were 87% (40 of 46) and 89% (617 of 695) respectively. 
The MR angiography studies published before 1995 (8 of 20) had an accuracy per 
subject of 92% (211 of 230) compared with the twelve studies published after 1994, which had 
an accuracy of 88% (537 of 611); the corresponding rates per aneurysm were 87% (227/260) 
and 91% (527 of 582) respectively. Thus there was a trend for more recently performed CT 
angiography studies, after spiral technology had been well established, to have greater 
accuracy than earlier studies. This effect was not seen with MR angiography, possibly 
reflecting the more mature state of this technique by 1994, although it should be noted that 
only two small studies utilised contrast enhanced time -of -flight MRA and none utilised the 
recent advances of fast gradient echo contrast enhanced sequences with manipulation of K- 
space filling to improve spatial and spatial resolution.181,197 
d) Related to study sample size 
To test for an increased bias in small studies, an analysis of subgroups according to 
study size was performed. Large was defined as a sample size of >_50 subjects (there is 
evidence that this is the minimum desirable study size for a comparison of diagnostic 
methods.130 For CT angiography, there was not a substantial difference between the 5 "large" 
and the 11 "small" studies with an accuracy per subject of 94% for large studies and of 90% 
for small studies- see table 2.1.4. 
For MR angiography, per subject the 14 smaller studies had a substantially higher PPV 
(97 %) and a substantially lower NPV (66 %) than the six larger studies, which had a PPV of 
89% and an NPV of 89 %. Per aneurysm, the larger MRA studies had a substantially higher 
specificity (97 %) and NPV (87 %), than did the smaller studies, which had a specificity of 83% 
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and an NPV of 45 %- see Table 2.1.4. Overall accuracies were not significantly different. 
Therefore these data for CTA and MRA do not support the hypothesis that a preponderance of 
small studies results in substantial bias leading to erroneously optimistic results for the 
diagnostic performance of non -invasive imaging methods. 
e) Related to aneurysm size 
We were able to extract adequate data to perform an analysis of sensitivity according 
to aneurysm size aneurysm for twelve CTA and twelve MRA studies. An additional two MR 
angiography studies provided a size breakdown very different from those in the other studies 
and in two further studies only a partial breakdown of detection according to size was given. 
The results of this analysis clearly showed that the sensitivity for aneurysm detection 
was significantly different (p <0.001) between aneurysms with a maximum dimension of 3mm 
and those aneurysms larger than 3mm. A substantial difference in sensitivity was not found 
between aneurysms 3 to10mm in maximum diameter and those 10mm or larger- see Table 
2.1.5. Unfortunately, adequate data were not available to directly compare performance in 
very small aneurysms ( <3mm) with small (3 -5mm) or medium to large aneurysms (5 1mm or 
larger), which are more clinically useful size groupings to aid planning of treatment (and 
relating it to the rupture risk in the case of an unruptured aneurysm). 
f) Related to aneurysm site 
Both CT angiography and MR angiography were each marginally more accurate at 
depicting posterior circulation aneurysms than at depicting anterior circulation ones but the 
differences were small and did not reach statistical significance- see Table 2.1.6. This 
difference may have been confounded by different aneurysm size distribution between anterior 
and posterior circulation aneurysms, but there were insufficient data to perform this subgroup 
analysis. The sensitivities for the detection of posterior circulation aneurysms were slightly 
lower than those for the detection of anterior circulation aneurysms: 88% (44 of 50; 95 %CI 
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76 -95 %) versus 92% (367 of 399; 95 %CI 89 -94 %) for CT angiography and 82% (46 of 56; 
95% CI 70 -91 %) versus 90% (410 of 456; 95% CI 87 -93 %) for MR angiography. This simply 
may have been because the posterior circulation aneurysms were located outside the examined 
volume in some cases (i.e. posterior inferior cerebellar or vertebral artery aneurysms). 
However the NPV was substantially better for posterior circulation aneurysms than for 
anterior circulation aneurysms for both CTA and MRA - see Table 2.1.6. The specificity for 
depiction of posterior circulation aneurysms was also slightly better than for anterior 
circulation aneurysms. 
A subanalysis of anterior circulation aneurysm detection in different locations was 
performed. Data on detection by site could be extracted for 11/16 (69 %) CTA and 16/20 
(80 %) MRA studies. There were considerable differences between studies with regard to how 
data were presented for aneurysm site: In some studies broad categories such as "internal 
carotid artery" or "middle cerebral artery" were used, whereas in others, more specific data 
were given. It was possible to extract data for anterior circulation aneurysms for six anatomic 
sites as follows: anterior communicating arterial aneurysms, "other" anterior cerebral arterial 
aneurysms, middle cerebral arterial aneurysms, posterior communicating arterial aneurysms, 
ophthalmic arterial aneurysms and "other" internal carotid arterial aneurysms. Thus, three of 
the six categories were broad anatomical groupings. The sensitivity of the imaging techniques 
for aneurysm detection by location was analysed independently. These results are also 
summarised in Table 2.1.6. Several studies did not provide details of site (and/or size) of false 
positive results. Therefore specificity, NPV and accuracy could not be calculated. 
With CT angiography, sensitivity was poorest for the detection of "other" anterior 
circulation aneurysms- 73% (11 of 15; 95% CI 45 -92 %). The next poorest sensitivity was for 
the detection of "other" internal carotid arterial aneurysms- 88% (50 of 57; 95% CI 76 -95 %). 
Because of the relatively small numbers of aneurysms in each site category, the CIs were wide 
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and overlapping. The relatively poor sensitivity for the detection of "other" anterior cerebral 
arterial aneurysms was probably because in cases where only the circle of Willis was 
examined (58% of all studies), the aneurysm could have been outside the examined volume. 
The terminal and intra- cavernous carotid regions are adjacent to bone, and, thus, aneurysms in 
these areas, particularly smaller ones, are difficult to visualise clearly at CT angiography. 
With MR angiography, sensitivity was poorest for the detection of posterior 
communicating artery aneurysms (41 of 50; 95% CI 69 -91 %) and the "other" ICA aneurysms 
(88 of 107; 95% CI 74 -89 %)- both 0.82 %. But again the differences between sites were small. 
The poorer detection at these two sites may have been due to the difficulty of detecting 
aneurysms, particularly small ones, at sites like these with marked vessel tortuosity and 




The results of our analysis of information published between 1988 and 1998 show that 
CTA and MRA perform very similarly in the detection of intracranial aneurysms. This was 
true on both a per- subject (patient) and a per -aneurysm basis, with the overall diagnostic 
accuracy of both methods in each case approximating to 90 %. There were many fewer 
published studies on TCDS from which data could be extracted; those available suggested an 
accuracy per aneurysm of approximately 80 %. There was limited information on interobserver 
reproducibility achieved with CT angiography and MR angiography and none on that achieved 
with TCDS. 
Technological advancements in all three methods continue apace, and we did find a 
trend towards better performance in the CT angiography studies published after 1995 to those 
published before then, although the differences were small and not statistically significant. 
With MR angiography, the accuracy per subject was marginally worse after 1995- from 92% 
to 88 %- but marginally better per aneurysm- from 87% to 91 %, implying little, if any, real 
change with time. One would expect these non -invasive imaging methods to become more 
accurate as technological improvements continue. For example, although to our knowledge no 
studies of contrast material- enhanced ultrasound, three- dimensional ultrasound, or digital 
subtraction MRA that met our inclusion standards were published before the end of 1998, all 
these advances have been reported to improve diagnostic performance.75' 
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Direct comparisons between the performances of the non -invasive modalities - for 
example, CT angiography versus MR angiography, should be interpreted cautiously, because 
very few patients underwent two of the non -invasive examinations, which is the most valid 
way to make a true direct comparison. Any apparent differences between modalities could 
have been due, at least in part, to differences in the populations studied, in the size and 
distribution of aneurysms, and/or in other study variables. Many of the studies included in the 
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systematic review were quite small (even though studies with less than 10 subjects were 
automatically excluded) and only five CT angiography, six MR angiography and one TCDS 
studies included fifty or more subjects. 
The accuracy of the reference standard is a vitally important factor in any comparison 
of tests. We regarded the intra- arterial DSA result as definitive, even if it was subsequently 
proven to be incorrect. This was justified by the rarity with which a second angiogram showed 
a different result- in only seven of 1765 subjects included in the meta -analysis (0.4 %)- did a 
second angiogram reveal an aneurysm not detected by a first IADSA examination. 
The studies identified in the preparation of the systematic review generally provided 
excellent information on the imaging equipment and techniques used. But much less detail 
was provided regarding other important methodological items such as exclusion criteria, the 
number of patients excluded, the method and degree of blinding of reviewers, the exact images 
reviewed and interobserver variability- and these are all potential and important sources of 
bias as discussed earlier (section 2.1.1). A recurrent problem was difficulty in extraction of 
data from papers to allow presentation of true /false positive and negative results per patient 
and /or aneurysm in a 2 x 2 table format. This is the necessary first step in performing a SROC 
analysis. Data on aneurysm site and size were sometimes provided only for false negative or 
false positive findings; a breakdown by size and or site was often lacking for the majority of 
aneurysms (the true positives). 
It is has been reported that non -invasive tests are much poorer in the detection of 
aneurysms smaller than 3mm than in the detection of those larger than 3mm- for example, a 
sensitivity of 25% versus 92% was achieved by the best observer in one study.198 The results 
of the current meta -analysis support 3mm as a practical size cut off point, beneath which the 
sensitivity for aneurysm detection with CTA or MRA decrease sharply, from 96% to 61% and 
94% to 38% respectively- see table 2.1.5. 
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Furthermore, small aneurysms may occur more commonly in asymptomatic patients 
than in those who have had a SAH: Aneurysms less than 5mm diameter accounted for up to a 
third of all aneurysms in one study of asymptomatic patients with unruptured aneurysms.66 
This represents a much higher proportion of small aneurysms than that in the majority of CTA, 
MRA or TCDS studies that have mainly included patients with acute SAH. There is relatively 
little information on the accuracy of non -invasive imaging in the detection of small 
aneurysms, but the information that is available suggests that accuracy is poor. 
There is evidence that aneurysms arising from the posterior circulation (i.e., 
intracranial vertebral arteries and basilar artery and its branches, including the posterior 
cerebral arteries) are at an increased risk of rupture compared to aneurysms arising from the 
anterior circulation (i.e., aneurysms arising from internal carotid arteries or its branches, 
including the posterior communicating arteries) 27' 73 and that if they do rupture, the outcome is 
poorer.133 Therefore the detection of the subgroup of posterior circulation aneurysms is 
particularly important. 
Judging from the results of this meta -analysis, the possibility of using non -invasive 
modalities to screen for an aneurysm may be attractive to physicians confronted by worried 
relatives of patients with a SAH. However, we believe that considerable caution is required in 
extrapolating data from this meta -analysis, in which the overall accuracy of CTA and MRA 
appeared encouraging, to the circumstances of screening when there would be a low aneurysm 
prevalence. Prevalence, even in at risk subgroups, would probably be in the region of 5% and 
no more than 10 %.27' 28, 65, 68 Only one study included in this systematic review had an 
aneurysm prevalence in this range;208 therefore, a subgroup analysis of studies with a truly 
low aneurysm prevalence compared with high -prevalence studies could not be performed. 
Only seven of the 38 studies did not include patients known to harbour an intracranial 
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aneurysms or presenting with recent acute SAH, and twenty (53 %) studies focussed almost 
exclusively on this patient group. 
Why is aneurysm prevalence matter so important? There are a number of reasons. 
When there is a high suspicion of an aneurysm being present, a high estimate of accuracy 
could result due to observer expectation bias. In SAH patients, the distribution of subarachnoid 
blood may be a strong clue to the presence and/or site of an aneurysm, as may a local 
haematoma or the presence of hydrocephalus. Furthermore, the results of a recent theoretical 
analysis suggest that increasing disease prevalence can lead to an apparent improvement in the 
sensitivity and specificity of a diagnostic examination.177 Whereas previously it had been 
thought that increasing prevalence influenced only the predictive values and not the sensitivity 
and specificity of an examination.177 Thus, high prevalence may introduce patient cohort bias 
(spectrum and population) as well as observer expectation bias. 
In clinical practice, there is usually a single reader of a diagnostic study, whereas in 
some of the studies in the systematic review, there was a consensus view by two or more 
readers in the analysis of accuracy, which could have resulted in a positive bias toward the 
non -invasive methods. These factors, coupled with publication bias and the other 
methodological problems outlined, suggest that the accuracy of the non -invasive examinations 
applied to models of the screening situation (90 %) might have been over- estimated.146' 155 
Furthermore, it is worth noting that the negative predictive values were poorer than all the 
other results: The values per subject were 80% for CTA and 84% for MRA (see table 2.1.3). 
When considering the use of any examination in the context of screening, a high NPV is just 
as critical as high sensitivity and specificity. 
In summary, there is very limited information about the accuracy of non -invasive 
imaging in the kind of subject likely to be screened. For the reasons outlined, it would be 
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incorrect to assume that the accuracy will equal that achieved in studies with a high prevalence 
of aneurysms and involving mainly symptomatic patients who have had a SAH. 
More data on non -invasive imaging tests in subjects with a low prevalence of 
aneurysms are required. When this has been done on a large scale it has been without 
comparison to DSA in the great majority of patients, so limited information on comparative 
diagnostic performance was provided.66' 144 Large, prospective, blinded studies of non- 
invasive imaging in patients undergoing angiography but without recent acute SAH are needed 
to clarify the present uncertainty, although such studies may be difficult to achieve. The small 
sample size in many of the published studies may increase the effect of random chance. 
Publication bias is also possible as studies in which the non -invasive test performed poorly 
may not have been submitted and/or published. 
A comparison of the different methods of reviewing the images obtained with the 
various techniques is needed. There is some evidence that interactive workstation 
reconstruction and interpretation by the radiologist are more accurate than review of only film 
hard -copy images.216 However, workstation reconstruction is time consuming, and it is not 
clear if the extra time taken is justified by the increased diagnostic yield and whether the 
workstation reconstruction can be adequately performed by a technician or needs to be done 
by the reporting radiologist. 
Although technology is continually advancing, it takes time for new methods to filter 
through to general clinical practice. Therefore this systematic review is relevant to the 
technologies likely to be available in most institutions now. New technologies like contrast - 
enhanced MR angiography with or without digital subtraction or manipulation of K -space 
filling must be rigorously evaluated before they are adopted into routine clinical practice. 
Importantly, this systematic review can provide a benchmark to judge new technologies by. 
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In Conclusion 
In the populations studied in this meta -analysis, most of which had high aneurysm 
prevalence, CTA and MRA had very similar diagnostic performances in the detection of 
intracranial aneurysms, with an accuracy of approximately 90 %. The NPV was substantially 
lower, particularly per aneurysm. Sensitivity was significantly poorer for the detection of 
aneurysms less than 3mm, and although CT angiography (61 %) performed better than did MR 
angiography (38 %), the 95% CIs overlapped. At present, data are too limited to determine 
confidently the accuracy of the non -invasive methods when they are used for screening. 
The systematic review has identified that more data are particularly needed in the 
following areas: 
Direct comparison between CT and MR angiography performed in the same subjects 
Diagnostic performance of all modalities in subjects with low aneurysm prevalence 
Effect of observer experience on diagnostic performance 
TCDS data in general are very limited compared with CT or MR angiography 
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Search strategy of electronic databases used for CT Angiography 
(EMBASE & MEDLINE) - 599 records met the search criteria in EMBASE 
Search History Results Display 
1 Computer assisted tomography/ j 91616 j Display 
2 angiogra$.ti, ab, hw, tn, mf. 
j 
58701 ¡ Display 
3 1 and 2 8863 I Display 
(CTA or C1' angiogra$ or compute$ assisted 
4 tomo$ angiogra$ or compute$ tomo$ 7837 Display 
angiogra$).ti, ab, hw, tn, mf. 
5 3 or 4 
limit 5 to (human and (adult < 18 to 64 years j 
6 
> or aged < 65 years >)) 
*Cerebrovascular disease /ep, et 
[Epidemiology, Etiology] 
Subarachnoid hemorrhage/ 
Intracranial aneurysm/ or brain artery 
aneurysm/ or brain artery aneurysm rupture/ 
(subarachnoid hemorrhag$ or subarachnoid 







(intrac$ aneurys$ or intrac$ aneurys$ rupture 
I I or intrac$ artery aneurys$ or intrac$ artery 2122 Display 
aneurys$ rupture).ti, ab, hw, tn, mf. 
(cerebral aneurys$ or cerebral aneurys$ 
12 rupture or cerebral artery aneurys$ or cerebral 
artery aneurys$ rupture).ti, ab, hw, tn, mf. 
13 (berry 
aneurys$ or berry aneurys$ rupture).ti, 
ab, hw, tn, mf. 
(brain aneurys$ or brain aneurysS rupture or 
14 brain artery aneurys$ or brain artery aneurys$ 
rupture).ti, ab, hw, tn, mf. 
(cerebral aneurys$ bleed$ or cerebral artery 
aneurys$ bleed$ or intrac$ aneurys$ bleed$ 










aneurys$ bleed$ or brain artery aneurys$ 
bleed$).ti, ab, hw, tn, mf. 
16 exp Subarachnoid hemorrhage/ 5294 Display 
17 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 10171 Display 
18 
limit 17 to (human and (adult < 18 to 64 4182 Display 
years > or aged < 65 years >)) 
*Cerebrovascular disease /ep, et 579 Display 
[Epidemiology, Etiology] 
20 17 or 19 10719 Display 
21 
limit 20 to (human and (adult < 18 to 64 4478 1 Display 
years > or aged < 65 years >)) 
1 
22 6 and 21 r 665 [ Display 
23 limit 22 to yr =1988 -1999 ¡ 599 Display 
Figure 2.1.4 
Results of CTA search strategy for MEDLINE - 884 records met search criteria 
Search History I Results , Display 
1 :Tomography, x -ray computed/ 97622 Display 
2 (CT or COMPUTE$ TOMOGR$).ti, ab, sh. 1 93721 Display 
3 1 or 2 ? 133489 Display 
4 Angiography/ 31660 Display 
(ANGIOGR$ or DSA or IADSA or 
DIGITAL SUBTRACTION ANGIOG$ or 
INTRA ARTERIAL DIGITAL 
SUBTRACTION ANGIO$ or ARTERIOG$ 
or DIGITAL SUBTRACTION 
ARTERIO$).ti, ab, sh. 
89807 Display 
6 ''4 and 5 x31660 Display 
7 4 or 5 ' 89807 Display 
,(CEREBR$ or INTRACEREBRS or 
8 INTRACR$ or CIRCLE OF WILLIS).ti, ab, 298885 Display 
'sh. (_ 
9 7 and 8 i 14964 Display 
10 3 and 9 ( 4643 Display 
11 (CTA 
or CT angio$ or compute$ tomogr$ 2082 Display 
angio$).ti, ab, sh. 
12 10 or 1 l 6289 Display 
limit 12 to (human and (adult < 19 to 44 
13 years 
> or middle age < 45 to 64 years > or 4285 Display 
"aged < 65 and over >" or "aged, 80 and 
over")) 
i{ 




Cerebral aneurysm/ or cerebral artery 24886 [-Display 
diseases/ or cerebral hemorrhage/ 
16 Subarachnoid hemorrhage/ i 7483 Display 
17 'Cerebral aneurysm/ 
j 
10275 rDisplay 
(subarachnoid hemorrhag$ or subarachnoid 
18 
haemorrhag$).ti, ab, sh. ¡ 
9149 Display 
(intrac$ aneurysm$ or intrac$ aneurysm$ ¡ 
T 
19 rupture or intrac$ artery aneurysm$ or intrac$ j 2549 Display 
'artery aneurysm$ rupture).ti, ab, sh. 
(cerebral aneurysm$ or cerebral aneurysm$ 
20 rupture or cerebral artery aneurysm$ or 10448 Display 
cerebral artery aneurysm$ rupture).ti, ab, sh. 
21 (berry 
aneurysm$ or berry aneurysm$ 142 Display 
rupture).ti, ab, sh. 
(brain aneurysm$ or brain aneurysm$ rupture 
22 or brain artery aneurysm$ or brain aretery 28 Display 
aneurysm$ rupture).ti, ab, sh. 
(cerebral aneurysm$ bleed$ or cerebral 
aretery aneurysm$ bleed$ or intrac$ 
aneurysm$ bleed$ or intrac$ artery 
23 
aneurysm$ bleed or brain aneurysm$ bleed$ 
10 Display or brain artery aneurysm$ bleed$ or intrac$ 
aneurysm$ hemorrhag$ or cerebral 
aneurysm$ haemorrhag$ or brain aneurysm$ 
hemorrhag$).ti, ab, sh. 
24 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 29995 f Display or 23 
limit 24 to (human and (adult < 19 to 44 F 
25 years > or middle age < 45 to 64 years > or 17668 Display "aged < 65 and over >" or "aged, 80 and 
over ")) 
26 13 and 25 
27 limit 26 to yr=1988 -1998 
1347 Display 
884 - Display 
17A 
Figure 2.1.5 
Search strategy of electronic databases for MR Angiography 
- 356 records met the search criteria in EMBASE 
Search History 
Magnetic Resonance Angiography/ 
Results Display 
1037 Display 
(magnetic and resonance and angiograph$).ti, 5729 Display 
'ab, hw, tn, mf. 
3 mra.ti. ab, hw, tn, mf. 754 Display 
4 mr angiograph$.ti, ab, hw, tn, mf. 1009 Display 
'magnetic resonance angiograph$.ti, ab, hw, 
5 'tn, mf. 
4258 Display 
6 1 or 2 or 3 or 4 or 5 5967 Display 
limit 6 to (human and (adult < 18 to 64 years 
7 
3291 Display 
> or aged < 65 years >)) 
8 




-9 Subarachnoid hemorrhage/ 5294 Display 
10 
Intracranial aneurysm/ or brain artery 4352 Display 
aneurysm/ or brain artery aneurysm rupture/ 
I I 
(subarachnoid hemorrhag$ or subarachnoid 6364 Display 
haemorrhag$).ti, ab, hw, tn. mf 
(intrac$ aneurys$ or intrac$ aneurys$ rupture 
12 or intracS artery aneurys$ or intrac$ artery 2122 Display 
aneurys$ rupture).ti. ab, hw, tn. mf. 
(cerebral aneurys$ or cerebral aneurys$ 
13 rupture or cerebral artery aneurys$ or cerebral 1609 Display 
artery aneurys$ rupture).ti, ab, hw, tn, mf. 
14 
(berry aneurys$ or berry aneurys$ rupture).ti, 95 
lab, hw, tn, mf. 
Display 
'(brain aneurys$ or brain aneurys$ rupture or 
15 brain artery aneurys$ or brain artery aneurys$ 4994 , Display 
rupture).ti, ab, hw, tn, mf. 
(cerebral aneurys$ bleed$ or cerebral artery 
aneurys$ bleed$ or intrac$ aneurys$ bleed$ 
16 or intracS artery aneurys$ bleeds or brain 
aneurys$ bleed$ or brain artery aneurys$ 
bleed$).ti, ab, hw, tn, mf. 
95 Display 
17 exp Subarachnoid hemorrhage/ 5294 Display 
18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 10171 Display 
19 ;limit 18 
to (human and (adult < 18 to 64 
;years > or aged < 65 years >)) 
4182 Display 
20 ¡ *Cerebrovascular disease /ep, et 579 Display 
1[Epidemiology, Etiology] 
'21ï 18 or 20 10719 1 Display --- -' 
22 limit 21 to (human and (adult < 18 to 64 4478 Display 
years > or aged < 65 years >)) 
23 17 and 22 J 359 Display 
24 limit 23 to yr =1988 -1999 356 Display  P 
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Figure 2.1.5 continued 
Results of MRA search strategy for MEDLINE - 351 records met the search criteria 
Search History 
1 Magnetic Resonance Angiography/ 
(MRA or MR angiogr$ or magnetic 
resonance angiogr$).ti, ab, sh. 
magnetic resonance.ti, ab, sh. 
(angiogr$ or arteriogr$ or DSA or IADSA or 
4 digital subtraction angiogr$ or intra- arterial 
subtraction angiogrS).ti, ab, sh. 





1 or 2 or 5 
Cerebral aneurysm/ or cerebral artery 
diseases/ or cerebral hemorrhage/ 
8 Subarachnoid hemorrhage/ 
9 Cerebral aneurysm/ 
(subarachnoid hemorrhag$ or subarachnoid 













47330 [ Display 
89711 Display 
3451 ¡ Display 
5017 j Display 
24886 r Display 
7483 r Display 
10275 r Display 
9149 , 
(intrac$ aneurysm$ or intrac$ aneurysmS 
rupture or intrac$ artery aneurysm$ or intrac$ 
artery aneurysm$ rupture).ti, ab, sh. 
(cerebral aneurysmS or cerebral aneurysm$ 
rupture or cerebral artery aneurysm$ or 
cerebral artery aneurysm$ rupture).ti, ab, sh. 
(berry aneurysm$ or berry aneurysm$ 
rupture).ti, ab, sh. 
(brain aneurysm$ or brain aneurysm$ rupture 
or brain artery aneurysm$ or brain aretery 





(cerebral aneurysms bleed$ or cerebral 
aretery aneurysm$ bleed$ or intrac$ 
aneurysm$ bleed$ or intrac$ artery 
aneurysm$ bleed or brain aneurysm$ bleed$ 
or brain artery aneurysm$ bleed$ or intrac$ 
aneurysm$ hemorrhag$ or cerebral 
aneurysm$ hacmorrhag$ or brain aneurysm$ 
hcmorrhag$).ti, ah, sh. 
16 7or8or9or10or11or 12or13or14or15' 
limit 16 to (human and (adult < 19 to 44 
17 years > or middle age < 45 to 
64 years > or 
"aged < 65 and over >" or "aged, 80 and 
over ")) 
18 6 and 17 
19 limit 18 to yr =1988 -1998 
10 Display 
29995 Display 





Search strategy of electronic databases used for Transcranial Doppler sonography 
- 145 records met the search criteria in EMBASE 
1 
2 '(ultrasonog$ or echograp$).ti, ab, hw, tn, mf. ¡ 63144 Display 
3 transcranial.ti, ab, hw, tn, mf. ¡ 3185 ¡ Display 
_. .._-___-._____ __ ..---___.__. .---._ ___._._. 
Display 4 
5 
Search History Results 
I 
Display 
exp Echography / 85930 ( Display 
3 and 4 
(transcranial doppler or TCD).ti, ab, hw, tn, 
6 ' 1993 Display 
993 { Display 
7 5 or 6 ` 2086 ' Display 
8 
limit 7 to (human and (adult < 18 to 64 years 
1266 Display 




* Ccrebrovascular disease /ep, et 
J Epidemiology, Etiology] i 
Display 579 
Subarachnoid hemorrhage/ ! 5294 Display 
Intracranial aneurysm/ or brain artery ! - 
aneurysm/ or brain artery aneurysm rupture/ ; 
4352 Display 
(subarachnoid hemorrhag$ or subarachnoid 
12 haemorrhag$).ti, ab, hw, tn, mf. 
6364 
(intrac$ aneurys$ or intrac$ aneurys$ rupture 
13 or intrac$ artery aneurys$ or intrac$ artery 2122 ! Display 





(cerebral aneurys$ or cerebral aneurys$ 
rupture or cerebral artery aneurys$ or cerebral' 1609 ¡ Display 
artery aneurys$ rupture).ti, ab, hw, tn, mf. ( 
(berry aneurys$ or berry aneurys$ rupture).ti, 95 Display 
ab, hw, tn, mf. 
(brain aneurys$ or brain aneurys$ rupture or 
brain artery aneurys$ or brain artery aneurys$ 4994 j Display 
rupture).ti, ab, hw, tn, mf. } j 
(cerebral aneurys$ bleed$ or cerebral artery ; ! 
aneurys$ bleed$ or intrac$ aneurys$ bleed$ 
17 or intrac$ artery aneurys$ bleed$ or brain 95 Display 
aneurys$ bleed$ or brain artery aneurys$ 
bleed$).ti, ab, hw, tn, mf. 
18 exp Subarachnoid hemorrhage/ 1 5294 Display 
19 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 10171 r Display 
20 
limit 19 to (human and (adult < 18 to 64 4182 Display 
years > or aged < 65 years >)) 
*Cerebrovascular disease /ep, et 579 Display 
[Epidemiology, Etiology] 




limit 22 to (human and (adult < 18 to 64 4478 Display 
years > or aged < 65 years >)) 
24 8 and 23 i 147 I Display 
25 .limit 24 to yr =1988 -1999 i 145 Display 
Figure 2.1.6 continued 
Results of TCDS search strategy for MEDLINE- 204 records met the search criteria 
l 
2 
Search History Results Display 
U|truxuuugrupby/ 28967 Display 
(ultrasound or ultrasono$).ti, ab, sh. 83627 
- - D__ 
(TCDmtranscranüúultraso$ortrauscamial 




6 4 and 5 
7 2 and 5 
8 l and 5 
(power -- --'-'- ultraso$).ti, ' 169 Display zy -_
uuooruuiul.óL sh. u6, 3314 ,- D¡spúar 
limit 9 to (human and (adult < 19 to 44 years 
| 
65 and over >"ur"uQcd,8O and over")) 
Cerebral aneurysm! or cerebral artery 
diseases/ or cerebral hemorrhage/ 
12 8uhuraobuoidhcmoobugc/ 
13 Cerebral aneurysm/ 
(subarachnoid or subarachnoid 
hxem ).ó.o6,xh. 
|5 rupture or intrac$ artery or intrac$ 
artery aneurysm$ rupture).ti, ab, sh. 
(cerebral aneurysm$ or cerebral aneurysm$ 
16 rupture or cerebral artery aneurysm$ or 10448 
cerebral artery aneurysm$ rupture).ti, ab, sh. 
_- (berry uucuryuo$orbcr'uocuryxoz3 
17 ( 142 cupku\Ú.xk 
(brain aneurysmS or brain aneurysmS rupture 
18 or brain artery aneurysm$ or brain aretery ( 28 
aneurysm$ rupture).ti, ab, sh. 
|l 
14 

















(cerebral bleedS or cerebral 
aretery bleod3o«intruu0 
aneurysm$ bleed or brain bleed$ 
or brain artery aneurysm$ bleed$ or intrac$ 
aneurysm$ hem or cerebra 
uneuryxnn$boonmurrbag$or brain u000ry0003 
bconoo6agS)1i, ab, ob. 
11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 
[ 
o _ _ _'__ - --- 
limit 20 to (human and (adult < 19 to 44 
21 
years .>m-de a<45.64ys > or 17668 Display and over >" or 80 and 
over")) 
22 \0 and 2} 217 Display 




Distribution of quality scores for studies included in and excluded from the 
systematic review of non -invasive imaging of intracranial aneurysms 
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Figure 2.1.10: Forrest plots of sensitivity and specificity per patient for 
CTA studies included in systematic review 
SENSITIVITY 
















0 0.2 0.4 0.6 0.8 1 
Figure 2.1.11: Forrest plots of sensitivity and specificity per patient for 
MRA studies included in systematic review 
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Figure 2.1.12 Forrest plots of sensitivity and specificity per aneurysm for CTA studies 
included in systematic review 
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Figure 2.1.13 Forrest plots of sensitivity and specificity per aneurysm 
for MRA studies included in systematic review 
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Figure 2.1.14 Forrest plots of sensitivity and specificity per aneurysm for 
TCDS studies included in systematic review 
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Data extracted from studies meeting primary inclusion criteria 
Appraisal Section Subsections Weighting 
Category (Low /Medium/High) 
Number in study with DSA for comparison L 
Study population adequately defined H 
Study population M 
Radiologist in authorship L 
Equipment used M 
Study design and Scan parameters adequately described (3 -4 items H 
examination methodology depending upon the non -invasive modality) 
Contrast usage L 
Complications assessed M 
Complication rate L 
Full anatomical coverage (of all potential IA sites) H 
Clear and adequate description of image H 
reconstruction techniques used 
Exclusion criteria stated H 
Numbers excluded stated M 
Image review process Blinding of readers explicitly stated H 
Details of image data available for review H 
No. of independent readers M 
Interobserver variability assessed M 
Interobserver variability rate L 
Prevalence of aneurysms on DSA M 
Distribution of aneurysms (site and size) M 
Presentation of result data Number of true positives for non -invasive test H 
(per patient and per aneurysm) 
Number of false positives H 
Number of false negatives H 
Number of true negatives H 
DSA- digital subtraction angiography 
IA- intracranial aneurysm 
Primary inclusion criteria: study from 1988 -1998 comparing a non -invasive test to 
IADSA in at least 10 adult subjects who had both examinations contemporaneously 
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- digital subtraction angiography 
Table 2.1.3 
Diagnostic test performance per subject and per aneurysm by imaging modality 





All studies with extractable 
data (2/4, 54 patients) 
Sensitivity 0.92 (338/366) 0.87 (424/486) - 
(95% Confidence Interval) (0.89 -0.95) (0.84 -0.90) 
Specificity 0.94 (113/120) 0.92 (334/365) - 
(0.88 -0.99) (0.88 -0.94) 
Positive Predictive Value 0.98 0.93 - 
Result per (PPV) (0.96 -0.99) (0.90 -0.95) 
Patient Negative Predictive Value 0.80 0.84 - 
(NPV) (0.73 -0.86) (0.80 -0.88) 
Accuracy 0.93 0.89 - 
(0.90 -0.95) (0.87 -0.91) 
Likelihood Ratio 15.84 10.28 - 
Sensitivity 0.90 (615/681) 0.87 (501/575) 0.82 (36/44) 
(0.88 -0.92) (0.84 -0.90) (0.67 -0.92) 
Specificity 0.86 (132/154) 0.95 (253/267) 0.70 (7/10) 
(0.79 -0.91) (0.91 -0.97) (0.35 -0.93) 
PPV 0.97 0.97 0.92 
Result per (0.95 -0.98) (0.95 -0.99) (0.79 -0.98) 
Aneurysm NPV 0.67 0.77 0.47 
(0.60 -0.73) (0.72 -0.82) (0.21 -0.73) 
Accuracy 0.89 0.90 0.80 
(0.87 -0.91) (0.87 -0.92) (0.66 -0.89) 
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Subgroup analysis: sensitivity per aneurysm
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Subgroup analysis: detection of aneurysm
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Summary of Part Two Chapter One 
The rationale and development of systematic reviews is described. 
The methodology used in this systematic review is described in detail. 
In high aneurysm prevalence populations, CTA and MRA have very similar diagnostic 
performance, with an accuracy of approximately 90 %. 
Detection of aneurysms <3mm in maximum angiographie dimension was significantly 
poorer than the detection of aneurysms larger than 3mm. 
In small aneurysms, there is a trend for CTA to have greater sensitivity than MRA. 
Data in the literature on TCDS were extremely limited 
Robust data on the effect of observer experience on diagnostic performance were lacking 
in the literature. 
Very few studies have directly compared the available non -invasive techniques with each 




Reports the results of the prospective studies of non -invasive imaging modalities in the 
detection of intracranial aneurysms (SAGE study) 
2.2.1 CT Angiography: Materials, methods and overall CTA results 
2.2.2 MR Angiography: Materials, methods and overall MRA results 
2.2.3 Direct comparison of CT versus MR Angiography 
2.2.4 Transcranial Power Doppler Sonography (TCDS) 
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2.2.1 CT Angiography The aims of the SAGE study are detailed fully in section 2.1.1 
Patient recruitment (this section also applies to MR Angiography and TCDS) 
The study was conducted in two regional neuroscience centres serving a population of 
approximately four million. Approval for the study was obtained from the appropriate hospital 
ethics committees (Southern General Hospital Ethics Committee and Lothian Regional Ethics 
Committee). Written informed consent was obtained from all participants. Patients undergoing 
cerebral angiography for the detection of a possible intracranial aneurysm on clinical grounds 
were eligible for inclusion. Patients did not have a cerebral angiogram in order to participate in 
the study. 
Exclusion criteria were patients with a poor grade of subarachnoid haemorrhage 
(World Federation of Neurosurgeons Grade 4 or worse) because obtaining informed consent 
was difficult or not possible. Patients with an absolute contraindication to one of the 
examinations were also excluded from the study- for example, a pacemaker, ferromagnetic 
aneurysm clip or cochlear implant would be an absolute contraindication to MR Angiography. 
Patients presenting with acute aneurysmal SAH who were treated before non -invasive imaging 
could be performed were also not eligible for inclusion, firstly because if the treatment was 
clipping, MRA was relatively contraindicated and secondly the location of the treated 
aneurysm would be obvious on CTA and MRA. Patients younger than 18 or older than 75 
years of age were also excluded. These are regarded as vulnerable groups by the Ethics 
Committees and it was not felt that special justification should be made for their inclusion as 
very few patients outside the age group 18 -75 undergo cerebral angiography to look for the 
presence of an intracranial aneurysm. 
Two hundred consecutive patients meeting the inclusion criteria and who agreed to 
participate were recruited prospectively between November 1997 and April 1999 (eighteen 
months in total). The intention was that patient recruitment should as far as possible be 
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consecutive, although for the weeks when I, as the Research Fellow, was on holiday, it was 
not possible for every eligible patient to be approached. Furthermore, in a few cases, patients 
who had consented to enter the trial were then treated before any of the non -invasive 
investigations could be performed. These patients were therefore excluded and were not 
counted amongst the two hundred finally recruited. However, the numbers in this category 
were relatively small- eight in Glasgow and six in Edinburgh, or less than one per month over 
the course of the recruitment period. 
During the period of the SAGE study 520 patients were admitted to the two centres 
with known aneurysm or suspected SAH (patient groups 1 -3 as described below) for cerebral 
angiography. Of these, around 2/3 (360) were eligible for the study- i.e. were aged 18 -75, not 
pregnant and in a good enough WFNS grade. Reasons for non -inclusion in the study included 
inadequate time prior to aneurysm treatment (which was often performed within 24 hours of 
presentation) and patient refusal. The patients admitted and treated following aneurysmal SAH 
before they could even be approached to enter the study were of course ineligible. This 
number was difficult to quantify precisely. But when this problem was quantified over a three 
month period at the start of the SAGE study, it was found to apply to, on average, one patient 
per week in Glasgow and slightly more in Edinburgh, giving an approximate figure of 150 
ineligible on grounds of very early treatment for both centres combined over the duration of 
SAGE study recruitment. 
All patients had to have completed cerebral angiography to be eligible for the SAGE 
study. In total, 173 of the 200 patients underwent CT Angiography (50 in Edinburgh, 121 in 
Glasgow and two in Ayr) as well as IADSA. 
Patients were grouped into 4 categories based on the clinical indication for cerebral 
angiography. Group 1 comprised patients with a known aneurysm(s) undergoing further 
assessment; Group 2 comprised patients with proven SAH; Group 3 comprised patients with 
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symptoms which might be due to an aneurysm and Group 4 comprised asymptomatic patients 
at risk of harbouring an aneurysm. For the purpose of subsequent subgroup analysis of 
accuracy by clinical category, group 1 was combined with group 2 and group 3 with group 4. 
Only 25 patients falling into category 4 were examined in Glasgow or Edinburgh with cerebral 
angiography during the course of the SAGE study and nearly all (23) were recruited into the 
study. 
Timing of examinations 
Imaging studies were performed contemporaneously if at all possible, and within a 
maximum of two months from the time of IADSA. For CTA, 46% of examinations were 
performed within a week of the IADSA, a further 17% within two weeks and the remaining 
37% from 2 weeks to 2 months following IADSA. In all cases CTA was undertaken following 
IADSA. 
Image Acquisition 
The background to the development and use of non -invasive imaging modalities in the 
detection of intracranial aneurysms has been explored in some detail in Part One, Chapter 
Three. In this section only the specific CTA examination techniques used for the SAGE study 
will be described (and see sections 2.2.2 and 2.2.4 for MRA and TCDS techniques 
respectively). The examination protocols for the SAGE studies were developed from careful 
review of the literature and from clinical experience. I am particularly grateful to Dr DA 
Collie and Dr D Hadley as well as Dr E Teasdale and Dr JM Wardlaw for their helpful advice 
with regard to these protocols. 
Neuroradiologists performed all the IADSA examinations using GE Advantx 
angiographic equipment (IGE Ltd., Milawaukee, USA). IADSA studies were three or four 
vessel selective angiograms with multiple projections obtained for each vessel. The 
examinations were printed onto hard copy film for analysis. 
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Spiral CTA examinations were performed on an Elscint Twin (97 examinations) or a 
GE HiSpeed (50 examinations) machine. The acquisition volume was angled parallel to the 
superior orbitomeatal baseline with the inferior margin at the superior surface of posterior arch 
of Cl (to include the posterior inferior cerebellar arteries) and extended superiorly to above 
the level of the pericallosal arteries. Tube angulation avoided irradiation of the orbits as well 
as allowing inclusion of all usual aneurysm sites in the minimum examination volume- see 
earlier Figure, 1.3.11. One hundred millilitres (ml) of non -ionic contrast were given by pump 
injector into an antecubital vein at 3ml/sec with an 18 -20sec delay. The delay was increased if 
the patient was known to have significant haemodynamic impairment (in such cases a bolus 
tracking facility was employed). Examination parameters were: 120kV, maximum tube current 
allowed, 512x512 matrix, 15 cm FOV, 1mm collimation, and pitch of 1.5 with 0.5mm 
reconstruction interval. 
For logistical reasons (mainly scanner availability or patient illness), a small number of 
patients in Glasgow (26) had a non -spiral CTA performed on an Elscint 2400 Elite scanner. In 
these 26 subjects, conventional axial CTA was performed dynamically using 2.5 mm slice 
width with 1mm table increment, 120 kV, 400 mAs, 20 cm FOV. Scanning commenced after 
50 mis of contrast had been injected rapidly by hand with a further 50 mis injected during 
scanning.217 A neuroradiologist supervised all the CTA examinations. 
Postprocessing of Images 
Various post -processing techniques may be used to produce three -dimensional images 
of the vascular tree from the base data obtained. Figure 2.2.1 provides examples of CTA 
maximum intensity projection (MIP), multiplanar reformat (MPR), surface shaded display 
(SSD) and targetted MIP reconstructions on a patient with intracranial aneurysms. 
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The maximum intensity projection (MIP) is a non -linear ray tracing postprocessing 
algorithm. This algorithm only displays the highest signal pixel along each ray path, which in 
the case of an angiographic sequence is of course blood flowing in vessels. Multiple rays are 
traced to provide a comprehensive display of the intracranial vasculature. MIP reconstructions 
have the advantage that they are generally rapid and automated. However a small vascular 
structure behind a larger one- for example, an aneurysm next to the internal carotid artery, may 
be overlooked.218 Hence the need for multiple MIP projections to be obtained and reviewed to 
overcome this inherent problem. A shaded surface display (SSD) is a computer -generated 
model connecting pixels of a similar density set by the operator. This produces a visual cast 
with apparent depth and shading, which may help in aneurysm detection.219 Due to the 
relatively narrow range of threshold density that can be set following intravenous contrast 
enhancement, SSD can suffer from partial volume effects such that vessels are missed out or 
falsely connected to others. Volume rendering is a newer image reconstruction technique that 
allows the operator greater control over the reconstruction process and early reports indicate it 
to be superior to either MIP or SSD in the evaluation of the intracranial vasculature.22° 
Volume rendering offers excellent lighting and shading capabilities. However, it was not 
available on the Omnipro at the start of the SAGE study, nor was it available on the 
Advantage Windows workstation. Therefore this postprocessing reconstruction method was 
not used in the SAGE study. 
The standard reconstruction method used in MRA has been the MIP and possibly as a 
result of this, it has also become the favoured reconstruction method for CT Angiography. 
There is some evidence that MIP reconstructions are superior at aneurysm detection in vivo to 
SSD.216 But there is some conflicting in vitro evidence that SSD may be superior to MIP.221 
As the balance of in vivo evidence favoured the use of MIP reconstructions for CTA and these 
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were also to be used for the MRA examinations, we stuck to using MIPs in the CTA studies 
and did not perform SSD routinely. 
For CTA studies, the neuroradiology research fellow (PW) performed reformatting of 
source images on offline workstations, without review of the IADSA study prior to 
performing reformats. The workstations used were Silicon Graphics 02 Omnipro for Elscint 
CTA examinations or GE Advantage Windows 1.2 for CTA examinations performed on the 
GE Hi -Speed machine. Standard axial and coronal oblique plus curved sagittal multiplanar 
reformats were performed on the Omnipro? 17 These reconstructions are demonstrated in 
Figure 2.2.2 "Angio MIP" reconstructions were also performed as follows: twelve projections 
at 15° intervals in both superior to inferior ( "head over heels ") and left to right projections, 
with bone editing by thresholding and manual cutting- also see figure 2.2.1. Targeted MIPs 
were performed of the right and left internal carotid circulations and the vertebrobasilar 
system- see Figure 2.2.3. The total time taken for these reconstructions was typically 20 -25 
minutes. 
On the Advantage Windows workstation, axial, coronal oblique and sagittal 
overlapping thick slab MIP images (8 -10mm at 3 -4mm increments) were performed- see 
Figure 2.2.4, with additional manual bone editing as required. Reconstruction time was less 
than 10 minutes unless manual bone editing was required. Source images were printed so as to 
be available to reviewers. 
Image Review 
Each patient was randomly allocated a study number, known only to the research 
fellow. IADSA images were presented as hardcopy- anonymised and identified only by the 
study number (with name, date and clinicians details removed) - in random order for 
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independent review by two neuroradiologists, one from each centre (ET, JMW). Where 
disagreements arose these were resolved by consensus review. 
Hard copy films of the CTA and MRA studies were presented in a similar anonymised, 
random fashion to the same two neuroradiologists at least 4 months later. The CTA and MRA 
studies of any individual subject were also reviewed separately and at least a month apart. 
A coding form was completed for each imaging examination reviewed so that all the 
major intracranial vessel segments were systematically considered and an assessment made as 
to whether the vessels were adequately demonstrated. Aneurysm site and size were recorded - 
see Figure 2.2.5. 
Site was recorded as follows: 1= middle cerebral artery (MCA) mainstem, 2 =MCA 
bifurcation, 3= distal MCA, 4= anterior communicating artery complex, 5= Pericallosal, 6 =A1 
anterior cerebral artery (ACA) segment, 7= internal carotid artery (ICA) bifurcation, 
8= posterior communicating artery, 9= Ophthalmic, 10 =ICA siphon, 11 =Other ICA, 
12= Basilar, 13= posterior inferior cerebellar artery (PICA) and 14 =other (specified)- see 
Figure 2.2.6. For the purpose of subgroup analysis, sites were grouped together into four 
categories: ACA complex, MCA complex, ICA complex (including posterior communicating 
artery) and vertebrobasilar system. 
Size was recorded as a) <3mm maximum angiographic dimension, b) 3 -5mm, c) 5.1- 
10mm and d) >10mm. Observer confidence was assessed on a simple 5 point scale as reported 
by Atlas et al: 5= aneurysm definitely absent, 4= aneurysm probably absent, 3= uncertain, 
2= aneurysm probably present and 1= aneurysm definitely present. ' 98 
In a multicentre, multimodality study such as SAGE utilising several different pieces 
of imaging equipment there are a large number of variables introduced. We studied the effect 
of several of these that have been suggested to be relevant to diagnostic accurac 
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y,210 including 
spiral versus non - spiral CTA, availability of spin echo images for MRA and availability of 
targeted MIP reconstructions for CTA and MRA. 
Statistical Analysis 
For both observers, 2x2 tables were constructed of true positives, false positives, false 
negatives and true negatives as compared to IADSA. Sensitivity, specificity, positive and 
negative predictive values and accuracy were compared on a per patient (the ability to 
correctly discriminate a patient as true positive or true negative for possession of at least one 
intracranial aneurysm) and per aneurysm (the ability to correctly identify all aneurysms) basis. 
Exact 95% Confidence Intervals (CI) based on binomial probabilities were calculated.222 
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Results 
By far the most important CTA and MRA results produced by the SAGE study were 
those relating to the patients who underwent both non -invasive modalities as well as IADSA, 
thus allowing a meaningful direct comparison between the two techniques. Therefore it is that 
group of results that will be considered in some detail in section 2.2.3. Only basic results will 
be presented for CTA and MRA considered in isolation in sections 2.2.1 and 2.2.2 and 
Appendices 2.1 and 2.2 respectively. Also, as the most important discussion by far relates to 
that direct comparison of non -invasive modalities, discussion will be restricted to section 
2.2.3. 
For CTA, observers A and B had virtually identical sensitivities on both a per subject 
and a per aneurysm basis but observer B had slightly better specificity and hence overall 
accuracy. However, for all the performance parameters, differences between observers were 
small and confidence intervals overlapped widely - see Table 2.2.1 
The level of agreement between observers for CTA examinations on a per subject basis 
was good, bordering on very good, with a Kappa statistic of 0.79, 95% CI 0.78 -0.80. 
Agreement on a per aneurysm basis was moderate, bordering on good, with a Kappa statistic 
of 0.59, 95% CI 0.58 -0.60. 
The numbers of patients who had each of the non -invasive tests and a breakdown by 
clinical subgroup is provided in Figure 2.2.11 on page 234. 
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Figure 2.2.1 
Illustrative examples of the different types of image display techniques that are 
available for CT Angiograms 
Thick slab MIP 
Targetted MIP (other vessels removed) 
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Multiplanar reformat 
3D Surface shaded display 
Figure 2.2.2 
Examples of reconstructions obtained for CTA examinations performed on Elscint CT 
scanners. The top row are "Angio MIP" reconstructions in a) superior to inferior and b) right 
to left projections and on the bottom row are curved multiplanar reconstructions in c) coronal 
oblique and d) sagittal planes 
Right posterior communicating artery 
aneurysm 
Again the right posterior communicating artery aneurysm is demonstrated 
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Figure 2.2.3 
Targeted MIP views of a CTA examination: in this case the right ICA 
(same patient as in Figure 4.2.2) 
Axial projection Coronal s ro'ection 
RT 
19 
a ital rojection 
The importance of multiple projections is seen: the right posterior communicating 
artery aneurysm is not appreciated on the axial projection 
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Figure 2.2.4 
Examples of CTA thick slab MIP reconstructions obtained on GE HiSpeed 






SAGE - EXAMINATION REPORT - CTA 
Patient code Reader Spiral Date of reading 
Tick material available for review: Angio MW 
Was review performed using: Hardcopy only 













Normal anatomy (if 
No, specify by code) 













Normal anatomy (if 
No, specify by code) 















Normal anatomy (if 
No, specify by code) 









Remember to code fur:- a) anatomical abnormality b) aneurysm site c) aneurysm size d) confidence in report 
(see separate laminated sheet for list of codes) 
How difficult did you find it to read this examination? (please circle) 
1. very easy 2. easy 3. satisfactory 
How long did it take you to complete the reading? (please circle) 
I. 5 -10 mins 2. 10 -15 mins 3. 15 -20 mins 
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4. difficult 5. very difficult 
4. 20-30 mins 5. >30 in ins 
Figure 2.2.6 
Aneurysm site 
SAGE - EXAMINATION REPORT CODES 















1 < 2mm 
2 3 -5 mm 
3 6 -9 mm 
4 >_ 10 mm 
5 
6 Anatomical Abnormality 
7 Infundibulum 
8 Tortuousity ++ 
9 Fetal PCA 
10 ACA fed mainly from contralat.side 
11 Proximal MCA bifurcation 
12 Basilar ends in sup.cerebellar a. 
13 Vertebral artery ends in PICA 
14 Other 
Level of confidence in reportingpresence /absence of aneurysms: 
Definitely present 1 
Probably present 2 
Uncertain 3 
Probably absent 4 























































































































































 true negative 
FN
=
 false negative 
FP=
 false positive 
2.2.2 Magnetic Resonance Angiography 
Patient recruitment has been fully described in section 2.1.1. 
Image Acquisition 
High field strength (1.5 or 2 Tesla) scanners were used. In Edinburgh examinations 
were performed on the Elscint 2T Prestige research scanner once it was installed, but a few 
early SAGE entrants had MRA examinations performed on the Siemens 1.5T Magnetom SP 
machine. In Glasgow, as many outpatient examinations as possible were performed on an 
identical Elscint 2T Prestige machine at Ayr Hospital, but inpatients and those unable to travel 
were examined on the identical Siemens Magnetom in the Institute. A standard examination 
protocol was followed for each of the two MRI machine types used for the SAGE study. 
Elscint 2T Prestige 
3 -D TOF MRA sequences with MTS and TONE followed by T2 FSE Axial sequence 
were employed: 
1. Two 3D slabs of 58 mm volume were set up after running a localiser sequence: 
i) top of first slab was positioned at the level of the top of the corpus callosum 
ii) the top of the second slab overlapped the bottom of the first by 1 -1.5 cm 
3D TOF parameters: 1mm slice thickness (minimum allowed), TR = 40, TE = 6, Flip 
angle = 30 °, FOV = 15 x 20 -22 cm, Matrix: adjusted to 204 x 300 (from default 160 x 
256),NEX= 1,TA =6:11. 
2. A standard FSE T2 axial sequence was acquired. This needed 16 -18 slices to cover the area 
of interest, with a TA of 2:30. 
Whilst the T2 acquisition was running the standard MIP reconstructions were 
performed. From each MRA group the top and bottom 4 images were discarded (to eliminate 
wraparound artefacts), then MIP reconstructions were obtained in the superior to inferior and 
right to left planes every 15° through 180 °, i.e. 12 images per reconstruction (see Figure 2.2.7). 
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Targetted M1P images were subsequently performed on the offline Omnipro workstation 
(using methodology as described for CTA)- see Figure 2.2.8. 
SIEMENS 1.5T Magnetom 
The MR Angiographic sequence used was a 3 -D TOF MRA also with TONE & MTS. 
The patient was positioned with their chin tucked in as for CTA studies, then a single 64 mm 
slab angled to13° was set up. The slab volume was positioned so that the bottom of the slab lay 
on the superior aspect of the posterior arch of C 1 (thereby including the posterior inferior 
cerebellar arteries in the imaging volume). Only if the localiser suggested that this would not 
give sufficient anatomical coverage (i.e. pericallosal arteries were not included as well) was a 
dual slab technique used. 
3D TOF parameters: TR =43, TE =8, flip angle =20 °, FOV 200 mm, Matrix = 256/512, 
NEX =1, TA= 11.48. A T2 axial FSE sequence was then performed whenever possible (and for 
all patients with acute SAH) but due to time constraints in fitting these patients into the NHS 
Magnetom scanners, this could not be obtained in all cases. 
Standard MIP reconstructions were performed as for the Elscint machine at 15° 
intervals in superior to inferior and right to left projections through 180° intervals- see Figure 
2.2.9. As there was no offline workstation available for the Siemens MRI machines, targeted 
MIP reconstructions were not routinely performed. Source images were available for all MRA 
examinations. 
The postprocessing methods used, the image review process and statistical analyses 
performed were identical for CTA and MRA and have already been described in detail in 
section 2.2.1. The proforma review sheet for MR Angiographic examinations was very similar 
to that for CT Angiography- compare Figures 2.2.5 and 2.2.10. Reflecting the more limited 
access to MRI than CT, fewer MRA studies could be performed as contemporaneously - 40.5% 
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were performed within a week of the IADSA, a further 10% within two weeks and the 
remaining 49.5% between 2 weeks and 2 months following IADSA. Two MRA studies were 
performed as part of a clinical MRI examination and because an aneurysm was suspected, 




Again the most important MRA results produced by the SAGE study were those 
relating to the patients who underwent both CTA and MRA as well as IADSA. Therefore it is 
that group of results that is considered in some detail in section 2.2.3. Only basic results are 
presented for MRA in isolation - see Table 2.2.2 and Appendix 2.2. As for CTA, the two 
observers had very similar sensitivity and specificity results, with observer B again having 
slightly better specificity and hence overall accuracy. 
Interobserver agreement for MRA examinations on a per subject basis was very good, 
with a Kappa statistic of 0.80, 95% CI 0.79 -0.81, almost identical to the result for CTA. On a 
per aneurysm basis the agreement for MRA was good (better than that for CTA) with a Kappa 
statistic of 0.74, 95% CI 0.73 -0.75. 
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Figure 2.2.7 
Superior to inferior MIP reconstructions from MRA examination on Elscint Prestige from: 





MRA targeted MIP reconstructions of the right ICA performed from a top slab 






MIP reconstructions performed on Siemens Magnetom: 
a) superior to inferior projection 
b) right to left projection 
c) axial base image for comparison 
The right PCom artery aneurysm* has sluggish flow 
within it, so is only poorly seen on the time -of -flight 
images, but is well demonstrated on the base images - 
emphasising the importance of reviewing base as well as 
reconstructed images in MRA as well as CTA. 
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Figure 2.2.10 
SAGE - EXAMINATION REPORT - MRA 
Patient code Reader 1 or 2 Slab Date of reading 
Tick material available for review: MIP Targetted MIP BASE SE 
Was review performed using: Hardcopy only Workstation only Both 










Normal anatomy (if 
No, specify by code) 













Normal anatomy (if 
No, specify by code) 













Normal anatomy (if 
No, specify by code) 









Remember to code for:- a) anatomical abnormality b) aneurysm site c) aneurysm size d) confidence in report 
(see separate laminated sheet Jor list of codes) 
How difficult did you find it to read this examination? (please circle) 
I. very easy 2. easy 3. satisfactory 4. difficult 5. very difficult 
How long did it take you to complete the reading? (please circle) 
1. 5 -10 mins 2. 10 -15 mins 3. 15 -20 mins 
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 true negative 
FN
=
 false negative 
FP=
 false positive 
2.2.3 Direct comparison of CTA versus MRA in detection of intracranial aneurysms 
The rationale behind, and the importance of, this comparison has been outlined in the 
preface to part two, and in the discussion section of the systematic review- 2.1.5. The 
methodology of patient recruitment, performance of CTA and MRA examinations, image 
postprocessing and image review have been described in detail in sections 2.2.1 and 2.2.2 
above. Therefore this section will concentrate on presenting the results obtained from a large, 
prospective study with fully blinded image review comparing the diagnostic performance of 
CT Angiography to MR Angiography in the detection of intracranial aneurysms. 
Only six studies have compared both CTA and MRA with DSA in the same patients, 
of which only two (sample size of 17 and 11 patients respectively) were prospective blinded 
studies.211, 
212 Of the other four, one concerned the assessment of treated aneurysms, not 
aneurysm detection;223 two studies by the same authors were not prospective or blinded and 
many patients in the second paper did not have IADSA for comparison;224' 225 the remaining 
study was also not a prospective blinded study, and only five of the ten subjects underwent all 
three imaging modalities.226 
Statistical Analysis 
For both modalities and both observers, 2x2 tables were constructed of true positives, 
false positives, false negatives and true negatives as compared to IADSA. Sensitivity, 
specificity, positive and negative predictive values and accuracy were compared on a per 
patient (the ability to correctly discriminate a patient as true positive or true negative for 
possession of at least one intracranial aneurysm) and per aneurysm (the ability to correctly 
identify all aneurysms) basis. Exact 95% Confidence Intervals (CI) based on binomial 
probabilities were calculated.222 McNemar's test for paired binary data was used to compare 
the sensitivity and specificity of CTA and MRA for each observer.227 The unweighted Kappa 
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statistic was used to assess the level of interobserver and inter -modality agreement.228 Kappa 
of 0.8 or above indicates excellent agreement, 0.6 -0.8 good agreement, 0.4 -0.6 fair agreement 
and less than 0.4 poor agreement. Confidence intervals for the difference between two 
proportions were constructed to show whether or not there was a difference between the 





One hundred and forty seven patients underwent both CTA and MRA examinations as 
well as IADSA (72 men and 75 women); median age 41 (range 19 -75 years). In 28 patients 
either CTA or MRA was obtained in addition to TCDS (and of course IADSA); in 6 patients 
only CTA, in 2 patients only MRA and in 17 only TCDS were performed in addition to 
IADSA, so these subjects were excluded from further analysis in this section. Five further 
patients (1 male and 4 female) were excluded because they were unable to complete the MRA 
examination resulting in a population of 142 patients completing both CTA and MRA 
examinations in addition to IADSA- 71% (128 underwent all three non -invasive tests). Figure 
2.2.11 illustrates the non -invasive examinations performed for the SAGE study. 
Aneurysm prevalence and location 
In this group of 142 subjects, 108 aneurysms were present in 63 of the 142 patients 
(44% prevalence) on consensus IADSA review- the reference standard. These findings are 
detailed with a breakdown of the site and size of aneurysms plus the corresponding CTA and 
MRA results for the two observers in Appendix 2.3. Of the total of 108 aneurysms, 24 (22 %) 
were <3mm in size, 48 (44 %) were 3 -5mm, 18 (17 %) were 5.1 -10mm and 18 (17 %) were 
>10mm. Twenty -two (20 %) were aneurysms of the anterior cerebral artery circulation, 29 
(27 %) of the middle cerebral artery circulation, 40 (37 %) of the internal carotid artery and 17 
(16 %) were aneurysms of the vertebrobasilar system. 
False negative and false positive results 
Details of all the false negative and positive results for CTA and MRA are given in 
Appendix 2.4. Observer A made 33 false negative readings for aneurysms on CTA and 52 on 
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MRA compared to 36 and 54 respectively for observer B. Combining the two readers mistakes 
together; for CTA, 28 (41%) of 69 false negative readings related to aneurysms <3mm, 37/69 
(54 %) to aneurysms 3 -5mm, 4 of 69 (6 %) to aneurysms 5.1 -10mm and none of the 69 to 
aneurysms >10mm. Six of 69 (9 %) false negative CTA readings related to ACA aneurysms, 
16 of 69 (23 %) to MCA aneurysms, 36 of 69 (52 %) to ICA aneurysms and 11 of 69 (16 %) to 
vertebrobasilar aneurysms. 
For MRA, 36 of 106 (34 %) false negative readings related to aneurysms <3mm, 61 of 
106 (58 %) to aneurysms 3 -5mm, 6 of 106 (6 %) to aneurysms 5.1 -10mm in size and 3 of 106 
(3 %) to aneurysms >10mm in size. Nineteen of the 106 (18 %) false negative MRA readings 
related to ACA aneurysms, 28 of 106 (26 %) to MCA aneurysms, 46 of 106 (43 %) to ICA 
aneurysms and 13 of 106 (12 %) to vertebrobasilar aneurysms. 
Observer A made 26 false positive readings for CTA and 11 for MRA compared to 18 
and 11 respectively for observer B. Combining the two readers together; for CTA, 28 of the 
44 (64 %) false positive aneurysms were <3mm, 14 of 44 (32 %) were 3 -5mm, 2 of 44 (5 %) 
were 5.1 -10mm and none were larger than 10mm. Eight of 44 (18 %) were categorised as 
ACA, 17 of 44 (39 %) as MCA, 15 of 44 (34 %) as ICA and 4 of 44 (9 %) as vertebrobasilar 
aneurysms. 
Again, combining the two readers false positive readings, for MRA, 15 of 22 (68 %) 
were <3mm, 5 of 22 (23 %) were 3 -5mm, one of 22 (5 %) was 5.1 -10mm and one of 22 (5 %) 
was larger than 10mm; distribution was 1/22 (5 %) ACA, 8/22 (36 %) MCA, 11/22 (50 %) ICA 
and 2/22 (9 %) vertebrobasilar. 
Comparative diagnostic performance of CTA and MRA 
The overall comparative diagnostic performance of CTA and MRA is provided (with 
95% confidence intervals) for both observers in Table 2.2.3 and graphically as Forrest plots in 
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Figures 2.2.12 and 2.2.13. Accuracy on a per patient basis was better than accuracy on a per 
aneurysm basis for both CTA and MRA. There was no significant difference in sensitivity 
between CTA and MRA: p= 0.11 for observer A and p= 0.10 for observer B (McNemar's 
test). For observer A only, CTA had a significantly poorer specificity than MRA, p =0.01 
(p =0.56 for observer B). Agreement between the non -invasive modalities was "good" with a 
Kappa of 0.61 (95% CI 0.48 -0.74) for observer A and 0.69 (0.57 -0.81) for observer B. 
Interobserver agreement was "good" for both non -invasive modalities with a Kappa statistic of 
0.73 (0.62 -0.84) for CTA and 0.74 (95% CI 0.63 -0.86) for MRA. 
Performance related to aneurysm size 
Small aneurysms were detected significantly less well by both CTA and MRA than 
those 5.1 -10 and larger than 10mm in size, p <0.01 (see Table 2.2.4). 
Performance related to aneurysm site 
There was a trend towards greater diagnostic accuracy for vertebrobasilar and anterior 
cerebral artery circulation aneurysms than for middle cerebral or internal carotid artery 
aneurysms (see Table 2.2.5), however the confidence limits are wide (due to the relatively 
small numbers in each category). An illustrative example of diagnostic difficulty relating to 
these sites is provided in Figure 2.2.14. 
Intracavernous (or carotid siphon) aneurysms, unless giant, may not be clinically 
important as they are extradural and do not cause a SAH if they rupture but they can be 
difficult to detect because of the tortuosity of the carotid arteries in the carotid siphon. Siphon 
aneurysms accounted for 12 of 108 (11 %) aneurysms in the study but for 17 of 69 (25 %) false 
negative readings (7 for observer A, 10 for B) and 3 of 44 (7 %) false positive readings (all 
observer B) for CTA. For MRA, they accounted for 17 of 106 (16 %) false negative readings 
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(7 A, 10 B) and one of 22 (5 %) false positive readings (B). Removing these siphon aneurysms 
from the analysis improved accuracy per aneurysm slightly- for CTA to 0.71 (128 of 180) and 
0.76 (136 of 179) for observers A and B respectively and for MRA to 0.7 (121 of 173) for both 
(see Table 2.2.6). 
Effect of technological advancements and timing of study on diagnostic performance 
The effect on diagnostic accuracy of spiral versus non -spiral CTA, availability of spin 
echo imaging on MRA and targeted MIP reconstructions on both CTA and MRA are also 
summarised in Table 2.2.6. For CTA, accuracy per patient for the most contemporaneous 
examinations (performed within a week of IADSA) was 0.83 (64 of 77) for observer A and 
0.87 (67 of 77) for observer B versus 0.82 (53 of 65) and 0.86 (56 of 65) respectively for 
delayed examinations. For MRA, accuracy per patient for the most contemporaneous 
examinations was 0.84 (54 of 64) for observers A and B versus 0.85 (66 of 78) for delayed 
examinations. The similarity of results for delayed and contemporaneous examinations also 
applied on a per aneurysm basis. 
Performance related to clinical subgroup of patient 
Clinically the most important categories of patients are those in Groups one (known 
aneurysm) and two (proven acute SAH) because they are much more likely to have aneurysms 
requiring treatment. Therefore, a subgroup analysis by site and size of aneurysm was 
performed to assess whether the clinical group influenced the diagnostic performance (i.e. 
groups l &2 versus groups 3 [symptoms possibly due to aneurysm & /or SAH] & 4 
[asymptomatic patient at risk of intracranial aneurysm]). These data are presented in Tables 
2.2.4 and 2.2.5, and indicate that although diagnostic accuracy was generally better in the 
combined group 3 &4, the differences were generally small with widely overlapping 
confidence intervals between the clinical groups. 
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The only exceptions were for MRA in both observers for aneurysms 3 -5mm in size, 
and for observer B for MRA of MCA complex aneurysms, where accuracy was substantially 
greater in group 3&4 than group 1&2. For patients in groups 1&2 combined, accuracy per 
patient for CTA was 0.82, 0.7 -0.9 (49 of 60) and 0.85, 0.73 -0.93 (51 of 60) for observers A 
and B respectively. For patients in groups 3 &4 combined, accuracy per patient for CTA was 
0.83, 0.73 -0.90 (68 of 82) and 0.89, 0.80 -0.95 (73 of 82) respectively. For MRA, accuracy per 
patient for group 1 &2 was 0.82, 0.7 -0.9 (49 of 60) and 0.83, 0.71 -0.92 (50 of 60) for observers 
A and B respectively; for group 3 &4 it was 0.87, 0.77 -0.93 (71 of 82) for both observers. 
Performance related to observer confidence 
Where observers were confident that an aneurysm was definitely present or absent 
(confidence scores 1 and 5 on the 5 point scale used), the proportion of cases interpreted 
correctly (as true positive or true negative) for CTA was 0.92 (85 of 92) for observer A and 
0.78 (124 of 159) for observer B. For MRA the proportions were 0.84 (99 of 118) and 0.74 
(114 of 154) respectively. Where the observers felt an aneurysm was probably present or 
absent (confidence scores 2 and 4), the proportion of cases interpreted correctly for CTA was 
0.6 (46 of 76) and 0.5 (9 of 18) respectively and for MRA 0.44 (27 of 61) and 0.36 (10 of 28). 
If observers were uncertain about the presence or absence of an aneurysm (score 3), the 
proportion of cases interpreted correctly for CTA was 0.29 (9 of 31) and 0.52 (11 of 21) 
respectively and for MRA it was 0.29 (4 of 14) and 0.36 (4 of 11) respectively. The difference 
between the proportions correctly interpreted (with 95% CI) were compared for the 
"uncertain" (confidence level 3) category against the combined "definite" and "probable" 
categories (confidence levels 1, 2, 4, and 5). For both observers, for both CTA and MRA, the 
difference in the proportion interpreted correctly was significantly poorer for the uncertain 
category compared to all the others, p <0.05. 
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Discussion 
Comparison with previous studies 
The results of this part of the SAGE study confirm the equivalent diagnostic accuracy 
of CTA and MRA in the detection of intracranial aneurysms. CTA and MRA have particularly 
good accuracy on a per patient basis at 0.85 (mean of the two observers). These are in line 
with previously reported results though with more precise confidence intervals than most 
studies due to the large sample size (Table 2.2.3). In the systematic review of the literature on 
the non -invasive imaging of intracranial aneurysms accuracy per patient for CTA was 0.93 
(for individual studies it ranged from 0.81211- 0.98189) and for MRA 0.89 (range for individual 
studies 0.781- 1.0181). The results per aneurysm are similar for both modalities, with an 
accuracy (mean of the 2 observers) of 0.72 (CTA) and 0.67 (MRA) respectively. These results 
are poorer than those reported in most previous studies. For example, from the studies 
included in the systematic review, overall accuracy per aneurysm was 0.89 for CTA (for 
individual studies it ranged from 0.73191- 0.98189) and 0.90 for MRA (range 0.7204- 0.97197). 
There are several possible reasons for this discrepancy, including aneurysm size 
distribution, prospective study design, lower prevalence of aneurysms, intention to image 
analysis, complete blinding of image review and use of hard copy images alone for the review 
in the SAGE study. Also there may be a trend in technology assessments towards small, early 
publications with highly selected populations producing more optimistic results than later 
larger studies. For the purposes of the study we deliberately employed widely available and 
established clinical imaging protocols rather than rapidly evolving "cutting edge" techniques 
such as ultrafast gradient echo contrast -enhanced MRA. The fact that the equipment utilised 
for the current study is now relatively out of date and produces lower quality images relative 
to cutting edge technology does not affect comparison with the literature, as equivalent 
technology was used for virtually all the studies published to the end of 1998. Such equipment 
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will only gradually be replaced and will continue in use for some time to come in many parts 
of the world, therefore the SAGE data are still relevant. 
Limitations of the techniques and anticipated improvements 
Clearly time -of -flight MR Angiography fails to depict some aneurysms. This is mainly 
due to spin saturation secondary to slow flow and /or phase dispersion effects due to turbulent 
flow in an aneurysm.229 In such turbulent or slow flow areas, rapid gradient echo techniques 
utilising very short TR/TE gadolinium contrast -enhanced (CE -MRA) imaging provide flow 
independent imaging of blood, greatly reduce turbulence artifacts and eliminate in plane 
saturation effects.23o -232 
Such techniques have been utilised in recent years in studies of the aorta, cervical 
arteries and other aortic branches. Due to the problems of timing of data acquisition to obtain 
precise filling of central k -space (the low spatial frequency data) at the time of maximal 
arterial contrast concentration in the vascular bed of interest, CE -MRA has not always proved 
superior to TOF MRA.233 Current technical developments such as fluoroscopic triggering or 
temporally resolved CE -MRA may solve this problem, facilitating the more general clinical 
use of CE- MRA.234 Surprisingly, until recently, little information was available on the in vivo 
clinical use of ultrafast CE -MRA for the detection of intracranial aneurysms.235 A very recent 
(to my knowledge the first) prospective study in 32 patients, 17 of whom had a total of 23 
aneurysms, found that CE -MRA had greater sensitivity than TOF MRA (100% vs 96 %) but 
poorer specificity (94% vs 100 %), both sensitivity and specificity on the state of the art MRI 
scanner used in this small series were impressive.235 A recent in vitro study of an aneurysm 
model has also indicated the advantage of ultrafast CE -MRA over TOF MRA.229 
Multislice CT with sub -millimetre collimation offering improved spatial resolution and 
reduced overlap from venous structures as a result of rapid scanning may further improve 
CTA accuracy, though prospective clinical studies are not yet available to confirm this. 
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Influence of aneurysm site and size on diagnostic performance 
In this study, 72 of the 108 (67 %) aneurysms were small (5mm or less). These are 
much harder to detect than larger ones. For example, sensitivity of 25% for aneurysms <3mm 
versus 92% for larger aneurysms 198 and accuracy for small aneurysms as low as 0.56 206 have 
been reported for MRA. Many previous studies have not provided detailed information on 
aneurysm size, and those that have had a greater proportion of aneurysms larger than 5mm in 
size. The false negative results in the present study are nearly all for aneurysms 5mm or 
smaller in size and were proportionately concentrated amongst those smaller than 3mm. 
Diagnostic performance for aneurysms larger than 5mm was excellent for CTA and MRA in 
both patients with acute SAH or known aneurysm and those without (see Table 2.2.4). 
Although aneurysms larger than 5mm comprised 36 of the 108 (33 %) aneurysms in this series, 
they accounted for only 4 of 69 (6 %) for CTA- 10 of 106 (9 %) for MRA of false negative 
readings and 2 of 44 (5 %) for CTA- 2 of 22 (9 %) for MRA of false positive readings. 
Conversely very small aneurysms ( <3mm) comprised only 22 of the108 (20 %) aneurysms, yet 
accounted for 36 of 106 (34 %) for MRA- 28 of 69 (41 %) for CTA of false negatives and 28 of 
44 (64 %) for CTA- 15 of 22 (68 %) for MRA of false positives. 
Influence of aneurysm prevalence and study population on diagnostic performance 
The population of the present study may have contributed to the poorer results per 
aneurysm than previously reported. We sought to recruit a mixed population of patients for the 
SAGE study, including those who did not have a known aneurysm or acute SAH (as well as 
acute SAH cases) because one cannot assume that the imaging results from previous studies in 
a high aneurysm prevalence population will necessarily be the same in lower prevalence 
population groups. In the present analysis, 60 of 142 (42 %) patients had a known aneurysm or 
proven SAH and the overall aneurysm prevalence was 63 of 142 (44 %). This is low compared 
to most of the previous studies, which generally had an aneurysm prevalence of 75% or 
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more.108, 
109, 144, 180, 185, 187, 190, 191, 197, 198, 200, 201, 204, 205, 209, 211, 212 There is evidence that 
increasing disease prevalence can lead to an improvement in sensitivity and specificity of a 
test.177 
As mentioned in the systematic review discussion, if nearly all patients in a study are 
known to have an aneurysm or SAH, this could lead to observer expectation bias. The 
distribution of subarachnoid blood may give a strong clue to the presence and /or site of an 
aneurysm, as may a local haematoma or the presence of hydrocephalus. However, this 
advantage may be offset by the potential for obtaining a poorer quality imaging in sick, 
restless acute SAH patients (the long acquisition time of 3D TOF MRA making it particularly 
susceptible to this problem -see Figure 2.2.14). The SAGE data support this conclusion as the 
diagnostic performance of CTA and MRA was consistently slightly better in clinical Groups 3 
& 4 than 1 & 2- see Tables 2.2.4 & 5. Asymptomatic patients are more likely to have small 
(than large) aneurysms compared to patients who have had a SAH. Aneurysms <_5mm 
diameter accounted for 1/3 of all aneurysms in one large study of asymptomatic patients with 
unruptured aneurysms 66 and for 72 of 108 (67 %) of the total aneurysms in the current 
analysis. As expected, aneurysm prevalence was greater in Group 2 (recent SAH) and the 
aneurysms were on average larger, with 21 of 53 (40 %) of the aneurysms being larger than 
5mm in size compared to 10 of 45 (22 %) in Groups 3 & 4. 
It was reassuring to find that in a large prospective, blinded study interobserver 
agreement was good for both CTA and MRA. Perhaps surprisingly, we did not find any 
advantage from employing targeted MIP reconstructions for either CTA or MRA (see Table 
2.2.6). One potential limitation of the SAGE study was the delay in some cases between 
IADSA and CTA or MRA. In theory, a delay of several weeks between IADSA and the non- 
invasive study could result in an aneurysm clotting off, or alternatively an aneurysm not seen 
on IADSA re- canalising. This could result in a false negative or false positive result for the 
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non -invasive test when in fact it was a true negative or positive. However, this effect, if it 
occurred, on the current study appears to have been very small as indicated by the similarity of 
the results for contemporaneous CTA and MRA studies to more delayed ones. 
In the small subgroup of 18 asymptomatic patients, 12 of the 18 had a total of 21 
aneurysms, but with only 3 of the 21 being larger than 5mm. It had been the initial intention to 
recruit more of this category of subject into the SAGE study, but part way through the 
recruitment period, the ISUTA study published its findings.73 This indicated a very much 
lower rupture risk for asymptomatic unruptured aneurysms than previously thought. As a 
direct result far fewer patients falling into this category were referred for cerebral angiography 
in the second half of the SAGE study (KW Lindsay, M O'Sullivan- personal 
communications). Probably reflecting the aneurysm size distribution, CTA and MRA 
performed poorly in this patient subgroup with a mean sensitivity per subject of 0.67 (16 of 24 
for CTA) and 0.55 (23 of 42 for MRA) and a mean accuracy per subject of 0.75 (27 of 36 for 
CTA) and 0.69 (25 of 36 for MRA). Therefore in a low prevalence, asymptomatic population 
(e.g. using non - invasive tests for aneurysm screening), one can predict considerably poorer 
diagnostic performance. Accuracy per subject was 12% (CTA) - 27% (MRA) lower in the 
"screening" subgroup (group 4) than in the other subgroups combined. For the observer (A) in 
whom this effect was largest, CTA accuracy per subject was 0.72 (13 of 18) versus 0.84 (104 
of 124) and for MRA, 0.61 (11 of 18) versus 0.88 (109 of 124). 
Practical clinical implications of the results 
There are a number of important lessons for the use of non -invasive tests for aneurysm 
detection highlighted by this section of the SAGE study. First, diagnostic performance is very 
significantly limited by aneurysm size. Secondly in certain sites, particularly where there is 
considerable vessel overlap or adjacent bone (such as the cavernous and terminal ICA 
segments or MCA bifurcation), both CTA and MRA perform more poorly. A higher than 
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expected number of false positives related to very small MCA aneurysms and a higher than 
expected proportion of false negative readings related to internal carotid artery aneurysms. 
Therefore caution should be exercised with regard to the interpretation of small aneurysms 
arising from the MCA bifurcation or the intracranial ICA and its branches on a CTA or MRA 
examination, particularly if observer confidence is also low. 
In the light of these data and those in the literature as described in the systematic 
review, it is clear that current standard clinical CTA & MRA systems cannot yet completely 
replace IADSA in the diagnostic work up of patients with acute SAH due to the low sensitivity 
of CTA and MRA for small aneurysms, though they may be a useful adjunct.189 It is well 
recognised that small aneurysms can rupture and the potential adverse consequences to the 
patient of missing such an aneurysm on CTA/MRA used instead of IADSA could be severe. In 
the clinical setting of acute SAH, a false positive result would probably have less serious 
consequences- provided confirmatory IADSA is performed prior to aneurysm treatment in all 
positive cases. 
In a patient with symptoms strongly suggestive of an aneurysm, these data indicate that 
although both CTA and MRA can fairly reliably exclude the presence of an aneurysm larger 
than 5mm in size (i.e, one likely to be large enough to cause compressive symptoms), IADSA 
should still be considered the investigation of choice because a negative CTA or MRA study 
will not completely reassure, and a positive study would almost certainly lead on to IADSA 
anyway. 
Where clinical suspicion of an aneurysm as the cause of the symptom(s) is low, a non- 
invasive test alone is adequate provided both the patient and clinician can live with the 
uncertainty that a small aneurysm (5mm or less) has not been completely excluded. In light of 
the ISUTA data, only aneurysms larger than 1 Omm should be considered for treatment in 
asymptomatic patients with no prior history of SAH and then only if the patient is less than 
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about 45 years of age. In older patients the risk benefit ratio does not justify treatment on 
grounds of the rupture risk. The results from the follow up period of the prospective arm of the 
ISUTA study are eagerly awaited to see if they support the very low rupture risk identified by 
the retrospective arm of the study. 
CTA or MRA may adequately investigate at risk patients, but again only if both the 
patient and the clinician can live with the uncertainty about small aneurysms. However, we 
would emphasise that on the best available evidence to date the investigation of asymptomatic 
at risk patients is not routinely indicated.75 
Conclusions 
CTA and MRA are equally accurate in the detection of intracranial aneurysms and 
aneurysms 5mm or smaller are detected significantly less well than those larger than 5mm. 
Accuracy on a per subject basis is better than on a per aneurysm basis. Interobserver 
agreement is good for both modalities. The cavernous /terminal ICA and MCA bifurcation are 
sites of particular diagnostic difficulty for the non -invasive modalities. Using a simple 
confidence scoring system is a useful means of determining individual cases where the non- 
invasive test is likely to be less reliable. In a screening situation, accuracy can be predicted to 
be substantially lower than the overall level (per patient) of 0.85 achieved in the SAGE study. 
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2.2.11 Non- invasive imaging examinations performed for the SAGE study 
10% 





CTA only 5 
MRA only 2 
TCD only 17 
All 3 tests 127 
CTA +MRA; -TCD 20 
CTA +TCD, -MRA 21 
MRA +TCD, -CTA R 
CTA MRA 
(includes 5 who did 
not complete MRA) 
TCDS 
(includes 14 with 
inadequate bone 
window) 
AU 3 tests 
Group 1 4 3 4 3 









74 69 69 58 
Group 4 
(n =23) 
18 20 21 15 
234 
Figure 2.2.12 Forrest plots of sensitivity and specificity for CTA and MRA per subject 
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Figure 2.2.13 Forrest plots of sensitivity and specificity for CTA and MRA per aneurysm 
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Figure 2.2.14 
15° oblique per orbital IADSA image demonstrating a 3 -mm right MCA aneurysm inferiorly 
(arrowed), a larger MCA bifurcation aneurysm and a large anterior communicating artery 
aneurysm. Although the aneurysms are all demonstrated on CTA and more poorly on MRA, 
MRA MIP 
CTA targeted "angio MIP" 
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=
 false negative 
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 false positive 
Table 2.2.4 Diagnostic performance of CTA and MRA related to clinical group and size (maximum 









(TP /TP +FN) 
Specificity 
95% CI 





(TP /TP +FN) 
Specificity 
95% CI 
(TN /TN +FP 
Accuracy 
95% CI 
0.25 0.63 0.53 0.25 0.92 0.75 
IA <3mm 0.03 -0.65 0.41 -0.81 0.35 -0.71 0.03 -0.65 0.73 -0.99 0.57 -0.89 
(2/8) (15/24) (17/32) (2/8) (22/24) (24/32) 
0.71 0.88 0.79 0.25 1.0 0.60 
IA 3 -5mm 0.51 -0.87 0.68 -0.97 0.65 -0.89 0.11 -0.45 0.86 -1.0 0.45 -0.73 
1 & 2 (20/28) (21/24) (41/52) (7/28) (24/24) (31/52) 
Observer 0.86 1.0 0.95 0.86 0.96 0.92 
A IA 5.1 -10mm 0.57 -0.98 0.86 -LO 0.82 -0.99 0.57 -0.98 0.79 -1.0 0.79 -0.98 
(12/14) (24/24) (36/38) (12/14) (23/24) (35/38) 
[Known IA 1.0 1.0 1.0 0.83 0.96 0.92 
or proven 
SAH] 












0.25 0.92 0.75 0.0 0.88 0.66 
IA <3mm 0.03 -0.65 0.81 -1.0 0.60 -0.90 0.0 -0.37 0.68 -0.97 0.47 -0.81 
(2/8) (22/24) (24/32) (0/8) (21/24) (21/32) 
0.61 0.75 0.67 0.21 0.96 0.56 
IA 3 -5mm 0.43 -0.79 0.58 -0.92 0.55 -0.80 0.08 -0.41 0.79 -1.0 0.41 -0.70 
1 & 2 (17/28) (18/24) (35/52) (6/28) (23/24) (29/52) 
Observer 0.86 0.96 0.92 0.86 1.0 0.95 
B IA 5.1 -10mm 0.67 -1.0 0.88 -1.0 0.84 -1.0 0.57 -0.98 0.86 -1.0 0.82 -0.99 
(12/14) (23/24) (35/38) (12/14) (24/24) (36/38) 
1.0 1.0 1.0 0.83 1.0 0.94 
IA >10mm 0.74 -1.0 0.86 -1.0 0.90 -1.0 0.52 -0.98 0.86 -1.0 0.81 -0.99 
(12/12) (24/24) (36/36) (10/12) (24/24) (34/36) 
0.44 0.76 0.69 0.31 0.89 0.76 
IA <3mm 0.20 -0.70 0.63 -0.87 0.57 -0.79 0.11 -0.59 0.78 -0.96 0.64 -0.85 
(7/16) (42/55) (49/71) (5/16) (49/55) (54/71) 
0.60 0.98 0.88 0.55 0.98 0.87 
IA 3 -5mm 0.36 -0.81 0.90 -1.0 0.78 -0.94 0.32 -0.77 0.90 -1.0 0.77 -0.93 
3 & 4 (12/20) (54/55) (66/75) (11/20) (54/55) (65/75) 
Observer 1.0 1.0 1.0 0.75 1.0 0.98 
A IA 5.1 -10mm 0.40 -1.0 0.94 -1.0 0.94 -1.0 0.19 -0.99 0.94 -1.0 0.91 -1.0 
(4/4) (55/55) (59/59) (3/4) (55/55) (58/59) 
[Possible 1.0 1.0 1.0 1.0 1.0 1.0 
SAH or IA IA >10mm 0.54 -1.0 0.94 -1.0 0.94 -1.0 0.54 -1.0 0.94 -1.0 0.94 -1.0 oraIAlkof (6 /6) (55/55) (61/61) (6/6) (55/55) (61/61) 
0.50 0.93 0.83 0.25 0.93 0.77 
IA <3mm 0.25 -0.75 0.82 -0.98 0.72 -0.91 0.07 -0.52 0.82 -0.87 0.66 -0.87 
(8/16) (51/55) (59/71) (4/16) (51/55) (55/71) 
0.50 0.93 0.81 0.55 0.95 0.84 
IA 3 -5mm 0.27 -0.73 0.82 -0.98 0.71 -0.89 0.32 -0.77 0.85 -0.99 0.74 -0.91 
3 & 4 (10/20) (51/55) (61/75) (11/20) (52/55) (63/75) 
Observer 1.0 0.98 0.98 0.75 1.0 0.98 
B IA 5.1 -10mm 0.40 -1.0 0.90 -1.0 0.91 -1.0 0.19 -0.99 0.94 -1.0 0.91 -1.0 
(4/4) (54/55) (58/59) (3/4) (55/55) (58/59) 
1.0 1.0 1.0 1.0 1.0 1.0 
IA >10mm 0.54 -1.0 0.94 -1.0 0.94 -1.0 0.54 -1.0 0.94 -1.0 0.94 -1.0 
(6/6) (55/55) (61/61) (6/6) (55/55) (61/61) 
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(TP /TP +FN) 
Specificity 
95% CI 





(TP /TP +FN) 
Specificity 
95% CI 
(TN /TN +FP) 
Accuracy 
95% CI 
0.94 0.88 0.90 0.50 1.0 0.80 
ACA 0.70 -1.0 0.68 -0.97 0.76 -0.97 0.25 -0.75 0.86 -1.0 0.64 -0.91 
(15/16) (21/24) (36/40) (8/16) (24/24) (32/40) 
0.72 0.75 0.74 0.44 0.92 0.71 
MCA 0.47 -0.90 0.53 -0.90 0.58 -0.86 0.22 -0.69 0.73 -0.99 0.55 -0.84 
1 & 2 (13/18) (18/24) (31/42) (8/18) (22/24) (30/42) 
Observer 0.68 0.92 0.81 0.47 0.92 0.72 
A ICA 0.43 -0.87 0.73 -0.99 0.67 -0.92 0.24 -0.71 0.73 -0.99 0.56 -0.85 
(13/19) (22/24) (35/43) (9/19) (22/24) (31/43) 
[Known IA Post. 0.56 0.96 0.85 0.67 1.0 0.91 
or proven Circulation 0.21 -0.86 0.79 -1.0 0.68 -0.95 0.30 -0.93 0.86 -1.0 0.76 -0.98 
SAH 
(5/9) (23/24) (28/33) (6/9) (24/24) (30/33) 
0.81 0.96 0.90 0.50 1.0 0.80 
ACA 0.54 -0.96 0.79 -1.0 0.76 -0.97 0.25 -0.75 0.86 -1.0 0.64 -0.91 
(13/16) (23/24) (36/40) (8/8) (24/24) (32/40) 
0.72 0.96 0.86 0.39 0.92 0.69 
MCA 0.47 -0.90 0.79 -1.0 0.71 -0.95 0.17 -0.64 0.73 -0.99 0.53 -0.82 
1 &2 (13/18) (23/24) (36/42) (7/18) (22/24) (29/42) 
Observer 0.63 0.75 0.70 0.47 0.96 0.74 
B ICA 0.38 -0.84 0.53 -0.90 0.54 -0.83 0.24 -0.71 0.79 -1.0 0.59 -0.86 
(12/19) (18/24) (30/43) (9/19) (23/24) (32/43) 
Post. 0.67 0.96 0.88 0.56 0.96 0.85 
Circulation 0.30 -0.93 0.79 -1.0 0.72 -0.97 0.21 -0.86 0.79 -1.0 0.68 -0.95 
(6/9) (23/24) (29/33) (5/9) (23/24) (28/33) 
0.67 0.95 0.92 0.67 1.0 0.97 
ACA 0.22 -0.96 0.85 -0.99 0.82 -0.97 0.22 -0.96 0.94 -1.0 0.89 -1.0 
(4/6) (52/55) (56/61) (4/6) (55/55) (59/61) 
0.73 0.85 0.83 0.64 0.93 0.88 
MCA 0.39 -0.94 0.73 -0.94 0.72 -0.91 0.31 -0.89 0.82 -0.98 0.78 -0.95 
3 & 4 (8/11) (47/55) (55/66) (7/11) (51/55) (58/66) 
Observer 0.52 0.96 0.84 0.43 0.95 0.80 
A ICA 0.30 -0.74 0.87 -1.0 0.74 -0.92 0.22 -0.66 0.85 -0.99 0.70 -0.89 
(11/21) (53/55) (64/76) (9/21) (52/55) (61/76) 
[Possible Post. 0.75 0.98 0.95 0.63 1.0 0.95 
SAH or IA 
or at risk of 
Circulation 0.35 -0.97 0.90 -1.0 0.87 -0.99 0.24 -0.91 0.94 -1.0 0.87 -0.99 
IA] (6/8) (54/55) (60/63) (5/8) (55/55) (60/63) 
1.0 0.98 0.98 0.83 0.98 0.97 
ACA 0.54 -1.0 0.90 -1.0 0.91 -1.0 0.36 -1.0 0.90 -1.0 0.89 -1.0 
(6/6) (54/55) (60/61) (5/6) (54/55) (59/61) 
0.73 0.96 0.92 0.64 1.0 0.94 
MCA 0.39 -0.94 0.87 -1.0 0.83 -0.97 0.31 -0.89 0.94 -1.0 0.85 -0.98 
3 & 4 (8/11) (53/55) (61/66) (7/11) (55/55) (62/66) 
Observer 0.38 0.91 0.76 0.33 0.91 0.75 
B ICA 0.18 -0.62 0.80 -0.97 0.65 -0.85 0.15 -0.60 0.80 -0.97 0.64 -0.84 
(8/21) (50/55) (58/76) (7/21) (50/55) (57/76) 
Post. 0.75 0.98 0.95 0.63 0.98 0.94 
Circulation 0.35 -0.97 0.90 -1.0 0.87 -0.99 0.24 -0.91 0.90 -1.0 0.85 -0.98 
(6/8) (54/55) (60/63) (5/8) (54/55) (59/63) 
l l ACA= anterior cerebral artery complex 
ICA= internal carotid artery complex 
MCA= middle cerebra artery comp ex 



















































0 (0.82, 110/134) 
-0.03 (0.84, 85/101) 
-0.01 (0.84,102/121) 
0 (0.85, 76/89) 
0 (0.7, 129/182) 
-0.03 (0.7, 93/133) 
+
0.01 (0.68, 111/163) 
+










0.02 (0.84, 103/122) 
0 (0.87, 106/122) 
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-0.12 (0.7, 14/20) 




0.03 (0.9, 18/20) 









-0.01 (0.84, 69/82) 
+
0.02 (0.69, 76/110) 
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0 (0.85, 70/82) 







0 (0.85, 51/60) 
-0.02 (0.65, 54/83) 
B
 
0 (0.85, 51/60) 
+






-0.01 (0.81, 82/101) 
-0.01 (0.84, 59/70) 
-0.05 (0.65, 96/147) 
-0.03 (0.64, 64/100) 
B
 
-0.01 (0.86, 87/101) 
-0.02 (0.83, 58/70) 
-0.05 (0.68, 100/146) 







0.03 (0.85, 35/41) 
0 (0.85, 61/72) 
+
0.15 (0.85, 44/52) 
+




0.03 (0.9, 37/41) 
+
0.03 (0.88, 63/72) 
+
0.12 (0.85, 44/52) 
+












0.01 (0.83, 109/131) 
+
0.03 (0.9, 118/131) 
+
0.01 (0.86, 113/131) 
+




0.03 (0.76, 136/179) 
+
0.03 (0.7, 121/173) 
+
0.04 (0.7, 121/173) 
First figure is the change in accuracy, then actual accuracy and the num
bers of subjects are given in brackets 
2.2.4 Transcranial Power Doppler Sonography (TCDS) 
Numerous studies have compared non -invasive techniques such as MR or CT 
Angiography with IADSA, and found similar overall accuracy of about 90 %, but there are 
relatively few data from prospective, blinded studies comparing transcranial colour duplex or 
power sonography (TCDS).110 Ultrasound has the advantage of lower capital cost and greater 
mobility than IADSA, CT angiography or MR angiography; there are no contraindications and 
no exposure to ionising radiation. However, up to 10% of patients will not have an adequate 
bone window and TCDS is operator dependent.13° 
After colour transcranial duplex ultrasound became available in the early 1990s 
successful identification of intracranial aneurysms was soon reported.128, 129 A more recent 
technological development of colour Doppler called Colour Doppler Energy (CDE) or "power 
Doppler" offers significantly greater sensitivity to flowing blood than standard colour flow 
imaging.130 Power Doppler can be readily combined with a spectral ultrasound examination to 
obtain additional velocity and waveform information. Using this technique overall sensitivity 
for detection of aneurysms of between 0.47 213and 0.89215 and specificity between 0.33 214 and 
0.89 130 have been reported in relatively small studies, predominantly in patients with recent 
subarachnoid haemorrhage (SAH). 
In order to define the accuracy and limitations of power TCDS in a broader range of 
patients and to add significantly to the small amount of data reported in the literature, a large, 
prospective, multicentre, blinded study comparing power TCDS with IADSA in the detection 
of intracranial aneurysms was undertaken as part of the SAGE study. We were also interested 
in the effect of combining TCDS to either CT or MR angiography and these data are presented 
in chapter three of part two of the thesis. 
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Subjects and Methods 
The subject group, inclusion and exclusion criteria, recruitment process etc. for the 
SAGE study have been considered in some detail already in section 2.2.1. 
Image Acquisition 
Power and angle corrected spectral TCDS examinations were performed 
contemporaneously on Acuson 128XP machines using 2 -2.5 MHz multihertz linear phased 
array transducers (Acuson, Mountain View, California, USA). Identical imaging parameters 
were used in each centre. A more detailed description of the TCDS scanning technique, 
optimization parameters and interpretation criteria is provided in Appendix 2.5. TCDS 
examinations were performed via the temporal bone window to insonate the circle of Willis in 
the axial and coronal planes.129, 130, 215 The transnuchal and transorbital routes were not 
routinely employed (some of the patients with SAH found these difficult to tolerate) and 
intravenous echo contrast was not used. Each major intracranial vessel segment was examined 
systematically using power and angle corrected spectral doppler ultrasound. Non -power 
colour -coded Doppler ultrasound was not used. 
Aneurysm size was determined on a frozen image using electronic callipers in the 
standard Acuson measurement software. A video record of each examination was made and a 
standard result proforma sheet was completed at the end of each examination by the 
sonographer. This recorded the opinion of normal or abnormal (abnormality specified) in each 
major artery/branching point including the sonographer's degree of confidence- see Figure 
2.2.15. The ultrasonographers comprised two neuroradiologists and three neuroradiographers. 
Two of the sonographers had several years experience in using power TCDS as well as 
spectral transcranial ultrasound. Three sonographers were experienced in using spectral 
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transcranial ultrasound in the detection of vasospasm but less experienced in power TCDS. 
They underwent three half -day training sessions in its use to detect aneurysms (as described 
above) prior to commencing the study. The sonographers were fully blinded to clinical data 
and the results of all other imaging investigations including plain CT and IADSA results. 
Image Review 
The review methodology for IADSA studies has already been described. For TCDS, 
the report completed at the end of each examination was used for the comparison with 
IADSA. For TCDS, aneurysm site(s) was recorded as follows: l= middle cerebral artery 
(MCA) mainstem, 2 =MCA bifurcation, 3= distal MCA, 4= anterior communicating artery 
complex (ACoA), 5= pericallosal, 6= terminal internal carotid artery (ICA) segment, 
7= posterior communicating artery (PCoA), 8= ophthalmic, 9 =other ICA, 10= basilar, 
11= posterior inferior cerebellar artery (PICA) and 12 =other (or unspecified). Aneurysm size 
was recorded as a) less than 3mm maximum dimension, b) 3 -5mm, c) 5.1 -10mm and d) larger 
than Omm. The confidence of the ultrasonographer in their report was assessed on a simple 5 
point scale as reported by Atlas et al and described earlier.198 An assessment was also made of 
the visibility of the major arterial segments comprising the circle of Willis on TCDS. We 
aimed to have two ultrasonographers examine a reasonable proportion of the same patients to 
assess interobserver variability. This proved difficult to achieve in practice in a multicentre 
study. Patients were frequently treated or discharged before a second sonographer was 
available to perform the power TCDS study or sometimes, even if a second sonographer was 
available, they were not blinded to the patients plain CT and/or IADSA findings. 
Statistical Analysis 
2x2 tables were constructed of true positives, false positives, false negatives and true 
negatives as compared to IADSA. Sensitivity, specificity, positive and negative predictive 
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values, accuracy and likelihood ratio were calculated and compared on a per patient and per 
aneurysm basis. Exact 95% Confidence Intervals (CI) based on binomial probabilities were 
calculated. Unweighted Kappa statistic was used to assess the level of interobserver agreement 
for a small number of cases where it was possible to have power TCDS performed by two 
operators. Confidence intervals for the difference between two proportions were constructed to 
show whether or not there was a difference between the proportions interpreted correctly at 
different levels of observer confidence. Sensitivity analyses were used to examine the effect of 
aneurysm size and site, clinical presentation and observer experience on the accuracy of TCD. 
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Results 
Excluded and included subjects 
Twenty -nine (15 %) of the 200 patients recruited into the SAGE study did not undergo 
power TCDS due to lack of availability of a "blinded" trained ultrasonographer prior to 
treatment or discharge, but did undergo CT and /or MR angiography. A further 14 patients 
(8 %), 9 men, 5 women) had an inadequate bone window so were excluded from further 
analysis. This left a total of 157 patients for further analysis. Patients were grouped into 4 
categories based on the clinical indication for cerebral angiography. Group 1 comprised 5 
patients with a known aneurysm undergoing further assessment; group 2, 67 patients with 
proven SAH; group 3, 64 patients with symptoms which might be due to an aneurysm and 
group 4, 21 asymptomatic patients at risk of harbouring an aneurysm because of a strong 
family history of aneurysmal SAH. 
Aneurysm prevalence, size and location 
On IADSA, 122 aneurysms were present in 67 of 157 (43 %) patients and these 
findings are detailed with a breakdown of the site and size of aneurysms plus the 
corresponding TCD result in Appendix 2.6. Details of all the false negative (FN) and positive 
(FP) results for TCD are also included in this Appendix. Twenty -two of 122 (18 %) were 
aneurysms of the anterior cerebral artery circulation (ACA), 32 of 122 (26 %) were aneurysms 
of the middle cerebral circulation (MCA), 51 of 122 (42 %) were aneurysms of the internal 
carotid artery including posterior communicating aneurysms (ICA) and 17 of 122 (14 %) were 
aneurysms of the vertebrobasilar system. These latter would not necessarily be expected to be 
detected by the power TCDS protocol used in the study as aneurysms in the posterior fossa 
distant from the circle of Willis would not be visualised. 
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Twenty -seven of the 105 (25.7 %) anterior circulation aneurysms were very small 
( <3mm maximum angiographic dimension), 51 of 105 (48.6 %) were small (3 -5mm) and 27 of 
105 (25.7 %) were larger than 5mm. Of the 17 vertebrobasilar aneurysms, 8 were 3 -5mm in 
size and 9 were larger than 5mm. Anterior circulation aneurysm prevalence was 60% (43/72) 
in patient groups 1 and 2 combined, 17% (11/64) in group 3 and 38% (8/21) in group 4. 
Diagnostic performance 
The overall comparative diagnostic performance of TCDS to IADSA is given (with 
95% confidence intervals) in Table 2.2.7. The accuracy on a per subject basis was much better 
than on a per aneurysm basis, at 0.85 versus 0.60. This difference was largely due to 
sonographers failing to identify a second (often smaller) aneurysm in patients where they had 
already identified an aneurysm (see Appendix 2.6). 
a) Related to experience of sonographer 
The two sonographers more experienced in power TCD performed 29% (45 of 157) of 
the examinations. There was a trend for the more experienced sonographers to be more 
accurate than the less experienced sonographers: accuracy per patient 0.89 (95% CI 0.76 -0.96) 
versus 0.83 (0.75 -0.89) and per aneurysm 0.62 (0.49 -0.74) versus 0.59 (0.51 -0.67) 
respectively. The differences were quite small and not statistically significant. However, this 
was not a true like for like comparison as it was not possible for logistical reasons for each 
patient to be examined by an experienced and a less experienced sonographer. In a small 
number of cases (12 of 157), two "blinded" less experienced sonographers were able to 
independently perform TCDS examinations. Interobserver agreement in this small sample was 
good with a Kappa statistic of 0.76. 
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b) Related to aneurysm site and size 
Analyses of the diagnostic performance by size and site of aneurysm are given in 
Tables 2.2.8 and 2.2.9. Sensitivity was substantially better for aneurysms larger than 5mm at 
0.81 (22 of 27) than for aneurysms 5mm or smaller in size at 0.35 (27 of 78). This difference 
was found for both the experienced and less experienced sonographers and the difference in 
sensitivity between small and larger aneurysms was very similar in magnitude (0.47 and 0.48 
respectively). 
Overall, within the anterior circulation, accuracy was poorer for ICA complex 
aneurysms, due to poorer sensitivity and slightly poorer specificity compared to the ACA and 
MCA complexes (see Table 2.2.9). The poorer sensitivity for ICA complex aneurysms was 
concentrated amongst the less experienced sonographers- 14 of 38 (37 %) aneurysms detected 
compared to 8 of 13 (62 %) for the more experienced sonographers. Whereas for the more 
experienced observers the MCA complex had the poorest sensitivity- 3 of 11 (27 %) aneurysms 
detected compared to 12 of 21 (57 %) for the less experienced sonographers. ACA complex 
sensitivity, specificity and accuracy were very similar for all sonographers. The posterior 
circulation (vertebrobasilar) results are included in Table 2.2.9 for information, although as 
described, the TCDS methodology used precluded visualisation of the more distal posterior 
circulation aneurysms. 
c) Related to clinical subgroup of patient 
Diagnostic performance was also analysed by clinical group and the results are 
presented in Table 2.2.10. Because of the small numbers, Group 1 was combined with Group 
2. Similar accuracy was found for the three clinical groups on a per subject basis, although the 
confidence intervals are wide due to the smaller numbers engendered by a subgroup analysis. 
On a per aneurysm basis, TCDS had poorer specificity in the subjects in Group 1 (known 
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aneurysm or proven SAH) and Group 4 (positive family history) than for subjects in Group 3- 
see Table 2.2.10. 
d) Related to confidence of sonographer 
TCDS performance was related to the level of ultrasonographer confidence for the less 
experienced observers- this confidence level was available for 106 of 112 examinations. 
Where the sonographer was confident (56 of the 106 patient TCDS examinations had a 
confidence score of 1 or 5), the accuracy per subject was 0.89 (50 of 56 correct) compared to 
0.75 (30 of 40 correct) for moderately confident (40 of the 106 TCDS examinations had a 
score of 2 or 4) and 0.70 (7 of 10 correct) if confidence was low (10 of 106 TCDS 
examinations had a score of 3). So there was a trend, as demonstrated previously for CTA and 
MRA, for confidence to relate to diagnostic performance. The confidence level was not 
recorded in enough of the examinations performed by the more experienced sonographers to 
enable a similar analysis to be performed for them. 
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Discussion 
The SAGE study is only the second large prospective study comparing power TCDS to 
IADSA and it is also one of the largest prospective studies of any non -invasive imaging 
technology including CT angiography, MR angiography and TCDS to date.236 In the 
systematic review of the literature on non -invasive imaging of intracranial aneurysms it was 
clear that data on TCDS were very limited compared to CT and MR angiography- reflecting 
the more mature state of those technologies and few conclusions could be drawn about the 
diagnostic performance of TCDS.11° Since the inception of the SAGE study and the 
systematic review, one large power TCDS study has been published.237 
Diagnostic performance by site and size of aneurysm 
Unsurprisingly we found diagnostic performance was much poorer in aneurysms 5mm 
or smaller in size. For anterior circulation aneurysms larger than 5mm in size, sensitivity was 
81 %, which is in line with the best of previous two- dimensional non -contrast TCDS reports. l to 
Although large aneurysms are more readily detected by TCDS, small aneurysms can be 
detected in patients with a good bone window- as demonstrated in Figure 2.2.16. This size 
related performance effect applies equally to CTA and MRA - see systematic review and CTA 
versus MRA data presented earlier. 
It was reassuring that the differences in sensitivity and specificity between the less and 
more experienced TCDS sonographers were quite small (overall per subject: 9% for sensitivity 
and 3% for specificity, and per aneurysm: 5% for sensitivity and 2% for specificity). These 
results indicate that diagnostic performance is not highly dependent on the experience of the 
sonographer and that satisfactory performance in the technique can be achieved without 
prolonged, extensive training if a sonographer is already competent in transcranial Doppler 
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ultrasound. Three half -day training sessions in power TCDS were provided for the less 
experienced sonographers in this study. Interobserver agreement (albeit on a small sample) 
was also good. The practical logistics of patient admission, investigation and treatment meant 
that we were unable to systematically have two "blinded" sonographers examine subjects. In 
particular it would have been valuable if an experienced and a less experienced sonographer 
could have done this. 
Due to the methodology of TCDS examination used in the SAGE study, in which only 
the temporal bone window was routinely insonated, it is not possible to comment on 
performance in the basilar and vertebral areas. Regarding the anterior circulation, overall 
accuracy was poorer for ICA complex aneurysms than the MCA or ACA complexes- largely 
due to the relatively greater number of false negative readings for the less experienced 
sonographers- 63% (24 of 38)- versus 38% (5 of 13) for the more experienced sonographers- 
see Table 2.2.9. It is interesting but difficult to explain why the experienced observers had a 
substantially lower detection rate for MCA aneurysms (0.27) than the less experienced 
observers (0.57) - although numbers were small and the confidence intervals do overlap 
widely. 
Overall accuracy for the patient groups was broadly similar on a per subject basis, 
suggesting that the influence of patient type on the accuracy of TCDS was not great. It is also 
interesting that where the less experienced sonographers felt confident about the findings in an 
individual patient, their accuracy was identical to that of the more experienced sonographers' 
overall result (both 89 %). 
Comparison with previous studies 
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The results on a per subject basis are encouraging with a sensitivity of 0.78, but those 
on a per aneurysm basis are less so with an overall sensitivity of 0.46. However, for any 
modality, the performance per aneurysm will always be poorer than that per subject (patient). 
The sensitivity per aneurysm in previous non -contrast TCDS studies has ranged from 0.40 237 
in the only previous large prospective study to 0.89 in a smaller study of 36 patients.215 
Several other small studies have also reported sensitivity in the range 0.53 -0.89 although all 
were in high aneurysm prevalence populations.126, 129, 130, 214 The difference between 
sensitivity in the SAGE study and that reported in the early small studies might be due to a 
number of factors- for example, fewer biases in this large, prospective, fully blinded study - 
particularly for expectation and recall bias. The mixed patient population with a lower 
aneurysm prevalence (43 %) than most previous studies might also have had an effect on 
sensitivity 177 and the inclusion of results from sonographers not very experienced in the 
technique (who performed 71% of the examinations). 
However, probably the most significant effect is the proportion of small and very small 
aneurysms in this study- 74% (78 of 105) of the anterior circulation aneurysms were 5mm or 
smaller. That compares to 33% 214 and 0% 
215 in two previous studies reporting better 
sensitivity per aneurysm and where aneurysm sizes were provided- and none of the small 
aneurysms were detected by TCDS. In the only other large, blinded study of TCDS to date, 
prevalence of aneurysms was higher at 63 %.237 In that study the combined sensitivity for 
contrast and non -contrast TCDS was 28% (24 of 87) for small aneurysms (smaller than 6mm) 
and 53% (43 of 81) for aneurysms 6mm or larger (all aneurysm sites), compared to 35% (5mm 
or smaller, not <6mm) and 81% (larger than 5mm) for anterior circulation aneurysms in the 
SAGE study. 
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Comparison of TCDS with other non -invasive modalities 
In comparison with reported studies of CT and MR angiography, TCDS appears to be 
inferior at aneurysm detection, particularly on a per aneurysm basis (overall accuracy per 
aneurysm of 60% for TCD in this study versus 90% for CT and MR angiography in the 
systematic review of published series.' I° On a per subject basis the differences between 
techniques are small- although none of the non -invasive modalities is yet accurate enough to 
routinely replace IADSA. 
However, these comparisons have not been strictly of like with like, i.e. of CT 
angiography, MR angiography and TCD in the same patients (with the same aneurysms). A 
proportion of the patients (114) in the SAGE study contemporaneously completed CT 
angiography, MR angiography and TCDS as well as IADSA. Taking the mean of two 
observers, the sensitivity per aneurysm for CTA for aneurysms 5mm or smaller was 56% (40 
of 72) and 94% (34 of 36) for aneurysms larger than 5mm. For MRA the sensitivity per 
aneurysm for aneurysms 5mm or smaller was 33% (24 of 72) and 89% (32 of 36) for 
aneurysms larger than 5mm versus 35% and 81% respectively for TCDS. However, specificity 
per aneurysm was better for MRA at 87 %. For CTA it was only slightly better at 76% 
compared to 72% for TCDS. Therefore in the same cohort of patients CTA and MRA were 
slightly more accurate overall per aneurysm at 72% and 67% respectively versus 60% for 
TCDS but there was no difference on a per subject basis with an accuracy of 85% for all three 
modalities. Although, unlike the TCDS results, the CTA and MRA results included posterior 
circulation aneurysms, the sensitivity and specificity were similar overall for anterior and 
posterior circulation aneurysms for both CTA and MRA. 
TCDS has not reached the same advanced point of technological development or 
maturity as CT or MR angiography and these techniques have been in much more widespread 
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use for longer than any form of TCDS. Therefore these first results of TCDS in a cohort of 
patients with CTA and MRA available for direct comparison appear promising. 
Anticipated developments 
Following the results of the International Study of Unruptured Intracranial 
Aneurysms,73 at present the role for any screening for intracranial aneurysms is controversial - 
although it can be difficult not to investigate the worried individual with a strong family 
history or other risk factor(s). In a screening context, it could be argued that because only 
aneurysms > 10mm in diameter would be considered for elective treatment, poor sensitivity for 
smaller aneurysms would not be clinically important, though it might be important medico - 
legally. Therefore TCDS should not yet be ignored as a method of diagnosing aneurysms. 
Indeed, future prospects for TCDS are encouraging- with the development of real time 
3D scanning techniques and the potential to combine these with contrast enhancement- with a 
sensitivity per aneurysm in a small study reported as 97 %.131 However, 3D and contrast 
techniques would increase the cost, duration and invasiveness of TCDS examinations. Only 
one large, prospective blinded study of contrast enhanced power TCDS has been published 
(105 subjects had power TCDS pre and post echo contrast). This demonstrated a significant 
increase in sensitivity for all aneurysm sites from 40% to 55% with the use of contrast, though 
at the cost of a small reduction in specificity.237 
Conclusion 
Power TCDS is a promising, quick, safe, reproducible and inexpensive non -invasive 
test for anterior circulation intracranial aneurysms. At present it is less accurate on a per 
aneurysm basis than CTA or MRA, though apparently similar on a per subject basis. As with 
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other non -invasive techniques, detection of small aneurysms is particularly poor. The 
cavernous carotid is the most difficult site to interpret, particularly for less experienced 
operators. The value of newer ultrasound techniques and in particular the role of 3D 
ultrasound and ultrasonic contrast agents require further evaluation in large, prospective fully 
blinded studies preferably comparing TCDS directly to the other alternative non -invasive 
modalities in the same patient cohort. The role of TCDS as an adjunctive test to CTA or MRA 
in the diagnosis of intracranial aneurysms (analogous to the situation in many centres in the 




SAGE STUDY: DETECTION OF ANEURYSMS BY TCD - RESULTS FORM 
Surname Forenames 
Consultant Date of Birth 
X -Ray No 
Date of Angiogram 
Date of TCD 




Bone window: (good =3, poor =2, absent =1) 
VISIBILITY OF ARTERIES: (1= absent, 2= vestigial, 3= normal, 4= dominant) 
Artery RA 1 RP1 RPCoA LA1 LP1 LPCoA 
TCD 
SITE OF ANEURYSM: coding system- 
MCA: mainstem = 1, trifurcation = 2, peripheral branch = 3 
ACA: ACoA = 4, pericallosal = 5 
ICA: terminal = 6, PCoA = 7, ophthalmic = 8, other = 9 
VB: basilar = 10, PICA = 11, other = 12 
Aneurysm 
(in order of size/ 
importance) 
1 2 3 4 
Site (0 -12) / 
Side (R =1, L =2, Mid =3) 
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0.55, 0.32 -0.76 
(12/22) 
0.89, 0.81 -0.95 
(81/91) 
0.47, 0.29 -0.65 
(15/32) 
0.91, 0.83 -0.96 
(81/89) 
0.43, 0.29 -0.58 
(22/51) 
0.86, 0.78 -0.92 
(81/94) 
0.06, 0.00 -0.26 
(1/17) 




0.82, 0.74 -0.89 
0.79, 0.71 -0.86 
0.71, 0.63 -0.79 





0.5 7, 0.18 -0.90 
0.27, 0.06 -0.61 
0.62, 0.32 -0.86 
















0.89, 0.71 -0.98 
0.96, 0.80 -1.00 
0.83, 0.64 -0.94 

















0.82, 0.65 -0.93 
0.75, 0.58 -0.88 
0.76, 0.61 -0.88 





0.53, 0.27 -0.79 
0.57, 0.34 -0.78 
0.37, 0.22 -0.55 
















0.89, 0.79 -0.95 
0.89, 0.79 -0.95 
0.88, 0.77 -0.95 

















0.82, 0.72 -0.90 
0.81, 0.71 -0.89 
0.69, 0.58 -0.77 
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0.81, 0.67 -0.91 
0.64, 0.31 -0.89 















0.88, 0.69 -0.97 
0.89, 0.77 -0.96 














0.83, 0.73 -0.91 








0.51, 0.39 -0.63 
0.53, 0.27 -0.79 















0.55, 0.38 -0.71 
0.85, 0.73 -0.94 












0.53, 0.43 -0.62 
0.79, 0.67 -0.87 






Summary of Part Two Chapter Two 
CTA and MRA have similar overall accuracy in the detection of intracranial aneurysms. 
SAGE study results are in line with the published literature. 
Both techniques are poorer in the detection of small (3 -5mm) and very small ( <3mm) 
aneurysms and in the detection of aneurysms around the cavernous /terminal carotid and 
MCA bifurcation regions. 
Imaging technology continues to improve and further advances should improve the 
diagnostic performance further for both CTA and MRA and these are discussed. 
Diagnostic performance is likely to be poorer in a low aneurysm prevalence, asymptomatic 
"screening" population. 
Interobserver agreement was good for both CTA and MRA. 
A simple scoring system for observer confidence is a useful means of determining cases in 
which a non -invasive tests for intracranial aneurysms is likely to be more (or less) reliable. 
Power TCDS is a promising, quick, safe and inexpensive non -invasive test for intracranial 
aneurysms; but its diagnostic performance is poorer than CTA or MRA on a per aneurysm 
basis, although similar on a per subject basis. 
Detection of small aneurysms by TCDS is particularly poor and experienced sonographers 
performed better than less experienced sonographers. 




Examines the effect on diagnostic performance of combining non -invasive 
imaging tests for the detection of intracranial aneurysms by comparing possible 







The accepted reference standard method for the identification of intracranial 
aneurysms is intra- arterial digital subtraction angiography (IADSA), but it is a time - 
consuming, invasive and relatively expensive technique. Consequently considerable 
interest has developed in the role of non -invasive imaging methods in the detection of 
intracranial aneurysms. Numerous studies have compared non -invasive techniques 
such as MR Angiography, CT Angiography or transcranial Doppler sonography 
(TCDS) to IADSA and these have been discussed in Part Two, Chapter One, in the 
context of a systematic review of the literature. The main drawback of all the non- 
invasive tests has been their low sensitivity compared to IADSA, particularly with 
regard to small aneurysms (those 5mm or smaller in maximum diameter). 
TCDS, despite its possible limitations as an isolated investigation,llo is an 
attractive technique in the investigation of intracranial aneurysms particularly in 
"screening" for unruptured aneurysms because of its safety, rapidity, repeatability, 
mobility and lower cost as compared to the other techniques. Part of the aim of the 
SAGE study was therefore to determine, in a fully blinded, prospective study, whether 
a strategy utilising a combination of power TCDS and either CTA or MRA, or CTA 
and MRA, could improve the sensitivity of a non -invasive investigation strategy for 
intracranial aneurysms. 
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2.3.2 Materials and Methods 
The methodology used for performing examinations, postprocessing of images 
and of image review in the SAGE study has been fully described in the appropriate 
sections of chapter two and will not be repeated here. Twelve of the 114 patients who 
completed all three non- invasive investigations (11 %) had a non -spiral CTA 
performed for logistical reasons; all other CTA examinations were spiral studies. 
Statistical methods 
2x2 tables were constructed of true positives, false positives, false negatives 
and true negatives for each modality as compared to the gold standard (IADSA) on a 
per patient and per aneurysm basis. Sensitivity, specificity, positive and negative 
predictive values and accuracy were calculated and compared on a per- subject and a 
per -aneurysm basis for the following investigative strategies: a) CTA alone, b) MRA 
alone, c) TCDS alone, d) CTA + TCDS, e) MRA + TCDS and f) CTA + MRA. 
Exact 95% Confidence Intervals (CI) based on binomial probabilities were 
calculated and the unweighted Kappa statistic was used to assess the level of 




One hundred and seventy three of the 200 SAGE subjects underwent CTA, 
157 MRA (152 completed the examination) and 171 TCDS examinations as well as 
the IADSA examination performed on clinical grounds. Of the 200 subjects, 127 
(64 %) patients underwent all three non -invasive tests. But of these, 5 were excluded 
because they were unable to complete the MRA examination. A further 8 patients had 
an inadequate bone window on TCDS so were also excluded, resulting in a subgroup 
of 114 patients who satisfactorily completed all three non -invasive imaging tests in 
addition to IADSA; 55 men and 59 women; median age 41 (range 19 -71 years). These 
114 subjects had similar age /sex distribution and aneurysm prevalence to the original 
200 subjects recruited. Patients were grouped into 4 categories based on the clinical 
indication for cerebral angiography. Group 1 comprised 3 patients with a known 
aneurysm(s) undergoing further assessment; group 2, 44 patients with proven SAH; 
group 3, 52 patients with symptoms which might be due to an aneurysm and group 4, 
15 asymptomatic patients at risk of harbouring an aneurysm. 
Complications 
Three of 114 patients experienced minor complications from IADSA (1 groin 
haematoma and two nausea and vomiting). One patient reported a moderate delayed 
contrast reaction after CTA (that responded rapidly to oral antihistamine and steroid). 
Two patients experienced claustrophobia during MRA but were able to complete the 
examination (plus five [excluded] patients who were unable to tolerate the MRA 
examination) and one patient reported mild scalp discomfort from the TCDS probe. 
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Diagnostic performance 
As reported in section 2.2.3, the diagnostic performance of both observers (for 
CTA and MRA) was similar and there was good interobserver agreement for CTA 
and MRA, with a Kappa value of 0.69, 0.56 -0.83 (95% CI) and 0.73, 0.60 -0.87 (95% 
CI) respectively. Overall, observer B had slightly better results with an accuracy per 
subject of 0.87, 0.79 -0.92 for both CTA and MRA compared to 0.81, 0.72 -0.87 for 
CTA and 0.84, 0.76 -0.90 for MRA for observer A. The results of observer B were 
used to evaluate further the different possible non -invasive imaging strategies. 
The sensitivity and specificity of the different imaging strategies are given in 
full on a per subject basis in Table 2.3.1. The sensitivity for CTA +TCDS was 0.83, 
0.66 -0.93; for MRA +TCDS it was 0.76, 0.59 -0.88 and for CTA +MRA it was 0.79, 
0.64 -0.91. Table 2.3.2a relates the performance of the non -invasive tests on a per 
aneurysm basis to the aneurysm size and shows that CTA and MRA performed 
substantially better than TCDS with regard to larger aneurysms and that each non- 
invasive method performed much worse in the detection of small aneurysms. Table 
2.3.2b indicates the effect on sensitivity on a per aneurysm basis from combining non- 
invasive tests together. Sensitivity was reduced on a per aneurysm basis by combining 
tests together because the methods frequently disagreed on the presence of an 
individual aneurysm or more often on the precise location and size of aneurysm (as 
indicated by the number of cases falling into the "uncertain" category). 
Despite the trend demonstrated for a combination of tests to improve the 
sensitivity and overall accuracy of non -invasive imaging on a per subject basis, the 
extent of improvement did not reach statistical significance. The statistical parameters 
for the increase in sensitivity of adding TCDS to CTA, TCDS to MRA and MRA to 
CTA were respectively: p =0.55 (x2 0.37), p =0.50 (x2 0.46) and p =0.95 (x2 0.004) 
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and for the improvement in accuracy were p =0.16 (x2 1.95), p =0.18 (x2 1.75) and 
p =0.18 (x2 1.75) respectively. 
The level of agreement for each method with the reference standard and with 
the other non -invasive tests was determined using the Kappa value (with 95% CI 
calculated). This method was also used to determine the level of agreement for the 
combinations of non -invasive tests with IADSA. These results are summarised in 
Table 2.3.3. The agreement between non -invasive modalities and IADSA on a per 
subject (patient) basis was good. The agreement of the non -invasive tests with each 
other was also good except for CTA and TCDS where agreement was only moderate. 
In comparison, agreement between the modalities was poorer on a per aneurysm 
basis, particularly between TCDS and either CTA or MRA. The improvement in 
Kappa was substantial for all combination strategies with an improvement to a "very 
good" level of agreement with the reference standard for the CTA + TCDS and CTA 
+ MRA strategies. 
Performance related to size of aneurysm 
In Table 2.3.4, sensitivity results are again given on a per subject basis but 
stratified according to the largest sized aneurysm that each patient had (whether or not 
the non -invasive test(s) detected it). The results on a per subject basis for the 
combination strategies was excellent for patients with an aneurysm(s) larger than 
5mm in maximum angiographic diameter, with a perfect sensitivity, specificity and 
accuracy of 1.0 for all three combination strategies. It is also worth commenting that 
the sensitivity for aneurysm detection (per subject) where the subject had an aneurysm 
of 3mm or larger for the most accurate combination (CTA +TCDS) was also excellent 
at 97% (27/28). 
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Of course a certain number of cases where the non -invasive tests disagreed 
were classed as "uncertain" and were therefore excluded from these analyses. This 
was done on the basis that if this disagreement occurred in clinical practice, 
confirmatory IADSA would be mandatory to resolve the discrepancy. For aneurysms 
between 3 and 5mm in maximum diameter, the results for the combination strategies 
are good, in particular for the CTA and TCDS combination. For aneurysms <3mm in 
size the sensitivity was very poor for all strategies (see Table 2.3.4). 
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2.3.3 Discussion 
In the context of intracranial aneurysm detection by non -invasive imaging, the 
most important performance criterion is sensitivity. This is because there is a 
confirmatory reference standard method available for the non -invasive tests, namely 
IADSA, which carries a relatively low risk in this group of subjects (0.07% rate of 
permanent neurological deficit103). Missing an aneurysm (false negative) is potentially 
disastrous for a patient whereas an unnecessary angiogram resulting from a false 
positive study is likely to be of much less consequence for the patient. 
Moreover, because it is likely that IADSA will be performed after a non- 
invasive test has shown a positive finding, the result on a per subject basis is more 
crucial for the non -invasive modalities than that on a per aneurysm basis. For 
example, not detecting one out of three aneurysms with a non -invasive test (i.e. True 
Positive per subject and for 2 aneurysms but False Negative for one aneurysm) is a 
much less important mistake than missing all the aneurysm(s) in a particular patient 
(i.e. FN per subject). Because, in the first scenario, the reference angiographic 
standard would subsequently be performed anyway, whereas in the second scenario it 
would not. 
The results presented are based on the "better" of the two observers. This 
observer (B) had lower sensitivity but greater specificity and slightly higher accuracy 
than observer A (see second paragraph of results). However, it should be remembered 
that the results of the two observers were very similar with good interobserver 
agreement- kappa of 0.69 for CTA and 0.73 for MRA. In fact, as can be seen in the 
footnote to Table 2.3.1, combination strategies using the "poorer" observer's results 
actually had a better sensitivity than those for the "better" observer! Therefore using 
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the most accurate observer's results has not biased the sensitivity results upwards at 
all, rather the reverse. 
Comparison with previous studies 
There are no other previous similar studies to compare with this one where it 
has been possible to determine the effects of combining non -invasive tests. 
Combining non -invasive tests together 
Combining power TCDS with either CTA or MRA can produce a non- 
invasive imaging strategy that, compared to any single test, has improved sensitivity 
and level of agreement with the reference angiographic standard (on a per subject 
basis). This is at the cost of a number of subjects falling into an "uncertain" category 
in which confirmatory IADSA would be required. The combination of CTA and 
power TCDS had the greatest sensitivity (83 %) and produced the highest level of 
agreement with IADSA (Kappa of 0.84). Nonetheless this strategy would have led to 
20 of 114 (18 %) subjects being classified as "uncertain" and requiring IADSA. 
Furthermore, in the true positive and false positive cases, IADSA would also have 
been necessary (29 and 1 subjects respectively). Thus in the population we studied, in 
order to achieve optimal sensitivity on a per subject basis with a combination of CTA 
and power TCDS, almost half the subjects would probably still have undergone 
IADSA (50 of 114, 44 %). 
The combination of MRA and CTA did not improve sensitivity over either 
examination alone, because they tended to detect or miss the same aneurysms. TCDS 
by detecting or missing different aneurysms did seem to complement CTA and MRA. 
Figure 2.3.1 indicates an example of this difference between modalities in practice. 
The CT angiogram in this 44 year old female presenting with SAH was correctly 
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interpreted by both observers as demonstrating a 4mm anterior communicating artery 
aneurysm (ruptured according to blood distribution on earlier plain CT) and an 
unruptured additional 3mm right middle cerebral artery (MCA) aneurysm. The MR 
angiogram was erroneously interpreted as demonstrating only the right MCA 
aneurysm by both observers, whereas the power TCDS demonstrated the ruptured 
4mm anterior communicating artery aneurysm, but the ultrasonographer did not detect 
the unruptured right MCA aneurysm. The quality of the non -invasive imaging in this 
example, particularly the MRA, is limited. This reflects the difficulty in obtaining 
good quality imaging in sick, anxious and often restless patients, and the fact that in 
routine clinical practice not all examinations can be performed on state of the art 
equipment using the very latest imaging sequences. 
All three of the combination strategies had a very similar overall accuracy per 
subject, and all had increased accuracy over the result of any single non -invasive 
method, although the improvement did not reach statistical significance. However, 
continuing technical improvements in all the non -invasive technologies studied mean 
that we can expect diagnostic performance to improve further in the near future. 
Combining tests together did not appear to improve performance on a per aneurysm 
basis because in many instances the modalities disagreed on the exact location and 
size of an aneurysm as well as disagreeing about the presence or absence of an 
aneurysm in other cases. This is indicated by the large number of aneurysms falling 
into the "uncertain" category in Table 2.3.2b. 
Future developments 
It is relevant to comment that we did not use contrast enhancement for either 
MRA or TCDS examinations. The SAGE study deliberately sought to examine 
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modalities that used the standard clinical imaging protocols available to most 
neuroscience centres. After the SAGE study started, evidence began to become 
available that suggested contrast enhancement might improve the diagnostic 
performance of both MRA and TCDS.131, 235, 237 However, as the evidence was early, 
limited and not yet established as standard clinical practice, we decided not to alter 
our examination protocols part way through the study, which would not have been 
sound scientific practice anyway. 
There is considerable data now available on the accuracy of contrast enhanced 
(CE) MRA in the investigation of cervical carotid, thoraco -abdominal and peripheral 
vasculature.238 There is evidence from in vitro models that CE MRA improves 
aneurysm detection229 However, the evidence in vivo for aneurysm detection is still 
very limited. It should also be remembered that the technical complexities of 
obtaining a good quality CE MRA study are greater than for conventional 3D TOF 
MRA. The timing of data acquisition and K -space filling needs to be precisely timed 
to the contrast bolus to gain the benefits of improved signal to noise ratio and reduced 
signal from adjacent venous structures. 
The only prospective, blinded study of aneurysm detection by CE MRA to 
date examined 32 patients and found CE MRA had an improved sensitivity of 100% 
compared to 96% for 3D TOF MRA but a lower specificity- 94% versus 100 %.235 
Although the results in this small series are impressive, this may be due in part to 
using a consensus result of MRA review and to the aneurysm size distribution- the 
mean aneurysm size was 6mm and only 39% (9 of 23) aneurysms were 5mm or 
smaller compared to 72% (59 of 82) in the combination part of the SAGE study. 
Nevertheless detection of all small aneurysms (compared to 31% for MRA in our 
study) does indicate the potential improvement that CE MRA may offer. Recent 
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evidence has also become available to indicate that contrast enhancement also 
improves the sensitivity of power TCDS- from 40 to 55% in the only large 
prospective study to date, though again at the expense of reduced specificity - from 
91% to 83 %.237 In summary, both CE MRA and CE power TCDS look promising on 
the limited data available so far. It should be borne in mind however that the cost, 
invasiveness and complexity of the examinations are increased by the use of contrast. 
Aneurysm screening 
Increasingly there is a desire for screening tests to be carried out in general 
hospitals. The procedures in this study (and virtually all of those referred to in the 
literature) were carried out under the direct supervision of a specialist 
neuroradiologist in a neuroscience centre. It is doubtful whether better, or even 
equivalent, results could be achieved if the examinations were performed outwith a 
specialist neuroimaging department. On the present evidence these non -invasive 
procedures are best performed, or at the very least interpreted, in specialist 
neuroradiology departments. 
Although the International Study of Unruptured Intracranial Aneurysms 
(ISUTA) data on risk of aneurysmal rupture and surgical morbidity require to be 
confirmed by prospective data, they provide a strong indication that most incidental 
aneurysms should not be considered for treatment. This topic was considered in some 
detail in sections 2.1.5 and 2.2.3. 
Table 2.3.4 indicates the performance of the non -invasive tests on a per 
subject basis stratified by maximum size of aneurysm. In practice failing to detect 
small aneurysms in patients with no history of SAH may not matter very much due to 
their very low risk of rupture, but whether asymptomatic patients should undergo any 
"screening" examination for intracranial aneurysms at all is highly questionable. 
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Conclusion 
The combination of transcranial power Doppler ultrasound with either CT 
angiography or MR angiography did improve the detection of intracranial aneurysms 
compared to either modality alone on a per subject basis. Non -invasive tests even in 
combination cannot yet replace IADSA in the detection of small and very small 
aneurysms. Non -invasive imaging tests performed and interpreted in neuroscience 
centres are a reliable method of detecting or excluding aneurysms larger than 5mm in 
diameter on a per subject basis- particularly when used in combination. 
Compared with the use of a single modality alone, employing a strategy 
combining two non - invasive tests would decrease the number of false negative results 
but at the cost of increasing the number of confirmatory IADSA studies required 
where the non -invasive tests do not agree. More information is still required on the 




IADSA demonstrates an anterior communicating artery aneurysm and additional 
unruptured 3 m right MCA aneurysm. Both aneurysms are seen on CTA (right) 
On MRA collapsed MIP (left), both aneurysms are subtly, seen but the base MRA 
image (right) does not clearly show the ACoA aneurysm. The observers detected both 
aneurysms on CTA, and the MCA but not the lar:er ACoA aneu sm on MRA 
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On TCDS image of the terminal 
left carotid region, the ACoA 
aneurysm is demonstrated. The 
right MCA aneurysm was not 
detected on TCDS. 
Table 2.3.1 Diagnostic 
Strategy 
performance per subject for different imaging strategies 
Sensitivity Specificity Accuracy Likelihood 
95% CI 95% CI 95% CI Ratio (of 
(TP /TP +FN) (TN /TN +FP) positive test) 
CTA* 0.80, 0.65 -0.90 0.91, 0.82 -0.97 0.87, 0.79- 9.2 
0.92 
(36/45) (63/69) (99/114) 
MRA* 0.71, 0.56 -0.84 0.97, 0.90 -1.00 0.87, 0.79- 24.5 
0.92 
(32/45) (67/69) (99/114) 
TCDS 0.73, 0.58 -0.85 0.91, 0.82 -0.97 0.84, 0.76- 8.43 
0.90 
(33/45) (63/69) (96/114) 
CTA+TCDS 0.83, 0.66 -0.93 0.98, 0.91 -1.00 0.93, 0.85- 43.5 
0.97 
(29/35) (58/59) (79/85) 
MRA+TCDS 0.76, 0.59 -0.88 1.00, 0.94 -1.00 0.92, 0.84- 00 
0.96 
(28/37) (61/61) (89/97) 
CTA+MRA 0.79, 0.64 -0.91 1.00, 0.94 -1.00 0.92, 0.85- CO 
0.96 
(31/39) (61/61) (92/100) 
*Results used for CTA and MRA were those of the "better" observer, although the results for both 
observers were very similar (see note in discussion.). For the "poorer" observer, sensitivity PP was 
0.82 and 0.71 for CTA and MRA respectively. For combination strategies using observer A's results, 
sensitivity PP was 0.86, 0.79 and 0.85 for CTA +TCDS, MRA +TCDS and CTA +MRA respectively. 
Where tests disagreed, the result was classified as "uncertain ", necessitating confirmatory IADSA 
rather than being classified as a True Positive (TP), true negative (TN), false positive (FP) or false 
negative (FN) result. For CTA +TCDS there were 20 "uncertain" cases, 16 for MRA +TCDS, and 14 
for CTA +MRA. 
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Table 2.3.2a 




Sensitivity 95% CI 
(TP /TP +FN) 
Specificity 95% CI 
(TN /TN +FP) 
<3mm 0.40, 0.19 -0.64 (8/20) 0.91, 0.82 -0.97 (63/69) 
CTA 3 -5mm 0.56, 0.40 -0.72 (22/39) 0.88, 0.78 -0.94 (63/72) 
5.1 -10mm 0.83, 0.52 -0.98 (10/12) 0.98, 0.91 -1.00 (63/64) 
>10mm 1.00, 0.72 -1.00 (11/11) 1.00, 0.94 -1.00 (63/63) 
All sizes 0.62, 0.51 -0.73 (51/82) 0.80, 0.69 -0.88 (63/77) 
<3mm 0.15, 0.03 -0.38 (3/20) 0.93, 0.85 -0.98 (67/72) 
MRA 3 -5mm 0.38, 0.23 -0.55 (15/39) 0.99, 0.92 -1.00 (67/68) 
5.1 -10mm 0.75, 0.43 -0.95 (9/12) 1.00, 0.95 -1.00 (67/67) 
>10mm 0.91, 0.59 -1.00 (10/11) 1.00, 0.95 -1.00 (67/67) 
All sizes 0.45, 0.34-0.57 (3 7/82) 0.92, 0.83 -0.97 (67/73) 
<3mm 0.15, 0.03 -0.38 (3/20) 
TCDS* 3 -5mm 0.36, 0.21 -0.53(14/39) 
5.1 -10mm 0.42, 0.15 -0.72 (5/12) 
>10mm 0.64, 0.31 -0.89 (7/11) 
All sizes 0.35, 0.25 -0.47 (29/82) 0.73, 0.63 -0.82 (63/86) 
For TCD, size categorisation was not available for all the false positive cases; 
therefore, specificity and accuracy could not be determined by aneurysm size category 
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Table 2.3.2b 




Sensitivity 95% CI 
(TP /TP +FN) 
Specificity 95% CI 
(TN /TN +FP) 
<3mm 0.00, 0.00 -0.31 
(0/10) 
CTA + TCDS* 3 -5mm 0.43, 0.23 -0.66 - 
(10/23) 
(64 5.1 -10mm 0.71, 0.29 -0.96 
(5/7) 
"uncertain") >10mm 1.00, 0.59 -1.00 
(7/7) 
All 0.47, 0.32 -0.62 0.95, 0.86 -0.99 
(22/47) (58/61) 
<3mm 0.00, 0.00 -0.22 - 
(0/15) 
MRA + TCDS* 3 -5mm 0.26, 0.10 -0.48 - 
(6/23) 
(55 5.1 -10mm 0.63, 0.24 -0.91 
(5/8) 
"uncertain") >10mm 1.00, 0.54 -1.00 
(10 /10) 
All 0.38, 0.25 -0.51 0.97, 0.89 -1.00 
(21/56) (61/63) 
<3mm 0.20, 0.04 -0.48 0.98, 0.91 -1.00 
(3/15) (61/62) 
CTA +MRA 3 -5mm 0.50, 0.31 -0.69 1.00, 0.94 -1.00 
(15/30) (61/61) 
(34 5.1 -10mm 0.89, 0.52 -1.00 1.00, 0.94 -1.00 
(8/9) (61/61) 
"uncertain") >10mm 1.00, 0.69 -1.00 1.00, 0.94 -1.00 
(10/10) (61/61) 
All 0.56, 0.43 -0.69 0.98, 0.91 -1.00 
(36/64) (61/62) 
"Uncertain" indicates that the tests disagreed about the presence of an aneurysm 
*For TCD, size categorisation was not available for all the false positive cases; so 
specificity and accuracy could not be determined by aneurysm size category 
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Table 2.3.3 
Level of agreement between modalities and the reference standard and with each 
other determined using unweighted Kappa statistic 
Modalities compared Kappa with 95% confidence intervals 
CTA with IADSA per subject (PP) 0.72, 0.59 -0.85 
MRA with IADSA per subject 0.71, 0.58 -0.85 
TCDS with IADSA per subject 0.66, 0.52 -0.81 
CTA with MRA per subject 0.73, 0.59 -0.86 
CTA with TCDS per subject 0.60, 0.45 -0.75 
MRA with TCDS per subject 0.66, 0.51 -0.81 
CTA with MRA per aneurysm 0.69, 0.56 -0.81 
CTA with TCDS per aneurysm 0.44, 0.27 -0.61 
MRAwith TCDS per aneurysm 0.50, 0.32 -0.68 
CTA +TCDS with IADSA PP* 0.84, 0.72 -0.95 
MRA +TCDS with IADSA PP* 0.79, 0.69 -0.94 
CTA +MRA with IADSA PP* 0.83, 0.71 -0.94 
A Kappa of <_0.20 indicates poor agreement, of 0.21 -0.40 fair agreement, of 0.41 -0.60 
moderate agreement, of 0.61 -0.80 good agreement and of >0.80 very good agreement 
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Table 2.3.4 
Sensitivity for aneurysm detection (per subject) according to max. aneurysm size 
Modality 
Size of subjects' 
largest aneurysm 
Sensitivity 95% CI 





0.25, 0.03 -0.65 (2/8) 
0.82, 0.57 -0.96 (14/17) 
0.89, 0.52 -1.00 (8/9) 
>10mm 1.00, 0.72 -1.00 (11/11) 
<3mm 0.125, 0.00 -0.53 (1/8) 
MRA 3 -5mm 0.71, 0.44 -0.90 (12/17) 
5.1 -10mm 0.89, 0.52 -1.00 (8/9) 
>10mm 1.00, 0.72 -1.00 (11/11) 
<3mm 0.25, 0.03 -0.65 (2/8) 
TCDS 3 -5mm 0.59, 0.33 -0.82 (10/17) 
5.1 -10mm 0.56, 0.21 -0.86 (5/9) 
>10mm 0.82, 0.48 -0.98 (9/11) 
CTA +TCDS <3mm 0.17, 0.00 -0.64 (1/6) 
(20/114 "uncertain" 3 -5mm 0.92, 0.62 -1.00 (11/12) 
and 10/20 had 5.1 -10mm 1.00, 0.59 -1.00 (7/7) 
aneurysm on IADSA) >10mm 1.00, 0.69 -1.00 (10/10) 
MRA +TCDS <3mm 0.14, 0.00 -0.58 (1/7) 
(16/114 "uncertain" 3 -5mm 0.75, 0.43 -0.95 (9/12) 
and 8/16 had 5.1 -10mm 1.00, 0.63 -1.00 (8/8) 
aneurysm on IADSA) >10mm 1.00, 0.69 -1.00 (10/10) 
CTA +MRA <3mm 0.14, 0.00 -0.58 (1/7) 
(14/114 "uncertain" 3 -5mm 0.85, 0.55 -0.98 (11/13) 
and 6/14 had 5.1 -10mm 1.00, 0.63 -1.00 (8/8) 
aneurysm on IADSA) >10mm 1.00, 0.72 -1.0 (11/11) 
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Summary of Part Two Chapter Three 
No previous studies have examined a diagnostic strategy for intracranial 
aneurysms involving a combination of non -invasive imaging tests. 
The most sensitive non -invasive imaging strategy for intracranial aneurysms is a 
combination of CTA and TCDS. This strategy also had the highest level of 
agreement with the reference standard. 
Confirmatory IADSA would be required where the non -invasive tests disagreed 
and would be required in up to 20% of subjects, as well as being necessary in 
those subjects who had an aneurysm demonstrated by both non -invasive tests. 
A non -invasive imaging strategy can reliably detect or exclude aneurysms larger 




Examines the effect of observer experience on the diagnostic performance of 
CTA and MRA used to detect intracranial aneurysms 
2.4.1 Introduction 





Most reports in the literature on CT and MR angiographic examinations of the 
cerebral vasculature have been from specialist neuroscience units.110 However, 
neuroradiologists are a relatively scarce resource in many countries and with the 
widespread availability of spiral CT and high field MR machines in general hospitals, 
increasingly radiologists outside neuroscience centres may be asked to undertake and 
interpret non -invasive angiographie studies of the cerebral vasculature. Might such a 
practice disadvantage the individual patient? 
There is no information available in the literature comparing the diagnostic 
performance of differently experienced readers in the detection of intracranial 
aneurysms using non -invasive methods. What information is available has compared 
observers of similar training and experience. One study compared three experienced 
neuroradiologists,198 another study compared five experienced, trained observers - 
three radiologists and two neurosurgeons (who were used to interpreting such studies 
in their role as endovascular interventionists) 206 and a further study compared two 
experienced neuroradiologists.235 
The purpose of this part of the SAGE study was to investigate whether less 
experienced observers from different clinical specialties - a vascular neurosurgeon 
(without endovascular training), a general cross sectional radiologist and a 
neuroradiographer - would perform as well as experienced neuroradiologists in 
identifying intracranial aneurysms on CTA and MRA. The effect of observer 
experience with regard to TCDS has already been examined in section 2.2.4. 
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2.4.2 Materials and Methods 
As described earlier in 2.2.3, from the SAGE population of 200 subjects, 142 
completed CTA, MRA and IADSA studies. For logistical reasons (in completing the 
separate review of CTA and MRA examinations by five readers in different centres 
within a reasonable time period), a representative sample of 60 patients was taken 
from the full cohort for the interobserver study. Half of the sample was chosen at 
random from the subgroup of patients with aneurysm(s) and half at random from 
those who did not. The examination methodology, image postprocessing techniques 
and image analysis /review used were derived from the literature and have already 
been detailed in chapter two.1 ss, 198, 206, 217, 219 
A similar blinded review- to that of the whole cohort performed by two 
neuroradiologists (JMW, ET)- was then undertaken of these 60 subjects MRA and 
CTA studies by three less experienced readers (SS- neuroradiographer, KWL- 
neurosurgeon, DKBP- general cross sectional radiologist). A coding form was 
completed for each imaging examination so that all the major intracranial vessel 
segments were systematically reviewed in turn (see Figures 2.2.5, 2.2.6 and 2.2.10). 
Aneurysm site and size were recorded as detailed earlier. Observer confidence was 
assessed on the simple 5 point scale used for the rest of the SAGE study.198 
The observers recorded the time taken to review each study and assessed their 
perceived difficulty of each case on a 5 point scale- 1= very easy (0.0- 1.50), 2= easy 




These were also as used in the rest of the SAGE study. 2x2 tables were 
constructed of true positives, false positives, false negatives and true negatives for 
each observer for both modalities as compared to the reference standard (IADSA) on 
a per subject and per aneurysm basis. Sensitivity, specificity, predictive values and 
accuracy were calculated with exact 95% Confidence Intervals (CI) based on binomial 
probabilities 222 and the unweighted Kappa statistic was used to assess the level of 
agreement for each observer with the reference standard.228 
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2.4.3 Results 
Thirty of the sixty subjects had aneurysms on IADSA, which was similar to 
the aneurysm prevalence in the larger cohort studied (44 %). Of the total of 63 
aneurysms, 18 (29 %) were <3mm in size, 27 (43 %) were 3 -5mm, 9 (14 %) were 5.1- 
10mm and 9 (14 %) were >10mm. Thirteen of 63 (21%) were aneurysms of the 
anterior cerebral artery circulation, 18 (29 %) of the middle cerebral artery circulation, 
20 (32 %) of the internal carotid artery and 12 (19 %) were aneurysms of the 
vertebrobasilar system. This distribution of aneurysms by size and site was also 
characteristic of the larger cohort from which the sixty subjects were drawn. 
The results in terms of sensitivity, specificity and accuracy are given with 95% 
confidence intervals for each observer on a per subject basis in Table 2.4.1 and on a 
per aneurysm basis in Table 2.4.2. Figures 2.4.1 and 2.4.2 compare the overall 
sensitivity on a per subject and a per aneurysm basis of the neuroradiologists to the 
other observers using Forrest plots. Table 2.4.3 indicates sensitivity for aneurysm 
detection related to size of aneurysm and Table 2.4.4 to the site of the aneurysm. As 
can be seen from Tables 2.4.1 and 2.4.2, the neuroradiologists performed better than 
the other observers but the differences were mostly small and the confidence intervals 
overlapped widely. The difference in accuracy per subject between the 
neuroradiologists (observers A and B) and observers C, D and E did not reach 
statistical significance for either CTA or MRA (x2- 2 degrees of freedom - for CTA 
was 2.06, 0.63 and 2.94 for observers C, D and E versus mean accuracy of the 
neuroradiologists; x2 for MRA was 0.12, 0.36 and 0.56 respectively). 
Likewise although the sensitivity per aneurysm was greater for 
neuroradiologists compared with the other observers, the differences again did not 
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reach statistical significance (x2 for CTA was 1.63, 2.64 and 1.21 for observers C, D 
& E respectively; )(,2 for MRA was 0.17, 0.56 and 0.34 respectively). 
For CTA, in patients who possessed at least one aneurysm that was larger than 
5mm (14 of the 60 subjects), both neuroradiologists correctly interpreted all 14 
patients as true positive or negative (on a per subject basis). For MRA, one of the 
neuroradiologists misinterpreted a patient with a 6mm left PICA aneurysm as false 
negative on a per subject basis i.e. the neuroradiologists were 93% (13 of 14) to 100% 
(14 of 14) accurate for this subgroup. In comparison, on CTA, all three non- 
neuroradiologists misinterpreted the patient with a 6mm left PICA aneurysm as false 
negative per subject and another observer misinterpreted a further patient as false 
negative, i.e.- 86% (12 of 14) to 93% (13 of 14) accuracy for this subgroup. For 
MRA, one of the non -neuroradiologists misinterpreted two patients as having 
aneurysms larger than 5mm that were not present on IADSA (false positive per 
subject) and another observer misinterpreted two patients as false negative per patient, 
i.e. 86% (12 of 14) to 100% (14 of 14) accuracy for this subgroup. 
The observers were asked to rate the reading difficulty of each case for CTA 
and MRA examinations- see methods section for description of scale. For CTA 
reading difficulty (mean ± standard deviation) was 3.1 ± 0.3 for observer A, 2.3 ± 1.1 
for observer B, 3.0 ± 0.8 for observer C, 3.1 ±1.0 for observer D and 3.3 ± 0.5 for 
observer E. For MRA, reading difficulty was 3.2 ± 0.4 for observer A, 2.5 ± 1.0 for 
observer B, 2.9 ± 0.9 for observer C, 3.0 ± 0.8 for observer D and 3.1 ± 0.4 for 
observer E. Therefore observers A, C, D and E all rated overall reading difficulty for 
both CTA and MRA as "satisfactory" (2.51 -3.50) and observer B rated overall 
reading difficulty as "easy" (1.51 -2.50) for both CTA and MRA. 
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The time taken to review each examination was also recorded. For CTA, this 
was (mean ± standard deviation) 7.5 ± 0.5 minutes for observer A, 8.25 ± 0.75 
minutes for observer B, 10.25 ± 1.75 minutes for observer C, 8.00 ± 1.25 minutes for 
observer D and 11.75 ± 1.75 minutes for observer E. For MRA, time taken was 7.5 ± 
0.25 minutes for observer A, 8.00 ± 1.25 minutes for observer B, 9.75 ± 1.75 minutes 
for observer C, 8.75 ± 1.25 minutes for observer D and 9.5 ± 1.5 minutes for observer 
E. For both CTA and MRA examinations the neuroradiologists took less time to 
review the examinations than the non -neuroradiologists except observer D versus B 
for CTA, where D was on average fifteen seconds faster. 
The level of agreement of each observer with the reference angiographic 
standard on a per subject basis was determined using the unweighted Kappa statistic 
with 95% confidence intervals. These results are presented in Table 2.4.5. The inter - 
rater variability was also determined for both CTA and MRA. Higher levels of 
agreement were found for MRA compared with CTA for nearly all observer pairs. For 
CTA the observer pairs with the greatest agreement (Kappa of 0.70, good agreement) 
were neuroradiologist with neuroradiologist (A/B) and neuroradiologist with general 
radiologist (A/E) and the pair with the worst level of agreement (K= 0.50, moderate 
agreement) was neuroradiographer with neurosurgeon (C /D). For MRA the pairs with 
the greatest agreement (Kappa 0.78 and 0.79 respectively) were the neuroradiologists 
(A/B) and neuroradiologist with general radiologist (B /E). The pairs with the worst 
agreement (Kappa 0.53 and 0.56 respectively) were neurosurgeon with general 
radiologist (D /E) and neuroradiographer with neurosurgeon (C /D). The 
neuroradiologists consistently had good agreement with each other and with the 
reference standard. Non -neuroradiologists had only moderate agreement with each 
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other except for observers C and E for MRA (Kappa 0.69) and only moderate 
agreement overall with the reference standard. 
The observers were asked to report their confidence level for each vessel 
segment reviewed using a simple 5 -point scale. There was little variation in the 
proportion of vessel segments observers B -E categorised confidently (aneurysm 
definitely present or absent) or less certainly. Observer A was confident on 42.8% 
(231 of 540) vessel segments on CTA and 61.1% (330 of 540) on MRA. Observer B 
was confident on 80.0% (432 of 540) of vessel segments on CTA and 83.3% (450 of 
540) on MRA. Despite this difference in perceived confidence the diagnostic 
performance was very similar (see Tables 2.4.1 and 2.4.2). 
By comparison, the non -neuroradiologists were confident on more vessel 
segments than the neuroradiologists were, but their diagnostic performance was 
poorer. Observer C was confident on 78.3% (423 of 540) vessel segments on CTA 
and 85.4% (461 of 540) on MRA; observer D was confident on 72.4% (391 of 540) of 
vessel segments on CTA and 85.6% (462 of 540) on MRA; Observer E was confident 
on 79.8% (431 of 540) of vessel segments on CTA and 89.6% (484 of 540) on MRA. 
When considering the use of a non -invasive test to detect aneurysms the 
positive and negative predictive values are an important performance parameter. The 
difference in predictive values was compared for observers when they were confident 
to when they were less confident to assess how useful the simple confidence scale 
might be in practice. These results are summarised in Table 2.4.6. A similar pattern 
for all the observers was found for CTA and MRA, with much better PPV values 
when observers were confident than when they were less confident but much smaller 
differences in NPV values between the confident and less confident categories. 
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2.4.4 Discussion 
The interobserver part of the SAGE study assessed a random but 
representative sample of sixty subjects from the larger prospective study of CTA and 
MRA versus IADSA in the detection of intracranial aneurysms. Despite the relatively 
smaller size of this sample, it is still larger than many published series and is the first 
study to allow useful comparisons to be drawn between experienced and less 
experienced observers. For both the more experienced (the neuroradiologists) and the 
less experienced observers, CTA had better accuracy than MRA on a per subject 
basis. On a per aneurysm basis CTA had better sensitivity and slightly poorer 
specificity than MRA but overall better accuracy. 
The neuroradiologists had better accuracy for CTA on a per subject and a per 
aneurysm basis than the non -neuroradiologists. For MRA, the difference in sensitivity 
between the more and less experienced observers was smaller (the neuroradiologists 
had better sensitivity per aneurysm but marginally poorer sensitivity per subject than 
the non -neuroradiologists), but again the neuroradiologists had better overall accuracy 
than the non -neuroradiologists on a per subject and a per aneurysm basis. Using the 
Kappa statistic to determine the level of agreement with the reference standard 
demonstrated an advantage to the neuroradiologists ( "good" agreement with reference 
standard) over the non -neuroradiologists ( "moderate" agreement). The 
neuroradiologists also had better agreement with each other than the non - 
neuroradiologists had with each other (or in general with the neuroradiologists), 
indicating a greater level of consistency for the neuroradiologists. 
Although many of the observed differences in this study of sixty subjects were 
quite small, the effects if confirmed on a population basis could be substantial. To 
illustrate this (by extrapolating these data), if non -neuroradiologists reported 1000 
291 
CTA studies instead of neuroradiologists, taking the 8% difference in accuracy rate 
(and the 95% CI) for the combined results for the two groups of observers, then 
somewhere between 0 and 190 with a mean of 80 additional subjects would be 
misdiagnosed. The mean error rate would increase from 130 to 210 per 1000 - a 
substantial 62% rise. Repeating the extrapolation exercise for MRA, the 
corresponding figure would be less striking with the range lying between 0 and 170 
with a mean of 40 extra subjects misdiagnosed (4% difference in accuracy rate), and 
the increase in the mean error rate would be from 180 to 220 -a more modest 22% 
rise. Clearly data extrapolation from small datasets leads to wide confidence intervals 
as demonstrated and needs to be interpreted with caution. 
As demonstrated in the SAGE and previous studies, aneurysm size is critical 
to detection by non -invasive modalities.I" Many of the aneurysms in the current 
study were small or very small (72 %), which probably explains why the overall 
sensitivity for the neuroradiologists in the current study is poorer than that reported in 
some previous studies.181' 189 As expected, the difference in aneurysm detection rates 
was markedly lower for aneurysms of 5 mm or smaller compared to larger aneurysms. 
Both the neuroradiologists and the other observers demonstrated this effect. 
Neuroradiologists had substantially better sensitivity for CTA in all aneurysm 
size categories. This applied to small and very small aneurysms with MRA, but not 
for larger aneurysms where the performance was similar and with the non - 
neuroradiologists performing slightly better in the 5.1 -10 mm size category. The 
consistently poor performance of non -invasive modalities in the detection/exclusion 
of small aneurysms remains a significant drawback to their wider use. 
Aneurysm site also has a major influence upon aneurysm detection using CTA 
and MRA.' io, 236 For CTA, the neuroradiologists performed better than the non- 
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neuroradiologists at all sites, but performed poorly themselves in the detection of 
aneurysms arising from the cavernous and terminal carotid segments. As discussed 
earlier in the thesis this is a site of particular diagnostic difficulty for both CTA and 
MRA. Similar problems can also occur at a complex MCA bifurcation, particularly if 
the aneurysm is small or if more than one aneurysm is present (see section 2.2.3). For 
MRA, the neuroradiologists performed better than the other observers at all sites 
except for vertebrobasilar aneurysms. 
It was interesting that although less experienced in the interpretation of CTA 
and MRA studies for intracranial aneurysms, the non -neuroradiologists (with poorer 
diagnostic performance overall) reported greater levels of confidence than did the 
neuroradiologists. For CTA, non -neuroradiologists were confident that an aneurysm 
was present or absent in 77% of vessels examined versus 61% for neuroradiologists; 
for MRA the figures were 87% and 82% respectively. It is uncertain whether this 
represents lack of confidence or greater objectivity (the wisdom of experience ?) on 
the part of the neuroradiologists or overconfidence on the part of the non- 
neuroradiologists. 
However, when observers of all levels of experience were confident, they did 
have substantially better positive, and slightly better negative, predictive values than 
when they were less confident. Therefore these data suggest that a simple confidence 
scale may still be a useful tool when interpreting such examinations in clinical 
practice, particularly when it is applied to more experienced observers. 
As might be expected, the neuroradiologists were quicker at interpreting the 
CTA and MRA examinations, but the differences were not great - at an average of 7.9 
versus 10 minutes for CTA and 7.8 versus 9.3 minutes for MRA, with the time for 
both modalities being very similar. 
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As was alluded to in section 2.3.4, the non -invasive examinations performed 
for the SAGE study (and virtually all of those referred to in the literature) were carried 
out under the direct supervision of a specialist neuroradiologist in a neuroscience 
centre. A neuroradiologist also performed all the CTA reconstructions for the SAGE 
study. It can be difficult to manually edit and separate vessels from bone or 
perivascular calcification on CTA and experience is required to do this speedily and 
effectively.21' These factors mean that it is doubtful whether better or even equivalent 
results could be obtained in a non -neuroscience centre performing such examinations 
on an occasional basis. Future improvements of techniques may improve the 
sensitivity of aneurysm detection. and these have also been discussed earlier in the 
thesis (sections 2.1.5 and 2.2.3 in particular). 
Conclusion 
For the non -invasive detection of intracranial aneurysms using CT and MR 
angiography, neuroradiologists performed better overall than the less experienced 
observers, although in this relatively small sample of sixty patients the differences did 
not reach statistical significance. However, even small differences in accuracy could 
have a substantial effect on misdiagnosis across the wider population. 
The neuroradiologists were more consistent and had better agreement with the 
reference standard than non -neuroradiologists. Observer confidence did not reflect 
experience, but when they were confident, observers performed better than when they 
were not confident. CTA or MRA performed and interpreted by neuroradiologists was 
a reliable method of detecting or excluding aneurysms 5mm or larger in diameter on a 
per subject basis. Small aneurysms and aneurysms arising from the cavernous and 
terminal internal carotid artery were poorly detected by all observers. 
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Figure 2.4.1 Forrest plot on a per subject basis comparing other observers 
with the neuroradiologists for CTA and MRA 
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Figure 2.4.2 Forrest plot on per aneurysm basis for other observers 
compared to neuroradiologists for CTA and MRA 
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Table 2.4.1: Diagnostic performance on a per subject basis compared to IADSA 
Sensitivity 95% CI 
(TP /TP +FN) 
Specificity 95% CI 
(TN /TN +FP) 
Accuracy 95% CI 
Observer A CTA 0.90, 0.73 -0.98 0.83, 0.65 -0.94 0.87, 0.75 -0.94 
(27/30) (25/30) 
Observer B CTA 0.80, 0.61 -0.92 0.93, 0.78 -0.99 0.87, 0.75 -0.94 
(24/30) (28/30) 
Observer C CTA 0.63, 0.44 -0.80 0.90, 0.73 -0.98 0.77, 0.68 -0.89 
(19/30) (27/30) 
Observer D CTA 0.80, 0.61 -0.92 0.83, 0.65 -0.94 0.82, 0.66 -0.88 
(24/30) (25/30) 




0.85, 0.73 -0.93 0.88, 0.77 -0.95 0.87, 0.79 -0.92 
Others combined 0.74, 0.64 -0.83 0.87, 0.78 -0.92 0.81, 0.75 -0.86 
CTA 
Observer A 0.67, 0.47 -0.83 0.90, 0.73- 0.98 0.78, 0.66 -0.88 
MRA (20/30) (27/30) 
Observer B MRA 0.70, 0.51 -0.85 1.00, 0.88 -1.00 0.85, 0.73 -0.93 
(21/30) (30/30) 
Observer C MRA 0.67, 0.47 -0.83 0.93, 0.78 -0.99 0.80. 0.68 -0.89 
(20/30) (28/30) 
Observer D 0.77, 0.58 -0.90 0.80, 0.61 -0.92 0.78, 0.66 -0.88 
MRA (23/30) (24/30) 
Observer E MRA 0.67, 0.47 -0.83 0.83, 0.65- 0.94 0.75, 0.62 -0.85 
(20/30) (25/30) 
Neuroradiol. 0.68, 0.55 -0.80 0.95, 0.86 -0.99 0.82, 0.74 -0.88 
Combined MRA 
Others combined 0.70, 0.59 -0.79 0.86, 0.77 -0.92 0.78, 0.71 -0.84 
MRA 
TP = true positive TN = true negative 
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FP = false positive FN = false negative 
Table 2.4.2 
Diagnostic performance on per aneurysm basis compared to IADSA 
Sensitivity 95% CI 
(TP /TP +FN) 
Specificity 95% CI 
(TN /TN +FP) 
Accuracy 95% CI 
Observer A CTA 0.67, 0.54 -0.78 0.63, 0.46 -0.77 0.65, 0.55 -0.74 
(43/63) (25/40) 
Observer B CTA 0.60, 0.47 -0.72 0.80, 0.63 -0.92 0.67, 0.57 -0.76 
(38/63) (28/35) 
Observer C CTA 0.52, 0.39 -0.65 0.84, 0.67 -0.95 0.63, 0.53 -0.73 
(33/63) (27/32) 
Observer D CTA 0.49, 0.36 -0.62 0.66, 0.49 -0.80 0.55, 0.45 -0.65 
(31/63) (25/38) 
Observer E CTA 0.54, 0.41 -0.67 0.71, 0.53 -0.85 0.60, 0.49 -0.70 
(34/63) (24/34) 
Neuroradiol. Combined 0.63, 0.54 -0.72 0.71, 0.59 -0.81 0.66, 0.59 -0.73 
CTA 
Others combined 0.52, 0.44 -0.59 0.73, 0.63 -0.81 0.59, 0.54 -0.65 
CTA 
Observer A MRA 0.41, 0.29 -0.54 0.82, 0.65 -0.93 0.55, 0.45 -0.65 
(26/63) (27/33) 
Observer B MRA 0.44, 0.32 -0.58 0.91, 0.76 -0.98 0.60, 0.50 -0.70 
(28/63) (30/33) 
Observer C MRA 0.40, 0.28 -0.53 0.82, 0.65 -0.93 0.55, 0.44 -0.65 
(25/63) (28/34) 
Observer D MRA 0.37, 0.25 -0.50 0.65, 0.47 -0.80 0.47, 0.37 -0.57 
(23/63) (24/37) 
Observer E MRA 0.38, 0.26 -0.51 0.76, 0.58 -0.89 0.51, 0.41 -0.61 
(24/63) (25/33) 
Neuroradiol. 0.43, 0.34 -0.52 0.86, 0.76 -0.94 0.58,0.50 -0.65 
CombinedMRA 
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0.85, 0.65 -0.96 
0.72, 0.55 -0.86 
0.43, 0.27 -0.59 
0.67, 0.45 -0.84 
0.62, 0.41 -0.80 
0.47, 0.30 -0.65 
0.23, 0.11 -0.38 






0.79, 0.64 -0.91 
0.56, 0.41 -0.69 
0.32, 0.20 -0.45 
0.47, 0.30 -0.65 
0.54, 0.37 -0.70 
0.41, 0.28 -0.55 
0.18, 0.10 -0.30 
0.58, 0.41 -0.74 
Table 2.4.5: 
Inter -modality agreement per subject for CTA and MRA 
-assessed using unweighted Kappa statistic 
Observer CTA with IADSA MRA with IADSA 
A 0.73, 0.56 -0.91 0.57, 0.36 -0.78 
B 0.73, 0.56 -0.91 0.70, 0.52 -0.88 
C 0.53, 0.32 -0.75 0.60, 0.40 -0.80 
D 0.63, 0.44 -0.83 0.57, 0.36 -0.78 
E 0.60, 0.40 -0.80 0.50, 0.28 -0.72 
Neuroradiologists 0.73, 0.61 -0.85 0.63, 0.49 -0.77 
Combined 

























































































































































































































































































































































































































































































































ethods section for precise details of sim
ple confidence scale utilised 
Summary of Part Two Chapter Four 
Neuroradiologists had better diagnostic performance overall on both a per subject 
and a per aneurysm basis than non -neuroradiologists. 
The differences between the two groups were smaller for MRA than for CTA. 
The neuroradiologists had consistently better agreement with each other and with 
the reference standard, IADSA, than did the non -neuroradiologists. 
Reported observer confidence did not reflect experience. 
When observers were more confident, diagnostic performance was better than 
when they were not confident. 
Small aneurysms and aneurysms arising from the cavernous and terminal carotid 
were very poorly detected by all readers. 
Extrapolating combined data for the two groups of readers, on CTA, non - 
neuroradiologists would misdiagnose a mean extra 80 (95% CI 0 -190) subjects per 
1000 studied compared to neuroradiologists and for MRA would misdiagnose an 




Reports the prospective patient assessment of the non -invasive imaging modalities 







The process of health care delivery has undergone a major evolutionary change over 
the last decade with a move to involving patients and their relatives much more closely in the 
decision making process about diagnosis and treatment. This includes discussing concepts 
such as risk benefit analysis and obtaining feedback from patients using tools such as 
satisfaction surveys.239 Patient satisfaction is an important outcome measure in itself and is 
useful in assessing consultations and patterns of communication.240 Furthermore, a patient's 
attitude about an intervention or diagnostic test is an essential component in cost - 
effectiveness models.241 Despite this emphasis change towards patient centred health care 
delivery, there remains very little information in the imaging literature regarding patient 
satisfaction with, or preferences towards, different imaging investigations, particularly those 
used to look for similar problems; for example MR versus conventional angiography. Only 
two such studies have been published in any of the journals indexed in Medline.241, 242 
With regard to imaging methods for intracranial aneurysms, no mention was made of 
patient assessment of the examinations performed on them in any of the papers identified and 
reviewed for the systematic review described in the first chapter of part two of this thesis. Yet 
despite this lack of data, cost -effectiveness models have been drawn up for aneurysm 
screening using MRA.146' 163 Even complications experienced by patients were only reported 
on in a handful of the papers identified for the systematic review (only 4 of 103 reported any 
complications).110 
Therefore the SAGE study offered an opportunity to find out how patients who had 
undergone the non -invasive imaging tests as well as invasive cerebral angiography found the 
experience and by reporting these results to facilitate the wider radiological community 
gaining a better understanding of the patient's perspective. 
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Methods 
All participants in the SAGE study were sent a questionnaire to fill in one to two 
weeks after they had completed the study examinations. This questionnaire asked them to 
grade the discomfort experienced during each test on a standard 10cm long visual analogue 
scale (0 being no discomfort and 10 being as uncomfortable or painful as they have ever 
experienced) and to rank the three non -invasive tests in order of preference- see Figure 2.5.1. 
A prepaid and addressed envelope was provided with the questionnaire. The returned 
questionnaires were anonymous. 
It is well recognised that telephone or face to face surveys have increased bias and are 
less likely to elicit criticism and that surveys mailed later produce the least biased situation, 
albeit for the trade off of a reduced response rate.243 Questionnaires should also be 
anonymised and confidential to minimise bias 244 as was the case in the SAGE study 
questionnaire. 
To ensure that comparisons between the tests were based on personal experience, only 
questionnaires returned by patients who had completed all three non -invasive examinations 
were analysed further. The paired t test was used to compare the differences in mean patient 
discomfort scores (on the visual analogue scale) between modalities. The x2 test was used to 
compare the reported differences between tests. 
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2.5.3 Results 
Twelve patients experienced complications and these were detailed in chapter three. 
Eighty -eight percent (100 out of 114) of the subjects who had completed all three non- 
invasive examinations returned satisfactorily completed questionnaires. This is an excellent 
response rate for a mailed questionnaire, with rates in the order of 25 -30% more commonly 
reported in the imaging literature.245 
The mean discomfort scores recorded on the visual analogue scale (with 95% CI) 
were as follows: for IADSA, 4.5 (3.9 -5.1); for CTA, 1.6 (1.2 -2.0); for MRA 2.9 (2.3 -3.5) and 
for TCDS, 0.5 (0.3 -0.7). These results are illustrated graphically in Figure 2.5.2. IADSA 
caused significantly more patient discomfort than did any of the non -invasive modalities. 
Using the paired t test, p was <0.01 with the value of the test statistic "t" = 9.14 for IADSA 
versus CTA, t = 5.49 for IADSA versus MRA and t = 12.2 for IADSA versus TCDS (a "t" 
value of more than 3.4 on 99 degrees of freedom is significant at the 0.1% level i.e. p<0.01). 
TCDS caused significantly less discomfort than CTA (t= 5.78) or MRA (t= 7.64), p also 
<0.01. CTA caused significantly less discomfort than MRA, p <0.01 (t= 3.53). 
Nine patients expressed no preference between any of the non -invasive modalities, 
four patients ranked CTA and TCDS equally and three MRA and TCDS equally. Of the 
remaining patients, 24 preferred CTA, 12 preferred MRA and 48 preferred TCDS. TCDS was 
preferred to both the other non -invasive modalities by significantly more subjects, p <0.001 
(x2= 39.76). The preference for CTA over MRA was also statistically significant, p<0.025 
(x2 = 7.88). 
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2.5.3 Discussion 
Patients experienced significantly less discomfort from the non -invasive imaging 
modalities than from conventional catheter angiography. These data are derived from a larger 
number of patient responses than either of the previously published reports in this field. The 
methodology used in the SAGE study of an anonymised mailed questionnaire was that 
preferred (by previous commentators) as minimising bias.243, 244 Therefore we believe that 
these data provide a robust and accurate reflection of typical patient experiences. 
It was interesting that significantly more patients preferred CT Angiography to MR 
Angiography despite the fact that CTA involved venepuncture and contrast administration 
but MRA in the SAGE study did not. The visual analogue score (VAS) reading for MRA was 
also surprisingly significantly higher than that for CTA or TCDS. Less surprising was the 
preference for completely non -invasive TCDS over the other modalities. 
What does this mean in practice? It reinforces the role for CT Angiography as the 
preferred initial non -invasive investigation for intracranial aneurysms because it is cheaper, 
often more readily available and slightly more accurate than time -of -flight MR Angiography, 
as well as causing less patient discomfort. The exposure to ionising radiation is a drawback to 
the repeated use of CTA for screening, but at present there is no robust evidence on how long 
and often one might choose to screen for intracranial aneurysms. Although causing less 
discomfort and preferred by more patients, the data presented on TCDS in chapters one to 
three (of part two) indicate it is not yet accurate enough to use as a stand -alone imaging tool 
for intracranial aneurysms. 
Chapter three (of part two) demonstrated that the most sensitive overall imaging 
strategy to detect intracranial aneurysms non -invasively was a combination of CTA and 
TCDS. The patient assessment data presented in this chapter dovetails well with this, as these 
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were the two non -invasive modalities preferred by patients and both caused significantly less 
discomfort on average than MRA. 
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Figure 2.5.1 
Davie Cooper Scottish Aneurysm study: questionnaire 
Name Date of Birth Today's date 
1) Please indicate the examinations you completed (tick as appropriate) 
MR Angiography CT Angiography Transcranial US scan 
2) Did you start a test but were not able to complete it? Yes /No 
-which test(s) did you not complete 
-what were the reasons for this? 
3) Could you indicate by a mark on the scale provided from 0 -10 how much discomfort or 
inconvenience each imaging test caused you. 
0 = no discomfort 
10 = very unpleasant or very significant discomfort 
Angio:- (OK) 0 10 (Bad) 
MRA:- (OK) 0 10 (Bad) 
10 (Bad) CTA:- (OK) 0 
TCDS:- (OK) 0 10 (Bad) 
4) Which of the tests do you think is the most convenient:- (tick as appropriate) 
MRA CTA TCDS 
5) If you underwent any of these tests again which of them would you prefer: - 
(tick as appropriate) 
MRA CTA TCDS 
6) If the method you did not prefer was shown to be more accurate than your preferred 
method would you be willing to undergo the less pleasant method: - 
(tick the box you think is the most appropriate) 
Readily With reluctance Not at all 
We would value any comments you have to make either in general or specifically about any 













1.5 gc 1 
0.5 
0 
Patient discomfort experienced during an 
examination 
IADSA CTA MRA 
Imaging modality 
TCDS 
IADSA caused significantly more discomfort than all the non -invasive tests, p <0.01 
TCDS caused significantly less discomfort than CTA or MRA, p <0.01 
CTA caused significantly less discomfort than MRA, p <0.01 
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Summary of Part Two Chapter Five 
All three non -invasive imaging tests caused significantly less patient discomfort than 
IADSA. 
TCDS caused significantly less discomfort than CTA, which in turn caused significantly 
less discomfort than MRA. 
Significantly more patients preferred TCDS to the other two tests and significantly more 
preferred CTA to MRA. 
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Summary of Part Two 
The rationale behind systematic reviews was discussed and the methodology used for 
a systematic review of non -invasive imaging tests in the detection of intracranial aneurysms 
was described in detail. In populations with a high prevalence of aneurysms, both CTA and 
MRA have equivalent diagnostic performance with an overall accuracy of -90 %. However, 
the detection of aneurysms smaller than 3mm was significantly poorer than the detection of 
aneurysms larger than 3mm, with a trend towards CTA performing better than MRA in very 
small aneurysms. The data on TCDS were more limited and indicated an accuracy of -80%. 
Robust data were found to be lacking in the literature on the effect of observer experience on 
diagnostic performance of the non -invasive tests. Very few studies have directly compared 
non -invasive tests in the same group of patients, making direct comparisons between 
modalities difficult. 
The prospective SAGE study was described- including the detailed examination, 
image processing and image review methodologies used. Future technological developments 
and their possible impact on diagnostic performance were reviewed. The SAGE study 
demonstrated similar overall accuracy for CTA and MRA compared to IADSA in the same 
cohort of patients. Interobserver agreement was good for both modalities. Small (3 -5mm) and 
very small ( <3mm) aneurysms were much more poorly detected than larger aneurysms by 
both observers. Aneurysms around the cavernous / terminal carotid region and MCA 
bifurcation were more poorly detected than aneurysms at other sites by both observers for 
CTA and MRA. Diagnostic performance of TCDS compared to IADSA was also determined. 
Accuracy per subject was similar to that for CTA and MRA at 85% but performance per 
aneurysm was poorer. 
The effect on diagnostic performance of combining non -invasive tests together was 
studied. The most accurate combination for the detection of intracranial aneurysm was 
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CTA +TCDS, with overall accuracy per subject of 93% and sensitivity for aneurysm detection 
where the maximum aneurysmal size in a subject was 3mm or larger was 97% (27/28). The 
drawback of combining tests together is that where they disagree confirmatory IADSA would 
be necessary and this might affect up to 20% of subjects. Although non -invasive imaging 
tests, particularly when used in combination, can reliably detect or exclude intracranial 
aneurysms >5mm, for several reasons discussed in the text, the diagnostic performance of 
non -invasive tests is likely to be lower in the context of their use as a screening test in 
asymptomatic, low aneurysm prevalence populations. 
Neuroradiologists were demonstrated to have better diagnostic performance for CTA 
and MRA than other observers in a subgroup of sixty cases randomly selected from the 
SAGE study. Neuroradiologists had consistently better agreement with each other and with 
the reference standard than the other observers. When observers of whatever experience were 
confident, their diagnostic performance was better. A simple scoring system for observer 
confidence might prove a useful adjunct to determine cases in which a non -invasive test for 
intracranial aneurysms is likely to be more (or less) reliable. 
All three non -invasive tests caused significantly less discomfort than IADSA. TCDS 
was the least uncomfortable test and was preferred by significantly more patients than CTA 
or MRA. Interestingly, MRA was more uncomfortable and preferred by significantly fewer 
subjects than CTA. 
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Part Three 
An epidemiological study of aneurysmal subarachnoid haemorrhage in the Scottish 






5 Implications arising from the SAGE and Davie Cooper studies 
a) For clinical practice 




Introduction to the epidemiological studies performed as part of the Davie Cooper 
Scottish Aneurysm Study 
3.1.1 Background to and rationale behind the epidemiological studies 
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3.1.1 Background to and rationale behind the epidemiological studies 
The epidemiology of aneurysmal SAH has been described in considerable detail with 
a thorough review of the existing literature (section 1.1.4). However, as outlined in the 
review, several gaps were apparent in the available data. Most importantly, none of the 
previous studies were performed in the UK, and most previous studies only identified a 
modest number of relatives and therefore only a very small number of subarachnoid 
haemorrhage events amongst these relatives. Population demographics might be quite an 
important factor in the results of previous studies. For instance, much of the work on 
aneurysmal SAH has come from Scandinavia and Finland in particular, where the rate of 
SAH is very high.40, 71, 81, 83 Finland has had an isolated and relatively stable population for a 
very long time. Even some of the studies from North America have been performed on 
relatively isolated populations, which have remained stable for a long time such as those in 
certain regions of Quebec such as Saguenay -Lac St Jean.76' 78 If genetic factors are as 
important as thought with regard to SAH risk, then results obtained from isolated populations 
may not be readily extrapolated to a country such as the UK, which has had much greater 
population mobility over the last 200 years and considerably greater ethnic diversity. 
The estimate of risk in relatives varied considerably between studies, as did the risk of 
SAH and the results might be population specific.75 No previous studies could provide a 
prospective risk in relatives and none could demonstrate clearly that recall, case 
ascertainment or other biases (such as a small number of badly affected families) were not 
unduly influencing their results. The possible bias of a small number of badly affected 
families is more likely to occur in smaller studies in geographically localized and stable 
populations, which comprise several of the previously published population -based studies 
(see Table 1.1.3). Although there is evidence for the risk being increased in first compared to 
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second -degree relatives,246 there is considerable variation between studies both in terms of 
methodology used and the results obtained. Some of the differences between studies may be 
due to selection bias; for example respondents may have been more likely to have a positive 
family history of SAH than non -responders, who could be anticipated to be less interested in 
a condition that has not affected their family. Certainly, previous studies have not included 
the same groups of relatives- some included only first -degree, some first and second -degree 
and others first to third (see Table 1.1.3), and the degree of relationship to the index case does 
seem to be important (see Table 1.1.4). Other possible biases present in previous studies 
include recall bias,79' 80 and ascertainment bias 82' 83 and these may all have influenced the 
results and help explain discrepancies between studies. 
An hierarchy of risk in terms of number and degree of relationship of affected 
relatives has not been quantified in any study.75 Both the degree of relationship with index 
cases and the number of relatives affected by SAH should be taken into account when 
determining the future risk of SAH in any individual family member. However, reliable data 
to address these points were lacking; i.e. there were insufficient data to be able to advise 
individual patients and their relatives of their likely risk. Yet this clinical scenario is 
encountered on an almost daily basis in neuroscience centres. 
Our epidemiological studies were designed to sample the whole Scottish population 
and thereby attempt to identify a large number of relatives (and therefore subarachnoid 
haemorrhages). By sampling the Scottish population in two different ways we aimed to 
compare the results obtained in order to determine the robustness of these data and assess the 
influence of any bias more objectively. Furthermore, the structure of the West of Scotland 
study was designed to allow a ten -year prospective risk to be calculated of SAH, with the risk 
linked to the family history of subarachnoid haemorrhage, in order to construct an hierarchy 
of risk. This would provide extremely useful data for clinicians when counselling individual 
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family members of someone who has sustained a subarachnoid haemorrhage regarding their 
own prospective risk of SAH. 
Summary of Part Three Chapter One 
Epidemiological data on aneurysmal SAH were lacking for the UK population. 
No data were available on the prospective risk of SAH in relatives of patients who have 




Methodology of the research studies into the epidemiology of aneurysmal subarachnoid 
haemorrhage in the Scottish population 
3.2.1 Preparatory work: study protocols, questionnaire booklet, databases, ethics approval, 
isd and NHSCR submissions /approval 
3.2.2 Implementation of studies 
3.2.3 Data analysis 
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3.2.1 Preparatory work for the epidemiological studies 
Extensive literature search and review was undertaken as a first preparatory step prior 
to submission of the research application and this was supplemented by further literature 
searching and updating by the research fellow, see section 1.1.4. 
The procedures undertaken for the two population based surveys subsequent to the 
identification of index cases are described as flow charts in Figures 3.2.1 and 3.2.2. These 
clearly demonstrate the considerable number of steps involved in this type of epidemiological 
research even after index cases have been identified and the numerous external 
agencies /resources that had to be utilised. However, before this work could even begin, the 
questionnaire to be utilised had to be developed and validated and subsequent to that, ethical 
approval had to be obtained for the whole of Scotland. 
The questionnaire 
Considerable time and effort was devoted to preparing a questionnaire that was as 
concise as possible, readable and understandable, but yet would provide sufficient 
information on family history for the purposes of the study. The final printed questionnaire 
booklet is included as Appendix 3.1. 
The research fellow developed the booklet with input from other members of the 
research team based upon extensive reading of the literature in this field. We tested it on a 
group of "control" patients in both Glasgow and Edinburgh (20 from each centre) who did 
not belong to our target populations (by date of SAH) for either the Scotland wide or West of 
Scotland studies. "Control" subjects were recruited from those attending the local self -help 
groups run by the Brain and Spinal Injuries Charity (BASIC) for survivors of aneurysmal 
SAH. We also piloted the questionnaire on office staff from the Trials Unit in Edinburgh 
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experienced in use of questionnaires in clinical trials and obtained valuable feedback from 
them on the structure and syntax of the questionnaire booklet. 
The consultation exercise established that subjects who had sustained a SAH were 
able to understand and complete the questionnaire booklet satisfactorily. Useful feedback was 
obtained from this exercise, which led to further streamlining and clarification of the booklet. 
To go along with the questionnaire booklet, letters explaining the study, including one 
to the GP, were devised- see Appendix 3.2. The questionnaire asked for details on every first 
and second -degree relative of the index subject, namely their name, date of birth (and death if 
applicable) and whether or not there was any history of subarachnoid haemorrhage or sudden 
unexplained death- see Appendix 3.1. In all, five to six meetings of the Davie Cooper Study 
collaborators' were substantially devoted to developing the questionnaire booklet and 
associated ethics applications. 
Ethical Approval 
Ethical approval was sought and obtained from the new Multicentre Ethics 
Committee (MREC) for Scotland in December 1997. This project was in fact one of the very 
first it dealt with. However, under the terms of MREC approval it was also necessary to 
obtain an endorsement of this permission from each Local Research Ethics Committee 
(LREC) in Scotland- fifteen in all. This bureaucratic process added considerably to the time 
taken for ethics approval, as we did not receive written approval from every LREC until May 
1998- almost six months after the initial submission to MREC. This delay timeline is 
demonstrated graphically in Figure 3.2.3. The MREC application is included as Appendix 3.3 
and this provides an idea of the large amount of work and sheer volume of paper required to 
submit an application. Fifteen copies of the application were required by the MREC with 
further copies (range 1 -10) also required by the LRECs. In additiona large amount of effort 
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was required to secure the necessary approvals for record access from the privacy advisory 
committees of the Information and Statistics Division, the General Registry Office and for the 
Community Health Index. 
isd Privacy Advisory Committee 
As outlined in Figure 3.2.1, the diagnosis of SAH for the Scotland wide study was 
obtained from central health records- in Scotland these are organised and held by the 
Information and Statistics Division (isd) of the General Register Office for Scotland. Before 
we could obtain any data from isd we had to submit our study protocol to their own privacy 
advisory committee. We received their approval for the Scotland Wide Study (SWS) in 
January 1998. They agreed to supply us with the details of all patients with the following 
International Classification of Disease (ICD) 9 codes: 430 (SAH), 4329 (unspecified 
intracerebral haemorrhage), 4373 (cerebral aneurysm), 7981 (instantaneous death), 7982 
(death occurring <24 hours, not explained), 7989 (unattended death) for the year July 1994 to 
June 1995 inclusive. Before receiving any data from isd, we had to obtain formal 
MREC /LREC ethical approval. 
There is evidence available on the accuracy of the isd coding from previous work 
undertaken by the Edinburgh Clinical Trials Unit looking at the accuracy of "stroke" coding. 
This indicated a sensitivity of 86% and specificity of 99.9% for SMR 1 (Scottish Morbidity 
Record form 1)- the form used by isd to code clinical episodes- compared to a prospectively 
collected hospital -based stroke register. Whilst not perfect this is really quite good and the 
authors concluded that routinely collected SMR1 data are a satisfactory means of identifying 
specific diagnostic groups.247 As SAH is a more specific diagnosis than "stroke" and because 
our index cases for the Scotland Wide Study were from the mid 1990s, most diagnoses of 
SAH will have been established using accurate imaging studies such as CT and cerebral 
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angiography supplemented by lumbar puncture and spectrophotometry of cerebrospinal fluid. 
Hence it is reasonable to assume that the accuracy of isd coding for SAH is likely to be at 
least equivalent to that for stroke and probably better. Evidence for the improved accuracy of 
diagnosis of SAH in the era following the widespread introduction of CT has been well 
documented.5 
Permission of consultants 
Professor Wardlaw had already written on behalf of the study investigators to all 
hospital clinical consultants in Scotland explaining the proposed study and asking if they 
would agree to us approaching (through the GP) any patients who might be identified by isd 
as having had a SAH and been under their care during a specified time period (i.e. June 1994 - 
July 1995 inclusive). Where further details were requested or no answer was forthcoming the 
research fellow wrote again. Of the 650 consultants approached, permission was eventually 
given by all but eight (1.2 %). Where a consultant had retired, moved or died, permission was 
sought from the clinical director of that unit instead. For the eight hospital consultants who 
refused permission, isd removed their patients from the dataset before supplying it to us so 
we do not know how many, if any, index cases were lost by their refusal but it is likely to 
have been few. None of the eight gave a reason for their refusal. One was a neurologist, one a 
stroke physician, three were psychiatrists and the remainder were general physicians and/or 
geriatricians. 
General Practitioner Identification 
In order to identify the current GP of any index subject and to check the address we 
held on the index case, we were grateful to the directors of public health in Scotland who 
allowed us to cross check the isd information against the community health index (CHI) in 
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order to determine the GP that the subject was currently registered with. Before they agreed 
to this we provided them with copies of ethical approval, study protocol, list of consultants 
agreeing to the study, and the isd PAC approval. 
Patients known to have died 
Where patients were coded as sudden death unspecified (798 *) or whom we identified 
had subsequently died (from GP or CHI information) we sought further information from the 
death certification. In order to do this we had to submit a separate application to the privacy 
advisory committee of the General Register Office for Scotland (GROS), National Health 
Services Central Registry (NHSCR) Division, as we already had to do with isd. We received 
their approval in March 1998. 
INS Patient Database 
For the West of Scotland study, the index subjects from 1986/87 were identified from 
the prospectively acquired in house computerised database maintained by Dr Evelyn 
Teasdale. All patients coming theough the neuroradiology Department of the Institute of 
Neurological Sciences (including the reporting of other hospital films such as CT brain scans) 
were automatically logged into this database with the diagnosis ascribed by the consultant 
neuroradiologist completing the report following the imaging investigation(s). The 
completion of codes in all cases is enforced by the fact that without the code(s) attached, the 
X -Ray secretaries do not type the report! CT scanning and or lumbar puncture, followed by 
confirmatory cerebral angiography in most instances, established the diagnosis of SAH in this 
cohort with a high degree of certainty. The research fellow checked the coding accuracy by 
cross -referencing the coded diagnosis with the imaging reports and clinical notes for each 
subject. Specificity was excellent with no case incorrectly coded. 
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Identical methods of approaching the subjects in the West of Scotland study were 
employed as for SWS with utilisation of both GROS and CHI records. 
Data Storage 
During the time that these numerous permissions were being sought, the project 
manager designed a tailor made Access database for the epidemiological studies. This was 
constructed to simplify the process of data entry and to automatically generate reminder 
letters to GPs or subjects as appropriate. The database was encrypted and password protected 
and stored on computers in research offices, which were kept locked when not occupied. The 
Scotland wide study database was maintained in the Department of Clinical Neurosciences in 
Edinburgh and the West of Scotland database was maintained in the University Dept. of 
Neurosurgery in Glasgow. 
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3.2.2 Implementation of epidemiological studies 
The flow diagrams in Figures 3.2.1 and 3.2.2 give an indication of the numerous steps 
necessary to conduct these epidemiological studies from the point where the index case had 
been identified. The means of identification of index cases either from isd (Scotland Wide 
Study) or Institute database (West of Scotland Study) is described fully in section 3.2.1. 
In list form these practical steps were as follows: 
1. Validate history of SAH (from medical records- imaging reports & /or clinical notes - 
by research fellow) 
2. Confirm or trace current whereabouts of subject and confirm current GP (CHI, and or 
medical records- by data managers) 
3. Write to GP asking to confirm history and whether it was appropriate to approach 
subject. Reminder if no response. 
4. Contact subject by post- with information pack (comprising letter requesting 
participation, information sheet and questionnaire booklet with reply paid envelope) 
5. Postal reminder if no response after six weeks 
6. Consider telephone contact if still no response after further six weeks, possibly after 
discussion between research fellow and GP 
7. Check returned questionnaire for completeness (data managers with input from 
project clinicians where necessary, Professor Wardlaw in Edinburgh and Dr White in 
Glasgow). Approach subject completing booklet for further details if incomplete 
8. Enter data into database (data managers) 
Where the index subject had died at the time of the SAH, or had died subsequently, 
we approached the next of kin for information on the family history- the spouse or a first- 
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degree relative. They were usually identified from the hospital medical records as the closest 
next of kin but occasionally next of kin were identified from death certification. If no next of 
kin could be traced then the index case was excluded. We approached the GP of the next of 
kin first to establish if there was any medical reason or objection from the GP as to why we 
should not approach them about their relative and their family history. 
Having obtained index case data from isd, data were checked, duplicate patient 
episodes were removed and accuracy of diagnosis was corroborated- hospital records were 
obtained whenever possible and reviewed by the research fellow to check that the coded 
diagnosis was correct. This was relatively straightforward for the Neuroscience centres- the 
Southern General Hospital (320 patients), the Western General Hospital (176), Aberdeen 
Royal Infirmary (76) and Dundee Royal Infirmary (33), which accounted together for 
605/1039 (58 %) of the index subjects, but was more difficult and time consuming for the 
other hospitals. However, to try and ensure nobody was approached inadvertently about the 
study, we also wrote to the registered general practitioner (GP) of each subject identified by 
the isd and asked them to confirm the diagnosis (preferably by sending a copy of the hospital 
discharge summary where available), sought their permission in addition to that already 
received from the hospital consultant to approach the patient, and asked them to let us know 
if they thought an approach was inappropriate. Where the GP did not agree, the index subject 
was not approached about the study. So we went to considerable efforts to check the 
diagnosis of SAH in index cases for both the SWS and WOS components. 
In the Scotland wide study, 1530 possible /probable SAH episodes were identified 
from isd records for the 642/650 hospital consultants participating using the ICD9 codes 
listed earlier. Only eight cases fell into 798* codes so we restricted index subjects to the more 
specific codes 430 (SAH), 4329 (unspecified intracerebral haemorrhage) and 4373 (cerebral 
aneurysm). Multiple hospital episodes per patient were also eliminated, leaving 1039 index 
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cases. In ninety cases (9 %), the isd coding was definitely incorrect. Reassuringly, this figure 
is similar (slightly better in fact) to that for isd coding of stroke found by Davenport et al 
previously.247 
In 238 cases (23 %) either the index subject or the next of kin could not be traced and 
in 59 cases (6 %) the GP advised that contact was inappropriate e.g. because of a chronic 
medical or psychiatric condition and 41 (4 %) were not approached for miscellaneous reasons. 
Therefore a total of 611 index subjects or their next of kin were approached (59 %). Three 
hundred and five booklets (50 %) were returned in an adequately completed manner for 
subsequent statistical analysis- see Figures 3.2.4 and 3.2.5. These yielded information on a 
total of 5,478 first and second degree relatives. 
In the West of Scotland study, 370 index cases were identified from the Institute of 
Neurological Sciences database. Of these 59 (16 %) could not be traced and in 16 cases (4 %), 
the GP advised that it was inappropriate to approach. In total 267 subjects or next of kin were 
approached (72 %). One hundred and forty eight booklets (55 %) were returned in an 
adequately completed manner for subsequent statistical analysis, yielding information on 
3,213 relatives- see Figures 3.2.6 and 3.2.7. 
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Figure 3.2.1 
Flow diagram of plan of Scotland wide survey of SAH in the Scottish population 
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(see page 323) 
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Statistical analyses 
Data Managers No response 
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Abbreviations 
CHI - Community Health Index 
ISD - Information and Statistics Division 
NHSCR - National Health Service Central Register 
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Follow up letter 
Telephone contact 
Figure 3.2.2 
Flow diagram of plan West of Scotland survey of SAH in relatives of index cases 
admitted to Institute of Neurological Sciences with SAH in 1986/87 
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CI -II - Community Health Index 
ISD - Information and Statistics Division 
NHSCR - National Health Service Central Register 
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Figure 3.2.3 Ethics Committees -time to process application 
v 
01 rn co 0 0 o o 0 0 0 o 0 
MREC had already approved the study before the Local REC's were approached to 
"rubber stamp" the authorisation 
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Figure 3.2.4 
Scotland Wide Study: Breakdown of booklets not sent out 
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Figure 3.2.5 
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West of Scotland study: breakdown of booklets sent out 
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3.2.3 Data Analysis 
The large and complex datasets of epidemiological information obtained were 
handled exclusively by the project statisticians- namely Professor Gordon Murray and Dr 
Valerie Easton and I am grateful for their input into this part of the thesis. 
Basic demographic data were extracted initially. Relatives were grouped by age 
bands, by sex and by degree of relationship to the index case and by whether they were still 
alive at the time of the index case SAH. 
Survival analysis was performed using two distinct strategies for each dataset. The 
first strategy retained as much data as possible from the original relatives database. The 
second strategy removed any relative with any incomplete data (such as date of birth known 
but not date of death, whether or not they had suffered a SAH unknown to index case etc.) 
from the analysis. Observation time begins with the birth of the index case's relative and ends 
with that relative suffering a SAH himself or herself or being censored by death from another 
cause, or at the end of the study period- taken to be 31/12/1999. 
A Cox proportional hazards regression model was fitted to the data with the degree of 
relationship being the only co- variate.248 This provides an estimate of lifetime risk of SAH. 
Kaplan -Meier/Proportional hazards curves were plotted for the time to SAH or censoring by 
death from other cause.228 Estimates of absolute lifetime risk come from a "competing 
hazards" analysis where deaths from other causes are censored. As such they do not have a 
simple direct interpretation as certain assumptions, namely the population incidence of SAH, 
are made. Correspondingly more weight should be placed on the calculated relative hazard 
for first- degree relatives compared to second -degree relatives and the calculation of absolute 
prospective ten -year risk described below because these data were all derived from our own 
study and did not rely on data on SAH incidence derived from other populations. 
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In the West of Scotland cohort the ten -year risk of SAH was determined for relatives 
of index cases. Again these results were determined using two strategies- the first retaining as 
much data as possible and the second removed any relative with missing data at the outset. 
Events occurring before 1986 and after 1997 were removed before analysis so that the 
prospective ten year prospective risk of SAH could be estimated. The relative ten -year risk 
for first degree versus second -degree relatives was calculated and an absolute ten -year risk 
was also determined assuming an annual population incidence of aneurysmal SAH of 8 -10 
per 100,000 per annum.27 
An analysis was performed on the West of Scotland dataset to investigate the 
interaction between the degree of relationship and the involvement of multiple family 
members upon the risk to other family members who were alive at the time of SAH occurring 
in the index case in 1986/87. The influence of the age of the relative upon the risk of SAH 
was also examined for the West of Scotland data. 
Summary of Part Three Chapter Two 
The very considerable preparatory work necessary to the Davie Cooper Scottish 
Aneurysm Study is detailed. 
The precise methodologies used in the study are detailed. 




Results of the research studies into the epidemiology of aneurysmal subarachnoid 
haemorrhage in the Scottish population 
3.3.1 Results of Scotland Wide Study 
Composition of population surveyed 
Survival analysis 
3.3.2 Results of West of Scotland Prospective study 
Composition of population surveyed 
Survival analysis 
Ten -year risk of SAH 
Involvement of multiple family members 
Age of relative 
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3.3.1 Scotland wide study (SWS) 
In the SWS, 5478 relatives were identified from the 305 completed booklets returned 
by, or on behalf of, the index cases who had sustained a SAH in the year 1st July 1994 to 30th 
June 1995 - a mean of 18 first and second -degree relatives per index case. Approximately 
half the relatives were male (2772) and almost 60% (3195) were alive at the time of the 
survey. Of the 5478, 35% (1931) were first- degree relatives (parents, siblings and children) 
and 65% (3547) were second -degree relatives (grandparents, aunts /uncles, nieces /nephews, 
grandchildren). The age distribution for first and second -degree relatives was very similar. 
Unsurprisingly, age data were less complete for second -degree than first- degree relatives - 
with ages (current or at time of death) missing for 35% versus 8% respectively. 
Ninety -five relatives were identified as having suffered a subarachnoid haemorrhage, 
of whom 56 (59 %) were first- degree and 39 (41 %) were second -degree relatives of the index 
cases. The relationship of index case to affected relatives is detailed precisely in Table 3.3.1. 
As described in the methods section two strategies were used in the survival analysis 
and data were combined from both epidemiological studies for this analysis- one retaining as 
much information as possible from the original relatives database, and the second removing 
any relative with missing data. Relatives with an unknown date of birth had to be removed 
from the initial pool of relatives (5478) before any survival analysis could be performed. 
These data were lacking in 53% of relatives, leaving a total of 2575 for the survival analysis. 
A Cox proportional hazards regression model was fitted with the degree of 
relationship being the only co- variate. Retaining as much information as possible, the 
estimated relative hazard of having a SAH in their lifetime for a first- degree versus a second - 
degree relative in the SWS was 2.29 (95% confidence intervals 1.36- 3.87). These results are 
summarised in Table 3.3.2.When the same model was fitted only to relatives with complete 
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data, the corresponding relative hazard was very similar at 2.18 (95% CI 1.30- 3.68). There 
was no statistically significant effect of gender on the risk of SAH, although the confidence 
intervals were wide. 
An estimate of absolute lifetime risk of SAH was calculated using a "competing 
hazards" analysis where deaths from other causes are censored. As a result of assumptions 
made, particularly of the population incidence of SAH (which may be biased by inclusion of 
severely affected families and those cases due to underlying diseases such as polycystic 
kidney disease), such estimates do not have a simple direct interpretation. Retaining as much 
information as possible, the estimated absolute lifetime (birth -70 years) risk in the SWS was 
4.7% (95% CI 3.2 -6.3 %) for first- degree and 1.9% (95% CI 1.0 -2.9 %) for second -degree 
relatives. These data are also are summarised in Table 3.3.2. The estimates where only cases 
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Risk of SAH in relatives of index SAH cases in the Scotland Wide Study 
Comparative risk of SAH RR 95% CI 
1 S` degree vs 2 "d degree 
Lifetime (70 year) risk of SAH* 
l S` degree 
"d 2 degree 
2.29, 1.36 -3.87 
Absolute risk 95% CI 
0.047, 0.03 -0.06 
0.019, 0.01- 0.03 
RR = relative risk (with 95% confidence intervals) 
* based on an estimate of population incidence 
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3.3.2 West of Scotland study (WOS) 
In the WOS, 3213 relatives were identified from the 148 completed booklets returned 
by index cases who had sustained a SAH in the year 1986/87. These had a mean of 21 first 
and second -degree relatives per index case. Approximately half the relatives were male 
(1656) and 81% (2606) were alive at the time of the survey. Of the 3213, 34% (1092) were 
first- degree relatives and 66% (2121) were second -degree relatives. The age distribution for 
first and second -degree relatives was again very similar; and age data were again less 
complete for second -degree than first- degree relatives. Overall complete data were available 
for 75% of the 2606 relatives known to be alive at the time of the index case SAH in 1986/87. 
Fifty -seven relatives (2 %) were identified as having suffered a subarachnoid 
haemorrhage during their lifetime, of whom 54% (31) were first -degree and 46% (26) were 
second -degree relatives of the index cases. The relationship of index case to affected relatives 
is detailed precisely in Table 3.3.3. Of the 2606 relatives known to be alive at the time that 
the index case sustained a SAH in 1986/87, over the next ten years, 20 (0.8 %) sustained a 
SAH. Complete data were available for 15 of these 20 and could be used in the calculation of 
a ten -year prospective risk of SAH. 
In the survival analysis described earlier, using the strategy that retained as much 
information as possible from the original relatives database (making necessary assumptions 
where there were missing data e.g. calculating year of birth from current age of relative or 
age at death) the relative risk of SAH for first- degree versus second -degree relatives was 2.43 
(95% CI 1.01 -5.87). The second strategy removing any relative with missing data from the 
analysis gave a similar relative risk for first- degree versus second -degree. These results are 
summarised in Table 3.3.4. Again there was no statistically significant effect of gender on the 
risk of SAH, although the confidence intervals were wide. 
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An estimate of absolute lifetime risk of SAH was calculated using a "competing 
hazards" analysis where deaths from other causes are censored. As a result of assumptions 
made, such estimates do not have a simple direct interpretation. Retaining as much 
information as possible, the estimated absolute lifetime (birth -70 years) risk in the WOS was 
4.2% (95% CI 2.2 -6.1 %) for first- degree and 2.3% (95% CI 0.8 -3.9 %) for second -degree 
relatives. These data are also are summarised in Table 3.3.4. As for the SWS, the estimates 
where only cases with complete data were retained in the analysis produced very similar 
results. 
The prospective ten -year risk analysis of SAH in relatives of index SAH cases from 
1986/87 was also performed using the two strategies- one retaining as much information as 
possible, making necessary assumptions where there were missing data and the other 
removing any relative with missing data at the outset. As in the survival analysis, the results 
for the two strategies were very similar. 
The estimated absolute ten -year prospective risk of SAH for a first -degree relative 
was 1.2% (95% CI 0.4- 2.0 %). The corresponding figure for a second -degree relative was 
0.5% (95% CI 0.1- 0.8 %). These can be compared to the widely quoted figure for SAH 
incidence in the general population of 8 -10 per 100,000 per annum, i.e. approximately a 0.1% 
prospective ten -year incidence.27 This indicates that the risk in the WOS cohort is increased 
approximately ten -fold compared to the general population for a first- degree relative and 
five -fold for a second -degree relative, although the absolute risk remains low. 
The WOS population was analysed to investigate the interaction between the degree 
of relationship and involvement of more than one family member (with SAH) upon the risk 
to the other family members alive at the time of the index case SAH in 1986/87. The families 
in which the 1986/87 index case was the first known SAH in that family were compared with 
those families in whom another member had sustained a SAH before the index case in 
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1986/87. Within the first group first- degree and second -degree relatives were compared. 
Within the second group (i.e. families with more than one affected member in 1986/87), 
comparisons were made between the family members with at least two first- degree relatives 
having a history of SAH, those with one first -degree and at least one second -degree relative 
affected, those with no first- degree but at least two second -degree relatives affected, and 
finally for those with only one second -degree relative affected by SAH. The analysis showed 
a hierarchy of ascending risk; lowest risk was for those with the index case being a second - 
degree relative and no other family members affected (0.003 cumulative SAH risk) to the 
highest risk in a member of a family with at least two other first- degree relatives affected 
(0.07 [7 %] cumulative SAH risk)- a twenty -three fold greater risk. However the numbers of 
families and individual cases of SAH involved were small- only 30 families were involved in 
this sub -analysis, of whom only six had three or more family members affected by SAH. The 
resulting confidence intervals were very wide; and none of the differences reached statistical 
significance- see Table 3.3.5. 
In the West of Scotland data, adding age to the Cox proportional hazards regression 
model meant that many relatives without a precise date of birth had to be excluded from the 
analysis. For the remaining 1955 relatives, the effect of age was highly significant (p<0.001). 
However, as the analysis was based on only fifteen SAH cases (where complete data were 
available) occurring in WOS relatives in the decade after the index family case of SAH in 
1986/87, there were insufficient data to establish the exact relationship between age of 
relative and risk of SAH. However, none of the subsequent cases of SAH (in the decade from 
1986/87 on) occurred in subjects under the age of twenty years and the risk from 40 -80 years 
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Risk of SAH in relatives of index SAH cases in the West of Scotland Study 
Comparative risk of SAH RR 95% CI 
1st degree vs 2nd degree 
Lifetime (70 year) risk of SAH* 
2.43, 1.01 -5.87 
Absolute risk 95% CI 
1St degree 0.042, 0.02 -0.06 
2nd degree 0.023, 0.01- 0.04 
10 year prospective risk 
1St degree 0.012, 0.004 -0.02 
2 "d degree 0.005, 0.001 -0.01 
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Summary of Part Three Chapter Three 
Family histories were obtained for 572 families including a total of 8691 first and second - 
degree relatives in the epidemiological studies. Sixty -seven percent were alive at the time 
of the survey and approximately one third were first -degree relatives. 
152 relatives were identified as having had a SAH during their lifetime. 
The comparative hazard for first versus second -degree relatives suffering a SAH was 2.29 
(95% CI 1.36 -3.87) for the Scotland wide study (SWS) and 2.43 (1.01 -5.87) for the West 
of Scotland study (WOS). 
Absolute lifetime (birth to 70 years) risk of SAH was 4.7% for first degree and 1.9% for 
second -degree relatives in the SWS compared to 4.2% and 2.3% respectively in the WOS. 
The prospective 10 year risk of SAH from data collected prospectively in the WOS was 
1.2% for a first- degree and 0.5% for a second degree relative compared to the background 
population risk of approximately 0.1% (derived from systematic review by Rinkel et aí27). 
The hierarchy of risk was greatest for a member of a family with at least two other first - 
degree relatives affected by SAH, with a more than twenty -fold increased risk over 
someone with just one second -degree relative affected by SAH. 
The risk of SAH was similar in each decade from 40 -80 years and no cases were reported 









This study has several strengths. Firstly the relatively large numbers of relatives 
surveyed and the large number of subarachnoid haemorrhage events disclosed. Information 
was obtained on 8691 first and second -degree relatives, of whom 152 (2 %) had suffered a 
SAH. This study is (by a considerable margin) the second largest group of relatives studied 
and the only larger study was purely registry based.83 In that study the number of SAH 
events revealed was extremely low, possibly reflecting the inherent weakness in relying 
solely on death registry data where incomplete or inaccurate certification could result in 
considerable bias with no way of assessing the size of the effect. 
For instance in the study by Gaist et al., they examined SAH events in Denmark from 
1977 to 1995. Their strategy relied upon the linkage of parental civil registration numbers 
with each individual case record in order to determine the family history of SAH. This has 
the advantage of eliminating selection and recall bias but relies wholly on the accuracy and 
completeness of the data recorded centrally. For subjects born before 1952, there was co- 
linkage of individual with parental registration numbers in less than 10% of cases, rising to 
43% linkage for the 1952 -1959 birth cohort, with excellent linkage rates post 1959.83 
However, clearly the vast majority of subarachnoid haemorrhages (with its' peak incidence in 
the fifth to sixth decades) occurring in Denmark between 1977 and 1995 were likely to have 
occurred in people born pre 1959, in whom central records were very incomplete even if the 
accuracy of completed records was good. This problem may well account for the low pick up 
of SAH events in relatives (19/14781 or 0.13 %), in that many SAH events that may have 
occurred in relatives could not be determined as familial due to the very incomplete family 
record linkage the researchers had to work with. 
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A particular strength of our study is using two cohorts from within the Scottish 
population identified by completely different methods from different time periods (SWS used 
central registry data from 1994/95 and WOS used a sample from 1986/87 on a prospectively 
acquired in house database for detecting index cases). No previous study has used two 
different approaches to identify samples of relatives from the population. The fact that we 
obtained results with such striking similarity for the two methods indicates the data are likely 
to be robust as it suggests that any bias inherent in the strategy for detecting index cases is 
very limited. The data from the Davie Cooper study are compared with the existing literature 
in Table 4.3.1. 
Limitations 
The major limitations of this study concern the proportion of index cases (or their next 
of kin if the index case was deceased) whose whereabouts could not be traced and the 
proportions who were contacted but who did not respond. The response rate of those 
approached was 50 % -55% in the Davie Cooper epidemiological studies and this is very much 
in line with that published in the literature.249 In view of the fact that completion of the 
questionnaire required information about other family members often requiring additional, 
sometimes considerable, effort by respondents, this is actually a fairly good response. There 
is evidence that preliminary notification and follow -up reminders improve the response rate 
to mailed questionnaires.249 We tried to provide some preliminary notification on a general 
level by use of media publicity, particularly in the Daily Record. Restricted resources limited 
the number of approaches we could make to individuals so it was decided not send everyone 
preliminary notification but to concentrate resources on maintaining contact with non- 
responders where possible. 
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Nevertheless, information was obtained from only 32% of families from the Scotland 
wide survey and 40% of families from the West of Scotland survey. This opens potential for 
bias between the features of families responding and those not responding, and those who 
could not be traced. However, we doubt that this produced any substantial distortion of the 
results because of the close comparability in the findings of two separate sets of relatives, 
separated in time (in relation to the year of the index case SAH) by ten years and with the 
data collected and entered independently of each other. As the most likely bias would be for 
families with more than one affected member to have a higher response rate, the effect, if 
any, would be to inflate the estimate of risk. 
The second main limitation concerns the validity /accuracy of the information on 
family history and the identification of cases amongst relatives obtained from respondents. At 
first sight this seems to be the biggest single weakness in the Davie Cooper study. There is 
always concern about the quality of data obtained in any questionnaire -based study but again 
the most likely bias would lead to an over estimate of risk with badly affected families 
possibly more likely to respond and possibly able to provide a more accurate family history of 
SAH. However, Bromberg et al, who used a similar method of deriving the family history as 
that used in the Davie Cooper study, examined this question in some detail. They found that 
the information from next of kin regarding the family history of SAH without supporting 
medical documents to have a predictive value of 0.7 (95% CI 0.4- 0.9).250 This is in line with 
previous work that has demonstrated the accuracy of family history to be only moderate in 
genera1.25 ' However, by performing a very large study (by comparison with previous 
community rather than registry based studies) we hoped that, in keeping with general 
statistical principles, the inaccuracies in the histories obtained would tend to even each other 
out somewhat. 
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Nevertheless, we were very aware of the extent of the potential problem with 
uncorroborated family histories. Therefore the Davie Cooper Study collaborators made 
considerable efforts to ascertain the validity of the family histories obtained and to quantify 
their accuracy. Since 1981 the Information and Statistics Division of the NHS in Scotland has 
kept computerised records of all hospital morbidity and mortality data by ICD codes linked to 
death records for the country as a whole. We provided isd with data on all relatives identified 
and known to be alive in 1981 for a comparison match to be run comparing their records with 
the information we obtained from family histories. The returned data were anonymised by isd 
to maintain confidentiality and remain within the bounds of the ethical permissions granted 
for the research. We also checked the death certification records through the General Registry 
Office for relatives said to have sustained a SAH and who died before 1981 for whom we had 
at least a year of birth or death reported. However, as these comprise large amounts of data, 
which are in the keeping the project statisticians and are yet to be formally analysed (as part 
of a separate sub -study), this information is not available for inclusion in the thesis. 
Additional limitations of epidemiological research 
There were major limitations placed upon us by the ethical considerations and 
concerns surrounding this type of research. For example why not just check family histories 
with the relatives concerned? This seems an obvious answer to the problem. But it was felt by 
the investigators that it would not be ethical to approach individual relatives identified from 
the family history questionnaires to corroborate the history. Preliminary discussions to sound 
out the appropriate ethics committees confirmed our own thoughts on the inappropriateness 
of such an approach. 
In fact subsequent to ethical approval being granted for the Davie Cooper study, 
concern about the use of centrally collected health data for the purposes of research has 
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increased further and it is questionable whether similar epidemiological research would 
receive ethical approval now as there has been a move towards requiring individual 
permission being required to access any health data on an individual (even if anonymised) 
without their express permission. For epidemiological projects like the Davie Cooper study 
this effectively prohibits the research as one can't know who to approach about obtaining 
permission without obtaining the information from centrally held records first- a real Catch 
22 situation! Researchers in the field have expressed considerable disquiet about this 
development.252 
Nevertheless the government has pressed ahead with this type of restriction under 
pressure from the media and some patient groups and this stance is now embodied in advice 
to doctors on research issued by the General Medical Council.253 They indicate that records 
made for the provision of care should not usually be disclosed for another purpose without 
the patient's consent. The only caveat to this is where the subject has been told in advance 
that medical records or data collected on them may be used for the purposes of research, 
epidemiology or surveillance and has expressly agreed to this. Refusal must be respected.253 
Because such information was not generally provided to subjects before this guidance was 
issued in 2001; it effectively prohibits much retrospective epidemiological research from 
being undertaken. Furthermore, the essence of unbiased epidemiological research is to 
include all subjects as far as possible, and persons opting out of allowing their records to be 
used for research may introduce unpredictable selection and sample biases. 
Another difficult confidentiality problem may arise with epidemiological research and 
we had one such episode in the Davie Cooper study. A patient complained because we 
approached her about the study. She had an aneurysm diagnosed after a late presentation to 
hospital following an episode of severe headache and coded as such by isd. SAH was not 
found at that time but it was never clear from the medical records if the aneurysm may have 
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bled earlier or not and it was never treated. The GP confirmed the history so the patient was 
approached. However, it seemed that the main reason the complaint arose was because her 
daughter, who was unaware of her mother's medical history, opened the study material and a 
major family row ensued as the daughter felt she might be at risk of an aneurysm and was not 
aware of it before. The daughter opened her mother's mail because her mother was now 
resident in Spain. We were unaware of this, as was her GP, as she was still registered with the 
GP as a permanent resident at her daughter's address. One can only speculate on why this 
arrangement was put in place by the index subject. Following an apology for the trouble 
caused and clear explanations about the family history from Professor Teasdale, the 
complaint was settled satisfactorily but the episode reveals some of the unexpected hazards of 
epidemiological research! 
Relation to previous studies 
It is both interesting and reassuring that the results we obtained for the Scottish 
population are similar to those of previous studies of risk of SAH amongst relatives of SAH 
patients. These studies were summarised in Table 1.1.3. Six of these eight studies either 
surveyed only a modest number of relatives or did not state the number surveyed at all.40'78' 80, 
81, 82, 84 
The increased relative risk of SAH in first- degree versus second -degree relatives has 
been estimated previously as 6.6 in the one previous study that directly compared first and 
second degree relatives,249 compared to approximately 2.4 in the current study. Other studies 
have compared risk amongst first or second -degree relatives with estimates from the general 
population as follows: First degree relatives approximately 3 to 5 fold; 2.9- 4.5,83 4.1,82 4.7 78 
compared to ten fold in the present study. For second -degree approximately 1.6 fold 
82 
compared to five fold in the current study. It is worth noting that we identified far more 
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first /second degree relatives with SAH in the current study (152) than that in any previous 
study and that the eight previous population based studies combined only identified a total of 
303 first /second degree relatives with definite or probable SAH. 
Previous studies have demonstrated a wide range for the actual proportion of first - 
degree relatives who have themselves suffered a SAH, from 0.1% ß3 to 11.4 %.80 The results 
for the other studies where this figure was available were as follows: 1.8 %,82 1% 66 and 
0.6 %.84 By comparison, the results for the current study were 2.9% (87/3023) for first -degree 
relatives and 1.1% (65/5668) for second -degree relatives. Our finding of an absolute 
increased risk of SAH in first and second -degree relatives of a patient with SAH compared to 
the general population is therefore in accord with previous studies. Assuming a maximum 
population occurrence of SAH of 0.1% per annum these data indicate an approximately 
increased risk compared to the general population of tenfold in first -degree and five fold in 
second -degree relatives. 
In two areas the Davie Cooper data differed slightly from previous reports. Firstly the 
gender difference in the Davie Cooper Study was smaller than in most previous reports with a 
female to male ratio of SAH events in relatives of 1.24:1. The gender difference did not reach 
statistical significance. The fact that 51% (4428/8691) of the relatives were male may have 
had an effect to reduce the sex ratio, but the effect of an additional 1% of male subjects can 
only hav ebeen quite small. In the literature a sex ratio of -1.6 to 2.0 is more usually accepted 
27, 75 with a female predilection also thought to apply for familial aneurysms.76 However, 
more careful review of the literature suggests that this might not be true! In all cases of 
familial aneurysms reported up to the end of 1993 (560), Schievink et al. found that 56% 
were female and 44% were male- hardly the strong female preponderance of 2:1 expected.254 
They also identified 12 affected families who had angiographic screening and noted that 
aneurysms were discovered significantly more often in siblings who had a male rather than a 
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female proband affected by SAH, at 22% versus 9% respectively.254 Interestingly in the 
Davie Cooper Study, the sex ratio for second degree relatives was increased- with 41/65 of 
the SAH events reported in second -degree relatives occurring in females, a sex ratio of 1.7:1 - 
exactly what we might have expected. However, for first- degree relatives the female to male 
sex ratio was 0.98:1. These data are very interesting and may indicate that the accepted 
female preponderance of SAH may not apply for truly familial cases of SAH. Furthermore, 
62% (23/37) of the SAH events in siblings occurred when the affected sibling was male 
rather than female, in keeping with the earlier findings of Schievink et al.254 
Secondly, in the Davie Cooper Studythe commonest relationship between the index 
case and relatives who had had a SAH was between index case and parent at 30% (45/152) 
compared with 24% (37/152) for sibling to sibling. Yet this latter has generally been thought 
to be the relationship carrying greatest risk.250 However, the numbers of cases upon which 
this concept was based were actually rather small- for example only 17 cases of SAH 
occurring in the study by Bromberg et aí.250 It is uncertain why we did not find the strong 
predilection towards the sibling -sibling relationship reported previously, although the sib -sib 
or sib -parent were by far the two commonest relationships identified in the Dvaie Cooper 
Study; these two, of the eight categories of relationship assessed (see Tables 3.3.1 and 3.3.3), 
accounted for 54% (82/152) of the total SAH events identified. 
Our data also support those of Schievink et al. in suggesting that the sib -sib 
relationship that poses a higher risk than any other first- degree relationship is that of having a 
brother affected by SAH- also in line of a perceived maternal transmission effect.254 We 
found that 62% of the SAH events in siblings occurred when the affected sibling was male, 
compared to the <50% expected by chance (assuming female preponderance of SAH 
pertains). The increased proportion of SAH events associated with having a male first- degree 
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relative affected by SAH did not seem to apply if the affected relative was a father- 44% of 
cases or a son- 25% (1/4) of cases. 
The risk stratification of SAH (see Table 3.3.5) indicates that the risk was lowest in 
those with only one second -degree relative affected (group 2), doubling for those with one 
first- degree relative affected (group 1). Subjects with two or more first -degree relatives 
affected (group 3) had a twenty -fold greater risk than subjects with only one second -degree 
relative affected. Groups 4 and 5 have a risk intermediate between groups 1 and 3. If those 
subjects with one second -degree relative affected have a risk approximately double that of the 
background population risk, as suggested by previous data 78' 82 then the group with two or g p p gg Y p g p 
more first- degree relatives affected have a risk some forty times the background population 
SAH risk, or around 4% per decade. 
Conclusions 
The Davie Cooper study has quantified the risk of SAH occurring in relatives of 
patients who have sustained a SAH for the UK population. The relative risk for first versus 
second -degree relatives is in line with previous studies at 2.3 -2.4. The absolute risk of 
sustaining a SAH is very small at a 4.2 -4.7% lifetime (0 -70 years) risk for first -degree and 
1.9 -2.3% lifetime risk for second -degree relatives. A ten -year prospective risk of SAH has 
been established for the first time, and this is also reassuringly low at 1.2% for first and 0.5% 
for second -degree relatives. These are robust data and will be of benefit to clinicians, patients 
and relatives alike. These data also support the established view that routine population or 
family screening for aneurysms is not justified by the low natural history risk compared to the 
risks of intervention.75 But for the small number of subjects with two or more first -degree 
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Summary of Part Three Chapter Four 
Although the relative risk of SAH is increased from five (for second -degree) to ten -fold 
(for first- degree), the absolute risk of SAH amongst relatives of a patient who suffers a 
SAH remains small- in the region of 1% per decade over the age of 20. 
The strengths and limitations of the epidemiological studies are discussed with reference 
to the literature. 
Routine family screening for aneurysms is not supported by our epidemiological data but 
certain badly affected families may need to be considered for screening on a case by case 
basis. 
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3.5.1 Implications of the SAGE study for clinical practice 
Non -invasive imaging of intracranial aneurysms 
The systematic review of the non -invasive imaging of intracranial aneurysms 
performed as part of the SAGE study, and subsequently published in Radiology,110 has 
provided the most robust evidence to date on the diagnostic performance of non -invasive 
imaging tests in the detection of intracranial aneurysms (see also see the accompanying 
editorial to the paper 236) 
CTA and MRA have equivalent overall accuracy in the detection of intracranial 
aneurysms of -90% in the high aneurysm prevalence populations studied to date. Also, 
several studies used review techniques that would not necessarily be appropriate in routine 
clinical practice such as consensus review of CTA or MRA examinations by several readers 
& /or review of non -invasive examination with knowledge of the IADSA result. 
Diagnostic performance is significantly poorer for all the non -invasive modalities in the 
detection of smaller aneurysms, particularly those <3mm. 
The cavernous and terminal carotid and MCA bifurcation are anatomical sites where all 
modalities demonstrate poorer diagnostic performance. 
Accuracy is likely to be lower in low prevalence populations on purely statistical 
grounds,'77 as well as due to the confounding variable of observer expectation bias. 
Furthermore in an asymptomatic population being screened, any aneurysms that are 
present may well be on average smaller than those in the post SAH population. 
The direct comparison in the SAGE study of a large patient cohort recruited 
prospectively, and reviewed using sound methodology, provided good confirmatory evidence 
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of the respective diagnostic performance of CTA and MRA. These data were published in 
Radiology 255 and reinforced the findings of the systematic review with respect to the 
strengths and weaknesses of the non -invasive tests. However, data directly comparing 
diagnostic performance to IASDSA in low aneurysm prevalence subjects are still very 
limited. For reasons explained in the text, we were unable to recruit as many of this group of 
subjects into the SAGE study as we had hoped. 
When the SAGE study started recruitment there were very limited data in the 
literature on the diagnostic performance of TCDS and this lack was highlighted in the 
systematic review (only 54 subjects with extractable data could be included). Yet TCDS is a 
promising technique, particularly in the screening context, as it is completely non -invasive 
(see Part 2 Chapter 5), safe, cheap and readily available. The SAGE data were published in 
Stroke,256 and added to that published a few months earlier by Turner and Kirkpatrick,237 
provide a much clearer idea of the performance of TCDS. Performance as a stand -alone test 
is still lower than that for CTA or MRA. 
Another role for TCDS might be as an adjunctive test to either CTA or MRA to help 
improve the sensitivity for aneurysm detection. The SAGE study was able to provide the first 
data on this.257 The results are encouraging and indicate that the most sensitive imaging 
strategy (as well as the cheapest and most readily available) was CTA +TCDS. The drawback 
was that although sensitivity, specificity and accuracy were all increased on a per subject 
basis, there were a moderate number of cases in which the modalities disagreed (18 %). In 
clinical practice this would necessitate confirmatory IADSA to resolve the discrepancy. 
Neuroradiologists do have better diagnostic performance, although in the subgroup of 
60 SAGE cases examined, the differences identified did not reach statistical significance. 
Neuroradiologists were also more consistent in their performance than non -neuroradiologists 
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(European Radiology in press). These differences would be of considerable relevance though 
if any large -scale aneurysm screening programme were to be considered in the future. 
Finally the SAGE study has provided the only data so far on patient experience and 
preferences of the available non -invasive tests compared with IADSA. TCDS was the least 
uncomfortable and the test preferred by most subjects, but it was interesting that MRA (non - 
contrast) caused significantly more discomfort on average than CTA (contrast injection 
required) and that significantly more subjects preferred CTA to MRA. There are clearly 
lessons applicable to clinical practice in these results. 
Epidemiology of aneurysmal SAH 
The epidemiological research projects comprising the Davie Cooper study, namely 
the Scotland Wide study and the West of Scotland study, have provided the first 
comprehensive data on the familial risk of SAH for the UK population. The relative risk of 
SAH for first versus second -degree relatives of patients who have sustained a SAH has been 
confirmed to be in line with that from previous European and North American studies at 2.3- 
2.4. The absolute lifetime (0 -70 years) risk has also been established using Davie Cooper 
study data compared with the established population incidence figures for SAH in European 
studies of 8 -10 per 100,000 person years.27 These indicate a low absolute lifetime risk of 
approximately 4.5% for first -degree and 2% for second -degree relatives, or some five 
(second- degree) to ten (first- degree) times the background population risk for what, it must 
be remembered, is still in population terms a relatively uncommon condition. 
Even more importantly a ten -year prospective risk of SAH has been established. It is 
these figures that are particularly valuable when it comes to counselling or advising relatives 
of patients who have sustained a SAH. These data from the West of Scotland study indicate a 
ten -year risk of 1.2% for first- degree and only 0.5% for second -degree relatives. No SAH 
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events occurred in people under twenty years of age and the risk per decade from 40 to 80 
was very similar. 
The Davie Cooper study has also provided very useful information for clinical 
practice with regard to the degree of risk by the strength of family history of SAH. Data on 
this risk were previously very limited, yet are clearly vital to the interpretation of the risk in 
any individual relative. The risk stratification of SAH performed (see table 3.3.5) indicates 
that the risk is lowest in people with one second -degree relative affected by SAH (group 2), 
doubling for those with one first- degree relative affected (group 1), increasing tenfold from 
there for people with two first- degree relatives affected by SAH (group 3). People with one 
first and one (or more) second -degree relatives have a risk intermediate between groups 1 and 
2, as do people with no first but two or more second -degree relatives affected. 
Screening for intracranial aneurysms 
Here data from the Davie Cooper and SAGE studies can provide very helpful advice 
and guidance for clinicians. The non -invasive tests by themselves are not yet good enough to 
reliably detect or exclude small aneurysms. In the context of a screening programme this 
would be extremely relevant. Using non -invasive tests in combination might be more 
satisfactory but would require an increased number of IADSA examinations to resolve the 
inevitable discrepancies between non -invasive tests. If performed to look for intracranial 
aneurysms, non -invasive tests should be supervised and reported by experienced 
neuroradiologists to maximise the diagnostic accuracy. Although very small aneurysms 
probably do have a lower rupture risk and therefore would be less likely to require treatment, 
a screening test that missed a lot of small aneurysms would probably be unacceptable to the 
public and media. 
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Furthermore finding an aneurysm that is small and does not require treatment based 
simply on its' rupture risk can prove devastating knowledge to the individual and can very 
adversely affect their quality of life. Just undergoing screening, whatever the outcome, can 
prove a stressful life experience.'54 
The low absolute risk of SAH in most relatives of SAH patients demonstrated by the 
Davie Cooper study is reassuring. On the back of the ISUTA data indicating an extremely low 
rupture risk of incidental unruptured aneurysms, we can be more definite than before that 
general familial screening of SAH patients is not indicated. The Davie Cooper data do 
indicate a subgroup of subjects with two or more first -degree relatives affected by SAH who 
are at a substantially greater risk of SAH- some twenty -fold greater than subjects with only 
one second -degree relative affected and therefore at a risk of up to forty times greater than the 
background population risk (i.e. up to 0.4% risk per annum). 
Even in this high -risk group, the case for screening is not proven, as the risk of 
treating an unruptured aneurysm must be taken into account. Overall in ISUTA, the risks for 
neurosurgical clipping of unruptured aneurysms were 3.8% mortality and 12.8% morbidity; 
although the risks were approximately half that in patients <45 years of age (and RR =5 for 
patients >65 compared to those <45).73 For coiling, the USA Multicentre Study Group found 
a 1% mortality and a 4% morbidity for unruptured aneurysm treatment for all ages 
combined.141 However, the long -term efficacy (durability) of coiling is not yet known. If it 
were to equate to that of clipping, then it might be appropriate to screen and coil high -risk 
individuals <55 -65 years as their natural history risk each decade would approximate to the 
risks of coiling. It is important to remember that most relatives of SAH patients have a very 
much lower risk than this- at 0.5 -1.2% (rather than 4 %) per decade. 
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Other risk factors such as smoking, hypertension, oral contraceptive use etc. should 
also be taken into account as necessary and attention given to eliminating or minimising these 
additional risks. 
In one reasonably large, prospective Dutch study of aneurysm screening (MARS 
Study Group), first -degree relatives had a 4.0% aneurysm prevalence rate (though DSA was 
not performed in all cases so the true figure may be greater) and being a sibling of the index 
patient was the most important factor- with RR 4 times that of children of the index case. 
Index patients of younger age and with multiple aneurysms were more likely to have relatives 
with aneurysms.258 The MARS study found that the treatment of unruptured aneurysms had a 
considerable short term negative impact on functional health and quality of life in most 
patients, despite the low rate of physical impairment.259 
Who may merit screening? 
Individuals with two or more first -degree relatives affected by documented 
aneurysmal SAH - these individuals are at a risk of SAH up to forty times greater 
than the background population risk (i.e. up to 0.4% risk per annum). 
Consider screening particularly if: 
o Aged 20 -50 (longer life expectancy = greater cumulative risk of SAH relative 
to risk of treatment). 
o They have other risk factors such as current smoking, hypertension etc. 
o One of their affected relatives is a brother or sister because there is some 
evidence in the literature that siblings- especially male- are the relatives of 
SAH patients most frequently affected themselves by SAH.75, 249, 254, 258 
How to screen? 
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 CTA ± TCDS is the most sensitive strategy. It is also the cheapest, most available and 
least invasive. This should be performed and reported in a specialist neuroscience 
centre. There are no reliable data on how often (or how long) to screen individuals. 
NB: Patients need careful documented counselling before screening on the limitations 
of the non -invasive tests, and the implications of a positive (and even of a negative) 
result before embarking on the screening process. 
How to treat? 
Consider treating all aneurysms >10mm in size and all posterior circulation 
aneurysms (0.5% per annum rupture risk) in patients <55 -65 years of age. Treatment 
of anterior circulation aneurysms <10mm requires very careful counselling regarding 
the risk benefit ratio whatever the age of the patient. 
At present coiling seems to offer the lowest risk option for unruptured aneurysms. 
Patients need to be made are aware that the very long -term durability of coiling ( >10 
years) is not yet known. 
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3.5.2 Implications of the SAGE and Davie Cooper studies for future research 
Non -invasive imaging of intracranial aneurysms 
The systematic review was also able to highlight areas where more research is required: 
Few studies, and none of any size, had directly compared the performance of non- 
invasive tests in the same cohort of subjects. Data were lacking on the diagnostic 
performance of non -invasive tests compared to IADSA in subjects likely to have a low 
prevalence of aneurysms and therefore more relevant to the use of non -invasive tests in 
screening for aneurysms. There were no data on the effect on diagnostic performance of 
combining non -invasive tests together. Robust data on the effect of observer experience on 
diagnostic performance were lacking. 
In some of these areas the SAGE study provided confirmatory evidence building upon 
that available in the literature (see points 1 and 2 above), and in others it has provided the 
first robust evidence available (see points 3 and 4). More prospective research is indicated in 
the role of TCDS, particularly using contrast enhancement and 3D reconstruction techniques 
together. Also, a strategy of combining non -invasive tests together definitely merits further 
investigation, particularly in subjects with expected low aneurysm prevalence. Clarification 
of the advantages (or not) of contrast enhanced ultrafast MRA techniques and of multislice 
CTA is also required. The applicability of all the results published to date to the screening 
situation will remain questionable until large prospective studies comparing non -invasive 
tests directly to IADSA can be performed in low prevalence subjects. 
Epidemiology of aneurysmal SAH 
More information on the population based genetics of aneurysm formation would be 
valuable as this could open the way to more clearly identifying very high risk individuals. 
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Resources, time and importantly ethical considerations precluded the Davie Cooper Study 
investigators from incorporating a genetic study into the original epidemiological research. 
However, clearly there is a genetic influence operating and further investigation is warranted. 
Pooling of data from studies in a meta -analysis would also be useful, although most of the 
studies on familial SAH published so far have such diverse methodologies that this would be 
difficult to achieve. 
There is also a role for more basic science research investigating the underlying 
pathophysiology in the vessel walls of subjects who develop aneurysms which subsequently 
rupture compared to those who do not harbour aneurysms and also to those subjects who do 
develop aneurysms but which have not ruptured over a period of time. Again this type of 
work was beyond the original remit, expertise and resources of the Davie Cooper study but 
with a pool of suitable subjects now identified, consideration should be given to undertaking 
this type of work in Scotland. 
Screening for intracranial aneurysms 
Any screening programme of high -risk subjects, even an ad hoc one would be of 
scientific benefit if it were incorporated into a properly constructed prospective study, or at 
the very least into a national or international registry. Unfortunately due to changes in 
guidance on the use of records for medical research in the UK, the position of registries as a 
scientific tool has been placed in considerable jeopardy.252 
We need to know on a prospective basis the outcome of screening high -risk 
individuals. To date only hypothetical models exist, and as discussed earlier in the thesis, 
there are considerable weaknesses inherent in these models. With no account taken of patient 
preferences and inadequate cost analyses performed. 
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Additionally information is required on the frequency of screening that might be 
necessary. This may come from a better understanding of the pathophysiological process of 
aneurysm formation and rupture. If aneurysms that rupture tend to develop and rupture in a 
short time frame (weeks to months), as has been suggested by some investigators,75 then 
there is no point at all in screening for aneurysms but robust data are not yet available to 
confirm or refute this hypothesis. 
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Summary of Part Three Chapter Five 
CTA and MRA performance is much more limited in the detection of small aneurysms 
and data are still lacking on performance in low aneurysm prevalence populations. 
Therefore their role as a screening test may well be limited. 
The Davie Cooper study established relative and absolute risks of SAH for first and 
second -degree relatives of SAH patients in the UK population. 
The data from the Davie Cooper and SAGE studies do not support the concept of routine 
screening of families of patients who have sustained a SAH. Non -invasive tests need to be 
employed cautiously as they have substantial limitations. 
Persons with two or more first- degree relatives affected by SAH are a special very high - 
risk subgroup and screening may be appropriate for them (after counselling) depending 
upon their age, precise family history, presence of other risk factors etc. 
Attention should be given to eliminating, controlling risk factors where possible. 
On current evidence, coiling would be the lower risk treatment option for such high risk 
individual subjects but the long -term efficacy of the treatment needs to be considered and 
confirmed. 
Areas requiring further research include: 
Genetic factors underlying familial cases of SAH. 
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 Pathophysiology of aneurysm formation and rupture. 
Diagnostic performance of non -invasive tests compared to IADSA in low aneurysm 
prevalence subjects. 
Diagnostic performance of new more advanced imaging techniques. 
Prospective examination either as a formal trial or at the very least as a registry of any 
screening of high -risk individuals that is undertaken. 
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Summary of Part Three 
The background to and the scientific rationale behind the Davie Cooper study are 
described. The importance of the study is discussed against the previous lack of data on the 
UK population and the absence of robust data on the prospective risk of SAH in relatives of 
patients who have suffered a SAH. The complexity of the research studies and the 
methodologies employed including the statistical techniques utilised are described in detail. 
The results of the epidemiological studies are then described, first the Scotland wide study 
and then the West of Scotland study. Data were obtained on a total of 8691 first and second - 
degree relatives making this by far the largest community based study into familial SAH and 
the second largest study in the field ever. One hundred and fifty two SAH events were 
reported in these 8691 relatives. The comparative risk for first versus second -degree relatives 
was 2.3 -2.4, which was in line with previous reports from Europe. An absolute lifetime SAH 
risk was also determined and was 4.2 -4.7% for first- degree and 1.9 -2.3% for second -degree 
relatives respectively. 
For the first time a prospective ten -year risk of SAH for relatives was determined and 
a hierarchy of risk related to family history of SAH constructed. The prospective ten -year risk 
was 1.2% for first -degree and 0.5% for second -degree relatives. The greatest risk of SAH was 
in persons who had two or more first- degree relatives affected by SAH and the lowest risk 
was in persons who had only one second -degree relative affected. The strengths and 
weaknesses of the Davie Cooper study are discussed in detail with reference to the literature. 
In the final chapter the implications of the SAGE and Davie Cooper study results for 
clinical practice and the areas identified where future research is required are considered. In 
high aneurysm prevalence populations the performance of CTA and MRA is good except for 
the detection of small aneurysms. Caution is required in extrapolating the results of the 
systematic review to a screening context. Combining non -invasive tests together to improve 
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diagnostic performance looks promising and further research is required, particularly in 
subjects with a low expected aneurysm prevalence (mirroring the screening situation). The 
data from these studies do not support the concept of routine screening for intracranial 
aneurysm of the families of patients who have suffered a SAH. An exception to this may be 
persons with a very bad family history of SAH- two or more first- degree relatives affected - 
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Appendix 1 
Glossary of terms and list of commonly used abbreviations 
ACA Anterior cerebral artery 
ADPKD Autosomal dominant polycystic kidney disease 
CCA Common carotid artery 
CDE Colour Doppler Energy or "Power Doppler" 
CE Contrast enhanced 
CHI Community Health Index 
CTA Computed tomographic angiography 
ECA External carotid artery 
EMBASE Database of biomedical journals 
GCS Glasgow Coma Score 
GDC Guglielmi Detachable Coil (for endovascular Rx of aneurysms) 
GP General Practitioner 
GRO General Register Office for Scotland 
IADSA Intra arterial digital subtraction angiography 
ICA Internal Carotid artery 
ICD International Classification of Disease (codes) 
INS Institute of Neurological Sciences in Glasgow 
ISAT International Study of Aneurysm Treatment 
Isd Information and Statistics Division (of GRO) 
ISUTA International Study of Unruptured Intracranial Aneurysms 
LREC Local Regional Ethics Committee 
MCA Middle cerebral artery 
MEDLINE Database of biomedical journals 





















Magnetic Resonance angiography 
Multicentre Regional Ethics Committee 
National Health Services Central Registry 
Odds Ratio 
Posterior cerebral artery 
Posterior inferior cerebellar artery 
Radiofrequency 
Relative Risk 
Study of Aneurysms in Glasgow and Edinburgh (imaging) 
Subarachnoid haemorrhage 
Summary Receiver Operating Curves (assess diagnostic performance) 
Scotland Wide Study (epidemiological) 
Transcranial Doppler Sonography 
Echo time in MRI 
Time -of -flight (type of angiographic sequence used in MM) 
Repetition time (between RF pulses in MRI) 
Vertebral artery 
World Federation of Neurosurgeons (clinical grade of SAH) 
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Appendix 2.3: True positive cases on IADSA for patients completing both CTA and MRA 
[0:4W AMP 
5 F 30 4 1 Rt ICA (11) a 
6 F 40 2 2 Rt MCA (2) d 
Lt ACA (14) b 
8 M 55 2 1 Lt ICA (11) a 
11 M 44 3 2 Bas (12) d 
Rt ICA (10) b 
12 F 49 2 1 ACA (5) b 
13 F 33 2 1 Rt MCA (2) a 
18 M 45 4 3 ACA (4) 
Lt MCA (2) b 
Rt MCA (2) a 
22 F 55 2 1 ACA (4) a 
25 F 41 3 2 Rt ICA (11) a 
Lt ICA (10) a 
31 F 44 2 2 Rt MCA (2) b 
ACA (4) b 
35 F 55 2 4 Lt MCA (2) b 
Rt MCA (2) b 
Lt ICA (7) 
Lt ICA (10) b 
41 M 50 1 1 Bas (12) c 
42 M 46 2 1 ACA (4) 
43 F 53 3 1 Rt ICA (8) b 
46 F 51 1 6 Rt ICA (8) b 
Lt ICA (8) b 
Lt ICA (11) a 
Rt MCA (2) b 
Rt PICA (13) d 
Rt PICA (13) c 
49 F 75 1 1 Lt ICA (10) d 
60 M 37 2 2 Lt ICA (9) b 
Lt ICA (10) b 
61 F 33 2 1 Lt ICA (8) 
63 M 26 3 1 Rt ICA (8) 
70 F 70 2 1 ACA (4) b 
72 M 38 2 1 Rt ICA (7) d 
76 M 54 3 2 Rt ICA (7) b 
Rt MCA (2) b 
77 F 37 4 2 Lt ICA (10) d 
Rt ICA (10) b 
79 M 35 2 3 ACA (4) c 
Rt MCA (3) c 
Rt MCA (2) b 
80 F 36 4 1 Lt ICA (10) b 
84 M 57 3 6 Lt MCA (2) b 
Lt MCA (3) a 
Lt ICA (8) b 
Lt ICA (14) a 
Bas (14) c 
Bas (14) b 
85 F 38 2 1 Lt ICA (10) b 
86 F 41 4 1 Rt ICA (8) a 
87 F 42 3 1 Rt PICA (13) b 
89 M 40 3 2 ACA (4) b 
Lt MCA (2) a 
90 M 30 4 1 Rt ICA (10) a 
92 F 54 3 2 Lt MCA (2) d 
Rt ICA (10) b 
Appendix 2.3: True positive cases on IADSA for patients completing both CTA and MRA 
''044.40 ' ' ' Af.'i,: 
96 M 25 3 1 Rt ICA (10) 
98 F 31 4 1 Rt ICA (11) 
99 F 58 3 1 Bas (12) 
101 M 26 4 1 ACA (4) 
102 M 47 2 1 Lt PICA (13) 
106 F 36 4 7 Rt ACA (5) 
Rt ACA (4) 
Rt ACA (14) 
Rt ICA (8) 
Lt ICA (9) 
Rt MCA (3) 
Bas (12) 
111 F 46 3 1 Bas (12) 
112 F 43 2 1 Rt ICA (9) 
113 F 62 2 3 Rt MCA (3) 
Rt MCA (2) 
Rt ICA (8) 
124 F 25 3 1 Lt ICA (11) 
125 M 39 2 2 ACA (4) 
Rt MCA (2) 
130 M 27 2 1 Lt ICA (7) 
131 M 52 1 3 ACA (4) 
Lt MCA (2) 
Bas (12) 
132 F 50 2 1 ACA (4) 
133 M 26 2 1 Lt ICA (7) 
137 M 50 2 1 ACA (4) 
139 M 50 2 1 ACA (4) 
146 F 54 3 1 Rt ICA (8) 
148 M 46 2 1 Rt ICA (8) 
150 F 57 2 2 Rt PICA (13) 
Bas (14) 
157 M 21 2 1 ACA (14) 
168 M 71 2 1 Lt PICA (13) 
169 M 70 2 3 ACA (4) 
Lt MCA (2) 
Rt MCA (2) 
173 F 27 4 1 Rt MCA (2) 
176 F 50 2 6 Lt MCA (2) 
Rt MCA (2) 
Lt MCA (2) 
Rt MCA (2) 
ACA (5) 
Lt ICA (7) 
181 F 31 4 1 Lt PICA (13) 
185 M 36 4 1 Lt MCA (2) 
188 F 53 2 1 Rt ICA (8) 
194 M 51 2 1 ACA (5) 
196 F 60 2 1 Rt PICA (13) 
198 M 34 3 1 Lt MCA (2) 
IA= intracranial aneurysm 
Size: see methods section 
0= aneurysm missed 1= aneurysm detected 
Appendix 2.4: Incorrect results (false negative and positive) for CTA and MRA 
Modality Reader Patient Sex Age Size 
,.. ,.. 
ConfidénCe àevel 'Resúlt per Aneury sm ,Résult,pér Pa 
CTA A 5 F 30 Rt ICA (11) a 4 FN FN 
CTA A 6 F 40 Lt ACA (14) b 3 FN TP 
CTA A 8 M 55 Lt ICA (11) a 4 FN FN 
CTA A 11 M 44 Rt ICA (10) b 5 FN TP 
CTA A 13 F 33 Rt MCA (2) a 5 FN FN 
CTA A 18 M 45 Rt MCA (2) a 4 FN TP 
CTA A 25 F 41 Lt ICA (10) a 4 FN TP 
CTA A 35 F 55 Lt ICA (10) b 3 FN TP 
CTA A 41 M 50 Bas (12) c 3 FN FN 




A 46 F 51 Lt ICA (11) 









CTA A 60 M 37 Lt ICA (10) b 2 FN TP 
CTA A 79 M 35 Rt MCA (2) b 1 FN TP 





A 84 M 57 Lt ICA (14) 
Lt ICA (8) 











CTA A 90 M 30 Rt ICA (10) a 4 FN FN 





A 106 F 36 Rt ACA (4) 
Rt ACA (14) 











CTA A 112 F 43 Rt ICA (9) a 4 FN FN 
CTA A 113 F 62 Rt MCA (2) a 3 FN TP 
CTA A 131 M 52 Lt MCA (2) a 4 FN TP 
CTA A 150 F 57 Bas (14) b 5 FN TP 
CTA A 168 M 71 Bas (13) b 4 FN FN 
CTA A 169 M 70 Rt MCA (2) b 4 FN TP 
CTA A 173 F 27 Rt MCA (2) b 4 FN FN 
CTA B 5 F 30 Rt ICA (11) a 5 FN FN 
CTA B 6 F 40 Lt ACA (14) b 5 FN TP 
CTA B 8 M 55 Lt ICA (11) a 5 FN FN 
CTA B 11 M 44 Rt ICA (10) b 5 FN TP 
CTA B 22 F 55 ACA (4) a 5 FN FN 
CTA 
CTA 
B 25 F 41 Rt ICA (11) 






CTA B 35 F 55 Lt ICA (10) b 1 FN TP 
CTA B 41 M 50 Bas (12) c 3 FN FN 




B 46 F 51 Lt ICA (11) 









CTA B 60 M 37 Lt ICA (10) b 1 FN TP 
CTA B 77 F 37 Rt ICA (10) b 5 FN TP 
CTA B 79 M 35 Rt MCA (2) b 1 FN TP 





B 84 M 57 Lt ICA (14) 
Lt ICA (8) 











CTA B 85 F 38 Lt ICA (10) b 5 FN FN 
Appendix 2.4: Incorrect results (false negative and positive) for CTA and MRA 
Modality Reader Patient Sex Age Site Size Confidence level Result per Aneurysm Result per Patient 
CTA B 89 M 40 Lt MCA (2) FN TP 
CTA B 90 M 30 Rt ICA (10) FN FN 
CTA B 92 F 54 Rt ICA (10) FN TP 
CTA B 96 M 25 Rt ICA (10) FN FN 
CTA B 106 F 36 Lt ICA (9) FN TP 
CTA Bas (12) FN 
CTA B 112 F 43 Rt ICA (9) FN FN 
CTA B 113 F 62 Rt ICA (8) FN TP 
CTA Rt MCA (2) FN 
CTA B 150 F 57 Bas (14) FN TP 
CTA B 169 M 70 Rt MCA (2) FN TP 
CTA B 173 F 27 Rt MCA (2) FN FN 
CTA B 176 F 50 ACA (5) FN TP 
CTA Lt MCA (2) FN 
MRA A 5 F 30 Rt ICA (11) FN FN 
MRA A 6 F 40 Lt ACA (14) FN FN 
MRA Rt MCA (2) FN 
MRA A 8 M 55 Lt ICA (11) FN FN 
MRA A 12 F 49 ACA (5) FN FN 
MRA A 22 F 55 ACA (4) FN FN 
MRA A 25 F 41 Rt ICA (11) FN FN 
MRA Lt ICA (10) FN 
MRA A 31 F 44 ACA (4) FN TP 
MRA A 35 F 55 Lt ICA (10) FN TP 
MRA Lt ICA (7) FN 
MRA Lt MCA (2) FN 
MRA A 43 F 53 Rt ICA (8) FN FN 
MRA A 46 F 51 Lt ICA (11) FN TP 
MRA Lt ICA (8) FN 
MRA Rt ICA (8) FN 
MRA Rt MCA (2) FN 
MRA A 60 M 37 Lt ICA (10) FN TP 
MRA A 70 F 70 ACA (4) FN FN 
MRA A 76 M 54 Rt ICA (7) FN TP 
MRA A 79 M 35 Rt MCA (2) FN TP 
MRA A 84 M 57 Lt ICA (14) FN TP 
MRA Lt ICA (8) FN 
MRA Lt MCA (3) FN 
MRA Lt MCA (2) FN 
MRA Bas (14) FN 
MRA A 85 F 38 Lt ICA (10) FN FN 
MRA A 86 F 41 Rt ICA (8) FN FN 
MRA A 89 M 40 Lt MCA (2) FN TP 
MRA A 90 M 30 Rt ICA (10) FN FN 
MRA A 92 F 54 Rt ICA (10) FN TP 
MRA A 96 M 25 Rt ICA (10) FN FN 
MRA A 98 F 31 Rt ICA (11) FN TP 
MRA A 106 F 36 Rt ACA (14) FN TP 
MRA Rt ACA (4) FN 
MRA Bas (12) FN 
MRA A 113 F 62 Rt ICA (8) 
FN FN 
MRA Rt MCA (3) FN 
MRA Rt MCA (2) FN 
MRA A 125 M 39 ACA (4) 
FN TP 
MRA A 131 M 52 Lt MCA (2) 
FN TP 
Appendix 2.4: Incorrect results (false negative and positive) for CTA and MRA 
Modality] Reader I Patient Sex I Age Site 
I Size I Confidence level I Result per Aneurysm I Result per Patient 
MRA Bas (12) c 5 FN 
MRA A 150 F 57 Bas (14) b 4 FN TP 
MRA A 157 M 21 ACA (14) b 4 FN FN 
MRA A 168 M 71 Bas (13) b 5 FN FN 
MRA A 169 M 70 Rt MCA (2) b 5 FN TP 





A 176 F 50 ACA (5) 
Lt ICA (7) 
Lt MCA (2) 










MRA A 181 F 31 Bas (13) c 5 FN FN 
MRA B 5 F 30 Rt ICA (11) a 5 FN FN 
MRA B 6 F 40 ACA (14) b 3 FN TP 
MRA B 8 M 55 Lt ICA (11) b 5 FN FN 
MRA B 11 M 44 Rt ICA (10) b 5 FN TP 
MRA B 13 F 33 Rt MCA (2) a 5 FN TP 
MRA B 18 M 45 Rt MCA (2) a 5 FN TP 
MRA B 22 F 55 ACA (4) a 5 FN FN 
MRA 
MRA 
B 25 F 41 Rt ICA (11) 






MRA B 31 F 44 ACA (4) b 4 FN TP 
MRA 
MRA 
B 35 F 55 Lt ICA (10) 












B 46 F 51 Lt ICA (11) 
Lt ICA (8) 
Rt ICA (8) 













MRA B 60 M 37 Lt ICA (10) b 1 FN TP 
MRA B 70 F 70 ACA (4) b 4 FN FN 
MRA B 76 M 54 Rt ICA (7) b 5 FN TP 
MRA B 77 F 37 Rt ICA (10) b 5 FN TP 
MRA B 79 M 35 Rt MCA (2) b 1 FN TP 





B 84 M 57 Lt ICA (14) 
Lt ICA (8) 











MRA B 85 F 38 Lt ICA (10) b 5 FN FN 
MRA B 86 F 41 Rt ICA (8) a 5 FN FN 
MRA B 89 M 40 Lt MCA (2) a 5 FN TP 
MRA B 90 M 30 Rt ICA (10) a 5 FN FN 
MRA B 92 F 54 Rt ICA (10) b 4 FN TP 




B 106 F 36 Rt ACA (14) 













B 113 F 62 Rt ICA (8) 
Rt MCA (3) 








MRA B 125 M 39 ACA (4) d 3 FN TP 
MRA 
MRA 







Appendix 2.4: Incorrect results (false negative and positive) for CTA and MRA 
Modality Reader Patient Sex Age Site Size Confidence level 
MRA B 139 M 50 ACA (4) b 5 FN FN 
INRA B 150 F 57 Bas (14) b 5 FN TP 
MRA B 157 M 21 ACA (14) b 4 FN FN 
INRA B 168 M 71 Bas (13) b 4 FN FN 
MRA B 169 M 70 Rt MCA (2) b 5 FN TP 
INRA B 176 F 50 ACA (5) b 5 FN TP 
MRA Lt ICA (7) b 5 FN 
MRA Lt MCA (2) b 1 FN 
MRA Rt MCA (2) b 1 FN 
MRA B 181 F 31 Bas (13) c 5 FN TP 
FALSE POSITIVES 
Modality Reader Patient Sex Age FP IA site size Confidence level Result per Aneurysm Result Per Patient 
CTA A 2 F 45 Rt MCA (3) a 3 FP FP 
CTA A 9 M 25 Bas (14) a 3 FP FP 
CTA A 36 F 31 Rt MCA (1) b 3 FP FP 
CTA A 46 F 51 Rt MCA (2) a 3 FP TP 
CTA A 71 M 61 ACA (4) b 3 FP FP 
CTA A Rt MCA (2) a 3 FP 
CTA A 79 M 35 Lt MCA (2) b 2 FP TP 
CTA A 83 F 54 ACA (4) a 2 FP FP 
CTA A Lt MCA (2) a 2 FP FP 
CTA A 87 F 42 ACA (4) a 3 FP TP 
CTA A Lt MCA (1) a 2 FP 
CTA A 91 M 46 ACA (4) a 2 FP FP 
CTA A 106 F 36 Rt MCA (2) a 2 FP TP 
CTA A 121 M 41 Rt MCA (2) a 3 FP FP 
CTA A 135 F 47 Rt ICA (9) a 3 FP FP 
CTA A 137 M 50 Rt ICA (9) a 3 FP TP 
CTA A 146 F 54 Bas (12) a 3 FP TP 
CTA A 150 F 57 Lt ICA (8) b 2 FP TP 
CTA A 152 F 37 Lt MCA (2) a 3 FP FP 
CTA A 167 F 44 Lt MCA (2) a 3 FP FP 
CTA A 170 F 28 Rt ICA (9) a 3 FP FP 
CTA A ACA (4) a 3 FP 
CTA A 178 M 19 ACA (5) a 3 FP FP 
CTA A 184 M 40 Rt MCA (2) a 2 FP FP 
CTA A 190 M 39 Rt MCA (2) a 3 FP FP 
CTA A 198 M 34 Lt MCA (2) a 1 FP TP 
CTA B 9 M 25 Bas (14) b 1 FP FP 
CTA B 10 F 24 Rt ICA (10) c 2 FP FP 
CTA B 43 F 53 Lt ICA (7) a 3 FP TP 
CTA B 79 M 35 Lt ICA (10) b 3 FP TP 
CTA B 83 F 54 Lt MCA (1) a 1 FP FP 
CTA B 84 M 57 Rt ICA (8) b 2 FP TP 
CTA B 86 F 41 Rt ICA (8) b 1 FP TP 
CTA B 87 F 42 ACA (4) b 2 FP TP 
CTA B 104 F 48 Lt ICA (8) b 2 FP FP 
CTA B 106 F 36 Rt MCA (2) b 1 FP TP 
CTA B 113 F 62 Lt ICA (11) a 3 FP TP 
CTA B 137 M 50 Rt ICA (10) c 3 FP TP 
CTA B 146 F 54 Bas (14) a 3 FP TP 
CTA B 151 M 40 Lt ICA (9) b 2 FP FP 
CTA B 168 M 71 ACA (4) b 3 FP TP 
Appendix 2.5 Detailed parameters of TCDS examination 
Power and angle corrected spectral TCDS examinations were performed 
Acuson 128XPlOV platform 
S219 (V2) 2 -2.5 MHz multihertz linear phased array transducer 
TCDS performed via temporal bone window to insonate the circle of Willis in the axial & 
coronal planes (transnuchaUtransorbital routes not routinely employed) 
Each major intracranial vessel segment examined systematically using power and angle 
corrected spectral doppler ultrasound. 
Aneurysm size determined on a frozen image using electronic calipers in the standard 
Acuson measurement software. 
Video record of each examination made 
Standard result proforma sheet completed at the end of each examination. Record the 
opinion of normal or abnormal (abnormality specified) in each major artery/branching 
point including sonographer's degree of confidence. 
Standard Acuson CDE package 
CD power <500 
Log comp= 50 -51 db 
Preprocessing = Acuson preset 1 
Persistence = Acuson preset 2 
Post processing = Acuson preset 6 
CDE Gate = 3 initially 
Filter = Acuson preset 3 
CDE Energy scale = +1 from default scale 
DGC = straight 
Gain = -4db 
CD Res box used once target vessels identified and gain on grey scale image kept low 
Appendix 2.6 Patients with aneurysms on IADSA (plus false positive cases on TCDS) 
. 





6 F 40 1 I : 1 TP Rt MCA c 
. 
. Lt ACA b 
8 M 55 I 5 1 ., FN Lt ICA a 
11 M 44 I 2 TP 
TP 
Rt ICA b Bas 
RtACA b 
15 M 24 TP Rt MCA b 
Lt MCA a 
22 F 55 E 1 TP ACA a 
24 F 62 E 1 TP ACA b 




30 F 41 TP Bas b 
31 F 44 TP ACA b Rt MCA b 
35 F 55- TP LUCA c LUCA 





39 M 61 TP Lt MCA b ; Rt ICA b 
Rt MCA 
Bas b 
41 M j 50 I 1 TP Bas 
43 F 2 FN Rt ICA 
44 F 57 1 FP 
45'F 60 1 TP ACA c 
46 F 51 1 TP -Rt MCA b Rt PICA 
Lt ICA a Rt PICA 
Rt PCoA 
Lt PCoA b 
51 M 38 FN Rt ICA b 
52 40 TP Rt MCA b 
53 M 50 E 1 TP Rt PCoA c 
54 F 47 E 1 TP LUCA c Rt ICA 
56 F 60 E 1 TP Lt ICA b Rt MCA ' b 
57 1 TP Rt MCA c Rt MCA 
58 F 54 1 TP Rt MCA c Lt MCA a 
60 37 1 TP Lt ICA r b Lt ICA b 
61 F 33 1 TP LUCA : c ! 
TP Rt ICA c 
....- 
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66 F 52 2 FP 
75 F 47 , 1 TP Rt MCA c Rt ICA 
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1= Less experienced 
E= Experienced 
TP =true positive 
FP =false positive 
FN =false negative 



















[DOB= / / 
THE DAVIE COOPER 
SCOTTISH ANEURYSM STUDY 
We have identified through the Scottish Office Information and Statistics Division that the above patient had a SAH in 
1994/95. We would be grateful if you could assist in an important Scottish research project supported by the British 
Brain and Spine Foundation's Davie Cooper Appeal, which aims to identify the prevalence of subarachnoid 
haemorrhage (SAH) within the families of patients who have had a SAH. Increasingly, relatives of such patients are 
concerned that they too might have an aneurysm. The information from this study will be helpful in advising such 
people about their own risk of a SAH, and as a basis for assessing the merits of investigating them. 
Approval for this research project has been obtained from the Multicentre Research Ethics Committee for Scotland and 
all Local Research Ethics Committees in Scotland. Permission to access patient data has been obtained from the 
hospital consultant responsible for the patient at the time of their SAH. We have written explaining the nature and 
potential value of this research project to all local GP subcommittees in Scotland. We wish to send patients a booklet 
which contains information about the study, a consent form and a questionnaire about their family. This asks for the 
names, dates of birth/death, country of residence, history of SAH and cause of death (if known) for each first and 
second degree relative. No other details about relatives are requested. We stress that participation in the study is 
entirely voluntary and patients can withdraw freely at any time without having to give a reason. 
We would be very grateful if you would arrange for completion and return the enclosed reply sheet in the SAE 
provided indicating your approval/disapproval for your patient to be contacted for the purposes of this study. If you 
agree to us contacting your patient, could you then please complete the address on the enclosed stamped envelope and 
post it to the patient. If you feel in this particular case that an approach from us to obtain a family history would be 
unreasonable, then we would be grateful if you could let us know. Please tell us of any other potential difficulties, such 
as a patient for whom English is not a first language so we can make special arrangements for them. If your patient has 
died, could you please indicate this and if you have the information available, the date of death. 
All information provided will remain strictly confidential and all data will be stored (and destroyed) in accordance 
with the Data Protection Act. Thank you very much for your help. Please do not hesitate to contact us if you would like 
more information. 
Yours sincerely, 
Prof. GM Teasdale Dr. JM Wardlaw 
The Department Of Neurosurgery 
Institute of Neurological Sciences 
Southern General Hospital NHS Trust 
Glasgow G51 4TF 
Tel: 0141-201 2570, Fax: 0141 -201 2995 
Dr. PM White Mr. K Lindsay 
The Neurosciences Trials Unit 
Department of Clinical Neurosciences 
The Western General Hospital NHS Trust 
Edinburgh EH4 2XU 
Tel: 0131 -343 6639, Fax: 0131 -332 5150 
Appendix 3.2b 
Dear 
THE DAVIE COOPER 
SCOTTISH ANEURYSM STUDY 
The Davie Cooper Scottish Aneurysm Study 
We are writing to ask you to take part in an important Scottish research project, the Davie Cooper 
Aneurysm study This is funded by money raised following the death of the international footballer Davie 
Cooper. 
Scottish NHS records for 1994 to 1995 suggest you might have had a type of brain haemorrhage called a 
subarachnoid haemorrhage (SAH) or an intracranial aneurysm. Our study is trying to find out whether this 
condition affects more than one person in a family, and if so how often. At the moment we do not know 
the answer, although it is a question doctors are often asked. 
Please take a little time to read the information on page 2 of the enclosed booklet. If you would like to 
take part in the study please complete and sign the Consent Form on page 3. All information you give 
us will be treated in the strictest confidence. However, you do not have to take part if you do not want to. 
please tell us about all your blood relatives even if no one else has had a SAH 
use the family tree diagram to help you remember all your relatives and send it back to us with the 
completed booklet 
please don't leave anyone out of the Family Questionnaire booklet. If there are any questions you 
can't answer about some of your relatives put "Don't know" in these boxes 
remember to include: your grandparents, parents, aunts & uncles, brothers & sisters, nieces & 
nephews, children & grandchildren. 
put the relationship of each person to you (e.g. mother)in the grey box at the top of the column 
indicate country of residence within the United Kingdom (e.g. Scotland) or abroad 
Please return the completed booklet and the family tree in the Freepost envelope provided. If you wish to 
find out more about the study please contact Dr Philip White on freephone 0800 783 3973. Thank you for 
taking the time to read about our study and we hope you will join us. 
Yours sincerely, 
Professor GM Teasdale 
The Department of Neurosurgery 
Institute of Neurological Sciences 
Southern General Hospital NHS Trust 
Glasgow G51 4TF 
Tel: 0141-201 2570, Fax: 0141 -201 2995 
The Neurosciences Trials Unit 
Department of Clinical Neurosciences 
The Western General Hospital NHS Trust 
Edinburgh EH4 2XU 
Tel: 0131 -343 6639, Fax: 0131 -332 5150 
Appendix 3.3 
MULTI CENTRE RESEARCH ETHICS COMMITTEE FOR SCOTLAND 
APPLICATION FORM 
MREC Procedures Checklist 
For MREC use only 
Number: Date received: 
Application Fee Enclosed: YES/NO/NOT APPLICABLE 
Received from MREC: Transferred from MREC: 
Date acknowledged: Applicant invited for interview: 
Outcome: Approved: Approved after amendment: 
Approved subject to amendment: Rejected: 
Applicant Informed 
Withdrawn: Reasons. 
MREC decision reviewed: Reasons. 
Progress reports received. Year 1 Year 2 Year 3 
Adverse events. 
Final reports received date 
appform.doc 
MULTI -CENTRE RESEARCH ETHICS COMMITTEE FOR 
SCOTLAND 
APPLICATION FORM 
INSTRUCTIONS: Please complete in type. Please place a circle around Yes /No options as 
appropriate. A version of this form is available on disc from the administrator of the MREC. 
It is essential that this form is completed fully and sent with relevant enclosures. Please refer to the 
accompanying Guidance Notes when completing the form and complete the checklist before sending. 
Where a question is not applicable it is important to make this clear and not to leave it blank. It is 
important that the language used in this application is clear and understandable to lay members. 
All abbreviations should be explained. 
Applicant's Checklist 
Please indicate if the following have been enclosed by placing a circle round Yes/No/Not 
applicable options. 
One copy of Application Form Yes No Not applicable 
Five Copies of protocol Yes No Not applicable 
Application Fee of £1000 Yes No Not applicable 
Research subject consent form Yes No Not applicable 
Research subject information sheet Yes No Not applicable 
Advertisement for research subjects Yes No Not applicable 
GP /consultant information sheet or letter Yes No Not applicable 
Interview schedules for research subjects Yes No Not applicable 
Letters of invitation to research subjects Yes No Not applicable 
Questionnaire* Finalised/Not yet finalised Yes No Not applicable 
Copy of researchers brochure or data sheet for all drugs 
(one copy only) 
Yes No Not applicable 
Copy of the statement of indemnity (one copy only) Yes No Not applicable 
Copy of CTX/CTC /DDX (one copy only) Yes No Not applicable 
Annexe A ** Yes No Not applicable 
Annexe B * ** Yes No Not applicable 
Annexe C * * ** Yes No Not applicable 
Please indicate if not yet finalised 
If the study involves the use of a new medicinal product or medical device, or the use of an 
existing product outside the terms of its product licence. Annexe A is attached to the 
Application Form. 
If the study includes the use of ionising, radioactive substances or X -Rays. Annexe B is attached 
to the Application Form. 
Information concerning local researchers should always be given where possible. Annexe C is 
attached to the Application Form. 
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SECTION 1 Details of applicant(s) 
1. Short title of project 
Full title 
The Davie Cooper Scottish Aneurysm Study 
The Study of Intracranial Aneurysms in Glasgow and 
Edinburgh (SAGE) 
Give one key word for each of the following: 
Condition Subarachnoid haemorrhage (SAH) 
Subject Patient with SAH 
Treatment Questionnaire 
2. Principal researcher (who will be responsible for dealing with the MREC) 
Surname: White Forename: Philip Title: Dr 




Tel: 0141 201 2570 
BSc. Pharmacology Liverpool 1988 
MBChB Liverpool 1990 
MSc. Clinical Imaging Edinburgh 1994 
FRCR London 1996 
University Department of Neurosurgery 
Institute of Neurological Sciences 
Southern General Hospital 
Glasgow 
G51 4TF 
Fax: 0141 201 2995 E -Mail: pmw @skull.dcn.ed.ac.uk 
or jr56q @clinmed.gla.ac.uk 
3. Senior researcher at LEAD centre (if different from above) 
Surname: Teasdale Wardlaw 
Present appt: Professor of Neurosurgery Senior Lecturer in 
Neuroradiology 
Qualifications: MBBS Durham 1963 MBChB Edinburgh 1982 
MRCP London 1967 MRCP Edinburgh 1982 
FRCS Edinburgh 1971 FRCR London 1988 
3 
4. Who is sponsoring the study? 
Contact name: Mrs J Alexander 
Organisation: The British Brain and Spine Foundation 
Address: 35 -43 Lincoln's Inn Fields 
London 
WC2A 3PN 
Tel: 0171 404 6106 Fax: 0171 404 6105 
Contact: Ms Sandra Radcliffe, Features Writer 
Organisation: The Daily Record 
Address: 40 Anderston Quay 
Glasgow 
G3 
Tel: 0141 248 7000 
SECTION 1 Details of applicant(s) 
5. Will researchers be paid for taking part in the study? 
Yes 
Will BMA guidelines (Manual II.47 - see Guidelines) be followed? If not, why not? 
Yes 
6. Proposed start date and duration October 1st 1997 2 Years 
7. What other centres are /do you intend to be involved in this project? 
Please use the form attached at Annexe C 
This is a joint project between Glasgow and Edinburgh with research staff based in both centres. 
Edinburgh correspondence address is: 
Neurosciences Trials Unit 
Dept. of Clinical Neurosciences 




Tel: 0131 343 6639 / 0131 537 3110 
Fax: 0131 332 5150 
email: jmw @skull.dcn.ed.ac.uk 
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SECTION 2 Details of project J 
This section must be completed A copy of the protocol should be enclosed with the application form, 
but it is not sufficient to complete questions by referring to the protocol. 
8. Aims and objectives of project 
This project aims to establish a firm understanding of the incidence and nature of subarachnoid 
haemorrhage amongst families in Scotland where at least one individual has had a subarachnoid 
haemorrhage (SAH): 
a) in a recent year, and 
b) in 1985/86 and treated in the Institute of Neurological Sciences in Glasgow 
9. Scientific background of study (Approx 250 words) 
SAH usually results from the rupture of a bulge in the wall of a cerebral artery called an aneurysm. The 
aneurysm can rupture at any time, causing a bleeding over the surface of the brain, resulting in a sudden 
increase in intracranial pressure. The consequences of rupture range from sudden severe headache to 
coma and death without recovery. Those who survive the initial event remain at risk of additional 
neurological damage from rebleeding or ischaemic brain damage. There are rarely preceding symptoms 
or signs that point to the presence of an aneurysm before rupture occurs. The overall mortality rate from 
SAH is 40 -55 %, however approximately 60% of patients treated in Neurosurgical Units after rupture of 
an aneurysm have a good neurological outcome. The mortality and morbidity from elective treatment of 
aneurysms is much lower than after emergency treatment, with a mortality of approximately 2% and a 
morbidity of 6 %. Therefore it would be much more satisfactory to prevent SAH than to treat those who 
have suffered it. 
The population prevalence of intracerebral aneurysms is generally accepted as around 1 -2 %. However, 
a recent Japanese study of 400 volunteers, who had cerebral angiography, found 6.5% had aneurysms, 
though this may be an unusual and self -selected group. The risk of bleeding from an asymptomatic 
previously unruptured aneurysm is cumulative year on year and evidence suggests a rate of 0.8 -1% per 
year. Close blood relatives of patients with SAH may be at an increased risk. Bromberg et al. found that 
SAH was seven times commoner in first degree relatives of patients with SAH than in second degree 
relatives.There is increasing interest in the possibility of identifying and screening subjects at risk of 
having an intracerebral aneurysm. Therefore we need to define in a much larger population than has 
been done so far, the true incidence of SAH amongst relatives of SAH patients, so that we can 
determine the potential return from screening. 
10. Brief outline of project (Approx 250 words) 
The Study aims to survey a) Patients with a subarachnoid haemorrhage (SAH) in Scotland in a recent year, and b) 
patients admitted with SAH to the Institute of Neurological Sciences (INS) in 1985/86, to determine the frequency of 
SAH in first and second degree relatives. 
Part a) will involve a postal questionnaire of all patients known to have had, or who might have had, a SAH in Scotland 
in a recent year, to be traced through the central Scottish Hospital Inpatient Discharge Statistics and Death Certification 
Records. Hospital case notes will be obtained to verify the diagnosis of spontaneous SAH. 
Part b) will trace all patients who were admitted to the INS in 1986/87 with SAH, through the hospital records to assess 
the prospective risk of SAH amongst their relatives during the subsequent ten year interval. 
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Permission to contact the patient (or relatives if the patient has died) will be obtained from the relevant hospital 
consultant and will be requested from General Practitioners of the subjects. Of 650 Scottish hospital consultants 
surveyed, 597 have already given permission to approach their patients and access medical records. A further 20 said 
they would probably agree once they had a chance to study the questionnaire. 
For each patient, we will construct a pedigree including all first and second degree relatives. Patients will be asked 
about episodes of SAH, and sudden death in their family. For deceased patients next of kin will be asked about the 
cause of death. Patient derived family histories will be verified through the ISD by using International Classification of 
Disease (ICD) record linkage. This information will enable us to assess the epidemiology of SAH in Scotland and the 
likely return from screening affected families for asymptomatic aneurysms. The study will be run jointly for two years 
between Glasgow and Edinburgh Neurosciences Units. 
SECTION 2 Details of project 
11. Study design (e.g. RCT, cohort, case control, epidemiological analysis) 
Epidemiological survey 
12. Size of the study 
i) How many patients will be recruited? 
Scotland wide study target population estimated 500 to 1000 
Glasgow survey target population 300 
This is likely to obtain details on approximately 14 -23000 relatives 
(assuming a 75% response rate and an average of 5 first and 18 second degree relatives) 
ii) How many controls will be recruited? 
None 
iii) What is the primary end point? 
How common SAH is amongst families where one member at least has had a definite SAH, 
compared with the background population. Background risk will be defined from the 
Scotland wide survey figures excluding familial cases of SAH (those families where at least 
two members have had SAH in addition to the index case) 
Additional end points are an estimate of the relative risk between first and second degree 
relatives of index patients, and the how the risk is affected if 0,1, 2, 3, or more than 3 family 
members have had a SAH, compared to the background population risk. 
iv) How was the size of the study determined? 
Determined by the number of patients coded by the ISD as having had a SAH, intracranial 
aneurysm or sudden death due to SAH between June 1994 and June 1995 and the number 
of admissions to the INS, Glasgow in 1986/87 with SAH. 
v) What is the statistical power of the study? 
The prevalence of intracranial aneurysm in the general population is at least 1 
-2% (from the 
literature). With a rupture rate of 0.8 -1% per annum, the annual incidence 
in Scotland is 
approximately 500 -1000 cases per annum. 
For simplicity we assume that the baseline risk of an observed SAH is 
0.5% (in keeping 
with data from Bromberg et al 1995). Then, assuming 1) a 75% response 
rate and that 2) 
each index patient has an average of 5 first degree and 18 second degree 
relatives 
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(supported by available data on the Scottish population), to detect an increase in risk from 
0.5 to 1% would require approximately 750 responders (with 18000 relatives) to achieve 
90% power. To detect an increase from 0.5% to 2% with the same power would require 
approximately 200 responders (and hence 3600 relatives). 
SECTION 3 Recruitment of subjects 
13. How will the subjects in the study be: 
i) selected? 
a) Patients who had a SAH in a recent year will be identified from the Information and 
Statistics Division (ISD) of the NHS records. 
b) patients admitted to INS in 1986/87 with SAH will be identified from hospital records 
and prospectively established at that time by Neuroradilogical investigation. 
c) relatives of index patients in the above groups. 
ii) recruited? 
A letter will be sent to subjects' GP with the information sheet and questionnaire. If there 
is no objection an introductory letter and questionnaire booklet will be sent to the subject. 
We will provide a prepaid letter for the GP to reply stating/refusing agreement. 
iii) what inclusion criteria will be used? 
We will be asking patients with SAH about all their first and second degree relatives and 
checking the patient derived information with ISD records. 
iv) what exclusion criteria will be used? 
We will not be asking about non blood relatives such as step family or adoptive family. 





vii) what inclusion criteria will be used? 
N/A 
viii) what exclusion criteria will be used? 
N/A 
SECTION 3 Recruitment of subjects 
14. Will there be payment to research subjects of any sort? 
7 
No 
If so, how much per subject and for what? N/A 
SECTION 4 Consent 
15. Is written consent to be obtained? 
If yes, please attach a copy of the consent form to be used. 
If no written consent is to be obtained, please justify. 
Yes 
Patients /next of kin who receive a questionnaire will be asked for their written consent. The 
computerised ISD records of the relatives identified from this questionnaire will be accessed as 
part of the study. Because we do not plan to approach the relatives, and data will be anonymised 
once collection is complete, we are not requesting their consent. 
16. How long will the subject have to decide whether to take part in the study? 
If fewer than 24 hours please justify. 
We will request that the consent form and completed questionnaire are returned within four 
weeks and will follow up if a reply is not received after that time. 
17. Will the subject be given a written information sheet or letter? Yes 
Please see Guidelines. 
If yes, please attach a copy to this application form. 
If no, please justify. 
18. Have any special arrangements been made for subjects 
for whom English is not a first language? Yes 
If yes, give details. 
Where appropriate, a Hospital/University interpreter will be identified from lists held by these 
institutions and translation will be arranged. We will liaise with GPs' to identify patients 
requring this assistance. 
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SECTION 4 Consent 
19. Will any of the subjects or controls be from one of the following vulnerable groups? Yes 
Children under 18 (16 in Scotland) 
People with learning difficulties 
Other vulnerable groups e.g. mental illness, dementia 
Unconscious or severely ill 
Please specify and justify 
As this project simply asks participants to complete a questionnaire, there is no physical 
intervention involved. We will not contact individuals under 18 years and clearly not those 
who are unconscious or severely ill. We will send a letter to the General Practitioner of each 
patient and shall ask them to inform us, if there is any reason why we should not contact the 
patient. For patients in one of the above categories we may approach the next of kin to 
supply details, again only with the GP's approval. 
i) What special arrangements have been made to deal with the issues of consent for the 
subjects above? Please see Guidelines. 
We have prepared an information sheet and consent form for next of kin. 
ii) Are any subjects likely to be involved in existing research or have been involved in any 
recent research in the last six months? Yes 
If yes, please justify their use in this project 
There may be a small number of people taking part in the International Study of 
Unruptured Intracranial Aneurysms (an observational study) and the International 
Subarachnoid Aneurysm Trial (a randomised controlled trial of clipping versus coiling 
of aneurysms). At the stage that we will make contact, these groups are under follow 
up only. The proposed study does not involve any active intervention- only questions 
about their family, so we feel there is no potential conflict in asking a few patients to 
participate in this study as well. 
SECTION 5 Details of interventions 
20. Does the study involve the use of a new medicinal product 
or medical device, or the use of an existing product outside 
the terms of its product licence? Please see Guidelines. 
If yes, please complete Annexe A of the Application Form. 
No 
21. Will any ionising or radioactive substances or X -Rays be administered? No 
Please ensure information in Question 13 includes exclusion criteria with regard to ionising 
radiation if appropriate. 
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If yes, please complete Annexe B.. 
22. Please list those procedures in the study to which subjects will be exposed indicating those 
which will be part of normal care and those that will be additional (eg taking more samples 
than would otherwise be necessary). Please also indicate where treatment is withheld as a 
result of taking part in the project. 
SECTION 6 Risks and ethical problems 
23. Are there any potential hazards? No 
If yes, please give details, and give the likelihood and details of precautions taken to meet them, 
and arrangements to deal with adverse events. 
24. Is this study likely to cause discomfort or distress? Yes 
There may be some distress caused by recalling any unpleasant major life event. There may be 
the added distress from the suggestion of an increased family risk of having a SAH. At present 
we do not know for certain if there is an increased risk and we will stress that we do not know if 
this is the case. The study is designed to answer this question. 
To help alleviate any distress we will offer to provide the results of the study to participants. We 
will provide contact addressses of the research team, who will be happy to provide further 
information and reassurance. If subjects are still concerned we will provide additional information 
to their General Practitioner. 
25. Are there any particular ethical problems or considerations that 
you consider to be important or difficult with the proposed study? Yes 
If yes, please give details. 
We do not know if there is a definite increased risk of intracranial aneurysms in the relatives of 
patients with SAH. The study is designed to ascertain this and quantify the risk on a population 
basis. The main ethical issue we forsee relates to the potential to cause some distress to patients 
and their relatives when asking them about their family history of this serious medical condition. 
26. Will information be given to the patient's General Practitioner? Yes 
Please note: permission should always be sought from research subjects before doing this. 
If yes, please enclose an information sheet for the GP. 
We will inform the General Practitioner that we have selected their patient for the study and will 
be asking permission to contact the patient. The GP will be asked to return a prepaid letter to 
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confirm their approval. However, we do not intend to pass on any information the patient gives 
to us. 
If no, please justify. 
If the study is on hospital patients, will consent of all 
consultants whose patients are involved in this research 
be sought? Yes 
We have sought permission from all hospital consultants in Scotland who regularly look after 
patients with SAH (Neurologists, Neurosurgeons, General Physicians, ITU consultants and 
Geriatricians). Of 650 contacted, 597 have so far given consent. 
If no, please justify. 
SECTION 7 Indemnity and confidentiality 
Product liability and consumer protection legislation make the supplier and producer (manufacturer) 
or any person changing the nature of a substance, eg by dilution, strictly liable for any harm resulting 
from a consumer's (subject or patient) use of a product. 
27. i) Have arrangements been made to provide indemnification and /or compensation in the 
event of a claim by, or on behalf of, a subject for negligent harm? 
(Please indicate N/A if not applicable) N/A 
If yes, please give details and enclose indemnity form with this application. 
ii) Have arrangements been made to provide indemnification 
and /or compensation in the event of a claim by, or on behalf 
of, a subject for non -negligent harm? N/A 
For NHS -sponsored research, HSG (96) 48 applies (reference no.2) 
For pharmaceutical company sponsored research, the company should conform to the most 
recent ABPI guidelines (Manual II.39) 
28. In cases of equipment or medical devices, have appropriate arrangements been made with 
the manufacturer to provide indemnification? 
(Please indicate N/A if not applicable) N/A 
29. i) Will the study data be retrieved from computer? 
Yes 
ii) Will the study data be held on a computer? 
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Yes 
iii) If yes, will the Data Protection Act (1984) be followed? Yes 
SECTION 7 Indemnity and confidentiality 
Audio /video recording 
Observation of patients 
If yes to either: 
i) How are confidentiality and anonymity to be ensured? 
No 
No 
ii) What arrangements have been made to obtain consent for these procedures? 
31. Will medical records be examined by research worker(s) 
outside the employment of the NHS? No 
All workers have NHS Honorary status and are familiar with handling medical records. 
If yes, please see Guidelines. 
32. What steps will be taken to safeguard confidentiality of personal records? 
The database storing results will be encrypted and password protected. Questionnaire answer 
sheets will be stored in a locked filing cabinet, in a locked office. Data on patient relatives will be 
anonymised once data collection is complete. 
33. What steps will be taken to safeguard specimens? 
N/A 
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PLEASE ENSURE THAT YOU COMPLETE THE CHECKLIST ON THE FRONT 
COVER OF THE APPLICATION FORM AND ENCLOSE ALL RELEVANT 
ADDITIONAL DOCUMENTS. 
DECLARATION 
The information in this form is accurate to the best of my knowledge and belief and I take full 
responsibility for it. 
I understand it is my responsibility to obtain management approval where appropriate from 
the relevant NHS body before the project takes place. 
I agree to supply interim and final reports on the pro forma provided, and to advise my 
sponsor, and the MREC from which approval was granted for this proposal and any local 
researchers taking part in the project of any adverse or unexpected events that may occur 
during this project. 
Signature of Principal Researcher: Date. 
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Annexe A Drugs and Devices 
This form is to be used if the study involves the use of a new medical product or medical device, 
or the use of an existing product outside the terms of its produce licence. 
i) Is a pharmaceutical or other commercial company arranging this trial? Yes No 
If no, has approval of the licensing authority been obtained by means of a DDX? Yes No 
Doctors' and Dentists' Exemption Number: 
ii) Does the drug(s) or device have a product licence(s) for 
the purpose for which it is to be used? Yes No 
If yes, please attach data sheet or equivalent. 
iii) Is any drug or medical device being supplied by a company 
with a Clinical Trial Certificate or Clinical Trial Exemption? Yes No 
If yes, give details: Clinical Trial Certificate Number: 
Clinical Trial Exemption Number: 
Please attach CTC, CTX, or DDX. 
iv) Details of drugs used or medical devices (Please complete the table below) 




v) Details of Medical Device 
vi) If an electrical device, has the device been through 
acceptance and safety testing? Yes No 
Give details: 
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Annexe B Radiation 
This form is to be used if the study involves the use of ionising or radioactive substances or 
X -Rays. 
a) RADIOACTIVE SUBSTANCES 
i) Details of substances to be administered (Please complete the table below) 
Investigation Radionucleide Chemical Quantity of radio- Route Frequency 
form activity to be 
administered 
(MBq) 
ii) Estimated Effective Dose (Effective Dose Equivalent)** (mSv): 
iii) Absorbed dose to organ or tissues concentrating radioactivity ** (mGy) 
(Specify dose and organ) 
b) X-RAYS 
i) Details of radiographic procedures 
Investigation Organ(s) Frequency 
ii) Estimated Effective Dose (Effective Dose Equivalent) ** (mSv): 
** Please supply source of reference or attach calculation 
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Annexe C 
OTHER CENTRES INVOLVED IN THIS STUDY 
Please provide the name and contact details of other researchers involved in this study. Please 
include your own name and centre if you are also a local researcher. 
Other local researchers: 
Dr Evelyn Teasdale, Consultant Neuroradiologist, 
Institute of Neurological Sciences, 
Southern General Hospital, 
Glasgow G51 4TF 
Tel: 0141 201 2111 
Professor Gordon Murray, Professor of Medical Statistics, 
University of Edinburgh, 
Mr Ken Lindsay, Consultant Neurosurgeon, 
Institute of Neurological Sciences, 
Southern General Hospital, Glasgow 
Mr David Signorini, Medical Statistician, 
Clinical Trials Unit, Dept. Of Clinical Neurosciences, 
Western General Hospital, Edinburgh 
Project Advisor: 
Professor Garth Cruickshank 
Professor of Neurosurgery 
University Department of Neurosurgery 




Please inform the MREC when other centres become involved in the future. 
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Appendix 4 
List of Abstracts 
"How reliable is the non -invasive imaging of intracranial aneurysms ?" PM White, JM 
Wardlaw. Presented at European Stroke Conference, Venice 1999. Published in 
Cerebrovascular Diseases 1999;9 (suppl 1):51 
"How rigorous are studies assessing new diagnostic imaging technologies ? - appraisal by 
reference to the imaging of intracranial aneurysms." PM White Annual Meeting of the 
International Society of Technology Assessment in Health Care, Edinburgh 2000 
"Can non -invasive imaging tests accurately detect intracranial aneurysms? A systematic 
review" PM White et al. BSNR, Sheffield 1999. Supplement in Neuroradiology 2000 
"Power Doppler Ultrasound in the detection of intracranial aneurysms." PM White et al. 
Presented at European Stroke Conference, Vienna 2000. Published in Cerebrovascular 
Diseases 2000;10 (suppl 1) 
"Is CTA or MRA the most accurate imaging method for intracranial aneurysms ?" PM White 
et al. Presented at European Stroke Conference, Vienna 2000. Published as a supplement in 
Cerebrovascular Diseases 2000;10 ( suppl l ) 
"A direct comparison of CTA and MRA in the detection of intracranial aneurysms." 
PM White et al. Presented at BSNR, Bristol 2000. Published as a supplement in 
Neuroradiology 2001 
"Epidemiology of SAH in the Scottish population ". PM White et al. Presented at BSNR, 
Bristol 2000. Published as a supplement in Neuroradiology 2001 
"What is the most sensitive non -invasive imaging strategy for intracranial aneurysms ?" PM 
White et al. Presented at the European Society of Neuroradiology, Oslo, September 2000. 
"The non- invasive imaging of intracranial aneurysms- do neuroradiologists do it better." PM 
White et al. Presented at ASNR 2001, Boston. Published as supplement in AJNR 2001 
The publications so far arising from this work follow. Appropriate permission has 
been obtained from the publishers to reproduce these papers in the thesis. 
Brain (2000), 123, 205 -221 
INVITED REVIEW 
The detection and management of unruptured 
intracranial aneurysms 
J. M. Wardlawl and P. M. White1,2 
'Department of Clinical Neurosciences, University of 
Edinburgh, Western General Hospital, Edinburgh and 
2University Department of Neurosurgery, Institute of 
Neurological Sciences, Southern General Hospital, 
Glasgow, UK 
Summary 
The incidence of subarachnoid haemorrhage (SAH) is 6- 
8 per 100 000 person years, peaking in the sixth decade. 
SAH, mostly due to rupture of an intracranial aneurysm, 
accounts for a quarter of cerebrovascular deaths. 
Aneurysms increase in frequency with age beyond the 
third decade, are 1.6 times more common in women 
and are associated with a number of genetic conditions. 
Prospective autopsy and angiographic studies indicate 
that between 3.6 and 6% of the population harbour an 
intracranial aneurysm. Studies have found an increased 
rate of SAH in first degree relatives of SAH patients 
(relative risk 3.7 -6.6). In affected families, the most 
frequent relationship between sufferers is sibling to 
sibling. The rupture rate of asymptomatic aneurysms 
was thought to be 1 -2% per annum, but the recent 
International Study of Unruptured Intracranial 
Aneurysms found that the rupture rate of small aneurysms 
was only 0.05% per annum in patients with no prior 
SAH, and 0.5% per annum for large ( >10 mm diameter) 
aneurysms and for all aneurysms in patients with previous 
SAH. Non -invasive tests such as magnetic resonance 
angiography (MRA), computed tomographic angiography 
(CTA) and transcranial Doppler (TCD) have been 
advocated as alternatives to intra- arterial digital 
subtraction angiography to screen for aneurysms. 
Correspondence to: J. M. Wardlaw, Department of Clinical 
Neurosciences, University of Edinburgh, Western General 
Hospital, Crewe Road, Edinburgh EH4 2XU, UK 
E -mail: jmw @skull.dcn.ed.ac.uk 
Although all are promising techniques, the quality of 
data testing their accuracy is limited. Overall reported 
sensitivity for CTA and MRA (TCD is poorer) was 76- 
98% and specificity was 85- 100 %, but many subjects had 
an aneurysm or recent SAH, which could overestimate 
accuracy. CTA and MRA are much poorer methods for 
the detection of aneurysms < mm diameter, which 
account for up to one -third of unruptured aneurysms. 
Elective surgical clipping of asymptomatic aneurysms has 
a morbidity of 10.9% and mortality of 3.8 %. Treatment 
of aneurysms by Guglielmi coils, for which there is less 
long -term follow -up available, has a 4 % morbidity and 
1% mortality, but only achieves complete aneurysm 
occlusion in 52-78% of cases. There has been interest in 
screening for aneurysms, but the indication for, and cost 
effectiveness of screening are unclear because aneurysm 
prevalence varies, rupture rate is low, non -invasive 
imaging tests are not yet accurate enough to exclude small 
aneurysms and the morbidity and mortality for elective 
surgical treatment of unruptured aneurysms is high. 
There may be a limited role for investigation of high risk 
subgroups. Ideally, screening in such subgroups should 
be tested in a randomized trial. The avoidance of risk 
factors for aneurysms such as smoking, hypertension and 
hypercholesterolaemia should be part of the management 
of at -risk subjects. 
Keywords: unruptured intracranial aneurysm; magnetic resonance angiography; CT angiography; transcranial ultrasound; 
screening 
Abbreviations: ADPKD = adult polycystic kidney disease; CI = confidence interval; CTA = computed tomographic 
angiography; GDC = Guglielmi detachable coils; IADSA = intra- arterial digital subtraction angiography; ISUTA = 
International Study of Unruptured Intracranial Aneurysms; MRA = magnetic resonance angiography; NSAID = non- steroid 
anti -inflammatory drug; RR = relative risk; SAII = subarachnoid haemorrhage; TCD = transcranial Doppler 
© Oxford University Press 2000 
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Introduction 
Subarachnoid haemorrhage (SAH), due to rupture of an 
intracranial aneurysm, is a serious disorder with a high 
mortality and morbidity. It accounts for about one -quarter of 
cerebrovascular deaths and, despite improvements in the 
management of patients with SAH (Fogelholm et al., 1993), 
the case -fatality rate is still reported as between 25 and 50 %, 
with most patients dying as a result of the initial bleed or its 
immediate complications (Hop et al., 1997). Of the survivors, 
-50% will be left disabled and dependent on others in 
activities of daily living (Hijdra et al., 1987). SAH is due to 
rupture of a saccular aneurysm in -75% of cases, which 
usually arise from the circle of Willis or branch artery 
(Sengupta and McAllister, 1986). 
In recent years, there has been increasing interest in 
the possibility of detection and treatment of intracranial 
aneurysms prior to rupture. Patients increasingly are being 
referred to neurological and neurosurgical clinics, concerned 
that they may have an aneurysm themselves following an 
SAH in a relative. In order to offer asymptomatic subjects 
reasonable advice, it is necessary to know what their risk of 
having an aneurysm is, and should they have one what the 
likely risk of rupture is, how one might go about detecting 
such an aneurysm without exposing the patient to unnecessary 
stress or risk, and having identified an asymptomatic 
aneurysm what treatment, if any, should be offered. The risk 
at each stage must be weighed against the risk of not doing 
anything in that individual. The present review summarizes 
the current state of knowledge and highlights where more 
information is needed. In the preparation of this review, we 
have drawn heavily on evidence from systematic reviews of 
the available evidence performed by others (supplemented 
by more recent evidence where appropriate) and our own 
systematic reviews where others had not already applied this 
technique. 
The relationship between SAH and 
unruptured intracranial aneurysm 
In a recent systematic review of 18 studies worldwide, the 
overall incidence of SAH in all studies was 10.5 per 100 
000 person years, but 6-8 per 100 000 person years in the 
most recent studies (with more frequent use of CT to confirm 
the diagnosis) and was greater for women than for men (Linn 
et al., 1996). SAH is associated with physical activity, but 
the formation of aneurysms per se is not (Schievink et al., 
1989). Spontaneous SAH occurs most commonly in subjects 
aged between 40 and 60 years, but can occur from childhood 
to old age. It is -1.6 times more common in women than in 
men (van Gijn, 1996; Rinkel et al., 1998). 
The risk factors for SAH and for having an unruptured 
intracranial aneurysm are very similar (see Table 1). Smoking, 
hypertension, alcohol consumption (particularly binge 
drinking) (Teunissen et al., 1996), cocaine and amphetamine 
abuse (Oyesiku et al., 1993), oral contraceptive use (Johnston 
et al., 1998) and plasma cholesterol concentration in the 
highest tertile ( >6.3 mmol/1) (Adamson et aL, 1994) are all 
associated with an increased risk of aneurysm formation and/ 
or SAH. 
Genetic conditions associated with SAH and intracranial 
aneurysms include adult polycystic kidney disease ( ADPKD) 
(Rinkel et al., 1998)- aneurysms occur in 10-15% of 
ADPKD patients (Hughes et al., 1996) and recur frequently 
in ADPKD patients with known aneurysms, particularly if 
there is a positive family history ( Ruggieri et al., 1994; 
Hughes et al., 1996). Less common hereditary conditions 
associated with intracranial aneurysms include type W 
Ehlers -Danlos syndrome (Schievink et al., 1990), possibly 
pseudoxanthoma elasticum (Munyer and Margulis, 1981) 
[although a very recent report refutes any association (van 
den Berg et al., 1999)], hereditary haemorrhagic telangiectasia 
(Roman et al., 1978), neurofibromatosis type I (Morooka and 
Waga, 1983; Mulvihill et al., 1990) and al- antitrypsin 
deficiency (Schievink et al., 1996). Marfan's syndrome was 
thought to be associated with aneurysms, but a recent detailed 
study of 135 patients with Marfan's syndrome (classified as 
such using standard criteria) found no evidence of a 
relationship (van den Berg et al., 1996). The authors suggested 
that previous case reports indicating an association may have 
been based on a doubtful or inconclusive diagnosis of 
Marfan's. The only caveat to this assertion (about the lack 
of an association) is that the average age in this large series 
was 21.3 years, whereas the median age of case reports in 
the literature was 41.3 years and, even in association with 
genetic disorders, aneurysms are rare below 20 years of age. 
Predilection to aneurysm formation has also been reported 
sporadically in other conditions including Klinefelter 
syndrome, tuberous sclerosis, Noonan's syndrome and a- 
glucosidase deficiency (King, 1997). While some studies 
have shown a relationship between aneurysms and HLA- 
B27, HLA -DR2 (Ostergaard and Hog, 1985) HLA -A28 and 
HLA -B40 (Norrgard et al., 1987b), other studies have failed 
to confirm these associations (Schievink et al., 1988; Leblanc 
et al., 1989). 
What is the frequency of intracranial 
aneurysms in the general population? 
Incidental aneurysms are found commonly at autopsy in 
patients dying of unrelated conditions, and the answer to the 
question `How common are unruptured aneurysms ?' depends 
on the method of case ascertainment (e.g. autopsy or 
angiography), whether the study is retro- or prospective, 
the population studied and -most importantly -how hard 
you look! 
`Symptomatic aneurysms' are those causing SAH 
following rupture, or exerting symptoms by a space - 
occupying effect (most commonly oculomotor nerve palsy 
produced by a posterior communicating artery aneurysm). 
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Table 1 Risk factors for aneurysm formation and rupture 
Risk factor Risk for 
aneurysm SAH 






Alcohol (heavy consumption) 
Oral contraceptive pill 
Atherosclerosis 
Ischaemic heart disease 
in women 
Cholesterol >6.3 mmol/1 
ADPKD 
Familial (two or more 
first or second degree) 
First degree relatives in families 














1.5 (low dose) 
1.9 (high dose) 
2.3 
(4.3) 
10.2 (odds ratio) 
4.4 
4.0 
Linn et al. (1996) 
Teunissen et al. (1996) 
Teunissen et al. (1996) 
Teunissen et al. (1996) 
Johnston et al. (1998) 
Rinkel et al. (1998) 
Uehara et al. (1998 
Adamson et al. (1994) 
Rinkel et al. (1998) 
Rinkel et al. (1998) 
4.5% 1.8 (see Tables 2 and 3 for references) 
`Asymptomatic aneurysms' may be defined as additional 
aneurysms found in patients with a symptomatic aneurysm, 
which are not responsible for the clinical presentation or 
those aneurysms found in patients investigated because they 
are at risk (of harbouring an aneurysm). `Incidental 
aneurysms' may be defined as those found. unexpectedly 
in patients undergoing investigation for other suspected 
pathology. 
Prior to the 1970s, several autopsy studies suggested that 
the overall prevalence of unruptured aneurysms in adults was 
as low as 0.3 %, but was as high as 9% in studies which 
looked specifically for aneurysms (Bannerman et al., 1970). 
Studies using angiography are confounded by the underlying 
disease for which the angiogram was done (e.g. tumour, 
stroke, intracranial haemorrhage), and the images may be 
suboptimal for detection of aneurysms, thereby 
underestimating frequency. Rinkel et al.'s systematic review 
of all studies (published between 1955 and 1996) of the 
frequency of aneurysms identified 23 studies including a 
total of 56 304 patients (Rinkel et al., 1998). The majority 
of these (78 %) were retrospective autopsy studies, 5% were 
retrospective angiography studies, and 11 and 7% were 
prospective autopsy and angiography studies, respectively. 
The prevalence of unruptured aneurysms varied considerably: 
0.4 and 3.6% (for retro- and prospective autopsy studies, 
respectively), and 3.7 and 6% (for retro- and prospective 
angiography studies, respectively). 
Subsequent data support the figures derived from earlier 
prospective studies. A recent prospective Japanese study of 
8680 `normal' people investigated with magnetic resonance 
angiography (MRA) found that 5.6% of men and 8.5% of 
women had intracranial aneurysms (Kojima et al., 1998). 
Another Japanese study found that 3.4% of men and 15.4% 
of women (out of a total of 120 patients) with ischaemic 
heart disease (but no neurological symptoms) had one or 
more asymptomatic aneurysms, compared with 2.6 and 3.6%, 
respectively in a control group (Uehara et al., 1998). A 
prospective autopsy study of unruptured intracranial 
aneurysms performed in East Finland (Ronkainen et al., 
1998) found 33 incidental unruptured aneurysms in 29 of 
532 patients (4.7 %) aged 30-70 years, of which 21 aneurysms 
in 18 patients (2.9 %) were 3 mm or greater in diameter. In 
this study, only a quarter of subjects were female, so it 
may have underestimated the true prevalence of unruptured 
aneurysms. An important technical point to note is that the 
size of an aneurysm at autopsy is significantly less than its 
size in life when it is distended by transmural (arterial minus 
intracranial) pressure. Perfusion of aneurysms identified at 
autopsy with saline at 70 mmHg increased aneurysm diameter 
by 30-60% and volume by up to 400% (see Fig. 1) 
(McCormick and Acosta -Rua, 1970). 
Of patients undergoing angiography following SAH, 20- 
25% are found to have at least one unruptured aneurysm in 
addition to the one which has ruptured (Lozano and Leblanc, 
1987). Additional aneurysms occur more commonly in 
females (Rinkel et al., 1998). Both smoking and female 
gender were important factors in the development of multiple 
aneurysms in the International Study of Unruptured 
Intracranial Aneurysms (ISUTA) study (International Study 
of Unruptured Intracranial Aneurysms Investigators, 1996). 
Thus it would appear that 3.6 -6.0 %, of the population 
aged over 30 years harbour an unruptured aneurysm, that 
these are commoner in females than in males, and increase 
in frequency with age; they are associated with smoking 
and alcohol consumption, possibly with hypertension, oral 
contraceptive use and hypercholesterolaemia. However, 
clearly only a modest proportion of these aneurysms actually 
rupture, so the key to the management of unruptured 
intracranial aneurysms is to identify (i) those at greatest risk 
of harbouring an aneurysm and (ii) which of those aneurysms 
are at greatest risk of rupture. 
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Fig. 1 The size of an aneurysm as seen at autopsy (left) and the effect of perfusion of the aneurysm with saline at 70 mmHg (right). 
Note the approximate doubling in size of the aneurysm when perfused at a pressure equivalent to normal transmural pressure in life. 
Reproduced from McCormick and Acosta -Rua (1970) with the permission of the publishers. 
Can we identify specific groups at higher risk 
of intracranial aneurysms? 
The association of SAH and aneurysms with specific genetic 
diseases and risk factors such as smoking has been mentioned 
earlier. SAH may affect several members of a family without 
any specific genetic `disease'. The first report of intracranial 
aneurysms affecting several members of the same family 
was made in 1942 (O'Brien, 1942), and the association 
is now well described. Familial SAH has been defined 
inconsistently, including as `families in which two or more 
members have had an SAH', which does not take account 
of the degree of relationship. Therefore, it would be preferable 
to use a more precise definition of familial SAH as given 
below. Some studies of the familial incidence of SAH 
included first to third degree relatives, and others only first 
and second degree, leading to potentially confusing results. 
Several examples of families in which numerous members 
are affected by SAH have been described in detail, and it 
may be that several of these badly affected families are 
raising the apparent prevalence of SAH in relatives of index 
patients with SAH in incidence studies (Leblanc, 1997). 
Though there is concern about the possibility of increased 
risk of intracranial aneurysms in families where only one 
member has had an SAH, it has been suggested that many 
cases of seeming `familial intracranial aneurysms' might 
simply represent accidental aggregation (ter Berg et al., 
1992). ter Berg et al. calculated that if each SAH patient had 
on average 17.5 relatives (first to third degree), and the 
prevalence of intracranial aneurysms in the general population 
was 1% and the annual rupture rate of aneurysms was also 
1 %, then each SAH patient had, on the basis of chance alone, 
a 5.6% possibility of having a first to third degree relative 
also affected by SAH. This is consistent with data from a 
case -control study by De Braekeleer and colleagues in 
Quebec, in which each SAH patient was matched with 
controls from the same geographical population (De 
Braekeleer et al., 1996). The proportion of SAH patients 
with third degree relatives who had had a SAH was the same 
as the proportion in the control population (14 %). The 
difference occurred in the proportion of second degree (9.6% 
versus 4.6 %, SAH versus control) and first degree relatives 
(9.0% versus 1.9 %) also affected by SAH (De Braekeleer 
et al., 1996). So is the risk of SAH in relatives of SAH 
patients truly increased in all cases or just in occasional 
families? 
Familial SAH should, therefore, be defined as families in 
which two or more close blood relatives (first or second 
degree) have a history of aneurysmal SAH without any other 
known heritable disease. Note that first degree relatives are 
parents, siblings and children; second degree relatives are 
grandparents, grandchildren, aunts and uncles, and nieces 
and nephews; and third degree relatives are cousins, great 
grandparents, great grandchildren, etc. 
Six studies since 1987 (Table 2) have examined the 
prevalence of unruptured aneurysms and/or SAH amongst 
relatives of patients with SAH (Norrgard et al., 1987a; 
Bromberg et al., 1995a; Schievink et al., 1995; Wang et al., 
1995; De Braekeleer et al., 1996; Ronkainen et al., 1997). 
A further recent Japanese study sought family histories 
of SAH amongst patients self -presenting for cranial MRI 
(including MRA) though they did not sample a defined 
population (Kojima et al., 1998). Other studies have described 
small groups of families affected by SAH but were not truly 
population -based (Alberts et al., 1995; Leblanc, 1997). In 
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Table 2 Summary of population -based studies of familial SAH 
Study Na. of index Country No. of relatives surveyed 
subjects 
I° 2° 
No. of relatives with SAH % 1° with Comment 
SAH 
3° 1° 2° 3° 
Norrgard et al. 
(1987) 
Wang et al. 
(1995) 
Shievink et al. 
(1995) 






De Braekeleer el al. 533 (+1599 
(1996) controls) 
Ronkainen et al. 91 
(1997) 
Umea, 1352 - 
Sweden (sibs only) 
Washington, N/S N/S 
USA 
Rochester, 608 N/S 
USA 
Utrecht, 1290 3588 
The Netherlands 
Quebec, N/S N/S 
Canada 
Kuopio, 716 relatives in total 
E. Finland (1 °, 2° and 3 °) 
22 - - 4.7 Sibs only surveyed - 
average six per index case 
N/S 18 16 - 11.4 OR for SAH in 1° relative 
= 1.8, 2 °= 2.4,P =NS 
N/S 11 5 - 1.8 RR of SAH in 1° relative 
= 4.14 (2.06 -7.4), 2° = 1.6 
N/S 10 + 71 4 + 121 - 1% RR of SAH in 1° relative 
= 6.6 (95% CI 2 -21) 
definite and 2.7 (95% CI 
1.4 -5.5) possible SAH 
N/S 48 51 77 - RR of SAH in 1° relative 
= 4.7, 2° = 2.1, 3° = 1.1 
76 37 in total 10.61 
OR = odds ratio; RR = relative risk; N/S = not stated. *No. surveyed/total sample available; tdefinite + possible SAH; relatives with 
SAH or aneurysm; §percentage of all relatives not just first degree. 
the six population -based studies, four were retrospective 
(studying families of patients who had had their SAH in a 
defined prior time period) and two prospective (studying 
families of patients presenting with SAH during the study 
period). Two were case- controlled and the others primary 
observational studies. Two were Scandinavian, two American, 
one Dutch and one Canadian. Four used a hospital -admitted 
population of SAH patients, and two were community- based. 
Three excluded patients known to have ADPKD. Four used 
a questionnaire or interview to determine the family history 
(which was validated only in the study by Bromberg et al., 
1995a) and two used centralized health data alone without 
contacting the patient or relatives at all. The six studies did 
not include similar groups of relatives, i.e. some only included 
first, some first and second degree, and some first to third 
degree relatives, and furthermore not all the studies analysed 
the results obtained by relationship to the index case. 
The studies where it was possible to calculate a relative 
risk (RR) for SAH in relatives compared with the background 
population were broadly in agreement: Schievink et al. found 
an RR for SAH of 4.14 for first degree and 1.6 for second 
degree relatives; Bromberg et al. found an RR of 6.6 for first 
and second degree relatives combined; and De Braekeleer 
et al. found an RR of 4.7 for first and 2.1 for second degree 
relatives. Whilst the relative risks appear large, it is important 
to bear in mind the small absolute number of relatives 
affected: Norrgard et al. found that 22 of 1352 (1.6 %) siblings 
had had an SAH; Schievink et al. found that 11 of 608 
(1.8 %) first degree relatives had had an SAH; and Bromberg 
et al. found that 17 of 1290 (1 %) first degree relatives had 
had a definite or probable SAH, giving a total of only 50 
out of 3250 (1.5 %) first degree relatives affected by SAH in 
studies from which it was possible to extract these data. 
Some of the differences between studies in the number of 
relatives with SAH per index case may be due to case 
ascertainment bias; e.g. in the study by Ronkainen and 
colleagues, only two -thirds of those invited to participate 
actually did so, and those who did may have been motivated 
by a positive family history, whereas the third who declined 
may have been less interested in a disease which did not 
appear to affect their family. Other possible sources of bias 
include recall bias, patients missed from hospital -based 
studies, lack of knowledge about family history, failure to 
recognize SAH, etc. In addition, some of the studies are 
relatively small and geographically localized, so that a few 
families with many affected members amongst a large number 
of families with no affected relatives could raise the overall 
average considerably. Despite these methodological 
problems, on the evidence available so far, somewhere 
between 1 (Bromberg et al., 1995a) and 11.4% (Wang et al., 
1995) of SAH patients will have at least one first degree 
relative with SAH, and between 16 (Ronkainen et al., 1997) 
and 29.8% (De Braekeleer et al., 1996) will have at least 
one first to third degree relative with SAH. Nevertheless, the 
great majority of relatives of SAH patients will not have had 
an aneurysmal SAH, which implies that the prevalence of 
aneurysms likely to become symptomatic is also small. 
Therefore, screening all relatives for aneurysms would 
necessitate examination of a very large proportion of 
unaffected people. 
Are any particular relations affected more 
frequently by SAH and aneurysms? 
Most of the above studies reported detailed family trees of 
the families in which two or more subjects were affected 
(including the index SAH case) (Table 3). The most frequent 
relationship was index patient to sibling only (44 %), followed 
by index patient to second or third degree relative only 
(25 %), followed by index patient to parent (18 %). Overall, 
a parent was affected in 24% of cases, i.e. in only a quarter 
of affected families was there a clear warning of the potential 
for SAH from a previous generation. The quarter of cases in 
which only a second or third degree relative has been affected 
offers an even more difficult target for screening as it would 
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Table 3 Breakdown of familial SAH by degree of relationship to index case 
Study No. of index 
patients 















Norrgard er al. (1987 23 17 52 0 0 0 0 0 30 
Leblanc et al. (1997) 17 23 42 6 0 18 0 0 12 
Wang et al. (1995) 17 36 12 3 0 0 0 0 4 
Bromberg et al. (1995)* 17 24 71 5 N/S N/S N/S N/S N/S 
Shievink et al. (1995) 15 20 47 0 0 7 0 0 27 
De Braekeleer et al. (1996)* 48 4 26 N/S N/S N/S N/S N/S N/S 
Ronkainen et al. (1997) 91 15 40 1 5 10 1 3 24 
Kojima et al. (1998)* 20 5 55 20 5 5 0 10 N/S 
Average (%) 16 44 5 3 3 0.2 3 25 
Sib. = sibling; N /S= not stated or data not extractable from the paper. *Studies which did not document detailed family histories for 
second or third degree relatives affected by SAH. 
be difficult to know whom to screen. As siblings are the 
most frequently affected relatives (affected in 52% of cases 
overall), these would be the obvious group of relatives 
towards whom any screening effort should be targeted. 
Familial intracranial aneurysms are reported to have 
distinguishing biological features, including rupture on 
average at a younger age than non -familial [most frequently 
in the fifth decade compared with the sixth decade for 
sporadic SAH (Kassell et al., 1990)], worse clinical outcome 
( -after matching for age and sex with non -familial cases) and 
an increased prevalence of middle cerebral artery aneurysms 
(Bromberg et al., 1995b; Kojima et al., 1998). From published 
case series of familial aneurysms, it appears there may be a 
younger age of rupture in subsequent generations (Bromberg 
et al., 1995b), implying possible anticipation.'' Familial 
aneurysms are also reported to have a predilection towards 
rupture in the same decade in individuals of the same 
family, particularly in siblings (Leblanc, 1997). Familial 
asymptomatic aneurysms are more likely to rupture in families 
having members with a history of SAH than in those without 
(Kojima et al., 1998), though this finding might be due, at 
least in part, to case ascertainment bias. 
What is the frequency of aneurysm rupture? 
A systematic review of the literature on the risk of rupture 
of aneurysms identified nine studies with a total of 3907 
patient years of follow -up (Rinkel et al., 1998), over half of 
these contributed by one study from Finland (Juvela et al., 
1993). During follow -up, 75 of 495 (15.2%) patients suffered 
an SAH, giving an annual rupture rate of 1.9% [95% 
confidence interval (CI) 1.5 -2.4] (Table 4). Aneurysms were 
significantly more likely to rupture in women than in men 
(RR 2.1, 95% CI 1.1 -3.9) and the risk of rupture increased 
with age, e.g. in the group of patients aged 60-79 years, RR 
of rupture was 1.7 (95% CI 0.7 -4.0) compared with those 
aged 40-59 years. Symptomatic aneurysms were significantly 
more likely to rupture than asymptomatic or additional 
aneurysms (6.5% versus 0.8% versus 1.4 %, respectively); 
RR of 8.2. Posterior circulation and large (>10 mm) 
aneurysms were significantly more likely to rupture; RR of 
4.4 and 4.0, respectively. The median time from diagnosis 
to rupture in the study by Juvela and colleagues was 9.6 
years (mean 9.4 years, range 1.2 -23.1 years), but this was 
the only study of the nine included in the systematic review 
to have a mean or median follow -up of >9 years. 
The initial size of the aneurysm and subsequent rupture 
rate is a complex issue. In Juvela's study, there was no 
disparity in the size of the aneurysm on intra- arterial digital 
subtraction angiography (IADSA) at the start of follow -up 
between patients who later had a SAH and those who did 
not (median 4 mm, range 2 -25 mm in those with later SAH 
versus median 4 mm, range 2 -26 mm in those without). Of 
the aneurysms which later ruptured, 67% were <6 mm in 
diameter, although the proportion of aneurysm ruptures 
increased almost constantly according to size (P = 0.03). 
Aneurysm size was not associated with the interval to rupture. 
In a logistic regression model, the only factor significantly 
related to aneurysm rupture was the size of the aneurysm, 
i.e. aneurysms of %7 mm had a relative risk of rupture of 
2.24 compared with smaller aneurysms (Juvela et al., 1993). 
Although the threshold size critical for SAH is not certain, 
most studies indicate minimal risk of rupture for incidental 
aneurysms measuring 3 mm or less (McCormick and Acosta - 
Rua, 1970; Wiebers et al., 1987). A proportion of the patients 
in the study of Juvela and colleagues had a repeat angiogram 
during follow -up: in patients with later SAH, the size of the 
aneurysms had increased from the start of follow -up, whereas 
in those without later SAH the size did not change. In 
addition, in patients undergoing angiography during follow - 
up, new aneurysms were found which had formed during the 
study in 19 %, giving an approximate rate of formation of 
2.2% per year. Some patients later suffered an SAH from 
these de novo aneurysms. 
The largest ever study to follow -up unruptured aneurysms 
is the ISUTA with 2621 patients (International Study of 
Unruptured Intracranial Aneurysms Investigators, 1998). This 
studied two groups of patients retrospectively: (i) patients 
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Table 4 Summary of data on risk of aneurysmal rupture 
Rinkel et al. (1998) ISUTA (1998) 
No. of subjects 
No. of aneurysms 
Duration of follow -up (patient years) 
No. ruptured 




Cumulative aneurysm rupture rate 
Symptomatic aneurysm rupture rate 
Asymptomatic aneurysm rupture rate 
Additional aneurysm rupture rate 








(mean of mean follow -ups 5.5, range 
75 




2.1 -13.7 years) (mean follow -up 8.3 years) 
32 
0.27 (32 in 12 023 years) 
0.7 (0.5 -1.0) 
4.0 (2.7 -5.8) 
10% per decade (from Juvela et al., 1993) 
6.5 (4.4 -9.1) 
0.8 (0.4 -1.5) 
1.4 (0.9 -2.0) 
4.4 (2.7 -6.8) 
0 (0-13) 
3.5 (1.4 -7.0) 
5.7 (3.4 -9.0) 
0.05 
0.5 
0.5 -5% per decade 
Data not extractable 
Data not extractable 
Data not extractable 
Data not extractable 
Data not extractable 
Data additional to those published in the systematic review were kindly supplied by Dr Gabriel Rinkel to allow calculation of duration of 
follow -up; the paper by Juvela et al. (1993) contributed 28% of the patients to the systematic review but almost half the patient -years of 
follow -up. 
with asymptomatic aneurysms with no prior SAH and (ii) 
those with multiple aneurysms who previously had sustained 
an aneurysmal SAH. The. investigators also studied 
prospectively the risks of treatment of asymptomatic 
unruptured aneurysms. The results of the ISUTA indicate a 
tiny rupture risk, compared with previous estimates, of 0.05% 
per annum for small aneurysms ( <10 mm diameter) in 
patients who have not had an SAH previously, and of 0.5% 
per annum for large aneurysms and for all aneurysms in 
patients who previously have sustained an SAH from another 
aneurysm. Of the 1449 included patients with 1937 unruptured 
saccular aneurysms '2 mm diameter, 32 patients had 
confirmed aneurysm rupture during follow -up; mean duration 
of follow -up 8.3 years (12 023 patient years in total). In the 
cohort that previously had not had an SAH, only one of 12 
aneurysmal ruptures occurred in an aneurysm <10 mm in 
diameter, compared with 17 of 20 patients in the cohort who 
previously had had an SAH. This study also found that the 
only significant predictors of rupture were the size and 
location of the aneurysm: aneurysms -?-10 min diameter had 
an RR of rupture of 11.6; for posterior circulation aneurysms 
the RR was 13.8 and 13.6 for basilar tip and vertebrobasilar 
locations, respectively, and 8.0 for posterior communicating 
artery aneurysms. The follow -up of patients in ISUTA is 
continuing until 2001. There is clearly a discrepancy between 
the size of unruptured aneurysms in people with no prior 
history of SAH which subsequently rupture as opposed to 
the mean size of aneurysms discovered only after rupture in 
other studies [ >10 mm versus 7.5 -9 mm (Wiebers et al., 
1987)). It has been postulated that this may be explained by 
a propensity for aneurysms that are going to rupture to do 
so soon after they form, possibly before collagen can form 
in their walls in significant amounts (D. O. Wiebers, personal 
communication). However, it may simply be that small 
aneurysms are so much more frequent than large aneurysms 
that despite a much lower rupture risk, ruptures occurring in 
small aneurysms outnumber those from large aneurysms. 
The discrepancy in aneurysmal rupture rates between the 
systematic review (Rinkel et al., 1998) and the ISUTA 
requires explanation. Annual rupture rate was 0.5% (ISUTA) 
versus 1.4% per annum (Rinkel et al.) for unruptured 
additional aneurysms in patients with a prior history of 
aneurysmal SAH; and 0.05% ( ISUTA <10 mm) versus 
0.8% (Rinkel et al., all sizes) per annum for asymptomatic 
aneurysms. Although the mean follow -up in the nine studies 
included in the systematic review ranged from 2.1 to 13.7 
years, compared with 8.3 years for the ISUTA, ISUTA follow - 
up was significantly shorter than the 13.7 years of Juvela 
et al. (which contributed substantially to the systematic 
review data), who found a median time to aneurysm rupture 
of 9.4 years (Juvela et al., 1993). ISUTA data from 1999 to 
2001 should clarify whether the duration of follow -up is a 
significant factor in explaining this discrepancy. Recruitment 
bias may have influenced the results. The majority of ISUTA 
patients were identified retrospectively from hospital records 
(1981 onwards, with the identification process commencing 
in 1992) and only survivors with persistently asymptomatic 
aneurysms, in whom a complete set of angiograms could be 
traced, were eligible for inclusion. These patients might 
not be entirely representative of the natural history of. all 
aneurysms: e.g. subjects who had suffered a fatal episode of 
SAH, or where an asymptomatic aneurysm had been treated 
since 1981, or who had incomplete angiograms could not be 
included in the ISUTA. The patients with asymptomatic 
aneurysms identified and followed up prospectively from 
1992 to 1998 provide less biased data but there were fewer 
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Fig. 2 Imaging of a right posterior communicating artery aneurysm (arrow) with the gold standard intra- arterial digital subtraction 
angiography (A), and two non -invasive techniques, i.e. magnetic resonance angiography (B) and computed tomographic angiography (C). 
The aneurysm is large and readily identified by both non -invasive techniques. 
of them, and 6 years of follow -up is too short. Finally, one 
also needs to bear in mind the relatively small numbers of 
ruptured aneurysms in the studies from which the rupture 
rates were calculated (32 in the ISUTA and 75 in the 
systematic review by Rinkel et al.) and the potential for the 
influence of chance. 
How should one search for aneurysms? 
The gold standard for identification of an intracranial 
aneurysm is an IADSA with selective cerebral arterial 
injections and multiple projections (Mayberg et al., 1994) 
(see Figs 2A and 3A). However, IADSA is invasive, requires 
a stay in hospital, is costly and carries a risk of complications. 
Modern IADSA has an overall 1% risk of transient and 0.5% 
risk of permanent neurological complication (Warnock et al., 
1993); but a recent meta -analysis indicated that the risk in 
SAH patients and patients with an aneurysm or arteriovenous 
malformation but no SAH is much lower at 0.07 %, and the 
risks of either transient or permanent neurological 
complication were greater in the SAH group than in the non - 
SAH group (Cloft et al., 1999). 
Due to these problems, IADSA is unsuitable for use in 
large numbers of subjects as a screening test. Intravenous 
digital subtraction angiography has inadequate resolution to 
replace IADSA (Atlas, 1994). Hence the increasing interest 
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Fig. 3 Imaging of a left anterior communicating artery aneurysm (arrow) with the gold standard intra- arterial digital subtraction 
angiography (A), and two non- invasive techniques, i.e. magnetic resonance angiography (B) and computed tomographic angiography (C). 
The aneurysm is small and very difficult to identify with certainty using the MRA or CTA. 
in using non -invasive tests such as MRA, dynamic spiral CT 
angiography (CTA) or transcranial Doppler ultrasound (TCD), 
all of which can be performed on out -patients. Any test 
aiming to replace IADSA in the detection of asymptomatic 
aneurysms has to be extremely sensitive because an 
undetected (`missed') aneurysm is a potentially life - 
threatening circumstance, yet one does not want to perform 
confirmatory IADSA (or, even worse, surgery) unnecessarily; 
therefore, specificity also has to be excellent. 
A systematic search of the English and non -English 
language literature to identify all studies of non -invasive 
imaging of aneurysms was performed by the authors. Over 
100 studies published between 1988 and 1998 (inclusive) 
have compared non -invasive imaging methods with IADSA. 
Most of these studies have been of MRA or CTA, a few of 
MRA and CTA, and a few of TCD. Most report apparently 
excellent results, but many are small studies and have 
methodological deficiencies, which combined may have led 
to an overestimation of the accuracy of these techniques in 
clinical practice. We identified 104 studies (to the end of 
1998) which met initial eligibility criteria (White and 
Wardlaw, 1999), i.e (i) comparison of a non -invasive method 
with IADSA (the gold standard); (ii) at least 10 subjects in 
the study; (iii) and published from January 1988 to December 
1998 inclusive. Two readers independently reviewed all these 
papers against a pre- defined set of inclusion criteria using an 
intrinsically weighted scoring system. 
The major methodological problems (summarized in Table 
5) included lack of clear and definite blinding (50 %), failure 
to list exclusion criteria and/or number excluded (79 %) and 
failure to present data in a way that enabled recalculation of 
the imaging test sensitivity, specificity, predictive values per 
aneurysm and/or per patient. The average sample size was 
only 37 (even though all studies were of ,10 subjects) and 
most studies were in patients with recent SAH so the aneurysm 
prevalence was high. A summary of the methodological 
weaknesses with studies comparing MRA, CTA or TCD with 
IADSA identified by our systematic review is given in Table 5. 
Studies testing MRA, CTA or TCD accuracy in patients 
with recent SAH are likely to have overestimated `accuracy' 
were these tests to be used for screening for the following 
reasons. (i) The prevalence of aneurysms was higher than it 
would be in asymptomatic individuals to be screened. It was 
thought that disease prevalence did not affect the sensitivity 
and specificity of diagnostic tests (Sackett et al., 1991), but 
there is statistical mathematical modelling to support the 
concept that, in addition to the effect of prevalence upon 
predictive values, increasing prevalence also improves the 
sensitivity and specificity of a test (Brenner and Gefeller, 
1997). (ii) The observer looks harder for aneurysms if there 
is a high probability of one being present (i.e. observer 
expectation bias). The addition of control groups without 
SAH has been used in some studies to reduce this bias but, 
as these control groups have not had corroborative IADSA, 
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Table 5 Methodological problems identified in studies of non -invasive imaging of aneurysms 
CTA MRA TCD 
No. of adequate studies /no. meeting initial inclusion criteria* 
Mean assessment score of adequate studiest 
No. of subjects (patients in adequate studies/total) 
17/45 (38 %) 
6.8 







Not definitely blinded 25 (56 %) 20 (42%) 7 (64%) 
Inclusion and/or exclusion criteria not stated 40 (89 %) 34 (71%) 8 (73%) 
Limited information on methodology (examination and/or review) 28 (62 %) 29 (60%) 7 (64%) 
Unable to extract relevant data from results presented 22 (49 %) 25 (52%) 6 (55%) 
Interobserver variability not assessed 39 (87 %) 42 (88%) 10 (91%) 
*Initial inclusion criteria were a study of a non- invasive imaging modality for aneurysms versus IADSA including %10 subjects. 
to score was derived for each paper from an aggregate of two independent reviewers' assessments against a list of predefined quality 
criteria A score of >5 was determined as indicating adequate quality. 
caution must still be employed in the interpretation of the 
results. (iii) The presence of subarachnoid blood can help to 
draw attention to the aneurysm. (iv) Publication bias: studies 
showing greater accuracy are more likely to be submitted 
(and published) than those with poorer accuracy. 
As a result of these methodological issues, the reported 
sensitivities, specificities and predictive values must be 
interpreted with some caution, particularly if one is 
considering using the non- invasive test to screen for 
aneurysms in a low prevalence population. Analysis of 
accuracy per patient rather than per aneurysm is of more 
clinical relevance to a screening programme where the 
detection of any aneurysm in a patient would lead to definitive 
IADSA, which would then detect any aneurysms missed by 
the non -invasive screening investigation. However, failure to 
identify any aneurysm by MRA (or any other imaging test) 
in a patient where one was actually present could offer false 
reassurance. 
For 18 adequate quality blinded- reader studies of MRA, 
the sensitivity for detection of at least one aneurysm per 
patient ranged from 69% (Huston et al., 1994) to 100% 
(Futatsuya et al., 1994) and the specificity from 75% 
(Gasparotti et al., 1994) to 100% (Futatsuya et al., 1994). 
For the detection of all aneurysms, sensitivity ranged from 
70% (Huston et al., 1994) to 97% (Aprile, 1996) and 
specificity from 75% (Gasparotti et al., 1994) to 100% 
(Wilcock et al., 1996). In many papers, it was not possible 
to extract the precise numbers of false - negative and false - 
positive results per patient and per aneurysm from the data 
presented. There is a trend towards a correlation between the 
results reported and the prevalence of aneurysms in the study 
population. The lower the prevalence, in general, the poorer 
the reported results: for the MRA studies with aneurysm 
prevalence %75% (12/18), median sensitivity for the detection 
of all aneurysms was 91% (range 70 -97 %), whereas for 
studies with aneurysm prevalence <75 %, median sensitivity 
was 82% range (77 -95 %). 
The accuracy of MRA and CTA may depend on how the 
images were processed and reviewed, though little work has 
been done in this area (Atlas et al., 1997). One study found 
a sensitivity (for identification of at least one aneurysm per 
patient) of 75% for MRA presented as Maximum Intensity 
Projection reconstructions alone (this type of image resembles 
an angiogram; see Figs 2B and 3B), but sensitivity increased 
to 95% when axial base and spin -echo images were reviewed 
as well (Ross et al., 1990). Aneurysm size is an important 
factor in aneurysm detection, with studies of MRA 
consistently indicating sensitivity rates of >95% for 
aneurysms >6 mm diameter but much less for smaller 
aneurysms (Atlas et al., 1997). For aneurysms <5 mm, 
detection rates as low as 56% have been reported (Korogi 
et al., 1996). With the standard time -of -flight MRA technique, 
flow -related artefacts may obscure some of the anatomical 
detail that is available with other methods such as CTA 
(Brown et al., 1997), but time -of -flight techniques have a 
greater sensitivity for aneurysm detection than phase -contrast 
techniques (Atlas, 1997). 
CTA (see Fig 2C and 3C for examples) has some 
disadvantages compared with MRA in that it requires an 
injection of iodine -based contrast (which may cause allergic 
reactions and can cause a deterioration in renal function in 
vulnerable groups) and is associated with radiation exposure 
(typically -2 mSv, equivalent to -1 years background 
radiation in the UK). The radiation dose would be a significant 
drawback in using CTA for community screening, particularly 
if this needed to be repeated several times during an 
individual's lifetime. However, CTA is more rapid than MRA, 
and some patients have a contraindication to MRI or suffer 
from claustrophobia and cannot tolerate the MRI examination. 
Spiral CT technology allows the acquisition of a volumetric 
data set which markedly improves the image data 
reconstruction techniques and allows the whole area of 
interest to be examined rapidly during peak arterial contrast 
concentration. CTA has been studied less extensively than 
MRA, but published data of CTA versus IADSA indicate 
that spiral CTA is at least as good, if not more accurate than 
MRA, with overall aneurysm detection rates of 85 -98% 
(Alberico et al., 1995; Hope et al., 1996). In our systematic 
review, we identified 16 adequate quality blinded- reader 
studies of CTA versus IADSA (of ,10 subjects, published 
1988- 1998). The prevalence of aneurysms was %75% in 13 
of 16 studies and >60% in all cases. It should be borne in 
mind that these are relatively early reports of spiral CTA, 
and the early results reported for MRA were often better 
than those reported in later years. 
Colour TCD ultrasound became available in the early 
1990s, with apparent success at identification of aneurysms 
(Tsuchiya et al., 1991; Becker et al., 1992). Ultrasound has 
the advantage of lower capital cost and mobility compared 
with IADSA, CTA and MRA. A recent technological 
development of colour Doppler called Colour Doppler Energy 
or Power Doppler, offers significantly greater sensitivity to 
flowing blood than standard colour flow imaging (Wardlaw 
and Cannon, 1996). Using this technique, one of the authors 
found an overall sensitivity for detection of aneurysms of 
80% but a sensitivity of 91% for detection of at least one 
aneurysm in patients harbouring aneurysm(s) who had an 
adequate temporal bone window. Specificity was 87.5% 
(Wardlaw and Cannon, 1996). Unfortunately, -10% of 
patients will not have an adequate bone window and the 
technique is very operator dependent. For our systematic 
review, we identified 11 papers comparing TCD with IADSA, 
of which only three were prospective blinded -reader studies, 
and aneurysm prevalence was >78% in all three. Ultrasonic 
contrast agents and 3D ultrasound imaging may improve 
accuracy. A very recent paper has combined these two 
technical advances together, and in a series of 30 patients 
with known aneurysms the authors reported a sensitivity for 
aneurysm detection of 87% and specificity of 100 %, although 
in this particular study the ultrasonographer was not fully 
blinded (Klotzsch et al., 1999). Nevertheless, the technology 
is improving and these results are encouraging. 
The results for non -invasive imaging methods are 
significantly poorer for smaller (<5 mm) aneurysms, which 
constitute as many as a third of aneurysms in asymptomatic 
patients (Kojima et al., 1998). These aneurysms cannot 
necessarily be ignored just because their current rupture risk 
is low. An example of the problems of current non -invasive 
imaging of aneurysms is the study by Ronkainen and 
colleagues who screened 85 families of patients with SAH 
using MRA (Ronkainen et al., 1997), and found 58 aneurysms 
in 45 of 438 subjects with MRA and performed IADSA in 
43 of these 45. Of these 43, seven did not in fact have an 
aneurysm (false positives), and the remaining 36 subjects 
actually had 60 aneurysms (13 of these had been missed by 
MRA, i.e. false negatives). Forty -seven aneurysms were 
found by both MRA and IADSA, giving a true positive rate 
per aneurysm of 78 %, a false -positive rate of 15% and a 
false -negative rate of 22 %. Data per patient could not be 
extracted. The positive predictive value was 87% but, as 395 
patients did not have IADSA, the true negative rate and 
negative predictive value rates cannot be calculated for the 
whole study. It is likely that some aneurysms were missed 
amongst the 395 MRA negative subjects and, indeed, one 
subject suffered an aneurysmal SAH 3 years after a negative 
MRA. Despite these limitations, MRA is being used to screen 
for aneurysms in some neuroscience centres in Europe and 
extensively in Japan (Kojima et al., 1998). MRA is also 
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being used in studies to identify the frequency of aneurysms 
in families of SAH patients (Ronkainen et al., 1995; Kojima 
et al., 1998; J. van Gijn, personal communication). 
Imaging technology is improving all the time, and recent 
developments such as contrast -enhanced subtraction MR 
techniques and 3D contrast- enhanced transcranial power 
Doppler sonography should lead to an improvement in 
diagnostic accuracy. Further studies of non -invasive imaging 
of aneurysms are ongoing, but what is particularly required 
is a larger study in patients without SAH but at risk of an 
aneurysm (and who all have digital subtraction angiography 
for verification), to eliminate the systematic bias in accuracy 
assessment of CTA/MRA/TCD introduced by a preponder- 
ance of recent SAH patients. In considering non -invasive 
screening for aneurysms, as well as the limitations of the 
tests themselves, one should also consider the need for 
subsequent follow -up to exclude de novo aneurysm formation 
or enlargement of any small aneurysms previously detected, 
which raises the question of how often to do this and for 
how long? No definite evidence -based answers exist to these 
questions at present. 
What should be done if an aneurysm is found, 
i.e. what are the risks of treatment? 
Aneurysms may be treated by surgical clipping (or wrapping) 
or by interventional neuroradiology. Surgical treatment, 
having been in use routinely for >40 years, has fairly clearly 
defined risks and morbidity. There are clear and important 
differences in risk between surgery for ruptured and 
unruptured aneurysms, the risks being much higher in patients 
who have sustained an aneurysmal SAH. A systematic review 
of surgical treatment for unruptured aneurysms was performed 
by Raaymakers and colleagues who identified 61 studies 
including 2460 patients and at least 2568 aneurysms published 
between 1966 and June 1996 ( Raaymakers et al., 1998). 
Only studies in which at least 90% of patients were treated 
by clipping (as opposed to wrapping or other surgical 
techniques) were included. Unfortunately, only eight of the 
studies were prospective, the rest being retrospective, and, 
in virtually all studies, the neurosurgeon performing the 
operation was also the observer of outcome. Median follow - 
up was at only 24 weeks (range 2 -234 weeks) in the 21 
studies which reported the time of outcome assessment. 
Overall permanent morbidity occurred in 10.9% (95% CI 
9.6- 12.2 %) of patients and mortality was 2.6% (95% CI 2.0- 
3.3 %). The lowest morbidity and mortality was found with 
small anterior circulation aneurysms (mortality 0.8 %, 
morbidity 1.9 %), and the worst with large posterior fossa 
aneurysms (mortality 9.6 %, morbidity 37.9 %), with large 
anterior circulation aneurysms (mortality 7.4 %, morbidity 
26.9 %) and small posterior fossa aneurysms (mortality 3.0 %, 
morbidity 12.9 %) being intermediate. To some extent, the 
higher mortality of posterior fossa (than anterior fossa) 
operations was due to confounding by aneurysm size, giant 
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aneurysms Risks associated with treatment of unruptured 
Outcome 
Management 




(% per decade) 
0.1t -1.0t 
(% per decade) 
2.61-3.8t% 
10.91-12.1t% 
1.01 -1.1 #% 
3.7L4.0 #% 
(221 -48 #% partially coiled) 
*No long term follow -up, procedure- related mortality rate quoted; tISUTA (1998); tRinkel et al. (1998); 1Raaymakers et al. (1997); 
1Vinuela et al. (1997); glElrilstra et al. (1999). 
aneurysms being more frequent in the posterior fossa in 
patients included in these studies. In the interpretation of 
these results, it is important to bear in mind the effect of 
publication bias. Studies which found higher mortality rates 
than the published literature of the time are less likely to 
have been published because, as Raaymakers et al. point out, 
public awareness of these results might be disadvantageous 
to the neurosurgeon or the hospital. 
The prospective arm of the ISUTA also addressed the issue 
of risks of surgical intervention in unruptured aneurysms. 
This enrolled 1172 patients (211 of whom had a history of 
previous SAH) and 996 underwent surgery. The surgery- 
related mortality at 1 year was 3.8% (95% CI 2.4 -5.4) in 
patients with no prior SAH and 2 %10 -2.6) in patients who 
previously had suffered an SAH from a different aneurysm, 
already treated. Morbidity was 12.0 and 12.1 %, respectively. 
These figures are based on current surgical practice and 
indicate higher mortality and morbidity than the overall 
figures quoted in the systematic review by Raaymakers and 
colleagues, although it must be noted that the 95% confidence 
intervals for these two papers overlap. The increased 
morbidity was ascribed largely to impaired mental status, 
which was not assessed in most previous studies (International 
Study of Unruptured Intracranial Aneurysms Investigators, 
1998). The mortality figures at 1 month in the ISUTA study 
were similar to those in the systematic review at a median 
of 24 weeks, 2.3% versus 2.6 %, respectively. Age was the 
only independent predictor of outcome in the ISUTA study: 
the RR of surgery- related morbidity and mortality at 1 year 
was -5 in the group >64 years of age compared with patients 
<45 years of age. These data are summarized in Table 6. 
The effectiveness and risks of aneurysm coiling are less 
certain because the technique is newer and still developing. 
Currently, interventional neuroradiology treatment would 
usually be with Guglielmi detachable coils (GDC), which 
were introduced in 1991 and revolutionized the endovascular 
treatment of intracranial aneurysms ( Guglielmi et al., 1991). 
The USA Multicenter Study Group identified a 1% mortality 
and a 4% morbidity for unruptured aneurysm treatment, with 
78% of aneurysms being completely occluded. The rupture 
rate of partially coiled aneurysms was 0.5% per annum from 
the limited follow -up data available (Vinuela et al., 1997). 
There is some evidence that even partial treatment by GDC 
confers benefit in the early post -rupture period; post -GDC 
treatment haemorrhage occurred in only nine of 403 patients, 
although the length of follow -up was very limited in many 
patients (Vinuela et al., 1997). A systematic review of 
aneurysm coiling (all observational studies) identified 48 
studies including 1383 patients (Brilstra et al., 1999). 
Permanent complications of coiling occurred in 3.7% (95% 
CI 2.7- 4.9 %), but only 54% (95% CI 50 -57 %) of aneurysms 
were completely occluded. Many included studies were 
retrospective and there was no indication of whether the 
outcome assessment was by an independent assessor or 
not. There is only one randomized trial -the International 
Subarachnoid Haemorrhage Trial -which is comparing 
coiling with clipping (though only in ruptured aneurysms) 
and that is ongoing. Coiling has not been utilized for long 
enough to know what the long -term success rate will be in 
preventing SAH or what other long -term complications might 
develop. It is difficult to make much sense of the morbidity 
and mortality data in observational case series (and hence in 
the systematic review) because the type of patients treated 
may be `worse' than those in surgically treated observational 
series, they may get more (or less) intensive after -care, and 
there are numerous other sources of bias and confounding 
which make it impossible to say more than that the coiling 
technique appears very promising but needs to be evaluated 
against surgery in randomized trials. 
In the case of an unruptured aneurysm, should one decide 
treatment was necessary, the long -term results of coiling are 
particularly relevant because coiling could provide a less 
invasive alternative to surgery. It is worth noting that the 
published rupture rate of partially coiled aneurysms is the 
same as that reported from the ISUTA study for untreated 
unruptured aneurysms > 10 mm diameter or for any 
unruptured aneurysm in a patient with a previous SAH. The 
regrowth rate of partially coiled aneurysms is still being 
defined, thus there are considerable uncertainties about the 
long- and short-term effectiveness of coiling. Current 
evidence suggesting an overall rupture rate of asymptomatic 
untreated unruptured aneurysms in the range 0.27% 
(International Study of Unruptured Intracranial Aneurysms 
Investigators, 1998) to 1.9% (Rinkel et al., 1998) means 
that the cost effectiveness of GDC treatment or surgery is 
decidedly uncertain. If the ISUTA rupture rate of 0.05% per 
annum (for aneurysms <10 mm in diameter) is correct (and 
it is the most rigorous large study to address this issue to 
date), then neither coiling nor surgery seems sufficiently safe 
to justify intervention in most patients with unruptured 
aneurysms. A randomized trial of best medical therapy versus 
intervention with long -term follow -up is required. 
Are there other worthwhile interventions? 
Apart from direct treatment of the aneurysm, it is likely that 
there are other ways of reducing the risk of rupture, which 
collectively could have a useful effect. Cessation of smoking, 
careful control of blood pressure, avoidance of risk factors 
for atherosclerosis (careful diet, regular exercise, etc.), while 
unproven, may help reduce both the risk of formation of 
aneurysms _:and the risk of rupture, as well as improving 
general health. Avoidance of anticoagulant (and possibly 
antithrombotic) drugs in patients known to harbour an 
unruptured aneurysm may reduce the risk of a poor outcome 
should the aneurysm rupture. There is evidence for a worse 
outcome of aneurysmal SAH in patients on anticoagulants 
(at least a doubling of the mortality rate) (Rinkel et al., 
1997), but less evidence for patients on aspirin. With the 
widespread use of aspirin, there must be a reasonable 
proportion of patients who happen to rupture an aneurysm 
while on aspirin and the prolonged bleeding time in patients 
on aspirin or other non -steroidal anti- inflammatory drugs 
(NSAID) theoretically -might result in a similar poor outcome 
to that found with anticoagulant drugs. However, a study on 
this subject has not confirmed the hypothesis. In fact, Juvela 
found that the use of NSAIDs preceding aneurysmal SAH 
did not significantly affect outcome, and that NSAIDs taken 
after the SAH might actually reduce the risk of secondary 
ischaemic events (Juvela, 1995). 
Screening for occult intracranial aneurysms 
There is a popular belief that screening to detect and so 
prevent disease `must' be beneficial as well as straightforward, 
effective and cost effective; in fact it is often complex, of 
arguable effectiveness and very expensive (Lancet Editorial, 
1998). To be effective, the screening test must discriminate 
between those with and without the disease, and not identify 
any self -limiting forms of disease which would not otherwise 
require treatment. A large administration infrastructure is 
required to deliver and maintain a national quality- assured 
screening programme. Some of the problems with screening 
as highlighted in the above -mentioned Lancet editorial may 
be illustrated further by the following examples. Screening 
for congenital dislocation of the hip failed to detect the 
condition in 70% of those children who subsequently required 
corrective surgery for it (Godward and Dezateux, 1998). 
In Japan, screening of children at 6 months of age for 
neuroblastoma found that screening at this age detects 
numerous cases that would have otherwise regressed 
spontaneously, and misses the more aggressive cases, in 
whom neuroblastoma develops later (Kudo et al., 1998). A 
trial of screening for colorectal cancer (Kronberg et al., 1996) 
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randomized 61 933 subjects to screening or no screening 
with faecal occult blood tests twice yearly for 10 years to 
demonstrate a 0.1% absolute reduction in deaths from 
colorectal cancer. The calculated cost for each colorectal 
cancer death prevented in a UK study of 152 580 patients 
(Hardcastle et aL, 1996) was $200 000 (Wagner et aL, 1996). 
Unless a screening test is very highly sensitive and specific, 
inexpensive, easy to administer and can be delivered in 
practice to the appropriate population successfully, it is 
unlikely to produce worthwhile results and is more likely to 
increase health care costs and stress amongst the population 
and health care staff alike (Lancet Editorial, 1998). 
Furthermore, unless one can differentiate between disease 
likely to remain sub -clinical and that likely to cause significant 
symptoms, the treatment of disease following on from a 
screening programme may have less impact than expected 
on cumulative mortality rates. In the case of intracranial 
aneurysms, because we cannot yet tell when aneurysms are 
going to rupture or form de novo, it would be difficult to 
know which to treat, which to leave alone, how often to 
screen, etc. The stress of being screened is difficult to quantify 
and probably depends in part upon the seriousness (in the 
mind of the screened population) of the disease being sought. 
McDonald et al. assessed patient reassurance after a normal 
test result in patients undergoing echocardiography for 
symptoms or an asymptomatic murmur (McDonald et al., 
1996). All those presenting with symptoms remained anxious 
despite the normal test result, and 39 of 52 people (75 %) 
presenting with an asymptomatic murmur became anxious 
after detection of the murmur. Over half of these (21139) 
remained anxious despite the normal echocardiogram result. 
Several groups have recommended screening for 
intracranial aneurysms in high -risk groups, namely ADPKD 
patients and those with a strong family history of aneurysmal 
SAH (Levey, 1990; Wiebers and Torres, 1992; Ronkainen 
et al., 1995; Butler et al., 1996; Kojima et al., 1998). The 
efficacy of screening for aneurysms depends crucially on 
certain parameters relating to the natural history of aneurysms, 
particularly the prevalence and the annual risk of rupture. 
Analysis of rupture risk is complicated further by the pattern 
of aneurysm rupture -some aneurysms appear to develop 
and rupture rapidly whilst others stabilize (Schievink et al., 
1991; Juvela et al., 1993; Black, 1994; International Study 
of Unruptured Intracranial Aneurysms Investigators, 1998). 
Screening will tend to detect the low -risk stable type rather 
than the high -risk aneurysms. The other critical considerations 
are the accuracy of screening test(s) and the safety and 
effectiveness of treatment. Several groups have applied 
detailed models to the screening decision analysis process 
for aneurysms (ter Berg et al., 1988; Leblanc et aL, 1994; 
King et al., 1995; Obuchowski et al., 1995; Kalimes et al., 
1998; Crawley et al., 1999), and only the most recent of 
these papers came out against screening, the others suggesting 
it was justified in the at -risk populations identified. This may 
be because the earlier studies assumed higher aneurysm 
rupture rates, higher MRA accuracy and a lower morbidity 
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rate from treatment than are apparent in the 
rigorous evidence now available. 
more recent and unruptured intracranial aneurysms? Clearly, the weight of 
evidence is against routine screening of all relatives of SAH 
patients. However, obtaining a careful and complete family 
history in patients with aneurysmal SAH should be mandatory. 
family 
member affected by SAH do not have a sufficiently increased 
risk to outweigh the risks of screening (and treatment). Those 
patients with the greatest risk of having an unruptured 
aneurysm, and of it then rupturing, are females aged over 30 
years from families with two or more first or second degree 
relatives affected by SAH. They are particularly at risk if 
they have additional identifiable risk factors such as smoking, 
excess alcohol consumption or hypercholesterolaemia, hyper- 
tension or.are using the oral contraceptive pill. Such subjects 
(and patiénts from the rare families with many affected 
members, and ADPKD patients) should be assessed on an 
individual basis taking all the relevant risk factors into 
account before offering screening for intracranial aneurysms. 
Until the accuracy of non -invasive tests is better defined, 
IADSA should be still be regarded as the only way definitively 
to exclude the presence of an intracranial aneurysm. The risk 
of rupture if an asymptomatic aneurysm is present is low 
(<0.5% per annum) and the risk of most aneurysms (small, 
non -posterior circulation aneurysms) is considerably out- 
weighed by the morbidity and mortality of surgery, the role 
of coiling being asst unproven, but known risk factors for 
aneurysm rupture should be stringently avoided. To resolve 
some of the issues highlighted above, we need more 
information on the genetic basis for aneurysm formation and 
randomized trials with long -term follow -up to evaluate the 
risks and effectiveness of best medical therapy compared 
with surgeryand/or coiling for the treatment of asymptomatic 
unruptured intracranial aneurysms. 
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Can Noninvasive Imaging 
Accurately Depict Intracranial 
Aneurysms? A Systematic 
Reviews 
PURPOSE: To perform a systematic review to determine the accuracy of computed 
tomographic (CT) angiography, magnetic resonance (MR) angiography, and trans - 
cranial Doppler ultrasonography (US) in depicting intracranial aneurysms. 
MATERIALS AND METHODS: A 1988 -1998 literature search for studies with 10 or 
more subjects in which noninvasive imaging was compared with angiography was 
undertaken. Studies meeting initial criteria were evaluated by using intrinsically 
weighted standardized assessment to determine suitability for inclusion. Studies 
scoring greater than 50% were included. 
RESULTS: Of 103 studies that met initial criteria, 38 scored greater than 50 %. CT 
angiography and MR angiography had accuracies per aneurysm of 89% (95% Cl: 
87%, 91 %) and 90% (95% Cl: 87 %, 92 %), respectively. For US, data were scanty 
and accuracy was lower, although the CIs overlapped those of CT angiography and 
MR angiography. Sensitivity was greater for detection of aneurysms larger than 3 
mm than for detection of aneurysms 3 mm or smaller -for CT angiography, 96% 
(95% Cl: 94 %, 98 %) versus 61% (95% Cl: 51 %, 70 %), and for MR angiography, 
94% (95% Cl: 90 %, 97 %) versus 38% (95% Cl: 25 %, 53 %). Diagnostic accuracy 
was similar for anterior and posterior circulation aneurysms. 
CONCLUSION: CT angiography and MR angiography depicted aneurysms with an 
accuracy of about 90%. Most studies were performed in populations with high 
aneurysm prevalence, which may have introduced bias toward noninvasive exam- 
inations. 
Supplemental material: http: / /radlology.rsnajnls.org /cgl /content /full/217/2/361/DC1. 
Intracranial aneurysms are imaged most reliably by using selective catheter angiography -that 
is, either conventional or digital subtraction angiography (DSA) (1). Although the risk associ- 
ated with these examinations is low (2), an even safer diagnostic examination would be useful, 
if it were sufficiently accurate. There has been increasing interest in the use of noninvasive 
imaging methods for the diagnosis of intracranial aneurysms (3 -5) -for example, to examine 
asymptomatic patients at risk of having an aneurysm because of a strong family history of 
aneurysmal subarachnoid hemorrhage (SAH) or autosomal dominant polycystic kidney dis- 
ease (6 -10). The currently available noninvasive imaging techniques are computed tomo- 
graphic (CT) angiography, magnetic resonance (MR) angiography, and transcranial Doppler 
ultrasonography (TCD) with a combination of spectral, color flow, or power Doppler tech- 
niques. Each of these techniques has advanced substantially in the past decade and been 
advocated as a replacement for angiography in some circumstances (11,12). Nevertheless, 
although the results of numerous individual studies have suggested that these noninvasive 
techniques have high sensitivity and specificity in the detection of intracranial aneurysms, a 
systematic overview of their performance compared with that of the reference standard, 
selective intraarterial angiography, is lacking. 
The aim of this study was to perform a systematic review of the evidence on the 
diagnostic accuracy of each of the three noninvasive methods compared with that of 
intraarterial DSA to determine whether accuracy was influenced by aneurysm prevalence, 
361 
sample size, or aneurysm site or size in 
the populations studied. Our purpose 
was also to determine whether the infor- 
mation already available is sufficient to 
be confident in the accuracy of noninva- 
sive examinations or more information is 
needed. 
MATERIALS AND METHODS 
Eligibility 
Initial criteria for inclusion in the sys- 
tematic review were studies (a) that were 
published between January 1988 and De- 
cember 1998, (b) in which the diagnostic 
accuracy of a noninvasive imaging exam- 
ination was compared with that of in- 
traarterial DSA, and (c) in which at least 
10 subjects underwent both the noninva- 
sive imaging examination and angiogra- 
phy performed contemporaneously. Stud- 
ies before 1988 were excluded because 
MR angiography was early in its develop- 
ment and not readily available, and spiral 
CT and power Doppler US were not avail- 
able. Studies on aneurysms of any size 
were eligible, but those with children 
were excluded. All articles, including 
those in non -English -language publica- 
tions, were sought. 
If studies met the initial criteria, they 
were then formally assessed for eligibility 
by two authors (P.M.W., J.M.W.) by us- 
ing predetermined quality criteria with a 
standardized assessment form. Each re- 
viewer independently assessed each 
study (ie, two reviews per study). This 
checklist method enabled an objective 
and reproducible assessment of each arti- 
cle to be performed. The form contained 
a checklist of 26 -27 items relevant to 
studies of diagnostic performance. The 
items were grouped into three main cat- 
egories, which are summarized in Table 
1. The predetermined weights applied to 
each item by the observers in deriving an 
assessment of each article also are given 
in Table 1. The actual outcome of a study 
in terms of diagnostic performance -that 
is, how well the noninvasive examina- 
tion performed -was not assessed with 
regard to inclusion or exclusion in the 
meta -analysis. 
For each of the three main categories, a 
score on a scale of 0 -3 (0 = very poor or 
not done, 1 = poor, 2 = acceptable, 3 = 
good) was assigned by the reviewer, with 
an additional mark given for the overall 
(ie, subjective) impression of the article; 
therefore, the possible range of scores 
was 0 -10. A score of greater than 5 (50 %) 
was deemed to be necessary for inclusion 
in the meta- analysis. The scoring system 
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TABLE 1 
Data Extracted from Studies Meeting Initial Inclusion Criteria 
Assessment Section 
Category Item Description 





No. of subjects in study who underwent DSA for comparison 
Study population adequately defined 
Study population 
Radiologist in authorship 
Equipment used 
Imaging parameters adequately described (three to four 
items, depending on the noninvasive modality) 
Contrast material usage 
Complications assessed 
Complication rate 
Full anatomic coverage of all potential ICA sites 
Clear and adequate description of image reconstruction 
techniques used 
Exclusion criteria stated 
Number of subjects excluded from study clearly stated 
Blinding of readers explicitly stated 
Details of image data available for review 
No. of independent readers 
Interobserver variability assessed 
Interobserver variability rate 
Presentation of result Prevalence of aneurysms at DSA 
data Distribution of aneurysms (site and size) 
Number of true -positive cases at noninvasive examination 
(per patient and per aneurysm) 
Number of false -positive cases 
Number of false- negative cases 


























Note. -ICA = intracranial aneurysm. 
was intrinsically weighted so that some 
items on the checklist -for example, the 
blinding of reviewers to the results of 
other examinations- carried more weight 
than did other items -for example, the 
inclusion of a radiologist in the author- 
ship. Although there is still a degree of ob- 
server subjectivity, even with this method 
of intrinsic weighting, this method has 
been demonstrated in a prospective trial 
to be more reliable and reproducible than 
alternative methods of assessing articles 
for meta- analyses (13). Interpretation dif- 
ferences between the assessors occurred 
in only seven (7 %) of 103 cases -in five 
CT angiography and two MR angiogra- 
phy studies -and all were resolved by 
means of consensus review. The K statis- 
tic for interrater agreement was 0.84 
(95% CI: 0.73, 0.95), which was indica- 
tive of very good agreement. 
Search Strategy 
Following advice from the Cochrane 
Database of Systematic Reviews Stroke 
Review Group Search coordinator (B. 
Thomas, personal communication, Octo- 
ber 1997), one author (P.M.W.) searched 
MEDLINE and EMBASE electronic databases 
for relevant articles by using exploded 
headings under the terms "tomography," 
"x -ray computed," "magnetic resonance 
angiography," and "ultrasonography" 
from January 1988 to December 1998. In 
addition, searching was performed by us- 
ing free -text terms, including all possible 
variations of "CT angiography," "MR an- 
giography," and "transcranial ultrasound." 
Both strategies were combined by using 
the Boolean operator, "OR." This search 
was then combined with a second search 
under "subarachnoid hemorrhage" and 
"intracranial aneurysms" (again derived 
from both exploded headings and free - 
text terms) by using the Boolean opera- 
tor, "AND." The search then was nar- 
rowed to studies with adult humans. 
For all the studies identified by using 
this search, the two authors (P.M.W., 
J.M.W.) cross checked the reference lists 
for additional articles and cheesed the 
reference lists of relevant review articles. 
This method of cross checking was con- 
tinued until no further studies were iden- 
tified. One of the authors (P.M.W.) also 
hand searched the journals not indexed 
in either of the above electronic data- 
bases in which relevant articles were 
identified from reference lists. The au- 
thors did not specifically search meeting 
abstracts, because only articles publish& 
White et al 
ip full could meet our inclusion criteria; 
however, they did check for subsequent 
Publications of potentially relevant works 
sha- were originally presented as an ab- 
stract. 
The search strategy was validated by 
Paforming a hand search (P.M.W.) of 
the RSNA Index to Imaging Literature, pub- 
['shed by the Radiological Society of 
North America, and the journals Neuro- 
surgery, Journal of Neurosurgery, and Stroke, 
Which are the three most common jour- 
nals quoted in the reference lists that 
Were not covered in the RSNA Index dur- 
ing 1988 -1997. The RSNA Index includes 
references to 42 major peer- reviewed 
iprnals on all diagnostic imaging mo- 
dalities but with an emphasis on current 
moss- sectional imaging modalities. By 
using the hand search of the RSNA Index, 
3l anti :'es that met the initial inclusion 
criteria were identified; 31 (97 %) of these 
litre picked by using the electronic 
search. The hand search of Neurosurgery, 
Stroke, and the Journal of Neurosurgery 
yielded 11 articles that met the initial 
inclusion criteria. All of these were iden- 
tified by using the electronic search. 
Data Extraction 
Two authors (P.M.W., J.M.W.) inde- 
pendently extracted data from the iden- 
tified studies by means of the standard- 
ized data extraction form (ie, two reviews 
per study). For non -English -language 
publications, data were extracted with 
the aid of a translator with a medical 
science be::: kground. The data extracted 
from each article are summarized in Ta- 
hk 1. By using the extracted data, the 
prevalence and distribution of intracra- 
rdal aneurysms at intraarterial DSA were 
'Mermined, and from the actual num- 
bers of aneurysms and subjects with a 
Otrect or incorrect diagnosis at noninva- 
¡magir, *, the true- positive rate for 
noninvasive examination versus an- 
rgraPhy, true -negative rate, false-posi- 
tive rate, and negative rates were calcu- 
on both a per- subject and per- 
rysm basis. When the same patients 
included in more than one study, 
extracted data from only the most 
t study to avoid inclusion of the 
e patie.' twice. When a second an- 
In had been obtained and showed 
aneurysm and the first angiogram had 
negative, the result of the second 
°8ram was used for the meta -analysis. 
heal Data Analyses 
line descriptive characteristics were 
ned fr:2.1 ,!ach study to allow calcu- 
lation of the mean numbers of patients 
and aneurysms and of the aneurysm 
prevalence per study for each modality. 
Our eligibility criteria permitted inclu- 
sion of studies that did not provide re- 
sults from which data on true- and false - 
positive rates and negative rates could be 
extracted per subject and per aneurysm, 
provided that the study's overall weighted 
assessment score was greater than 5, but 
these studies were excluded from further 
analysis because the necessary data could 
not be extracted. By using the data ex- 
tracted from each study, the true- and 
false -positive rates and negative rates per 
aneurysm and per subject were tabulated 
into 2 x 2 tables for each modality, and 
the sensitivity, specificity, predictive, and 
accuracy values were calculated. Exact 
95% CIs based on binomial probabilities 
were calculated (14). 
To combine independent studies of the 
same diagnostic examination for meta - 
analysis, the method of Moses et al (15) 
was used. With this method, a logistic 
transformation of data in simple 2 x 2 
tables was used, and then linear regres- 
sion curves were fit for the true- and false - 
positive rates by using the least- squares 
method. The results of these regression 
curve analyses were used to plot each 
study into summary receiver operating 
characteristic curves by using an S-PLUS, 
version 4.5 statistical software package 
(STATSCI, Seattle, Wash). By using re- 
ceiver operating characteristic analysis, 
which jointly considers the sensitivity 
and specificity of an examination, greater 
insight into the difference in perfor- 
mance between examinations is pro- 
vided compared with that achieved by 
examining accuracy alone. With the sum- 
mary receiver operating characteristic 
method, the area under the curve cannot 
be determined, but the differences be- 
tween two examinations can be assessed 
by comparing the proportion of data 
points lying above and below the best -fit 
line with a standard x2 test. A detailed de- 
scription of this statistical methodology is 
given in the article by Moses et al (15). 
We also examined the effects of aneu- 
rysm prevalence in the study population, 
study sample size, aneurysm size, recent 
versus older study, and aneurysm site (ie, 
anterior vs posterior circulation) on the 
accuracy of noninvasive modalities in 
the detection of intracranial aneurysms. 
RESULTS 
Study Characteristics 
We identified 1,473 studies, 103 (7%) 
of which met the initial -inclusion crite- 
ria. After formal assessment with the cri- 
teria described, 38 studies, published in 
four languages (32 in English, three in 
German, two in French, and one in Ital- 
ian), were included. There were several 
articles that were first published in Japa- 
nese and subsequently appeared in En- 
glish- language journals, but we counted 
these as English -language studies because 
the English versions were more recent. 
The 38 studies included 1,765 patients: 
in 14 of the studies, CT angiography was 
compared with angiography (6,12,16 -27); 
in 18, MR angiography was compared with 
angiography (4,8,11,28 -42); in two, both 
MR angiography and CT angiography were 
compared with angiography (43,44); and 
in four, TCD was compared with angiogra- 
phy (7,45,46,47). The median assessment 
score for the CT angiography studies in- 
cluded in the meta -analysis was 6.5 (inter - 
quartile range [IQR], 6.0 -8.0); that for the 
excluded studies was 4.0 (IQR, 3.0 -5.0). 
The median assessment score for MR an- 
giography was 6.0 (IQR, 6.0 -7.0) for the 
included and 4.0 (IQR, 3.0 -4.0) for the ex- 
cluded studies. For TCD, the median score 
was 6.0 (IQR, 6.0 -6.3) for the included and 
4.0 (IQR, 4.0 -4.5) for the excluded studies. 
The median sample size for CT angiog- 
raphy was 30 subjects; for MR angiogra- 
phy, 29; and for TCD, 38 (Table 2). The 
median prevalence of aneurysm in the 
CT angiography studies was 79.5% (IQR, 
74.0 -100.0); in the MR angiography stud- 
ies, 76.0% (IQR, 52.0- 97.0); and in the 
TCD studies, 89.5% (IQR, 79.0- 100.0) (Ta- 
ble 2). The median prevalences of aneu- 
rysm in the excluded studies were 95.5% 
(IQR, 67.0- 100.0) for CT angiography, 
82.5% (IQR, 84.0- 100.0) for MR angiogra- 
phy, and 100.0% (IQR, 79.0- 100.0) for 
TCD. The similarities in median averages 
and IQRs indicated that there was no dif- 
ference between the excluded and in- 
cluded studies with regard to aneurysm 
prevalence. In cases in which a second in- 
traarterial DSA study was required -usu- 
ally owing to technical failure in an elderly 
or restless patient or to vasospasm -the re- 
sult of the second angiogram was used. In 
seven (0.4 %) of the 1,765 patients, a sec- 
ond angiogram, obtained after the first im- 
age was negative, showed an aneurysm. 
Radiologists were included in the au- 
thorship of 35 (92 %) of the 38 studies. In 
just over half (22 (58 %]) of the studies, 
the assessment was confined to the circle 
of Willis and the pericallosal, distal ver- 
tebral, and posterior inferior cerebellar 
arteries were excluded. Complications 
were specifically mentioned in only three 
(11 %) of 28 studies -two CT angiogra- 
phy and one MR angiography. The blind- 
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TABLE 2 
Data from Included Studies versus from Studies Meeting Initial Inclusion Criteria 
No. of Exclusion Examination Blinding of 
Total No. Median Median Study Patients with Adequate Criteria Limited to Reviewers Interob: 
Imaging No. of of Study Aneurysm Aneurysm Methodological Clearly Circle of Explicitly Variat 
Study Studies* Subjects Sizest Prevalence ( %)t at DSA Detail Supplied Defined Willis Stated Assess 
CTA 16/45 677/1,691 30 79.5 523/677 16/16 3/16 9/16 15/16 5/1 
(36) (40.0) (11 -106) (60 -100) (77.2) (100) (19) (56) (94) (42 
MRA 20/48 926/1,799 29 76.0 548/926 15/20 11/20 11/20 18/20 5/1 
(42) (51.5) (11 -193) (10 -100) (59.2) (75) (55) (55) (90) (31 
TCD 4/10 162/380 38 89.5 150/162 3/4 1/4 2/4 3/4 c/t 
(40) (42.6) (14 -72) (78 -100) (93.0) (75) (25) (50) (75) 
Note. -Unless otherwise noted, data are the number of studies (or included subjects) actually included in the present meta -analysis /the numi 
studies (or included subjects) that met the initial inclusion criteria, and the numbers in parentheses are percentages. CTA = CT angiography, M 
MR angiography. 
*In two studies each, both CT angiography and MR angiography were compared with DSA. 
t The numbers in parentheses are ranges. 
t Data are numbers of subjects. 
4 Data apply to studies with two or more readers. 
ing of reviewers was explicitly stated in 
34 (89 %) of the 38 studies and implied in 
the others. Nonblinded studies were dis- 
criminated against with the weighted as- 
sessment criteria, and, thus, most (49 of 
64 [77 %]) of the nonblinded studies - 
that is, those in which the blinding of 
reviewers was not explicitly stated -were 
excluded. Patient exclusion criteria -for 
example, the number of examinations 
excluded from analysis because the im- 
ages were poor -were not clearly stated 
in 23 (61 %) of the 38 studies. Two or 
more readers read the images obtained at 
noninvasive examination in 26 (68%) of 
the 38 studies, but a formal analysis of 
interobserver variability was only re- 
ported in 10 (38 %) of 26 studies (or 26% 
of the 38 total studies). 
In 14 (88 %) of 16 CT angiography 
studies, spiral technology was used. In all 
the MR angiography studies, a three -di- 
mensional time -of flight technique was 
used. In one study, two- dimensional 
time -of flight imaging (28) also was used, 
and in three, time -of flight and phase 
contrast MR angiography (32,35,42) was 
used. For TCD, color flow imaging (7,48) 
was used in two studies and power Dopp- 
ler US (46,47) was used in two studies. A 
US contrast agent was used in only one 
study (47). 
Several authors (8,38,42) have prospec- 
tively studied the importance of review- 
ing base as well as reconstructed MR an- 
giograms and concluded that it was very 
useful. In the current meta -analysis, the 
material reviewed was explicitly stated in 
19 of 20 MR angiography studies. In only 
three small studies (11,28,39) out of the 
remaining 19 (induding only 79 pa- 
tients), neither the base nor the recon- 
structed images were explicitly reviewed. 
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However, the accuracy in this subgroup 
was very good: Per subject it was 97% (77 
of 79), and per aneurysm it was 95% (55 
of 58). However, the difference was not 
substantial compared with the results of 
the studies in which base images were 
reviewed, in which the accuracy was 88% 
(681 of 772) per subject and 89% (699 of 
784) per aneurysm, and, owing to the 
small numbers, the CIs in the subgroup 
in which neither base nor reconstructed 
image review was explicit were very wide. 
In three CT angiography articles, exactly 
which images were available for review 
was not explicitly stated; in all the other 
CT angiography studies, it was indicated 
that base as well as reconstructed images 
were available for review, so a similar 
subgroup analysis was not possible. 
Of 16 CT angiography studies, three 
were performed in patients who were not 
known to have an aneurysm or recent SAH 
but had symptoms that could be attributed 
to an underlying aneurysm (12,15,17); 
seven were performed in a population in 
which predominantly all of the patients 
were known to have an intracranial aneu- 
rysm or recent SAH (18- 20,23,25,26,43); 
and six were performed in a population 
that consisted of a mixture of these groups. 
The corresponding data for MR angio- 
graphy studies were three (37 -39), 11 
(8,27,28,30- 32,35,36,40,41,43), and five 
of 20 studies, respectively. One MR angiog- 
raphy study was performed in an asymp- 
tomatic population at increased risk for an 
aneurysm (4). All TCD studies were per- 
formed in patients known to have an an- 
eurysm or recent SAH. Thus, in only one of 
38 studies was noninvasive imaging as- 
sessed in a group of asymptomatic subjects 









Results per subject could be extracted 
from 11 of 16 CT angiography and 18 of 
20 MR angiography studies, and results 
per aneurysm could be extracted from all 
16 CT angiography, 18 of 20 MR angiog. 
raphy, and two of four TCD studies. 
Complete result data -that is, - .rue -posi- 
tive, false -positive, and negative rates - 
could be extracted both per subject and 
per aneurysm from 11 of 16 CT angiog- 
raphy and 16 of 20 MR angiography stud- 
ies but from none of the TCD studies (ie, 
27 of 38 studies in total). The baseline 
characteristics indicated that the studies 
of CT angiography and MR angiography 
were very similar (Table 2). There were 
much fewer reports on the use of TCD 
compared with angiography in the detec- 
tion of aneurysms. 
It is important to remember that all 
study patients who did not undergo cor- 
roborative DSA were excluded from fur- 
ther analysis. This means that the num- 
ber data presented in the meta analysis 
results may not match the total number 
of subjects in a study. For example, in the 
study by Korogi et al (38), nine of 202 
subjects did not undergo DSA, and, 
therefore, 193 subjects were included in 
the meta -analysis. 
Diagnostic Performance 
The full results of the meta -analysis of 
CT angiography and MR angiography 
performance on a per -patient basis are 
presented as summary receiver operating 
characteristic curves in Figure 1. The re- 
sults on a per- aneurysm basis can he 
viewed in an electronic format (Fig El, 
http : / /radiology.rsnajnls.org /cgi /contend 
full/217/2/361/DC1). The results indicate 
that both modalities performed well: The 
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Figure 1. Graph of summary receiver operating characteristic (SROC) curves per subject for CT 
angiography (CTA) and MR angiography (MRA) compared with the reference standard, intraar- 
erial DSA. Both curves are concentrated in the upper left corner of the receiver operating 
:haracteristic space, with a large area under the curve. This indicates that both examinations 
erform0 well. The CT angiography curve is marginally better than the MR angiography curve, 
lut the ui:ference is not significant. 
TABLE 3 







Result per subject* 
Sensitivity 92 (338/366) 87 (424/486) 
89, 95 84, 90 
Specificity 94 (11 3/120) 92 (334/365) 
88, 99 88, 94 
PPV 98 93 
96, 99 90, 95 
NPV 80 84 
73, 86 80, 88 
Accuracy 93 89 
likelihood ratio 












































-For sensitivity, specificity, positive predictive value (PPV), NPV, and accuracy, which are 
sled as percentages, the numbers on the second line are 95% CIs. 
The  
numbers 
in parentheses are numbers of aneurysms. 
curves are concentrated toward the upper 
left corner of the receiver operating char- 
acteristic space, and the scattering of 
results is close to the fit lines for CT an- 
giography and MR angiography. CT an- 
giography performed marginally better, 
but the difference was not significant 
(P = .411). The summary receiver operat- 
ing characteristic curves on a per -aneu- 
rysm basis were very similar, with again 
no significant difference between CT an- 
giography and MR angiography (P = .09). 
There were insufficient data to obtain a 
meaningful summary receiver operating 
characteristic curve for TCD. A compari- 
son of sensitivity and specificity results, 
with 95% CIs and meta -analysis results, 
is presented as Forrest plots for both stud- 
ies individually in Figure 2. These data 
clearly illustrate the similarity in sensitiv- 
ity and specificity between CT angiogra- 
phy and MR angiography. 
The actual values for sensitivity, speci- 
ficity, positive predictive value, negative 
predictive value (NPV), and accuracy, 
with exact 95% CIs, are listed in Table 3. 
Per subject, the results for CT angiogra- 
phy and MR angiography showed an 
overlap of 95% CI values for all parame- 
ters except the positive predictive value, 
in which CT angiography was better. CT 
angiography also had a higher likelihood 
ratio per subject. Per aneurysm, MR an- 
giography had a higher likelihood ratio 
than did CT angiography. However, most 
of the subjects examined by using CT 
angiography were not examined by using 
MR angiography, so the results of direct 
comparisons between the two techniques 
should be interpreted with caution. 
We were unable to compare the accu- 
racy of the noninvasive techniques be- 
tween populations with high as opposed 
to low prevalence of aneurysm, because 
in only two studies was the prevalence 
lower than 40% (34,40) and only one of 
these studies concerned a population 
with a realistically low prevalence (10 %) 
(40). In addition, it was not possible to 
compare symptomatic patients (eg, those 
with an acute SAH, cranial nerve palsy, 
etc) with asymptomatic subjects, because 
the latter group comprised a substantial 
part of the population examined in only 
one study. This study yielded data for the 
meta -analysis from only the small num- 
ber of subjects (32 of 400) who under- 
went angiography as well as MR angiog- 
raphy (4). 
We were unable to analyze perfor- 
mance versus time of the noninvasive 
examination -for example, before an 
SAH, in which extensive blood might in- 
terfere with the f ll an- _ _ _ _ 
217 Number 2 Can Noninvasive Imaging Accurately Depict Intracranial Aneurysms? 365 
SENSITIVITY SPECIFICITY' 









































0 0.2 0.4 0.6 0.8 
-4 
a. b. 
Figure 2. Forrest plots for (a) CT angiography (CTA) and (b) MR angiography (MRA) illustrate the sensitivity and specificity results per subject, with 
95% CIs and overall results of the meta -analysis. The 95% CIs are indicated by the horizontal lines. The plots clearly demonstrate the effect that 
aggregating studies together in a meta -analysis has on 95% CIs. 
eurysms on both CT angiograms and MR 
angiograms, because the precise time of 
the examination relative to the onset of 
an SAH in most studies was unclear. 
The CT angiography studies published 
before 1995 (two of 16) had an accuracy 
per subject of 84% (27 of 32) compared 
with the 14 studies published after 1994, 
which had an accuracy of 93% (424 of 
454); the corresponding accuracy rates 
per aneurysm were 87% (40 of 46) and 
89% (617 of 695), respectively. The MR 
angiography studies published before 
1995 (8 of 20) had an accuracy per sub- 
ject of 92% (211 of 230) compared with 
the 12 studies published after 1994, 
which had an accuracy of 88% (537 of 
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611); the corresponding rates per aneu- 
rysm were 87% (227 of 260) and 91% 
(527 of 582), respectively. Thus, there 
was a trend for the more recently per- 
formed CT angiography studies, after spi- 
ral technology had been well established, 
to have greater accuracy than the studies 
performed earlier. This effect was not 
seen with MR angiography, possibly be- 
cause of the more mature status of this 
technique by 1994. 
To test for increased bias in the small 
studies, an analysis of subgroups accord- 
ing to study size was performed. Large 
was defined as a sample size of 50 or more 
subjects. (There is evidence that this is 
the minimum desirable study size for a 
comparison of diagnostic methods [46]). 
For CT angiography, there was no sub- 
stantial difference between the five large 
and 11 small studies: The accuracy per 
subject was 94% (583 of 649; 95% CL 
91 %, 97 %) versus 90% (164 of 182; 95% 
CI: 85 %, 94 %), respectively. 
For MR angiography per subject, the 14 
smaller studies had a substantially higher 
positive predictive value, 97% (236 of 
243; 95% CI: 94 %, 99 %), and a substan- 
tially lower NPV, 66% (51 of 77; 95% C1: 
55 %, 77%), than did the six larger stud- 
ies, which had a positive predictive value 
of 89% (188 of 212; 95% CI: 84 %, 93%) 
and an NPV of 89% (283 of 319; 95% CI: 
85 %, 92 %). Per aneurysm, the larger MR 
White et al .j 
BLE 4 
group Analysis: Sensitivity per Aneurysm Relative to Underlying Aneurysm Size (Maximum Angiographic Dimension) 
Detection of 
paging Study Aneurysms <_3 mm 
angiography 
!angiography 
Detection of All 
Aneurysms >3 mm 
Detection of Aneurysms Detection of Aneurysms 
>3 mm but <10 mm* >10 mm* 
61 (67/110) 96 (424/440) 93 (162/174) 100 (90/90) 
51, 70 94, 98 88, 96 96, 100 
38 (20/52) 94 (239/254) 92 (178/193) 99 (81/82) 
25, 53 90, 97 88, 96 93, 100 
le. -All data are sensitivity values, expressed as percentages. The numbers in parentheses are numbers of aneurysms, and the numbers on the second 
eare 95% Cls. The data on CT angiography were extracted from 12 of 16 studies with 556 subjects. The data on MR angiography were extracted 
0112 of 20 studies with 407 subjects. 
'From studies in which data on subdivisions of aneurysms >_3 mm could be extracted. 
gography studies had a substantially 
her specificity, 97% (218 of 225; 95% 
94 %, 99 %), and NPV, 87% (218 of 
); 95% CI: 82 %, 91 %), than did the 
aller studies, which had a specificity of 
6 (35 of 42; 95% CI: 69 %, 93 %) and an 
V of 45% (35 of 77; 95% CI: 34 %, 
)6). These data do not support the hy- 
thesis that a preponderance of small 
!dies results in substantial bias that 
ids to erroneously optimistic results for 
e diagnostic performance of noninva- 
Te imaging methods (Table El, http: // 
diology.rsnajnIs.org/cgi/content/full/21 7 
!361/DC1). 
We were able to extract adequate data 
can analysis of sensitivity according to 
ieurysm size from 12 CT angiography 
d 12 MR angiography studies. In an 
ilditional two MR angiography studies, 
!size breakdown based on factors that 
ere ve: different from those in the 
Cher studies was provided, and in two 
idles, only a partial breakdown of de- 
talon according to size was given. The 
esults of this analysis clearly showed 
hat the sensitivity for aneurysm detec- 
lan was substantially different between 
'eurysms with a maximum dimension 
13 men or less and those larger than 3 
A substantial difference in sensitiv- 
was not found between aneurysms 
10 mm in maximum diameter and 
ose i0 mm or larger (Table 4). 
Both CT angiography and MR angiog- 
pllY were marginally more accurate at 
rttang posterior circulation aneu- 
Ins than at depicting anterior circula- 
n°nes, hrit the differences were small. 
CT angiography, accuracy was 92% 
' of 509; 95% CI: 89 %, 94 %) for the 
Ion of all anterior circulation aneu- 
CI: 8 %) for the (det tion5of 
eior circulation aneurysms. For MR 
° raPhy, the corresponding . accu- 
values were 91% (604 of 662; 95% 89% 
93'' I and 95% (240 of 252; 95% 
CI: 92 %, 98 %). The sensitivities for the 
detection of posterior circulation aneu- 
rysms were slightly lower than those for 
the detection of anterior circulation an- 
eurysms: 88% (44 of 50; 95% CI: 76 %, 
95 %) versus 92% (367 of 399; 95% CI: 
89 %, 94 %) for CT angiography and 82% 
(46 of 56; 95% CI: 70 %, 91 %) versus 90% 
(410 of 456; 95% CI: 87 %, 93 %) for MR 
angiography. This simply may have been 
because the posterior circulation aneu- 
rysms were outside the examined volume 
in some cases (ie, posterior inferior cere- 
bellar or vertebral arterial aneurysms). 
However, the NPV was substantially bet- 
ter for the detection of posterior circula- 
tion aneurysms than for the detection of 
anterior circulation aneurysms for both 
CT angiography (94% [99 of 105]; 95% 
CI: 88 %, 98% versus 76% [99 of 131]; 
95% CI: 67 %, 83 %) and MR angiography 
(95% [194 of 204]; 95% CI: 91 %, 98% 
versus 81% [194 of 240]; 95% CI: 75 %, 
86%) (Table E2, http: / /radiology.rsnajnls 
.org/ cgi /content/full /217/2/361/DC1). 
A subanalysis of anterior circulation 
aneurysm detection in different locations 
was performed. Data on detection by site 
could be extracted from 11 (69 %) of 16 
CT angiography and 16 (80 %) of 20 MR 
angiography studies. There were consid- 
erable differences between studies with 
regard to how data were presented for 
aneurysm site: In some studies, broad 
categories such as "internal carotid ar- 
tery" or "middle cerebral artery" were 
used, whereas in others, more specific 
data were given. It was possible to extract 
data on anterior circulation aneurysms in 
six anatomic sites as follows: anterior 
communicating arterial aneurysms, "oth- 
er" anterior cerebral arterial aneurysms, 
middle cerebral arterial aneurysms, pos- 
terior communicating arterial aneu- 
rysms, ophthalmic arterial aneurysms, 
and "other" internal carotid arterial an- 
eurysms. (Three of the six site categories 
were broad anatomic groupings.) The 
sensitivity of the imaging techniques for 
aneurysm detection by location was ana- 
lyzed independently. Several studies did 
not include details on the site and /or size 
of the false -positive aneurysms. There- 
fore, specificity, NPV, and accuracy could 
not be calculated. 
With CT angiography, sensitivity was 
poorest for the detection of other ante- 
rior cerebral arterial aneurysms -73% (11 
of 15; 95% CI: 45%, 92 %). The next poor- 
est sensitivity was for the detection of 
other intracranial aneurysms -88% (50 
of 57; 95% CI: 76 %, 95 %). Because of the 
relatively small numbers of aneurysms in 
each site category, the CIs were wide and 
. overlapping. The relatively poor sensitiv- 
ity for the detection of other anterior ce- 
rebral arterial aneurysms was probably 
because in cases in which the circle of 
Willis was examined, the aneurysms 
could have been outside the examined 
volume. The terminal and intracavern- 
ous carotid regions are adjacent to bone, 
and, thus, aneurysms in these areas, par- 
ticularly the small ones, are difficult to 
visualize clearly at CT angiography. With 
MR angiography, sensitivity was poorest 
for the detection of posterior communi- 
cating arterial aneurysms (41 of 50) and 
the other intracranial aneurysms (88 of 
107), 82 %, but again the differences were 
small. The poorer detection at these sites 
may have been due to the difficulty in 
detecting aneurysms, particularly the 
small ones, at sites with marked vessel 
tortuosity and overlapping at MR angiog- 
raphy. 
DISCUSSION 
The results of our analysis of information 
published between 1988 and 1998 show 
that CT angiography and MR angiogra- 
phy perform very similarly in the detec- 
tion of intracranial aneurysms. This was 
true on both a per- subject and per -aneu- 
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rysm basis, with the overall diagnostic 
accuracy of both methods in each case ap- 
proaching 90%. There were much fewer 
published works on TCD from which data 
could be extracted; this suggested an accu- 
racy per aneurysm of approximately 80%. 
There was limited information on the in- 
terobserver reproducibility achieved with 
CT angiography and MR angiography and 
none on that achieved with TCD. The 
technological advancements in all three 
methods continue apace, and we found a 
trend toward better performance in the CT 
angiography studies published after 1995 
compared with those published before 
then, although the differences were small; 
with MR angiography, the accuracy per 
subject was marginally worse after 1995 - 
from 92% to 88% -but marginally better 
per aneurysm -from 87% to 91%. We ex- 
pect these noninvasive imaging methods 
to become more accurate as improvements 
continue. For example, although, to our 
knowledge, no studies of contrast materi- 
al- enhanced US, three -dimensional US, or 
digital subtraction MR angiography that 
met our inclusion standards were pub- 
lished before the end of 1998, all of these 
advances have been reported to improve 
diagnostic performance. 
The results of direct comparisons be- 
tween the performances of the noninva- 
sive modalities -for example, CT angiog- 
raphy versus MR angiography -should 
be interpreted cautiously, because very 
few patients underwent any two of the 
noninvasive examinations, which is the 
most appropriate way to make a true di- 
rect comparison. Any apparent differ- 
ences in modality performance could 
have been due, at least in part, to differ- 
ences in the populations studied, in the 
size and distribution of the aneurysms, 
and /or in other study variables. Many of 
the studies included in our systematic re- 
view were quite small (even though stud- 
ies with less than 10 subjects were ex- 
cluded), and only five CT angiography 
studies, six MR angiography studies, and 
one TCD study included 50 or more sub- 
jects. 
The accuracy of the reference standard 
is an important factor in any comparison 
of examinations. We regarded the in- 
traarterial DSA result as definitive, even if 
it was subsequently proved to be incor- 
rect. This was justified by the rarity with 
which a second angiogram showed a dif- 
ferent result -in seven (0.4 %) of 1,765 
patients included in the meta -analysis. 
It has been reported that noninvasive 
imaging examinations are much poorer 
in the detection of aneurysms smaller 
than 3 mm than in the detection of those 
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larger than 3 mm -for example, a sensi- 
tivity of 25% versus 92% was achieved by 
the best observer in one study (29). The 
results of the current meta -analysis sup- 
port 3 mm as a practical size cutoff point, 
beneath which the sensitivity for aneu- 
rysm detection with CT angiography or 
MR angiography decreases sharply, from 
96% to 61% and from 94% to 38 %, re- 
spectively (Table 4). Furthermore, small 
aneurysms are seen more commonly in 
asymptomatic patients than in those 
who have an SAH: Aneurysms less than 5 
mm in diameter accounted for up to a 
third of all the aneurysms in one study 
involving asymptomatic patients with 
nonruptured aneurysms (49); this repre- 
sents a much higher proportion of small 
aneurysms than that in the majority of 
CT angiography, MR angiography, or 
TCD studies that have mainly included 
patients with aneurysms. There is rela- 
tively little information on the accuracy 
of noninvasive imaging in the detection 
of small aneurysms, but the information 
that is available suggests that accuracy is 
poor. 
There is evidence that aneurysms aris- 
ing from the posterior circulation (ie, in- 
tracranial vertebral arteries and basilar ar- 
tery and its branches, including the 
posterior cerebral arteries) are at in- 
creased risk of rupture compared with an- 
eurysms arising from the anterior circu- 
lation (ie, from the internal carotid 
arteries or its branches, including the 
posterior communicating arteries) (50,51) 
and that if they do rupture, the outcome 
is poorer (49). The detection of the sub- 
group of posterior circulation aneurysms 
is therefore particularly important. 
Judging from the results of this meta - 
analysis, the possibility of using nonin- 
vasive modalities to screen for an aneu- 
rysm may be attractive to physicians who 
must deal with worried relatives of pa- 
tients with an SAH. However, we believe 
that considerable caution is required in 
extrapolating data from this meta -analy- 
sis, in which the overall accuracy of CT 
angiography and MR angiography ap- 
peared encouraging, to the circum- 
stances of screening, in which there is a 
low aneurysm prevalence -probably in 
the region of 5% and no more than 
10% -even in at risk subgroups (51,52- 
54). Only one study included in this sys- 
tematic review had an aneurysm preva- 
lence in this range (40); therefore, a 
subgroup analysis of studies with a truly 
low aneurysm prevalence compared with 
high -prevalence studies could not be per- 
formed. Only seven of the 38 studies did 
not include patients known to have an 
intracranial aneurysm or recent a 
SAH, and 20 (53 %) studies focused 
most exclusively on this patient gro 
When there is high suspicion of 
aneurysm being present, a high es 
of accuracy could result owing to 
server expectation bias. The distribug 
of subarachnoid blood may be a s 
clue to the presence and /or site of 
aneurysm, as may a local hernatoma 
the presence of hydrocephalus. Fu 
more, the results of a recent theo 
analysis suggest that increasing dis 
prevalence can lead to an apparent 
provement in the sensitivity and spe 
ity of a diagnostic examination, wh 
previously it had been thought that 
creasing prevalence influenced only 
predictive values -not the sensitivity 
specificity -of an examination (55). 
clinical practice, there usually is a sin 
reader of a diagnostic study, whereas 
some of the studies in the current syst 
atic review, there was a consensus revi 
by two or more readers in the analysis 
accuracy, which could have resulted in 
positive bias toward the noninvasi 
methods. These factors, coupled with:. 
publication bias and the other method- 
ological problems outlined, suggest that 
the accuracy of the noninvasive exams: 
nations in the screening situation (9,10) 
may have been overestimated. Further- 
more, it is worth noting that the NPVs;;< 
were poorer than all the other results:. 
The values per subject were 80% for CT; . =_. 
angiography and 84% for MR angiogra- 
phy (Table 3). When considering the use'; 
of any examination in the context of I 
screening, a high NPV is just as critical as _" 
high sensitivity and specificity. 
In summary, there is very limited in 41 
formation about the accuracy of nonin 
vasive imaging in the kind of subject 
to be screened, and it would be 
incorrect to assume that the accuracy will 
be equal to that achieved in studies with 
a high prevalence of aneurysms and in-, 
volving symptomatic patients who have 
an SAH. 
More data on noninvasive imaging 
performed in subjects with a low preva- 
lence of aneurysms are required. When 
this has been done on a large scale (4,56), 
it has been without comparison with j 
DSA in the majority of patients, so lim-r 
ited information on comparative diag- 
nostic performance was provided. Large, `1 
prospective, blinded studies of noninva- 
sive imaging in patients undergoing an' 
giography but without a recent acute 
SAH are needed to clarify the present un- 
certainty, and such studies may be difh- 
cult to achieve. The small sample size in 4 
White et aI 
published studies may increase the 
of random chance. 
pmparison of the different methods 
viewing the images obtained with 
Irions techniques is needed. There is 
evidence that interactive worksta- 
econstruction and interpretation by 
adiologist are more accurate than 
w of only film hard -copy images 
However, workstation reconstruc- 
stirne consuming, and it is not clear 
her the extra time taken is justified 
he increased diagnostic yield and 
Cher the workstation reconstruction 
oe adequately performed by a tech - 
n or needs to be done by the report- 
though technology is continually 
lacing, it takes time for new methods 
Iter through to general clinical prac- 
Therefore, this meta -analysis is rele- 
t to the technologies likely to be 
fable in most institutions now. New 
urologies like contrast -enhanced MR 
iography with or without digital sub - 
ion must be rigorously evaluated be- 
!they are adopted into routine clini- 
practice. However, as technology 
!hues to progress, there clearly will 
,rrole for systematic reviews in many 
as of radiology, and these should be 
plarly updated to reflect technological 
dances. 
n conclusion, in the populations 
!died in this meta -analysis, most of 
rich had a high aneurysm prevalence, 
angiography and MR angiography 
td very similar diagnostic perfor- 
tnces in the detection of intracranial 
leurysms, with an accuracy of approx- 
aately 90 %. The NPV per aneurysm 
%significantly lower than the other 
alysis parameters, both with CT an- 
Braphy and MR angiography -67% 
d77%, respectively (Table 3), and al- 
gh the NPV of MR angiography 
better, the 95% CI of this modality 
erlaPped with that of the NPV of CT 
Biography. Sensitivity was signifi- 
tly poorer for the detection of aneu- 
ms smaller than 3 mm, and although 
angiography (61 %) performed bet - 
than did MR angiography (38 %), 
Ill the 95% CIs overlapped. The cur- 
t data are too limited to determine 
fidently the accuracy of the nonin- 
ve methods when they are used for 
ping. More information is needed 
'gle optimum method for image re- 
and on the accuracy of noninva- 
e 
imaging in subjects with a low 
alence of aneurysm. 
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White et +l -: 
Power Transcranial Doppler Ultrasound in the Detection of 
Intracranial Aneurysms 
Philip M. White, FRCR; Joanna M. Wardlaw, FRCR; Evelyn Teasdale, FRCR; Stuart Sloss, DCR; 
Jim Cannon, DCR; Valerie Easton, BSc 
Background and Purpose -We sought to perform a large, prospective, multicenter, blinded study comparing power 
transcranial color duplex sonography (power TCDS) with intra- arterial digital subtraction angiography (IADSA) in the 
detection of intracranial aneurysms. 
Methods- Contemporaneous TCDS and IADSA examinations were performed in 171 subjects with suspected intracranial 
aneurysm. Via the temporal bone window, a 2- dimensional hand -held noncontrast transcranial duplex ultrasound 
imaging system was used operating in power and spectral modes. Sonographers were blinded to clinical history and 
results of brain CT and IADSA. 
Results -We found that 157 subjects (92 %) had an adequate bone window. Sensitivity per patient was 0.78 (95% CI, 0.66 
to 0.87) and 0.46 (95% CI, 0.36 to 0.56) for any anterior circulation aneurysms. Sensitivity was 0.35 (95% CI, 0.24 to 
0.46) for aneurysms s5 mm and 0.81 (95% CI, 0.62 to 0.94) for aneurysms >5 mm. Accuracy was lower for aneurysms 
on the cavernous and terminal internal carotid arteries, including posterior communicating artery origin (0.71; 95% CI, 
0.63 to 0.79), than for those on the anterior (0.82; 95% CI, 0.74 to 0.89) or the middle cerebral arteries (0.79; 95% CI, 
0.71 to 0.86). 
Conclusions -Power TCDS is a promising, inexpensive, noninvasive test for anterior circulation intracranial aneurysms 
but is less sensitive per aneurysm than alternatives such as CT angiography or MR angiography. Sensitivity is poor for 
aneurysms mm in diameter. The internal carotid artery is the most difficult segment to interpret. (Stroke. 2001;32: 
1291 -1297.) 
Key Words: cerebral aneurysm cerebral angiography ultrasonography, Doppler, transcranial 
The accepted reference standard for the detection of 
intracranial aneurysms is intra- arterial digital subtraction 
angiography (IADSA).' -3 This has a permanent neurological 
complication rate in patients investigated for a suspected 
aneurysm of 0.07 %4 and is invasive, time consuming, and 
relatively expensive. As a consequence, there has been 
considerable interest in whether noninvasive imaging meth- 
ods can detect intracranial aneurysms reliably in both symp- 
tomatic and asymptomatic patients.s Numerous studies have 
compared noninvasive techniques such as MR angiography 
(MRA) or CT angiography (CTA) with IADSA and found 
similar overall accuracy of approximately 90%, but there are 
relatively few data from prospective, blinded studies compar- 
ing transcranial color duplex sonography (TCDS) with 
IADSA .6 
TCDS became available in the early 1990s, with successful 
identification of intracranial aneurysms soon reported.7 8 Ul- 
trasound has the advantage of lower capital cost and greater 
mobility than IADSA, CTA, or MRA; additionally, there are 
no contraindications and no exposure to ionizing radiation. A 
more recent technological development of color Doppler 
termed color Doppler energy or "power Doppler" offers 
significantly greater sensitivity to flowing blood than stan- 
dard color flow imaging.9 Power Doppler can be readily 
combined with a spectral ultrasound examination to obtain 
additional velocity and waveform information. With this 
technique, overall sensitivity for detection of aneurysms 
between 0.4710 and 0.891' and specificity between 0.3312 and 
0.899 have been reported in relatively small studies, predom- 
inantly in patients with recent subarachnoid hemorrhage 
(SAH). Unfortunately, up to 10% of patients will not have an 
adequate bone window, and TCDS is operator dependent. To 
define the accuracy and limitations of power TCDS in a 
broader range of patients, we undertook a large, prospective, 
multicenter, blinded study comparing power TCDS with 
IADSA in the detection of intracranial aneurysms. Many of 
these subjects were also examined with MRA and CTA, and 
these results have been reported separately.13 
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Subjects and Methods 
Subjects 
Any patient undergoing cerebral angiography for the detection of an 
intracranial aneurysm in either of the 2 participating regional 
neuroscience centers (total catchment population, 4 million) during 
the 18 -month period of the study (November 1997 to April 1999) 
was eligible. Therefore, asymptomatic patients undergoing angiog- 
raphy to exclude an aneurysm because of a strong family history of 
aneurysmal SAH or patients with symptoms suggestive of an 
aneurysm (eg, late presentation after severe sudden occipital head- 
ache or á third nerve palsy) were eligible as well as patients with 
proven recent SAH. Exclusion criteria were patients with a poor 
grade (World Federation of Neurosurgeons [WFNS] grade 3 or 
worse) of subarachnoid hemorrhage (because ethically obtaining 
informed patient consent was not possible), age <18 or >75 years, 
or pregnancy. Approval for the study was obtained from the 
appropriate hospital ethics committees, and written informed consent 
was obtained from participants. 
Image Acquisition 
Neuroradiologists performed all the IADSA examinations using 
Advantx DX angiographie equipment (IGE Medical Systems). 
IADSA studies were 3- or 4 -vessel selective angiograms with 
multiple projections obtained for eacà vessel. Power and angle - 
corrected spectral TCDS examinations were performed contempora- 
neously on Acuson 128XP machines with the use of 2- to 2.5 -MHz 
multihertz linear phased array transducers (Acuson). Identical imag- 
ing parameters were used in each center. A more detailed description 
of the TCDS scanning technique, optimization parameters, and 
interpretation criteria is provided in Appendix 2 (which can be 
found, with Appendix 1, at http : / /strolre.ahajournals.org). 
TCDS examinations were performed via the temporal bone 
window to insonate the circle of Willis in the axial and coronal 
planes.7.9" The transnuchal and traavorbital routes were not rou- 
tinely used (some of the patients found these difficult to tolerate), 
and intravenous echo contrast was not used. Each major intracranial 
vessel segment was examined systematically with power and angle - 
corrected spectral Doppler ultrasound_ We did not use nonpower 
color -coded Doppler ultrasound. Aneurysm size was determined on 
a frozen image with the use of electronic calipers in the standard 
Acuson measurement software. A video record of each examination 
was made, and a standard result pro forma sheet was completed at 
the end of each examination by the sonographer. This recorded the 
opinion of normal or abnormal (abnormality specified) in each major 
artery/branching point, including the sonographer's degree of 
confidence. 
Ultrasonographers comprised 2 neuroradiologists and 3 neurora- 
diographers. Two sonographers had several years of experience in 
using power TCDS as well as spectral transcranial ultrasound. Three 
sonographers were experienced in using spectral transcranial ultra- 
sound in the detection of vasospasm but less experienced in power 
TCDS and had undergone 3 half -day training sessions in its use to 
detect aneurysms (as described above) before the start of the study. 
Sonographers were fully blinded to clinical data and the results of all 
other imaging investigations, including plain CT and IADSA results. 
Image Review 
IADSA images were presented as anonymous, randomly numbered 
studies with no clinical details or results of other imaging for 
independent review by 2 consultant oeuroradiologists. Disagree- 
ments were resolved by consensus review. For TCD, the report 
completed at the end of each examination was used for the compar- 
ison with IADSA. Aneurysm site(s) were recorded as follows: 
l= middle cerebral artery (MCA) main stem; 2 =MCA bifurcation; 
3= distal MCA; 4= anterior communicating artery complex; 5 =peri- 
callosal segment; 6= terminal internal carotid artery (ICA) segment; 
7= posterior communicating artery (PCoA); 8= ophthalmic artery; 
9 =other ICA; 10= basilar artery; 11 =posterior inferior cerebellar 
arte and l2 =other or uns,ecified . Aneu sm size was recorded 
as follows: (1) <3 mint maximum angiographie dimension, (2) 3 to 
5 mm, (3) 5.1 to 10 mm, and (4) >10 mm. The confidence of the 
ultrasonographer in the report was assessed on a simple 5 -point scale 
as reported by Atlas et aí14: 5= aneurysm definitely abseil,. 4 =an- 
eurysm probably absent, 3= uncertain, 2= aneurysm probably pres- 
ent, and 1= aneurysm definitely present. An assessment was also 
made of the visibility of the major arterial segments comprising the 
circle of Willis. We aimed to have 2 ultrasonographers examine a 
reasonable proportion of the same patients to assess interobserver 
variability. This proved difficult to achieve in practice in al- center 
study in which patients were frequently treated or discharged before 
a second sonographer was available to perform the power TCDS 
study; sometimes, even if a second sonographer was available, the 
second sonographer was not blinded to the patient's CTITADSA 
findings. 
Statistical Analysis 
We constructed 2X2 tables of true positives, false -positives, false - 
negatives, and true negatives compared with IADSA. Sensitivity, 
specificity, positive and negative predictive values, accuracy, and 
likelihood ratios were calculated and compared on a per patient and 
per aneurysm basis. Exact 95% Cls based on binomial probabilities 
were calculated.15 The unweighted K statistic was used to assess the 
level of interobserver agreement for a small number of cases in 
which it was possible to have power TCDS performed by 2 
operators.16 CIs for the difference between 2 proportions were 
constructed to show whether there was a difference between the 
proportions interpreted correctly at different levels of observer 
confidence. Sensitivity analyses were used to examine the effect of 
aneurysm size and site, clinical presentation, and observer experi- 
ence on the accuracy of TCD. 
Results 
Two hundred patients meeting the inclusion criteria and who 
agreed to participate were recruited prospectively over an 
18 -month period. During the period of the study, 520 patients 
were admitted to the 2 centers with suspected SAH, of whom 
almost two thirds (ie, approximately 345) were eligible for 
the study, ie, were aged I8 to 75 years, not pregnant, and were 
classified with a good WFNS grade. Major reasons for the 
noninclusion of the other 155 patients in the study included 
inadequate time before aneurysm treatment (which was often 
performed within 24 hours of presentation) and patient 
refusal. Twenty-nine (15 %) of the 200 patients recruited did 
not undergo power TCDS because of lack of availability of a 
blinded trained ultrasonographer before treatment or dis- 
charge but did undergo CTA and/or MRA (these results are 
reported separately '3). The final total was therefore 171 
patients who underwent contemporaneous TCDS and IADSA 
(84 men, 87 women) with a median age of 43 years (range, 19 
to 71 years). Fourteen of the 171 patients (8 %) (9 men and 5 
women) had an inadequate bone window and therefore were 
excluded from further analysis. Patients were grouped into 3 
categories on the basis of the clinical indication for cerebral 
angiography_ Group 1 comprised 72 patients with a known 
aneurysm undergoing further assessment (n =5) or patients 
with proven SAH (n =67); group 2, 64 patients with symp- 
toms that might be due to an aneurysm (eg, painful oculo- 
motor nerve palsy); and group 3, 21 asymptomatic patients at 
risk of harboring an aneurysm because of a strong family 
history of aneurysmal SAH. 
On IADSA, 122 aneurysms were present in 43% of 
patients (67/157); these findings are detailed with a break- 
down of the site and size of aneu sms, lus the corresuond- 
ing TCDS result, in Appendix 2. Details of the false- negative 
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TCDs, per patient 0.78 (0.66-0.87) 0.90 (0.82 -0.95) 0.85 (0.74 -0.93) 0.84 (0.76-0.91) 0.85 (0.78 -0.90) 7.76 
[52/67] [81/90] 
TCDs, per aneurysm 0.46 (0.36-0.56) 0.72 (0.63-0.80) 0.61 (0.49-0.72) 0.59 (0.50 -0.67) 0.60 (0.53 -0.66) 1.67 
[48/105] [81/112] 
Experienced operators, per patient 0.84 (0.60-0.97) 0.92 (0.75-0.99) 0.89 (0.65-0.99) 0.89 (0.71 -0.98) 0.89 (0.76 -0.96) 10.95 
[16/19] [24/26] 
Less experienced operators, per 0.75 (0.60-0.86) 0.89 (0.79-0.95) 0.84 (0.69 -0.93) 0.83 (0.72 -0.91) 0.83 (0.75-0.89) 6.86 
patient [36/48] [57/64] 
Experienced operators, per aneurysm 0.50 (0.31 -0.69) 0.73 (0.54-0.87) 0.63 (0.41 -031) 0.62 (0.45-0.77) 0.62 (0.49-0.74) 1.83 
[15/30] [24/33] 
Less experienced operators, per 0.45 (0.34 -0.57) 0.71 (0.6 -0.81) 0.59 (0.45-072) 0.59 (0.48-0.69) 0.59 (0.51 -0.67) 1.57 
aneurysm [33/73] [57/80] 
Values in parentheses are 95% Cls. TP indicates true positive; TN, true negative; FN, false- negative; and FP, false -positive; PPV, positive predictive value; and NPV, 
negative predictive value. 
*A likelihood ratio of >10 impies a large change in likelihood; 5-10, moderate change; 2 -5, small change; and 1, no change in likelihood. 
and -positive results for TCD are also included. Twenty -two 
(18 %) were aneurysms of the anterior cerebral artery (ACA) 
circulation, 32 (26 %) of the MCA, 51 (42 %) of the ICA 
(including PCoA aneurysms), and 17 (14 %) of the vertebro- 
basilar system. These latter would not be expected to be 
detected by the power TCDS protocol used in the study since 
aneurysms in the posterior fossa distant from the circle of 
Willis would not be visualized. Twenty-seven (25.7 %) of the 
anterior circulation aneurysms were very small (<3 mm 
maximum angiographic dimension), 51 (48.6 %) were small 
(3 to 5 mm), and 27 (25.7 %) were >5 mm. Of the 17 
vertebrobasilar aneurysms in the patients, 8 were 3 to 5 mm 
and 9 were >5 mm. Anterior circulation aneurysm preva- 
lence was 60% (43/72) in patient group 1, 17% (11/64) in 
group 2, and 38% (8/21) in group 3. 
The overall comparative diagnostic performance of TCDS 
to IADSA is given (with 95% Cls) in Table 1. The accuracy 
on a per patient basis (the ability to correctly discriminate a 
patient as true positive or true negative for possession of an 
intracranial aneurysm) of 0.85 was much better than the 
accuracy on a per aneurysm basis (the ability to detect 
correctly the precise site of all aneurysms in each patient) of 
0.60. This difference was largely due to sonographers failing 
to identify a second (often smaller) aneurysm in patients in 
whom they had already identified an aneurysm (Appendix 2). 
The 2 sonographers more experienced in power TCD 
performed 29% (45/157) of the examinations. There was a 
trend for the more experienced sonographers to be more 
accurate than the less experienced sonographers: accuracy per 
patient 0.89 (95% CI, 0.76 to 0.96) versus 0.83 (0.75 to 0.89) 
and per aneurysm 0.62 (95% CI, 0.49 to 0.74) versus 0.59 
(95% CI, 0.51 to 0.67), respectively. The differences were 
quite small and not statistically significant (P>0.05). How- 
ever, this was not a comparison of like entities because it was 
not possible for logistical reasons for each patient to be 
examined by both an experienced and a less experienced 
sonographer. In a small number of cases (n =12), 2 blinded, 
less experienced sonographers were able to independently 
perform TCDS examinations. Interobserver agreement in this 
small sample was good, with a rc statistic of 0.76, but the 
sample was too small to be a true test of observer variability. 
Analyses of the diagnostic performance by size and site of 
aneurysm are given in Tables 2 and 3. Sensitivity was substan- 
tially better for aneurysms >5 mm, at 0.81 (22/27), than for 
aneurysms < -5 mm in size, at 0.35 (27/78). This magnitude of 
difference was similar for both the experienced and less expe- 
TABLE 2. Sensitivity of TCDS Related to Aneurysm Size* 
Aneurysm Size, mm 
<3 3-5 <5 >5 
All operators combined 0.19 (0.07 -0.39) 0.43 (0.29-0.58) 0.35 (0.24 -0.46) 0.81 (0.62 -0.94) 
[5/26] [22/51] [27/78) [22/27] 
Experienced operators 0.33 (0.04 -0.78) 0.41 (0.18-0.67) 0.39 (0.20 -0.61) 0.86 (0.42 -1.00) 
[2/6] [7/17] [9/23] [6/7] 
Less experienced operators 0.15 (0.03 -0.38) 0.42 (0.25-0.61) 0.32 (0.20 -0.46) 0.80 (0.56 -0.94) 
[3/20] [14/33] [17/53] [16/20] 
Values are sensitivity (95% CI) (TP/TP +FN1. Abbreviations are as defined in Table 1. 
*Size relates to maximum angiographic dimension. 
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TABLE 3. Diagnostic Performance of TCDS Related to Aneurysm Site (With Posterior 
Circulation for Comparison) 




Sensitivity [TP/TP +FN] 0.55 (0.32 -0.76) 0.47 (0.29 -0.65) 0.43 (0.29-0.58) 0.06 (0.00-0.26) 
[12/22] [15/32) [22/51] [1/17] 
Specificity [TN/TN +FP] 0.89 (0.81 -0.95) 0.91 (0.83-0.96) 0.86 (0.78-0.92) 0.98 (0.92 -1.00) 
[81/91] [81/89] [81/94] [81/83] 
Accuracy 0.82 (0.74-0.89) 0.79 (0.71 -0.86) 0.71 (0.63 -0.79) 0.80 (0.71 -0.88) 
Experienced operators 
Sensitivity [TP/TP +FN] 0.57 (0.18-0.90) 0.27 (0.06-0.61) 0.62 (0.32 -0.86) 0.50 (0.01 -0.99) 
[4/7] [3/11] [8/13] [1/2] 
Specificity [TN/TN +FP] 0.89 (0.71 -0.98) 0.96 (0.80 -1.00) 0.83 (0.64-0.94) 0.92 (0.75-0.99) 
[24/27] [24/25] [24/29] [24/26] 
Accuracy 0.82 (0.65-0.93) 0.75 (0.58-0.88) 0.76 (0.61 -0.88) 0.89 (0.72 -0.98) 
Less experienced operators 
Sensitivity [TP/TP +FN] 0.53 (0.27 -0.79) 0.57 (0.34-0.78) 0.37 (0.22 -0.55) 0.00 (0.00-0.22) 
[8/15] [12/21] [14/38] [0/15] 
Specificity [TN/TN +FP] 0.89 (0.79-0.95) 0.89 (0.79-0.95) 0.88 (0.77 -0.95) 1.00 (0.94 -1.00) 
[57/64] [57/64] [57/65] [57/57) 
Accuracy 0.82 (0.72 -0.90) 0.81 (0.71 -0.89) 0.69 (0.58 -0.77) 0.79 (0.68-0.88) 
Values in parentheses are 95% Cls. Abbreviations are as defined in Table 1. 
rienced sonographers. Overall, within the anterior circulation, 
accuracy was poorer for ICA complex aneurysms because of 
poorer sensitivity and slightly poorer specificity than for the 
ACA and MCA complexes (Table 3). The poorer sensitivity for 
ICA complex aneurysms was concentrated in the less experi- 
enced sonographers: 14 of 38 aneurysms detected compared 
with 8 of 13 for the more experienced sonographers. Whereas 
for the more experienced observers the MCA complex had the 
poorest sensitivity (3 of 11 aneurysms detected compared with 
12 of 21 for the less experienced sonographers), sensitivity, 
specificity, and accuracy for the ACA complex were very 
similar for all sonographers. 
Diagnostic performance was also analyzed by clinical group, 
and the results are presented in Table 4. Similar accuracy was 
found for the 3 clinical groups on a per patient basis, although 
the CIs are wide because of the smaller numbers engendered by 
a subgroup analysis. On a per aneurysm basis, TCDS had poorer 
specificity in the subjects in group I (known aneurysm or proven 
SAH) and group 3 (positive family history) than for subjects in 
group 2 (Table 4). 
TCDS performance was related to the level of ultrasonog- 
rapher confidence for the less experienced observers; this was 
available in 106 of 112 examinations. In cases in which the 
sonographer was confident (56 of 106 patients had a confi- 
dence score of 1 or 5), the accuracy per patient was 0.89 
(50/56) compared with 0.75 (30/40) for moderate confidence 
(40 of 106 patients had a score of 2 or 4) and 0.70 (7/10) if 
confidence was low (10 of 106 patients had a score of 3). 
TABLE 4. Diagnostic Performance for Anterior Circulation Aneurysms by 
Patient Type 
Group 1 




Due to Aneurysm but 





Sensitivity [TP/TP +FN] 0.81 (0.67 -0.91) 0.64 (0.31 -0.89) 0.78 (0.40-0.97) 
[38/47] [7/11] [7/9) 
Specificity ITN/TN +FP] 0.88 (0.69-0.97) 0.89 (0.77 -0.96) 1.00 (0.74 -1.00) 
[22/25] [47/53] [12/12] 
Accuracy 0.83 (0.73-0.91) 0.84 (0.73-0.92) 0.90 (0.70-0.99) 
Per aneurysm 
Sensitivity [TP/TP +FN] 0.51 (0.39-0.63) 0.53 (0.27 -0.79) 0.14 (0.02 -0.43) 
[38/74] [8/15] [2/14] 
Specificity [TN/TN +FP] 0.55 (0.38 -0.71) 0.85 (0.73 -0.94) 0.67 (0.41 -0.87) 
(22/401 [47/55] [12/18] 
Accuracy 0.53 (0.43 -0.62) 0.79 (0.67 -0.87) 0.44 (0.26-0.62) 
Values in parentheses are 95% CIs. Abbreviations are as defined in Table 1. 
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Discussion 
This study is only the second large prospective study com- 
paring power TCDS with IADSA, and it is also one of the 
largest prospective studies of any noninvasive imaging tech- 
nology (eg, CTA, MRA, and TCDS) to date.6'7 In a system- 
atic review of the literature on noninvasive imaging of 
intracranial aneurysms, it was clear that data on TCDS were 
very limited compared with CTA and MRA, reflecting the 
more mature state of those technologies. Few conclusions 
could be drawn about the diagnostic performance of TCDS 
from the data available before the present study. 
Diagnostic Performance by Site and 
Size of Aneurysm 
Unsurprisingly, we found diagnostic performance was much 
poorer in aneurysms < -5 mm in size. For anterior circulation 
aneurysms >5 mm in size, sensitivity was 0.81, which is in 
agreement with the best of previous 2- dimensional noncon- 
trast TCDS reports. Although large aneurysms are more 
readily detected by TCDS, small aneurysms can be detected 
in patients with a good bone window, as demonstrated in 
Figures 1 and 2, respectively. This size- related performance 
effect applies equally to CTA and MRA 6.13 
It is reassuring that the differences in sensitivity and 
specificity between the less and more experienced TCDS 
sonographers were quite small (difference overall per patient: 
9% for sensitivity, 3% for specificity; difference per aneu- 
rysm: 5% for sensitivity, 2% for specificity). These results 
indicate that diagnostic performance is not highly dependent 
on the experience of the sonographer and that satisfactory 
performance in the technique can be achieved without pro- 
longed, extensive training if a sonographer is already com- 
petent in spectral transcranial Doppler ultrasound. Three 
half -day training sessions in power TCDS were provided for 
the less experienced sonographers in this study. Interobserver 
agreement (albeit on a small sample) was also good. The 
practical logistics of patient admission, investigation, and 
treatment meant that we were unable systematically to have 2 
blinded sonographers examine subjects. In particular, it 
would have been valuable if an experienced and a less 
experienced sonographer could have done this, but this 
proved to be impractical within the available resources. 
Because of the methodology of this study, in which only 
the temporal bone window was routinely insonated, it is not 
possible to comment on performance in the basilar and 
vertebral areas. Regarding the anterior circulation, overall 
accuracy was poorer for ICA complex aneurysms than the 
MCA or ACA complexes, largely because of the relatively 
greater number of false- negative readings for the less expe- 
rienced sonographers (24 of 38 versus 5 of 13 for the more 
experienced sonographers; Table 3). The ICA complex was 
also a difficult area for detection of aneurysms with CTA and 
MRA.6 3 It is interesting but difficult to explain why the 
experienced observers had a substantially lower detection rate 
for MCA aneurysms (0.27) than the less experienced observ- 
ers (0.57), although the Cis overlap widely. 
Overall accuracy between the different patient groups was 
broadly similar on a 'er .atient basis su::estin_ that the 
influence of patient type on the accuracy of TCDS was not 
Figure 1. A, IADSA image demonstrating an obvious large right 
PCoA aneurysm (An). B, TCDS of same aneurysm, also showing 
part of the circle of Willis. RT indicates right; LT, left; PCA, pos- 
terior cerebral artery; and Bas, basilar artery. 
great. It is also interesting that in cases in which the less 
experienced sonographers felt confident about the findings in 
an individual patient, their accuracy was identical to that of 
the more experienced sonographers (0.89). 
Comparison With Previous Studies 
The results on a per patient basis are encouraging, with a 
sensitivity of 0.78, but those on a per aneurysm basis are less 
so, with an overall sensitivity of 0.46. However, for any 
modality, the performance per aneurysm will always be 
poorer than that per patient. The sensitivity per aneurysm in 
previous noncontrast TCDS studies has ranged from 0.4018 
in the only previous large prospective study (n =203) to 0.89 
in a smaller study of 36 patients." Several other small studies 
have also reported sensitivity in the range of 0.53 to 
0.89,7.9.'2.'9 although all were in populations with a high 
prevalence of aneurysms. The difference between sensitivity 
in the 1 .11 I. ..- 
studies might be due to a number of factors. There might be 
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Figure 2. A, IADSA of a small 3-mm left terminal carotid aneu- 
rysm (arrow). This was missed on the initial angiogram. B, TCDS 
showing this aneurysm. In a patient with a very good bone win- 
dow, even small aneurysms can be detected by power TCDS. 
Abbreviations are as defined in Figure 1 legend. 
fewer biases in the present large, prospective, fully blinded 
study, eg, expectation and recall bias; the mixed patient 
population with a lower aneurysm prevalence (43 %) than 
most previous studies might also have had an effect on 
sensitivity,20 as well as the inclusion of results from sonog- 
raphers less experienced in the technique (who performed 
71% of the examinations). However, probably the most 
significant effect is the proportion of small and very small 
aneurysms in this study: 74% (78/105) of the aneurysms were 
s5 mm. In 2 previous studies reporting better sensitivity per 
aneurysm than the present study and in which aneurysm sizes 
were provided, 33 %12 and 0 %11 were s5 mm, and none of 
the small aneurysms were detected. In the onl othe la e 
blinded study of TCDS to date, the prevalence of aneurysms 
was 63 %.18 In that study the combined sensitivity for contrast 
and noncontrast TCDS was 0.28 (24/87) for small aneurysms 
(<6 mm) and 0.53 (43/81) for aneurysms ?6 mm (all 
aneurysm sites), compared with 0.35 ( <_5 mm) and 0.81 
( >5 mm) for anterior circulation aneurysms in the present 
study. 
Comparison of TCDS With Other 
Noninvasive Modalities 
In comparison with reported studies of CTA and MRA, 
TCDS appears to be inferior at aneurysm detection, particu- 
larly on a per aneurysm basis, although on a per patient basis 
the differences between techniques are sma11.6 However, 
these comparisons have not been of like entities, ie, of CTA, 
MRA, and TCD in the same patients (with the same aneu- 
rysms). A proportion of the patients (n =114) in the present 
study underwent IADSA, CTA, MRA, and TCDS contempo- 
raneously. These results are reported separately." When we 
use the mean of 2 observers, the sensitivity per aneurysm for 
CTA was 0.56 (40/72) for aneurysms 55 mm and 0.94 
(34/36) for aneurysms >5 mil. For MRA the sensitivity per 
aneurysm was 0.33 (24/72) for aneurysms 55 mm and 0.89 
(32/36) for aneurysms >5 mm versus 0.35 and 0.81, respec- 
tively, for TCDS. However, overall specificity per aneurysm 
was better for MRA at 0.87. For CTA it was only slightly 
better at 0.76 compared with 0.72 for TCDS. Therefore, in the 
same cohort of patients CTA and MRA were slightly more 
accurate overall per aneurysm at 0.72 and 0.67, respectively, 
than TCDS at 0.60. However, there was no difference on a 
per patient basis, with an accuracy of 0.85 for all 3 modalities. 
Although, unlike the TCDS results, the CTA and MRA 
results included posterior circulation aneurysms, the sensitiv- 
ity and specificity were similar overall for anterior and 
posterior circulation aneurysms for both CTA and MRA." 
TCDS has not reached the same advanced point of tech- 
nological development or maturity as CTA or MRA, and 
these techniques have been in much more widespread use for 
longer than any form of TCDS. Therefore, these first results 
of TCDS in a cohort ofpatients with CTA and MRA available 
for direct comparison appear promising. 
After the results of the International Study of Unruptured 
Intracranial Aneurysms were reported,Z1 the role for any 
screening for intracranial aneurysms has remained controver- 
sial, although it can be difficult not to investigate the worried 
individual with a strong family history or other risk factor(s). 
In a screening context, it could be argued that because only 
aneurysms >10 mm in diameter would be considered for 
elective treatment, poor sensitivity for smaller aneurysms 
would not be clinically important, although it might be 
important from a medicolegal perspective. Therefore, TCDS 
should not yet be ignored as a method of diagnosing aneu- 
rysms. Indeed, future prospects for TCDS are encouraging, 
with the development of real -time 3- dimensional scanning 
techniques and the potential to combine these with contrast 
enhancement; sensitivity per aneurysm in a small study was 
reported as 97 %.22 However, 3- dimensional and contrast 
techniques would increase the cost, duration, and invasive- 
. is -1 . I I 11 - 
blinded study of contrast- enhanced power TCDS has been 
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published (105 subjects had power TCDS before and after 
echo contrast). This demonstrated a significant increase in 
sensitivity for all aneurysm sites from 0.40 to 0.55 with the 
use of contrast, although at the cost of a small reduction in 
specificity.'a 
In conclusion, power TCD is a promising, quick, safe, 
reproducible, and inexpensive noninvasive test for anterior 
circulation intracranial aneurysms. At present it is less accu- 
rate on a per aneurysm basis than CTA or MRA, although 
identical on a per patient basis. As with other noninvasive 
techniques, detection of small aneurysms is particularly poor. 
The cavernous carotid is the most difficult site to interpret, 
particularly for less experienced operators. The value of 
newer ultrasound techniques, and in particular the role of 
3- dimensional ultrasound and ultrasonic contrast agents, re- 
quires further evaluation in large, prospective, fully blinded 
studies preferably comparing TCDS directly with the other 
alternative noninvasive modalities in the same patient cohort. 
The role of TCDS as an adjunctive test to CTA or MRA in the 
diagnosis of intracranial aneurysms (analogous to the situa- 
tion in many centers in the diagnosis of carotid stenosis) also 
merits investigation. 
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Intracranial Aneurysms: 
CT Angiography and MR 
Angiography for Detection 
Prospective Blinded Comparison 
in a Large Patient Cohort 1 
The accepted reference standard for identification of intracranial aneurysms is intraarterial 
digital subtraction angiography (DSA) (1 -3). Intraarterial DSA has a permanent neurologic 
complication rate of 0.07% in patients examined for suspected aneurysm (4) and is 
invasive, time- consuming, and relatively expensive. During the past decade, there has 
been considerable interest in the role of noninvasive imaging in the detection of intra- 
cranial aneurysms (5). There have been numerous studies to compare either magnetic 
resonance (MR) angiography or computed tomographic (CT) angiography with intraarte- 
rial DSA. The results of these studies indicate that CT angiography and MR angiography 
have a similar overall accuracy of about 90% but a sensitivity ranging from 0.67 (95% CI: 
0.55, 0.78) (6) to 1.00 (95% CI: 0.85, 1.00) (7) for CT angiography and from 0.70 (95% CI: 
0.50, 0.86) (8) to 0.97 (95% CI, 0.87, 1.00) (9) for MR angiography. Most of these studies 
were performed predominantly or exclusively in patients with a known aneurysm or 
recent acute subarachnoid hemorrhage (SAH), many had a small sample size, and most 
were not blinded prospective studies (5). 
739 
To compare imaging modalities di- 
rectly, it is necessary to perform the ex- 
aminations that are being evaluated in 
the same patient cohort. To our knowl- 
edge, however, only six studies have in- 
volved comparisons of both CT angiog- 
raphy and MR angiography with DSA in 
the same patients, and only two (sample 
sizes of 17 and 11 patients) of these six 
were prospective blinded studies (10,11). 
Of the four other studies, one focused on 
assessment of treated aneurysms rather 
than aneurysm detection (12). Two other 
studies by the same authors (13,14) were 
not prospective or blinded, and many pa- 
tients in the second investigation did not 
undergo intraarterial DSA for compari- 
son. The remaining study (15) also was 
not a prospective blinded investigation, 
and only five of 10 subjects underwent all 
three imaging examinations. 
Although there is increasing interest in 
the use of CT angiography or MR angiog- 
raphy to replace intraarterial DSA as the 
primary angiographic modality in pa- 
tients who present with SAH (16 -19), 
perhaps the main use of CT angiography 
or MR angiography at present is to facil- 
itate a diagnosis of aneurysm in asymp- 
tomatic at -risk patients or in patients 
who have symptoms that could have an 
aneurysmal origin but do not have acute 
SAI-I. Most previously published studies 
did not include such patients, so the ac- 
curacy in this type of population could 
not be truly determined. The purpose of 
our prospective blinded study was to 
compare CT angiography and MR an- 
giography with intraarterial DSA for the 
detection of intracranial aneurysms in a 
large patient cohort. 
MATERIALS AND METHODS 
Patients 
The study was conducted in two re- 
gional neuroscience centers (Institute of 
Neurological Sciences, Southern General 
Hospital, and the University of Edin- 
burgh Department of Clinical Neuro- 
sciences) serving a population of 4.2 mil- 
lion people. Patients undergoing cerebral 
angiography for detection of a possible 
intracranial aneurysm were eligible for 
inclusion. Exclusion criteria were poor 
grade of subarachnoid SAH (World Feder- 
ation of Neurosurgeons grade 3 or high- 
er), because obtaining informed consent 
was not possible; absolute contraindica- 
tion to one of the examinations; or age 
younger than 18 years or older than 75 
years. Approval for the study was ob- 
tained from the appropriate,hospital eth- Image Acquisition 
ics committees, and written informed con- Neuroradiologists (E.M.T, P.M.W.)-per= 
formed all the intraarterial DSA examina- 
tions by using Advantx angiographic 
equipment (GE Medical Systems, Milwau- 
kee, Wis). For intraarterial DSA, three- or 
four- vessel selective angiograms were ac- 
quired, with multiple projections ob- 
tained for each vessel. The images were 
printed onto film hard copy for analysis. 
Spiral CT angiography was performed 
with a Twin scanner ( Elscint, Haifa, Israel) 
in 81 examinations and with a HiSpeed 
Advantage scanner (GE Medical Systems) 
in 41 examinations. The acquisition vol- 
ume was angled parallel to the superior 
orbitomeatal baseline, with the inferior 
margin at the superior surface of the pos- 
terior arch of the Cl vertebra (to include 
the posteroinferior cerebellar arteries) and 
extended superiorly to above the level of 
the pericallosal arteries. Tube angulation 
prevented irradiation of the orbits and 
allowed inclusión of all the usual aneu- 
rysm sites in the minimum examination 
volume. One hundred milliliters of non- 
ionic contrast material (iopamidol 300; 
Bracco Diagnostics, Milan, Italy) was ad- 
ministered into an antecubital vein by 
using a pump injector at 3 mL /sec with 
an 18- 20- second delay. The delay was 
increased when the patient was known to 
have substantial hemodynamic impair- 
ment; in such cases, a bolus tracking fa- 
cility was used. CT examination parame- 
ters were 120 -kV maximum tube current 
allowed, 512 x 512 matrix; 15 -cm field of 
view, 1 -mm collimation, and a pitch of 
1.5 with a 0.5 -mm reconstruction inter- 
val. 
For logistic reasons -mainly scanner 
availability or patient illness -a small 
number of patients (n = 20) in Glasgow 
underwent nonspiral CT angiography 
with a 2400 Elite scanner (Elscint). Con- 
ventional transverse CT angiography was 
performed dynamically by using a 2.5 -mm 
section width, 1 -mm table increment, 
120 -kV 400 -mAs tube current, and 20-cm 
field of view. Scanning began after 50 mL 
of iòpamidol 300 was injected rapidly by 
hand; an additional 50 mL was injected 
during scanning (1). 
MR angiography was performed by us- 
ing a Prestige 2.0 -T unit (Elscint) in 66 
examinations and a Magnetom SP 1.5 -T 
unit (Siemens, Erlangen, Germany) in 76 
examinations, with three -dimensional time - 
of- flight MR angiographic sequences with 
magnetization transfer suppression and 
tilted optimized nonsaturating excita- 
tion, followed by a transverse T2- weighted 
fast spin -echo sequence. With the Prestige 
sent was obtained from participants: 
One hundred eighty-three consecutive 
patients who met the inclusion criteria 
and agreed to participate were recruited 
prospectively during an 18 -month pe- 
riod. One hundred forty-seven of these 
patients (72 men, 75 women; median 
age, 41 years; age range, 1f -75 years) un- 
derwent CT angíograph}l,, MR angiogra- 
phy, and intraarterial DSA. In 36 of 183 
patients, only CT angiography or MR an- 
giography could be performed in addi- 
tion to intraarterial DSA, so these patients 
were excluded from further analysis. Five 
additional patients (one man and four 
women) were excluded because they 
were unable to complete the MR angio- 
graphic examination. Thus, our study 
population consisted of 142 patients. 
Patients were grouped into fourrtego- 
ries on the basis of the clinical incifcation 
for cerebral angiography. Grout 1 con- 
sisted of four patients with orié or more 
known aneurysms who underwent fur- 
ther assessment; group 2, 56 patients 
with proved SAH; group 3, 64 patients 
with symptoms that might be due to an- 
eurysm; and group 4, 18 asymptomatic 
patients at risk of harboring an aneu- 
rysm. For subgroup analysis of accuracy 
according to clinical category, groups 1 
and 2 were combined and groups 3 and 4 
were combined. 
The imaging studies were performed 
contemporaneously, if possible, and within 
a maximum of 2 months after intraarte- 
rial DSA. For CT angiography, 77 (54%) 
of 142 examinations were performed 
within 1 week after intraarterial DSA; an 
additional eight (6 %) examinations, within 
2 weeks; and the remaining 57 (40%) ex- 
aminations, from 2 weeks to 2 months 
after intraarterial DSA. Reflecting the 
more limited access to MR imaging in the 
United Kingdom, fewer MR angiographic 
studies could be performed contempora- 
neously: 64 (45%) of 142 examinations 
were performed within 1 week after in- 
traarterial DSA; an additional five (4%) 
examinations, within 2 weeks; and the 
remaining 73 (51%) examinations, from 
2 weeks to 2 months after intraarterial 
DSA. Two MR angiographic studies were 
performed as part of a clinical MR imag- 
ing examination and because an aneu- 
rysm was suspected; intraarterial DSA was 
subsequently performed within 1 week. 
In all other cases, CT angiography and 
MR angiography were performed after in- 
traarterial DSA. 
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TABLE 1 
- Comparative Diagnostic Performance of-CT T Añgíography and MR Angiography 
Lielihood 
Examination Sensitivity Specificity PPV NPV Accuracy Ratio 
Per patient 
CT angiography 
Observer A 0.83 (52/63) 0.82 (65/79) 0.79 (52/66) 0.86 (65/76) 0.82 (117/142) 4.66 
0.71, 0.91 0.72, 0.9 0.67, 0.88 0.76, 0.93 0.75, 0.88 
Observer B 0.83 (52/63) 0.91 (72/79) 0.88 (52/59) 0.87 (72/83) 0.87 (124/142) 9.32 
0.71, 0.91 0.83, 0.96 0.77, 0.91 0.78, 0.93 0.81, 0.92 
MR angiography 
Observer A 0.73 (46/63) 0.94 (74/79) 0.90 (46/51) 0.81 (74/91) 0.85 (120/142) 1154 
0.60, 0.83 0.86, 0.98 0.79, 0.97 0.72, 0.89 0.77, 0.90 
Observer B 0:75 (47/63) 0.94 (74/79) 0.90 (47/52) 0.82 (74/90) 0.85 (121/142) 1179 
0.62, 0.85 0.86, 0.98 0.79, 0:97 0.73, 0.89 0.78, 0.91 
Per aneurysm 
CT angiography 
Observer A 0.69 (75/108) 0.71 (65/91) 0.74 (75/101) 0.66 (65/98) 0.70 (140/199) L43 
0.60, 0.78 0.61, 0.8. 0.65, 0.82 0.56, 0.76 0.63, 0.77 
Observer B 0.67 (72/108) 0.80 (72/90) 0.80 (72/90) 0.67 (72/108) 0.73 (144/198) ' 333 
0.60, 0.75 0.70, 0.87 0.70, 0.88 0.57, 0.75 0.66, 0.79 
MR angiography 
Observer A 0.52 (56/108) 0.87 (74/85) 0.84 (56/67) 0.59 (74/126) 0.67 (130/193) 4.01 
0.42, 0.62 0.78, 0.93 0.73, 0.92 0.50, 0.67 0.60, 0.74 
Observer B 0.50 (54/108) 0.87 (74/85) 0.83 (54/65) , ,p 58 (74/128) 0.66 (128/193) 186 
0.40, 0.6 0.78, 0.93 0.72, 0.91 Ç -0.49, 0.66 0.59,0.73 
Note. -For sensitivity (true -positive /[true- postive + false- negative]), specificity (true -négative /[true -negative + false- positive]), accuracy, negative 
predictive value (NPV, true- negative /[true -negative + false -negative]), and positive prédictive value (PPV, true- positive /[true -positive + false- positive]) 
data, the numbers in parentheses are numbers of patients or aneurysms and the two numbers on thé second line are 95% CIs. 
unit, two overlapping 58 -mm slabs were 
acquired with the following parameters: 
40/6 (repetition time msec /echo time 
msec), 30° flip angle, 15 x 20 -cm field of 
view, 204 x 300 matrix, one signal ac- 
quired, and acquisition time of 7 minutes 
53 seconds. With the Magnetom unit, 
one 64 -mm slab angled 13° was obtained 
by using three -dimensional time -of -flight 
MR angiography. The parameters were 
43/8, 20° flip angle, 20-cm field of view, 
256 x 512 oversampled matrix, one sig- 
nal acquired, and acquisition time of 11 
minutes 48 seconds: Neuroradiologists 
supervised all CT angiographic and MR 
angiographic studies. 
Postprocessing of Images 
For CT angiography, reformatting of 
source images was performed on offline 
workstations (02 Omnipro; Silicon Graph- 
ics, Mountain View, Calif, or Advantage 
Windows; GE Medical Systems) by a neu- 
roradiology research fellow (P.M.W.) 
without review of the intraarterial DSA 
data prior to reformatting. Standard trans- 
verse and coronal oblique images plus 
curved sagittal multiplanar reformatted 
images were obtained by using the Om- 
nipro workstation (1). Maximum inten- 
sity projection reconstructed angiograms 
also were obtained (12 projections at 15° 
intervals in both cranial -to- caudal and 
left -to -right projections), with bone edit- 
ing performed by thresholding and man- 
ual cutting. Targeted maximum intensity 
projection imaging of the right and left 
internal carotid circulations and the ver- 
tebrobasilar system was performed. The 
total time for these reconstructions typi- 
cally was 20 -25 minutes. 
With the Advantage Windows work- 
station, transverse, coronal oblique, and 
sagittal overlapping thick -slab (8 -10 mm 
at 3 -4 -mm increments) maximum inten- 
sity projection images were obtained, 
with additional manual bone editing per- 
formed as required (2). The reconstruc- 
tion time was less than 10 minutes unless 
manual bone editing was required. For 
MR angiography, standard maximum in- 
tensity projection reconstructed images 
were obtained at 15° -180° intervals (in 
cranial -to- caudal and left-to -right projec- 
tions) at the time of MR angiography per- 
formed by the neuroradiographer. Tar- 
geted maximum intensity projection 
reconstructed images, were obtained at 
examinations performed with the Pres- 
tige unit and Omnipro workstation, as in 
the previously described CT angiographic 
examination, again by the neuroradiol- 
ogy fellow and without review of the in- 
traarterial DSA data in each case. Source 
CT angiograms and MR angiograms were 
available to the reviewers. 
Image Review 
Each patient was allocated a study num- 
ber that was known only to the research 
fellow. The intraarterial DSA images were 
presented as film hard -copy images that 
were identified only by the study num- 
ber-the patient names, examination dates, 
and clinician details were removed -in ran- 
dom order for independent review by 
two neuroradiologists (E.M.T., J.M.W.), 
one each from each center. Interpreta- 
tion disagreements were resolved by 
means of consensus review. The CT an- 
giograms and MR angiograms were pre- 
sented in an anonymous random fashion 
to the same two neuroradiologists. The 
CT angiograms and MR angiograms ob- 
tained in any individual patient were re- 
viewed separately, and at least 4 months 
elapsed between the review of DSA im- 
ages and the review of the noninvasive 
studies in the same patient. 
A number coding form was completed 
for each image so that all the major in- 
tracranial vessel segments were systemat- 
ically reviewed in turn and an assessment 
was made as to whether the vessels were 
adequately demonstrated. The aneurysm 
sites and sizes were recorded. Site was 
recorded with the following codes: 1 for 
middle cerebral artery (MCA) mainstem, 
2 for MCA bifurcation, 3 for distal MCA, 
4 for anterior cerebral artery (ACA) corn- 
neurysms 7 !4i- 
P 
lea, 5 for pericallosal 
artery, 6 for Al 
ACA segment, 7 for 
internal carotid ar- 
tery (ICA) bifurcation, 
8 for posterior 
communicating 
artery, 9 for ophthalmic 
artery, 10 for ICA 
siphon, 11 for other 
ICA, 12 forbasilar 
artery, 13 for posterior 
inferior cerebellar 
artery, and 14 for other 
artery (specified). 
For subgroup analysis, 
the sites were grouped 
into four catego- 
ries: ACA complex, 
MCA complex, ICA 
complex (including 
posterior communi- 
cating artery), and 
vertebrobasilar sys- 
tem. Size was recorded 
as maximum an- 
Biographic dimension (a) 
smaller than 3 
mm, (b) 3-5 mm, (c) 
5.1 -10.0 mm, or 
(d) larger than 10 mm. 
Observer confidence was 
assessed by 
using a five -point scale, 
as reported by 
Atlas et al (20), on which 
a score of 5 
meant aneurysm definitely 
absent; 4, an- 
eurysm probably absent; 
3, uncertain; 2, 
aneurysm probably present; 
and 1, aneu- 
rysm definitely present. In a 
multicenter 
multimodality study involving 
several 
types of imaging equipment, 
a large 
number of variables are introduced. 
We 
studied the effect of several 
variables that 
have been suggested to be 
relevant to 
diagnostic accuracy (21), 
including the 
use of spiral versus nonspiral 
CT angiog- 
raphy, the availability of 
spin -echo se- 
quences for MR angiography, 
and the 
availability of targeted maximum 
inten- 
sity projection reconstruction 
for CT an 
giography and MR angiography. 
Statistical Analyses 
For both modalities and both 
observ- 
ers, 2 x 2 tables of the true- positive, 
false - 
positive, true- negative, and false 
-nega- 
tive cases at MR angiography 
and CT 
angiography, as compared with 
those at 
intraarterial DSA, were constructed. 
Sen- 
sitivity, specificity, positive and 
negative 
predictive values, and accuracy 
were 
compared on a per -patient (ie, 
the ability 
to correctly designate a patient as 
a true - 
positive or true- negative case 
on the basis 
of possession of at least one 
intracranial 
aneurysm) and per- aneurysm 
(ie, the abil- 
ity to correctly identify all aneurysms) 
basis. Exact 95% CIs based 
on binomial 
probabilities were calculated 
(22). The 
McNemar test for paired binary 
data was 
used to compare the sensitivity 
and spec- 
ificity of CT angiography and 
MR angiog- 
raphy with each observer (23). 
The un- 
weighted K statistic was used 
to assess 
interobserver and intermodality 
agree- 
ment (24). A K value of 0.8 
or above in- 
dicated excellent agreement; 
0.6 -0.8, 
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Figure 1. Forrest plots of 
sensitivity and specificity (with 
95% CIs) 
for CT angiography (CTA) and 
MR angiography (MRA) (a) 
per patient 
and (b) per aneurysm for both 
observers. 
the difference between two proportions 
were calculated to determine 
whether 
there was a difference between 
the pro- 
portions interpreted correctly 
for each 
modality and each observer at 
different 
levels of observer confidence 
(23). 
RESULTS 
At intraarterial DSA, 108 aneurysms 
were 
present in 63 (44%) of 142 
patients. 
These findings, as well as a breakdown 
of 
the sites and sizes of the aneurysms 
and 
the corresponding CT angiographic 
and 
MR angiographic results for 
the two ob- 
servers, are summarized in Table 
El (ra- 
cliology.rsnajnIs.org/cgi/content/full/219/3/ 
739/DC1). Twenty-four (22%) 
of 108 an- 
eurysms were smaller than 
3 mm; 48 
44% , 3 -5 mm; 18 (17%), 5.1 -10.0 
mm; 
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and 18 (17%), larger than 10 
mm. Twen- 
ty-two (20%) were aneurysms 
of the ACA 
circulation; 29 (27%), the MCA 
circula- 
tion; 40 (37%), the ICA; and 
17 (16%), 
the vertebrobasilar system. 
Details of all the false- negative 
and false - 
positive results of CT angiography 
and 
MR angiography are given 
in Table E2 
( radiology .rsnajnls.org /cgi /cantent/full 
/219/ 
3/739/DC1). Observer A made 
33 false - 
negative readings of aneurysms 
at CT an- 
giography and 52 at MR 
angiography, 
compared with observer B, who 
made 36 
and 54 false- negative readings, 
respec- 
tively. When the two readers' 
mistakes 
were combined, 28 (41 %) of the 
69 false - 
negative readings at CT angiography 
were 
related to aneurysms smaller 
than 3 mm; 
37 (54%), to aneurysms 3 -5 
mm; four 
(6%), to aneurysms 5.1 -10.0 
mm; and 
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TABLE 2 
; 
-Diagnostic Performance of-CT-Angiography and MR Angiography as Related to Cii &I Group and Aneurysm Size 
(Maximum Angiographic Dimension) 
Aneurysm Size 
CT Angiography MR Angiography 
(mm) Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
Groups 1 and 2 
Observer A 
< 3 0.25 (2/8) 0.63 (15/24) 0.53 (17/32) 0.25 (2/8) 0.92 (22/24) 0.75 (24/32) 
0.03, 0.65 0.41, 0.81 0.35, 0.71 ' 0.03, 0.65 0.73, 0.99 0.57, 0.89 1 
3-5 0.71 (20/28) 0.88 (21/24) 0.79 (41/52) 0.25 (7/28) 1.00 (24/24) 0.60 (31 /52) 
0.51, 0.87 0.68, 0.97 0.65, 0.89 0.11, 0.45 0.86, 1.0 0.45, 0.73 
5.1 -10.0 0.86 (12/14) 1.00 (24/24) 0.95 (36/38) 0.86 (12/14) 0.96 (23/24) 0.92 (35/38) 
0.57, 0.98 0.86, 1.0 0.82, 0.99 0.57, 0.98 0.79, 1.0 0.79, 0.98 
> 10 1.00 (12/12) 1.00 (24/24) 1.00 (36/36) ,, 0.83 (10/12) 0.96 (23/24) 0.92 (33/36) 
0.74, 1.00 0.86, 1.00 0.90, 1.00 0.52, 0.98 0.79, 1.00 178, 0.98 
Observer B 
< 3 0.25 (2/8) 0.92 (22/24) 0.75 (24/32) 0.00 (0/8) 0.88 (21/24) 0.66 (21/32) 
0.03, 0.65 0.81, 1.00 0.60, 0.90 0.0, 0.37 0.68, 0.97 0.47, 0.81 
3 -5 0.61 (17/28) 0.75 (18/24) 0.67 (35/52) 0.21 (6/28) 0.96 (23/24) 0.56 (29/52) 
0.43, 0.79 0.58, 0.92 0.55, 0.80 0.08, 0.41 0.79, 1.00 141, 0.70 
5.1 -10.0 0.86 (12/14) 0.96 (23/24) 0.92 (35/38) 0.86 (12/14) 1.00 (24/24) 0.95 (36/38) 
0.67, 1.00 0.88, 1.00 0.84, 1.00 0.57, 0.98 0.86, 1.0 182, 0.99 
> 10 1.00 (12/12) 1.00 (24/24) 1.00 (36/36) 0.83 (10/12) 1.00 (24/24) 0.94 (34/36) 
0.74, 1.00 0.86, 1.00 0.90, 1.00 0.52, 0.98 0.86, 1.00 0.81, 0.99 
Groups 3 and 4 
Observer A 
< 3 0.44 (7/16) 0.76 (42/55) 0.69 (49/71) 0.311 (5/16) 0.89 (49/55) 176 (54/71) 
0.20, 0.70 0.63, 0.87 0.57, 0.79 0.11, 0.59 0.78, 0.96 164, 0.85 
3 -5 0.60 (12/20) 0.98 (54/55) 0.88 (66/75) 0.55 (11/20) 0.98 (54/55) 0.87 (65/75) 
0.36, 0.81 0.90, 1.00 0.78, 0.94 0.32, 0.77 0.90, 1.00 0.77, 0.93 
5.1 -10.0 1.00 (4/4) 1.00 (55/55) 1.00 (59/59) 0.75 (3/4) 1.00 (55/55) 098 (58/59) 
0.40, 1.00 0.94, 1.00 0.94, 1.00 0.19, 0.99 0.94, 1.00 0.91, 1.00 
> 10 1.00 (6/6) 1'200 (55/55) 1.0 (61 /61) 1.00 (6/6) 1.00 (55/55) 1.00 (61/61) 
0.54, 1.00 0.94, 1.00 0.94, 1.00 0.54, 1.00 0.94, 1.00 094, 1.00 
Observer B 
< 3 0.50 (8/16) 0.93 (51/55) 0.83 (59/71) 0.25 (4/16) 0.93 (51/55) 077 (55/71) 
0.25, 0.75 0.82, 0.98 0.72, 0.91 0.07, 0.52 0.82, 0.87 0.66, 0.87 
3 -5 0.50 (10/20) 0.93 (51/55) 0.81 (61/75) 0.55 (11/20) 0.95 (52/55) 0.84 (63/75) 
0.27, 0.73 0.82, 0.98 0.71, 0.89 0.32, 0.77 0.85, 0.99 074, 0.91 
5.1 -10.0 1.00 (4/4) 0.98 (54/55) 0.98 (58/59) 0.75 (3/4) 1.00 (55/55) 0.98 (58/59) 
0.40, 1.00 0.90, 1.00 0.91, 1.00 0.19, 0.99 0.94, 1.00 091, 1.00 
> 10 1.00 (6/6) 1.00 (55/55) 1.00 (61/61) 1.00 (6/6) 1.00 (55/55) 1.00 (61/61) 
0.54, 1.00 0.94, 1.00 0.94, 1.00 0.54, 1.00 0.94, 1.00 0.94, 1.00 
Note.- Sensitivity = true -positive /(true -positive + false -negative). Specificity = true -negative /(true- negative + false -positive). The numbers in paren- 
theses are numbers of aneurysms. The two numbers on the second line are 95% Cls. 
none, to aneurysms larger than 10 mm. 
Six (9 %) of the 69 false -negative CT an- 
giographic readings were related to ACA 
aneurysms; 16 (23 %), to MCA aneurysms; 
36 (52 %), to ICA aneurysms; and 11 
(16 %), to vertebrobasilar aneurysms. At 
MR angiography, 36 (34 %) of the 106 
false- negative readings were related to 
aneurysms smaller than 3 mm; 61 (58 %), 
to aneurysms 3 -5 mm; six (6 %), to aneu- 
rysms 5.1 -10.0 mm; and three (3 %), to 
aneurysms larger than 10 mm. Nineteen 
18 %) of the 106 false- negative MR an- 
giographic readings were related to ACA 
aneurysms; 28 (26 %), to MCA aneurysms; 
16 (43 %), to ICA aneurysms; and 13 
(12 %), to vertebrobasilar aneurysms. 
Observer A made 26 false -positive read-. 
zgs at CT angiography and 11 at MR 
angiography compared with observer B, 
wrho made 18 and 11 false -positive read- 
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ings, respectively. When the two observ- 
ers' readings were combined, at CT an- 
giography, 28 (64 %) of 44 false -positive 
aneurysms were smaller than 3 mm; 14 
(32 %), 3 -5 mm; two (4 %), 5.1 -10.0 mm; 
and none, larger than 10 mm. Eight 
(18 %) of these 44 findings were catego- 
rized as ACA aneurysms; 17 (39 %), MCA 
aneurysms; 15 (34%), ICA aneurysms; 
and four (9 %), vertebrobasilar aneu- 
rysms. At MR angiography, 15 (68%) of 
22 false -positive aneurysms were smaller 
than 3 mm; five (23 %), 3 -5 mm; one 
(4 %), 5.1 -10.0 mm; and one (4%), larger 
than 10 mm. One (4 %) of these 22 false - 
positive findings was an ACA aneurysm; 
eight (36%), MCA aneurysms; 11 (50 %), 
ICA aneurysms; and two (9%), vertebro- 
basilar aneurysms. 
The overall comparative diagnostic 
performances of CT angiography and MR 
angiography (with 95% Cls) for both ob- 
servers are listed in Table 1 and illustrated 
graphically as Forrest plots in Figure 1 
(25). The accuracy of both CT angiogra- 
phy and MR angiography on a per -pa- 
tient basis was better than the accuracy 
on a per -aneurysm basis. There wa* no 
significant difference in sensitivity be- 
tween CT angiography and MR angiogra- 
phy (P = .11 for observer A and P = .10 
for observer B, McNemar test). For ob- 
server A only (P = .01), CT angiography 
had significantly poorer specificity than 
did MR angiography (P = .56 for observer 
B). Agreement between the noninvasive 
modalities was good: the K statistic for 
observer A was 0.61 (95% CI: 0.48, 0.74) 
and for observer B, 0.69 (95% CI: 0.57, 
0.81). Interobserver agreement was good 
for both noninvasive modalities, with a K 
statistic of 0.73 (95% CI: 0.62, 0.84) for 
TABLE 3 
Diagnostic Performance of CT Angiography and MR Angiógraphyas Related to Clinical-Group and-Aneurysm-Site- 
Aneurysm Site* 
CT Angiography MR Angiography 
Sensitivity Specificity Accuracy , Sensitivity Specificity Accuracy 
Groups 1 and 2 
Observer A 
ACA 0.94 (15/16) 0.88 (21/24) 0.90 (36/40) 0.50 (8/16) LOO (24/24) 0.80 (32/40) 
0.70, 1.00 0.68, 0.97 0.76, 0.97 0.25, 0.75 9.86, 1.00 0.64, 0.91 
MCA 0.72 (13/18) 0.75 (18/24) 0.74 (31/4?) 0.44 (8/18) 0.92 (22/24) 0.71 (30/42) 
0.47, 0.90 0.53, 0.90 0.58, 0.8 0.22, 0.69 0.73, 0.99 0.55, 0.84 
ICA 0.68 (13/19) 0.92 (22/24) 0.81 (35/43) 0.47 (9/19) 0.92 (22/24) 0.72 (31/43) 
0.43, 0.87 0.73, 0.99 0.67, 0.92 0.24, 0.71 0.73, 0.99 0.56, 0.85 
Postcirculation 0.56 (5/9) 0.96 (23/24) 0.85 (28/33) 0.67 (6/9) LOO (24/24) 0.91 (30/33) 
0.21, 0.86 0.79, 1.00 0.68, 0.,25 0.30, 0.93 0.86, 1.00 0.76, 0.98 
Observer B 
ACA 0.81 (13/16) 0.96 (23/24) 0.90 (36/40) 0.50 (8/8) 1.00 (24/24) 0.80 (32/40) 
0.54, 0.96 0.79, 1.0 0.76, 0.97 0.25, 0.75 0.86, 1.00 0.64, 0.91 
MCA 0.72 (13/18) 0.96 (23/24) 0.86 (36/42) 0.39 (7/18) 0.92 (22/24) 0.69 (29/42) 
0.47, 0.90 0.79, 1.00 0.71, 0.95 0.17, 0.64 0.73, 0.99 0.53, 0.82 
ICA 0.63 (12/19) 0.75 (18/24) 0.70 (30/43) 0.47 (9/19) 0.96 (23/24) 0.74 (32/43) 
0.38, 0.84 0.53, 0.90 0.54, 0.83 0.24, 0.71 0.79, 1.00 0.59, 0.86 
Postcirculation 0.67 (6/9) 0.96 (23/24) 0.88 (29/33) 0.56 (5/9) 0.96 (23/24) 0.85 (28/33) 
0.30, 0.93 0.79, 1.00 0.72, 0.97 0.21, 0.86 0.79, 1.00 0.68, 0.95 
Groups 3 and 4 
Group A 
ACA 0.67 (4/6) 0.95 (52/55) 0.92 (56/61) ,1.0.67 (4/6) 1.00 (55/55) 0.97 (59/61) 
0.22, 0.96 0.85, 0.99 0.82, 0.97 0.22, 0.96 0.94, 1.00 0.89, 1.00 
MCA 0.73 (8/11) 0.85 (47/55) 0.83 (55/66) et 0.64 (7/11) 0.93 (51/55) 0.88 (58/66) 
0.39, 0.94 0.73, 0.94 0.72, 0.91 0.31, 0.89 0.82, 0.98 0.78, 0.95 
ICA 0.52 (11/21) 0.96 (53/55) 0.84 (64/76) 0.43 (9/21) 0.95 (52/55) 0.80 (61/76) 
0.30, 0.74 0.87, 1.00 0.74, 0.92 0.22, 0.66 0.85, 0.99 0.70, 0.89 
Postcirculation 0.75 (6/8) 0.98 (54/55) 0.95 (60/63) 0.63 (5/8) 1.00 (55/55) 0.95 (60/63) 
0.35, 0.97 0.90, V.00 0.87, 0.99 0.24, 0.91 0.94, 1.00 0.87, 0.99 
Group B 
ACA 1.00 (6/6) 0.98 (54/55) 0.98 (60/61) 0.83 (5/6) 0.98 (54/55) 0.97 (59/61) 
0.54, 1.00 0.90, 1.00 0.91, 1.00 0.36, 1.00 0.90, 1.00 0.89, 1.00 
MCA 0.73 (8/11) 0.96 (53/55) 0.92 (61 /66) 0.64 (7/11) 1.00 (55/55) 0.94 (62/66) 
0.39, 0.94 0.87, 1.00 0.83, 0.97 0.31, 0.89 0.94, 1.00 0.85, 0.98 
ICA. 0.38 (8/21) 0.91 (50/55) 0.76 (58/76) 0.33 (7/21) 0.91 (50/55) 0.75 (57/76) 
0.18, 0.62 0.80, 0.97 0.65, 0.85 0.15, 0.60 0.80, 0.97 0.64, 0.84 
Postcirculation 0.75 (6/8) 0.98 (54/55) 0.95 (60/63) 0.63 (5/8) 0.98 (54/55) 0.94 (59/63) 
0.35, 0.97 0.90, 1.00 0.87, 0.99 0.24, 0.91 0-90, 1.00 0.85, 0.98 
Note. -Sensitivity = true- positive /(true- positive + false- negative). Specificity = true -negative /(true- negative + false-positive). The numbers in paren- 
theses are numbers of aneurysms. The two numbers on_the second line are 95% CIs. 
* Postcirculation = vertebrobasilar system. 
CT angiography and of 0.74 (95% CI: 
0.63, 0.86) for MR angiography (24). 
Small aneurysms were detected substan- 
tially less well at both CT angiography 
and MR angiography than aneurysms 
5.1 -10.0 mm and larger than 10 mm (Ta- 
ble 2). There was a trend toward greater 
diagnostic accuracy for vertebrobasilar 
and ACA circulation aneurysms com- 
pared with the accuracy for MCA or ICA 
aneurysms (Table 3); however, the CIs 
were wide owing to the relatively small 
numbers in each category. Examples of 
diagnostic difficulty relating to these sites 
are provided in Figures 2 and 3. 
Intracavernous (ie, carotid siphon) an- 
eurysms, unless they are giant, may not 
be clinically important, because they are 
extradural and do not cause SAH if they 
rupture. They can be difficult to detect 
because of the tortuosity of the carotid 
- Itudieleur 
arteries in the carotid siphon. Siphon an- 
eurysms accounted for 12 (11%) of all 
108 aneurysms in this study, but they 
accounted for 17 (25 %) of the 69 false - 
negative readings (seven for observer A, 
10 for observer B) and for three (7%) of 
the 44 false -positive readings (all ob- 
server B) at CT angiography. They ac- 
counted for 17 (16 %) of the 106 false - 
negative readings (seven observer A, 10 
observer B) and for one (4%) of the 22 
false -positive readings (observer B) at MR 
angiography. Removing these aneurysms 
from the analysis improved the accuracy 
per aneurysm slightly: at CT angiogra- 
phy, to 0.71 (128 of 180) and 0.76 (136 of 
179) for observers A and B, respectively, 
and at MR angiography, to 0.70 (121 of 
173) for both observers (Table 4). The 
effects on diagnostic accuracy of spiral 
versus nonspiral CT angiography, the 
availability of spin -echo imaging at MR 
angiography, and targeted maximum in- 
tensity reconstructions at both CT an- 
giography and MR angiography also are 
summarized in Table 4. 
At CT angiography, the accuracy per 
patient for contemporaneous examina- 
tions (performed within 1 week after in- 
traarterial DSA) was 0.83 (64 of 77) for 
observer A and 0.87 (67 of 77) for ob- 
server B versus 0.82 (53 of 65) and 0.86 
(56 of 65), respectively, for delayed exam- 
inations. At MR angiography, the accu- 
racy per patient for contemporaneous ex- 
aminations was 0.84 (54 of 64) for 
observers A and B versus 0.85 (66 of 78) 
for delayed examinations. The similarity 
of results for delayed and contemporane- 
ous examinations also applied on a per - 
aneurysm basis. 
Because clinically the most important 
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c. 
Figure 2. (a) Frontal (through the orbit) 15° 
oblique intraarterial DSA image shows a 3 -nun 
right MCA aneurysm (thick arrow), a slightly 
larger MCA bifurcation aneurysm (thin arrow), 
and a large anterior communicating artery an- 
eurysm (arrowhead). (b) Targeted maximum 
intensity projection CT angiograni, obtained 
in the same patient, at an angle comparable to 
that in a shows the MCA aneurysms (arrows) 
and the large anterior communicating artery 
aneurysm (arrowhead). The 3 -mm right MCA 
bifurcation aneurysm (thin arrow) was missed 
by both observers at CT angiography. (c) Tar- 
geted maximum intensity projection MR an- 
giogram (three -dimensional time -of- flight, 43/8, 
20° flip angle, 20 -cm field of view, one signal 
acquired, 256 x 512 matrix, acquisition time 
of 11 minutes 48 seconds), obtained in the 
same patient, from an angle comparable to 
that in a shows the MCA bifurcation aneu- 
rysms (arrows) and the large anterior commu- 
nicating artery aneurysm (arrowhead). The in- 
ferior 3 -mm right MCA aneurysm (thick arrow) 
was poorly demonstrated and was missed by 
both observers at MR angiography. 
categories of patients were those in groups 
I and 2- because they were much more 
likely to have aneurysms that required 
treatment -an assessment was made also 
to determine whether the clinical group 
influenced diagnostic performance by 
site and aneurysm size (ie, groups 1 and 2 
versus groups 3 and 4). These data are 
presented in Tables 2 and 3 and indicate 
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b. 
that although diagnostic accuracy was 
generally better in groups 3 and 4 com- 
bined, the differences were generally small, 
with widely overlapping 95% CIs be- 
tween the clinical groups. The only 
ceptions were the diagnostic accuraç t 
MR angiography of aneurysms 3 -S1mm 
for both observers and that at MR afigiog- 
raphy of MCA complex aneurysms for 
observer B: Accuracy was substantially 
greater in groups 3 and 4 than in groups 
1 and 2. 
For patients in groups 1 and 2 corn - 
bined, the accuracies per patient for CT 
angiography were 0.82 (49 of 60) (95% 
CI: 0.7, 0.9) and 0.85 (51 of 60) (95% CI: 
0.73, 0.93) for observers A and B, respec- 
tively. For patients in groups 3 and 4 
combined, the accuracies per patient for 
CT angiography were 0.83 (68 of 82) 
(95% CI: 0.73, 0.90) and 0.89 (73 of 82) 
(95% CI: 0.80, 0.95) for observers A and 
B, respectively. For MR angiography, the 
accuracies per patient for groups 1 and 2 
were 0.82 (49 of 60) (95% CI: 0.7, 0.9) 
and 0.83 (50 of 60) (95% CI: 0.71, 0.92) 
for observers A and B, respectively; for 
groups 3 and 4, this value was 0.87 (71 of 
82) (95% Cl: 0.77, 0.93) for both observ- 
ers. 
When observers were confident that an 
aneurysm was present or absent (confi- 
dence score 1 or 5, respectively, on a five - 
point scale), the proportion of cases in- 
terpreted correctly (ie, as true- positive or 
true- negative) at CT angiography was 
0.92 (85 of 92) for observer A and 0.78 
(124 of 159) for observer B. At MR an- 
giography, these proportions were 0.84 
(99 of 118) and 0.74 (114 of 154), respec- 
tively. When the observers believed that 
an aneurysm was probably present or ab- 
sent (confidence score of 2 or and 4, re- 
spectively), the proportion of cases inter- 
preted correctly at CT angiography was 
0.60 (46 of 76) for observer A and 0.50 
(nine of 18) for observer B; at MR angiog- 
raphy, these values were 0.44 (27 of 61) 
and 0.36 (10 of 28), respectively. When 
the observers were uncertain about the 
presence or absence of an aneurysm 
(score 3), the proportion of cases inter- 
preted correctly at CT angiography was 
0.29 (nine of 31) for observer A and 0.52 
(11 of 21) for observer B; for MR angiog- 
raphy, these values were 0.29 (four of 14) 
and 0.36 (four of 11), respectively. 
The difference in proportion of studies 
correctly interpreted (with 95% CI) in the 
uncertain (confidence score 3) category 
was compared with this proportion in 
the combined definite and probable cat- 
egories (confidence scores 1, 2, 4, and 5). 
For both observers and at both CT an- 
giography and MR angiography, the dif- 
ference in proportion interpreted cor- 
rectly was significantly poorer for the 
uncertain category compared with all 
other categories (P <. 05). 
DISCUSSION 
The results of this study confirm the 
equivalent diagnostic accuracy of CT an- 
giography and MR angiography in the 
detection of intracranial aneurysms. CT 
angiography and MR angiography have 
particularly good accuracy on a per -pa- 
tient basis; the mean accuracy of the two 
observers was 0.85. These data are in line 
with previously reported results but with 
more precise 95% CIs than most studies 
due to the large sample size (Table 1). In 
a systematic review of the literature on 
noninvasive imaging of intracranial an- 
eurysms (25), the accuracy per patient for 
CT angiography was 0.93 (range in indi- 
vidual studies, 0.81 [10] to 0.98 [26]) and 
for MR angiography, 0.89 (range in indi- 
vidual studies, 0.78 [27] to 1.00 [28]). The 
accuracy per aneurysm (mean of the two 
observers) for both modalities was simi- 
lar: 0.72 for CT angiography and 0.67 for 
MR angiography. These results are poorer 
than those reported in most previous 
studies. For example, for the studies in- 
cluded in the same systematic review, the 
overall accuracy per aneurysm was 0.89 
for CT angiography (range in individual 
studies, 0.73 [6] to 0.98 [26]) and 0.90 for 
MR angiography (range in individual 
studies, 0.7 [8] to 0.97 [9]). The MR an- 
giographic studies involved time-of -flight 
or phase- contrast MR angiography, not 
contrast material- enhanced MR angiog- 
raphy. 
There are several possible reasons for 
this discrepancy, including the aneurysm 
size distribution, prospective study de- 
CT Anglography and MR Anglography of Intracranial Aneurysms 745 
dower prevalence of aneurysms, 
-m-- -- -- 
i7n to image analysis, complete 
blind - 
,ufimage 
review, and use of film hard- 
! images alone for review in this 
y, In addition, there may be a trend 
.chnology assessment toward small, 
/publications, with highly selected 
alations producing more optimistic 
jl than later larger studies. For the 
loses of the study, we deliberately 
widely available and established clin- 
imaging protocols rather than rapidly 
long "cutting- edge" techniques such 
1st gradient -echo' contrast -enhanced 
,rngiography. The fact that the equip- 
used for the current study is now 
Lively out of date and pro4%icegclower 
Wry images relative to advanced tech - 
agy did not affect the comparison of 
study data with those in the litera- 
because equivalent technology was 
for virtually all the studies pub - 
Rd to the end of 1998. Such equip- 
!( will be replaced gradually and con - 
>ein use for some time in many parts 
fie world; therefore, these data are 
want to many radiologists. 
me -of -flight MR angiography does 
depict some aneurysms. This is 
ioly because of spin saturation sec-. 
Jary to slow flow and /or phase dispéf- 
a effects due to turbulent flow in an 
nrysm (29). In such turbulent or slow 
1/ areas, rapid gradient -echo tech - 
4s with very short repetition and 
Ames and gadolinium -enhanced im- 
ng enable flow -independent imaging 
blood, greatly reduce turbulence arti- 
s, and eliminate in -plane saturation 
ihts (30 -32). Such techniques have 
eused in recent years in studies of the 
-t, cervical arteries, and other aortic 
eches. Owing to the problems of data 
fatsition timing to obtain precise fill - 
!of central k space (the low spatial 
quency data) at the time of maximal 
erial contrast material concentration 
the vascular bed of interest, contrast - 
danced MR angiography has not al- 
p proved superior to time -of -flight 
tangiography (33). Current technical 
aelopments such as fluoroscopic trig- 
=mg or temporally resolved contrast - 
lanced MR angiography may solve 
u problem and thereby facilitate the 
ae general clinical use of contrast -en- 
inced MR angiography (34). 
luprisingly, until recently, little infor- 
hon was available on the in vivo clin- 
d use of ultrafast contrast- enhanced 
langiography for the detection of in- 
tcranial aneurysms (35). In a very re- 
st (to our knowledge, the first) pro- 
active study (35) involving 32 patients, 
a. b. 
c. 
Figure 3. (a) Cranial anteroposterior 15° intraarterial DSA 
image shows a 2 -mm aneurysm 
(arrow) of the right intracavemous carotid artery. (b) On 
the targeted maximum intensity 
projection CT angiogram, obtained in the same patient, at 
an angle comparable to that in a, the 
site of the 2 -mm aneurysm of the right intracavemous carotid 
artery is indicated (arrow), but the 
aneurysm cannot be readily appreciated. (c) On the collapsed maximum 
intensity projection MR 
angiogram in the coronal plane (three -dimensional time -of- 
flight, 43/8, 20° flip angle, 20 -cm 
field of view, one signal acquired, 256 x 512 matrix, acquisition 
time of 11 minutes 48 seconds), 
similar to findings in b, the site of the 2 -mm aneurysm of 
the right intracavernous carotid artery 
is indicated (arrow), but the aneurysm cannot be readily appreciated. 
17 of whom had a total of 23 aneurysms, 
contrast -enhanced MR angiography had 
greater sensitivity than did time -of -flight 
MR angiography (100% vs 96%) but 
poorer specificity (94% vs 100 %); both 
the sensitivity and specificity with the 
state -of- the -art MR imaging unit used in 
this small series were impressive. Results 
of a recent in vitro study (29) of an an- 
eurysm model also indicated the advan- 
tage of ultrafast contrast -enhanced MR 
angiography over time -of -flight MR an- 
giography. Multisection CT with submil- 
limeter collimation, which offers im- 
proved spatial resolution and reduced 
overlap from venous structures as a result 
of rapid scanning, may further improve 
CT angiography accuracy, although pro- 
spective clinical studies have not yet been 
performed to confirm this. 
In this study, 72 (67%) of 108 aneu- 
rysms were small ( <_5 mm). Small aneu- 
rysms are much harder to detect than are 
larger aneurysms; for example, a sensitiv- 
ity of 25% for detection of aneurysms 
smaller than 3 mm versus 92% for detec- 
tion of larger aneurysms (36) and an ac- 
curacy for detection of small aneurysms 
as low as 0.56 (37) have been reported at 
MR angiography. Many previous studies 
have not provided detailed information 
on aneurysm size, and those that have 
had a greater proportion of aneurysms 
larger than 5 mm. Nearly all of the false- 
k' Radiology June 2001 
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TABLE 4 
Effect- of- Imaging -Variables on the-Diagnostic Accuracy of CT Arrgiography-artd MR Ar giographÿ 
Imaging Variable* 
Per Patient Per Aneurysm 
CT Angiography MR Angiography CT Angiography MR Angiography 
Removal of patients with a vessel 
segment not adequately seen 
Observer A 0 (0.82, 110/134) -0.01 (0.84, 102/121) 0 (0.7, 129/182) +0.01 (0.68, 111/163) 
Observer B - 0.03 (0.84, 85/101) 0 (0.85, 76/89) -0.03 (0.7, 93/1 33) +0.05 (0.71, 80/11 2) 
Spiral CT angiography 
Observer A +0.02 (0.84, 103/122) +0.02 (0.72, 123/171) 
Observer B 0 (0.87, 106/122) 0 (0.73, 122/168) 
Nonspiral CT angiography 
Observer A -0.12 (0.7, 14/20) -0.09 (0.61, 17/28) 
Observer B +0.03 (0.9, 18/20) 0 (0.73, 22/30) 
Spin -echo MR imaging plus MR 
angiography 
Observer A -0.01 (0.84, 69/82) +0.02 (0.69, 76/110) 
Observer B 0 (0.85, 70/82) 0 (0.66, 74/112) 
MR angiography only 
Observer A 0 (0.85, 51/60) -0.02 (0.65, 54/83) 
Observer B o (0.85,51/60) +0.01 (0.67, 54/81) 
Targeted MIP available 
Observer A -0.01 (0.81, 82/101) -0.01 (0.84, 59/70) -0.05 (0.65, 96/147) -0.03 (0.64, 64/100) 
Observer B -0.01 (0.86, 87/101) -0.02 (0.83, 58/70) -0.05 (0.68, 100/146) -0.03 (0.63, 62/98) 
Targeted MIP unavailable 
Observer A +0.03 (0.85, 35/41) 0 (0.85, 61/72) +0.15 (0.85, 44/52) +0.05 (0.72, 66/92) 
Observer B +0.03 (0.90, 37/41) +0.03 (0.88, 63/72)1 +0.12 (0.85, 44/52) +0.03 (0.69, 66/95) 
Removal of intracavernous 
(extradural) aneurysms 
Observer A +0.01 (0.83, 109/131) +0.01 (0.86, 113/131) +0.01 (0.71, 128/180) +0.03 (0.70, 121/173) 
Observer B +0.03 (0.90, 118/131) +0.01 (0.86, 113/131) +0.03 (0.76, 136/179) +0.04 (0.70, 121/173) 
Note. -Data are the changes in diagnostic accuracy values,. The first number in parentheses is the diagnostic accuracy found in relation to the imaging 
variable in the first column. The second set of numbers in parentheses comprises the proportion of patients or aneurysms (of the total number) with 
correct interpretations used to calculate the accuracy. 
* MIP = maximum intensity projection. - 
negative results in the present study were 
for aneurysms 5 mm or smaller and were 
proportionately concentrated among those 
smaller than 3 mm. The diagnostic per- 
formance of CT angiography and MR an- 
giography for detection of aneurysms 
larger than 5 mm was excellent in pa- 
tients with acute SAH or known aneu- 
rysm and those without these abnormal- 
ities (Table 2). Although aneurysms larger 
than 5 mm comprised 33% (36 of 108) 
of the aneurysms in this series, they ac- 
counted for only 6% (four of 69 at CT 
angiography) to 9% (10 of 106 at MR 
angiography) of the false- negative read- 
ings and 4% (two of 44 at CT angiog- 
raphy) to 9% (two of 22 at MR angiogra- 
phy) of the false -positive readings. Con- 
versely, very small aneurysms ( <3 mm) 
comprised 22% (22 of 108) of all aneu- 
rysms, yet they accounted for 34% (36 of 
106 at MR angiography) to 41% (28 of 69 
at CT angiography) of the false- negative 
readings and 64% (28 of 44 at CT angiog- 
raphy) to 68% (15 of 22 at MR angiogra- 
phy) of the false -positive readings. 
The population in the present study 
may have contributed to the poorer re- 
sults per aneurysm than those previously 
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reported. We sought to recruit patients 
who did not have a known aneurysm or 
acute SAH (as well as acute SAH cases), 
because one cannot assume that the im- 
aging results from previous studies in a 
high aneurysm prevalence population 
will necessarily be the same in lower 
prevalence population groups. In the 
present study, 60 (42 %) of 142 patients 
had a known aneurysm or proved SAH, 
and the overall aneurysm prevalence was 
63 (44 %) of 142 patients. This is low 
compared with the results in most of the 
previous studies, in which the aneurysm 
prevalence was 75% or greater in the ma- 
jority of cases (2,6,8- 11,17,18,20,27,38 - 
44). There is evidence that increasing 
disease prevalence can lead to an im- 
provement in the sensitivity and specific- 
ity of an examination, whereas it had 
previously been thought that increasing 
prevalence only influenced the predic- 
tive values (45). 
If nearly all the patients in a study are 
known to have an aneurysm or SAH, this 
could lead to observer expectation bias. 
The distribution of subarachnoid blood 
may provide a strong clue to the presence 
and /or site of an aneurysm, as may a 
local hematoma or the presence of hy- 
drocephalus. However, this advantage 
may be offset by the potential to obtain 
poorer quality images in sick, restless pa- 
tients with acute SAH: The long acqui- 
sition time of three -dimensional time - 
of -flight MR angiography makes these 
patients particularly susceptible to this 
problem (Fig 2). Our study data support 
this conclusion, because the diagnostic 
performance of CT angiography and MR 
angiography was consistently slightly 
better in clinical groups 3 and 4 than in 
groups 1 and 2 (Tables 2 and 3). Asymp- 
tomatic patients are more likely to have 
small aneurysms compared witlipatients 
who have an SAH. Aneurysms 5 nun or 
smaller accounted for one -third of all the 
aneurysms in one large study (46) involv- 
ing asymptomatic patients with unrup- 
tured aneurysms, and they accounted for 
72 (67 %) of the 108 aneurysms in the 
current study. As expected, in group 2 
(with recent SAH), aneurysm prevalence 
was greater and the aneurysms were on 
average larger: 21 (40 %) of 53 aneurysms 
were smaller than 5 mm compared with 
10 (22%) of 45 aneurysms in groups 3 
and 4. 
--Irrclinical practice; which-we- attempted - 
to reproduce in this study, a single reader 
of a diagnostic imaging study is usuaL 
Some earlier studies (10,11,15- 17,26,28, 
39,42 -44,47 -53) involved consensus re- 
view by two or more readers in the anal- 
ysis of accuracy; this could result in better 
accuracy and therefore a positive bias to- 
ward the noninvasive methods. It was 
reassuring to find that in a large prospec- 
tive blinded study, interobserver agree- 
ment was good for both CT angiography 
and MR angiography. It was somewhat 
surprising, however, that we did not find 
any advantage in using targeted maxi- 
mum intensity projection reconstructions 
at either CT angiography or MR angiogra- 
phy (Table 4). One potential limitation of 
this study was the delay in some cases 
between intraarterial DSA and CT an- 
giography or MR angiography (see Mate- 
rials and Methods). A delay of several 
weeks between intraarterial DSA and the 
noninvasive study could result in an an- 
eurysm clotting or not being seen at in- 
traarterial DSA recanalization. This could 
result in a false -negative or false -positive 
result for the noninvasive examination 
when in fact it was a true- negative or 
true- positive study. In the current study, 
however, this effect appeared to be very 
small, as indicated by the results of a 
comparison of contemporaneous CT an- 
giography and MR angiography with de- 
layed examinations. 
In the small subgroup of 18 asymp- 
tomatic patients, 12 had a total of 21 
aneurysms, three of which were larger 
than 5 mm. Probably reflecting this size 
distribution, CT angiography and MR an- 
giography performed poorly in this pa- 
tient subgroup, with mean sensitivities 
per patient of 0.67 (16 of 24 at CT angiog- 
raphy) and 0.55 (23 of 42 at MR angiog- 
raphy) and mean accuracies per patient 
of 0.75 (27 of 36 at CT angiography) and 
0.69 (25 of 36 at MR angiography). There- 
fore, in a low -prevalence asymptomatic 
population (eg, one undergoing nonin- 
vasive examinations for aneurysm screen- 
ing), one can expect considerably poorer 
diagnostic performance. The accuracy 
per patient was 12% (at CT angiography) 
to 27% (at MR angiography) lower in the 
"screening" subgroup (group 4) than that 
in the other subgroups combined: 0.72 
(13 of 18) versus 0.84 (104 of 124) at CT 
angiography and 0.61 (11 of 18) versus 
0.88 (109 of 124) at MR angiography for 
the observer with the largest such effect 
(observer A). 
A number of important lessons for the 
use of noninvasive examinations for an- 
eurysm detection were highlighted in 
this- study. First, .diagnostic performance 
is substantially limited by aneurysm size. 
Second, at certain sites, particularly those 
where there is considerable vessel overlap 
or adjacent bone (such as the' cavernous 
and terminal ICA segments or the MCA 
bifurcation), both CT angiography and 
MR angiography perform more poorly. A 
higher than expected numbeer of false -pos- 
itive readings were related to very small 
MCA aneurysms, and a higher than ex- 
pected proportion of false -negative read- 
ings were related to IÇA aneurysms. 
Therefore, caution should be exercised in 
the interpretation of small aneurysms 
arising from the MCA bifurcation or the 
intracranial ICA and its branches at CT 
angiography or MR angiography, partic- 
ularly if observer confidence is Iow. 
In light of these data and those in the 
literature (25), we believe that current 
standard clinical CT angiography aiMR 
angiography cannot yet safely rep /lace in- 
traarterial DSA in the diagnostic work -up 
of patients with acute SAH because of the 
low sensitivity of these modalities in the 
detection of small aneurysms; however, 
these, examinations may be useful ad- 
juncts (26). It is well recognized that small 
aneurysms can rupture, and the potential 
adverse consequences to the patient of 
missing such an aneurysm at CT angiog- 
raphy and /or MR angiography performed 
instead of intraarterial DSA are severe. In 
this clinical setting, a false- positive result 
would have less serious consequences, 
provided that confirmatory intraarterial 
DSA was performed before aneurysm 
treatment in all positive cases. For pa- 
tients with symptoms that are strongly 
suggestive of an aneurysm, we believe 
that although both CT angiography and 
MR angiography can help exclude the 
presence of an aneurysm larger than 5 
mm (ie, one likely to be large enough to 
cause compressive symptoms) fairly reli- 
ably, intraarterial DSA should be consid- 
ered the investigation of choice, because 
a negative CT angiogram or MR angio- 
gram cannot completely ensure the diag- 
nosis, and a positive study will lead to 
intraarterial DSA. 
When clinical suspicion of aneurysm 
as the cause of the symptoms is low, a 
noninvasive examination alone is ade- 
quate, provided both the patient and cli- 
nician can accept the uncertainty that a 
small aneurysm ( <5 mm) has not been 
excluded. In light of the International 
Study of Unruptured Intracranial Aneu- 
rysms Investigators data (54), only aneu- 
rysms larger than 10 mm should be con- 
sidered for treatment in asymptomatic 
patients with no prior history of SAH. 
Therefore,_ at-risk patients may be ade- 
quately examined by using CT angiogra- 
phy or MR angiography alone, but again, 
only if both the patient and the dinician 
can accept the uncertainty about small 
aneurysms. We emphasize that according 
to the best available evidence, the exam- 
ination of asymptomatic at -risk patients 
is not routinely indicated (5). 
In conclusion, CT angiography and 
MR angiography are equally accurate in 
the detection of intracranial aneurysms, 
and aneurysms 5 mm or smaller are de- 
tected substantially less well than are 
those larger than 5 mm. Accuracy on a 
per -patient basis is better than that on a 
per -aneurysm basis. Interobserver agree- 
ment is good for both modalities. Using a 
simple confidence scoring system is a 
useful means of determining individual 
cases in which the noninvasive examina- 
tion is likely to be less reliable. In a 
screening situation, accuracy is expected 
to be lower than the overall per -patient 
accuracy level of 0.85 that was achieved 
in this study. 
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Abstract 
Objectives -To determine whether com- 
bining non -invasive tests for intracranial 
aneurysms together would significantly 
improve aneurysm detection over indi- 
vidual tests. 
Methods -114 patients undergoing intra- 
arterial digital subtraction angiography to 
confirm or exclude an intracranial aneu- 
rysm were also examined by CT angio- 
graphy, MR angiography, and transcranial 
power Doppler ultrasound. The reviewers 
and ultrasonographers were blinded to the 
angiogram result, other imaging results 
and all clinical information. 
Results -The combination of non- 
invasive tests did improve diagnostic per- 
formance on a per patient basis. The 
combination of power Doppler and CT 
angiography had the greatest sensitivity 
for aneurysm detection (0.83; 05% confi- 
dence interval (95% CI) 0.66 -0.93) and the 
level of agreement for this strategy with 
the reference angiographic standard was 
excellent (x 0.84; 95% CI 0.72 -0.95). The 
improvement in sensitivity of adding 
power Doppler to CT angiography was not 
significant (p =0.55) but the improvement 
in the level of agreement with the refer- 
ence standard was substantial. However, 
even the most sensitive combination strat- 
egy performed poorly in the detection of 
small (3 -5 mm) and very small (<3 mm) 
aneurysms with a sensitivity of 0.43 (95% 
CI 0.23 -0.66) and 0.00 (95% CI 0.00 -0.31) 
respectively. 
Conclusions -The addition of transcra- 
nial power Doppler' ultrasound to either 
CT angiography4 MR angiography does 
improve diagnostic performance on a per 
patient basis but aneurysms of 5 mm or 
smaller can still not be reliably identified 
by current standard clinical non -invasive 
imaging modalities. 
(.7 Neurol Neurosurg Psychiatry 2001;71:322 -328) 
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The accepted reference standard method for the 
identification of intracranial juaeurysms is intra- 
arterial digital subtraction angiography 
( IADSA).'-' The rate of permanent neurological 
complication in patients investigated for a 
suspected aneurysm with IADSA is 0.07 %,' but 
it is a time consuming, invasive, and relatively 
expensive technique. Consequently consider- 
able interest has developed in the role of 
non -invasive imaging methods in the detection 
of intracranial aneurysms.' Numerous studies 
have compared non -invasive techniques such as 
MR angiography, CT angiography, or transcra- 
nial Doppler ultrasound (TCD) to IADSA.6 
These have found similar overall accuracy/ 
aneurysm for CTA and MRA of about 90% but 
with sensitivity ranging from 0.67 (95 %CI 
0.55 -0.78)' to 1.0 (95 %CI 0.85 -1)8 for CTA 
and 0.70 (95 %CI 0.5- 0.86)9 to 0.97 (95 %CI 
0.87 -1)1° for MRA. The data on TCD are much 
more limited but overall accuracy /aneurysm 
appears lower, in the range 0.57 " -0.80.' The 
main drawback of all the non -invasive tests has 
been their low sensitivity compared with 
IADSA, particularly for small aneurysms (those 
mm in maximum diameter). 
Despite its possible limitations as an isolated 
investigation, TCD is an attractive technique in 
the investigation of intracranial aneurysms par- 
ticularly in "screening" for unruptured aneu- 
rysms because of its safety, rapidity, repeatabil- 
ity, mobility, and lower cost compared with the 
other techniques." Our aim, therefore, was to 
determine, in a fully blinded prospective study, 
whether a strategy utilising a combination of 
power TCD and either CTA or MRA, or CTA 
and MRA, could improve the sensitivity of a 
non -invasive investigation strategy for intracra- 
nial aneurysms. We also wished to determine 
which tests were preferred by patients. 
Subjects and methods 
Approval for the study was obtained from the 
appropriate hospital ethics committees and 
written informed consent was obtained from 
participants. 
PATIENTS 
The study was conducted in two regional 
neuroscience centres serving a population of 4.2 
million. Patients undergoing cerebral angio- 
graphy for the detection of a possible intracra- 
nìal aneurysm were eligible for inclusion. Exclu- 
sion criteria were patients with a poor grade of 
subarachnoid haemorrhage (World Federation 
of Neurosurgeons grade 3 or worse) because 
obtaining informed consent was not possible, 
patients with an absolute contraindication to 
one of the examinations, or patients less than 18 
or older than 75 years of age. Two hundred con- 
secutive patients meeting the inclusion criteria 
and who agreed to participate were recruited 
prospectively over an 18 month period, of whom 
173 underwent CTA, 152 MRA, and 171 TCD 
as well as IADSA examination. One hundred 
and thirty (65 %) patients underwent all three 
non -invasive tests but of these, five were 
excluded because they were unable to complete 
the MRA examination and a further 11 patients 
had an inadequate bone window on TCD so 
were also excluded, resulting in our study popu- 
lation=af 114-patients (55 men and 59 wot err); 
median age 41 (range 19 -71 years). Imaging 
studies were performed contemporaneously 
(within a week of IADSA) if at all possible, and 
within a maximum of 2 months from the time of 
IADSA; 54% of CTA, 45% of MRA, and 61% 
o .. . 
poraneously, with a further 6 %, 4 %, and 8% 
respectively being performed within 2 weeks of 
IADSA. 
Patients were grouped into four categories 
based on the clinical indication for cerebral 
angiography. Group 1 comprised three patients 
with a known aneurysm(s) undergoing further 
assessment; group 2, 44 patients with proved 
subarachnoid haemorrhage; group 3, 52 pa- 
tients with symptoms which might be due to an 
aneurysm, and group 4, 15 asymptomatic 
patients at risk of harbouring an aneurysm. 
IMAGE ACQUISITION 
Neuroradiologists performed all IADSA ex- 
aminations using GE Advantx angiographic 
equipment (IGE Ltd, Milawaukee, USA). The 
IADSA studies were three or four vessel selec- 
uve angiograms with multiple projections 
obtained for each vessel. 
CTA TECHNIQUE 
Spiral CTA examinations were performed on 
Elscint Twin or GE HiSpeed machines using a 
standard technique.' 100 ml non -ionic contrast 
were given by pump injector into an antecu- 
bital vein at 3m1/s with an 18 -20s delay. Exam- 
ination protocol was 12.0 kV, maximum tube 
current allowed, 512x512 matrix, 15 cm FOV, 
1 mm collimation, and pitch of 1.5 with 0.5 
mm reconstruction interval. For logistical 
reasons, a few patients (12) had a non -spiral 
CTA performed on an Elscint 2400 Elite scan- 
ner. Conventional axial CTA was performed 
dynamically using 2.5 mm slice width with 1 
mm table increment, 120 kV, 400 mAs, 20 cm 
FOV. Scanning started after 50 ml contrast had 
been injected rapidly by hand with a further 50 
ml injected during scanning.' 
MAGNETIC RESONANCE ANpIOGRAPHY TECHNIQUE 
Magnetic resonance argiography examinations 
were performed on ¡Mint Prestige 2T or Sie- 
mens Magnetom 91X1.5T machines using 3D 
time of flight (TOF) MRA sequences with 
MTS and TONE followed by a T2 FSE axial 
sequence using a standard technique. On the 
Prestige, settings were TR 40 ms, TE 6 ms, flip 
angle 300, FOV 15x20 an, 204x300 matrix, 
NEX 1, TA =7:53. On the Magnetom, settings 
were TR 43 ms, TE 8 ms, flip angle 200, FOV 
20 cm, 256/512/ oversampled matrix, NEX =1, 
TA= 11.48. Neuroradiologists supervised all 
CTA and MRA examinations. 
ULTRASOUND TECHNIQUE 
Transcranial power Dopplet ultrasound exami- 
nations were performed on Acuson 128XP 
machines using 2 -2.5 MHz multihertz linear 
transducers (Acuson, Mountain View, Califor- 
nia, USA). Identical imaging settings were used 
on the machine in each centre. Transcranial 
Doppler examinations were performed via the 
temporal bone window to insonate the circle of 
www.jnnp.com 
Willis in the axial and coronal planes. " -1' The 
transnuchal and transorbital routes were not 
routinely employed and intravenous echo con- 
trast was not used. Each major intracranial 
vessel segment was examined systematically 
al Do .ler ultrasound. . . . 
Aneurysm size was determined on a frozen 
image using electronic calipers. A video record 
of each examination was made and a standard 
result proforma sheet was completed at the end 
of each examination. Ultrasonographers com- 
prising two neuroradiologists and three neuro- 
radiographers (two very experienced in power 
transcranial Doppler and three less experi- 
enced), were blinded to clinical data and the 
results of all other imaging investigations 
including plain CT and IADSA results. 
POSTPROCESSING OF IMAGES 
For CTA studies, reformatting of source 
images was performed by a neuroradiology 
research fellow on offline workstations without 
review of the IADSA study before performing 
reformats (Silicon Graphics 02 Omnipro or 
GE Advantage Windows). Standard axial, 
corona] oblique, and curved sagittal multipla- 
nar reformats were performed on the Omni - 
pro.' "Angio MIP" (maximum intensity pro- 
jection) reconstructions were also performed 
(12 projections at 15° intervals in both "head 
over heels" and "left to right" projections), with 
bone editing by thresholding and manual 
cutting. Targeted MIPs were performed of the 
right and left internal carotid circulations and 
the vertebrobasilar system. The total time 
taken for these reconstructions was typically 
20 -25 minutes. On the advantage windows 
workstation, axial, coronal oblique, and sagittal 
overlapping thick slab MIP images (8 -10 mm 
at 3 -4 mm increments) were performed, with 
additional manual bone editing as required.' 
Reconstruction time was less than 10 minutes 
unless manual bone editing was required. For 
MRA, standard MIP reconstructions were per- 
formed at 15° intervals through 180° (in "head 
over heels" and "left to right" projections) at 
the time of examination by the neuroradiogra- 
pher performing the examination. Targeted 
MIP reconstructions were performed for ex- 
aminations performed on the Prestige ma- 
chines on the Omnipro workstation, as in the 
CTA technique. Source images were available 
to reviewers for CTA and MRA examinations. 
IMAGE REVIEW 
The IADSA images were presented on hard 
copy as anonymised, randomly numbered 
studies with no clinical details or results of 
other imaging for independent review by two 
consultant neuroradiologists (JMW, ET). 
Where disagreements arose these were resolved 
by consensus review. For TCD, the report 
completed at the end of each examination was 
used for the comparison with IADSA. The 
CTA and MRA studies were presented in an 
anonymised, random fashion to the same two 
neuroradiologists, they were reviewed sepa- 
rately and at least 4 months elapsed between 
review of an angiogram and reviewing the non- 
invasive studies on the same patient. For the 
Table I Diagnostic performance per patient for different imaging strategies 
Strategy Sensitivity (95% CI) (TP/TP+FN) Specificity (95% CI) (7N /TN +FP) 
CTA* 0.80 (0.65-0.90) (36/45) 0.91 (0.82 -0.97) (63/69) 
MRA* 0.71 0.56-0.84 32/45 0 I *t- Is 
TCD 0.73 (0.58-0.85) (33/45) 0.91 (0.82 -0.97) (63/69) 
CTA+TCD 0.83 (0.66-0.93) (29/35) 0.98 (0.91 -1.00) (58/59) 
MRA+TCD 0.76 (0.59-0.88) (28/37) 1.00 (0.94 -1.00) (61/61) 
CTA+MRA 0.79 (0.64-0.91) (31/39) 1.00 (0.94 -1.00) (61/61) 
*Results used for CTA and MRA were those of the "better" observer, although the results for both 
observers were very similar (see note in discussion). For the "poorer" observer, sensitivity per 
patient (PP) was 0.82 and 0.71 for CTA and MRA respectively. For combination strategies, sen- 
sitivity PP was 0.86, 0.79, and 0.85 for CTA +TCD, MRA+TCD, and CTA +MRA respectively. 
Where tests disagreed, the result was classified as "uncertain ", necessitating confirmatory IADSA 
rather than being classified as a true positive (T1'), true negative (1N), false positive (FP), or false 
negative (FN) result. For CTA +TCD there were 20 "uncertain" cases, 16 for MRA +TCD and 14 
for CTA +MRA. 
Table 2 Diagnostic performance per aneurysm for non-invasive imaging tests 
Size of Sensitivity (95% CI) Specificity (95% CI) 
Modality aneurysm (77'17P +FN) (TN /7N +FP) 
CTA <3 mm 0.40 (0.19 -0.64) (8/20) 0.91 (0.82 -0.97) (63/69) 
3 -5 mm 0.56 (0.40 -0.72) (22/39) 0.88 (0.78 -0.94) (63/72) 
5.1 -10 mm 0.83 (0.52 -0.98) (10/12) 0.98 (0.91 -1.00) (63/64) 
>10mm 1.00 (0.72 -1.00) (11 /11) 1.00 (0.94 -1.00) (63/63) 
All sizes 0.62 (0.51 -0.73) (51/82) 0.80 (0.69 -0.88) (63/77) 
MRA <3 mm 0.15 (0.03 -0.38) (3/20) 0.93 (0.85-0.98) (67/72) 
3-5 mm 0.38 (0.23 -0.55) (15/39) 0.99 (0.92 -1.00) (67/68) 
5.1 -10 mm 0.75 (0.43 -0.95) (9/12) 1.00 (0.95 -1.00) (67/67) 
>10mm 0.91 (0.59 -1.00) (10/11) 1.00 (0.95 -1.00) (67/67) 
All sizes 0.45 (0.34 -0.57) (37/82) 0.92 (0.83 -0.97) (67/73) 
TCD* <3mm 0.15 (0.03 -0.38) (3/20) 
3-5 mm 0.36 (0.21 -0.53) (14/39) 
5.1 -10 mm 0.42 (0.15 -0.72) (5/12) 
>10mm 0.64 (0.31 -0.89) (7/11) 
All sizes 0.35 (0.25 -0.47) (29/82) 0.73 (0.63 -0.82) (63/86) 
*For TCD, size categorisation was not available for all the false positive cases; therefore, specifi- 
city and accuracy could not be determined by aneurysm size category. 
purpose of subgroup analysis, aneurysms were 
grouped into four size categories: (1) <3 mm 
maximum angiographic dimension, (2) 3 -5 
mm, (3) 5.1 -10 mm, and (4) >10 mm. 
PATIENT 11 ABACK 
All participants were sent a questionnaire 1 -2 
weeks after completing the study examinations. 
This asked them to grade the discomfort expe- 
rienced during each test on a 10 cm long visual 
analogue scale (0 being no discomfort and 10 
being as uncomfortable or painful as they have 
ever experienced) arid to rank the three 
non -invasive tests ír order of preference. A 
prepaid and addred envelope was provided 
with the questionnaire. 
STATISTICAL METHODS 
2x2 tables were constructed of true positives, 
false positives, false negatives, and true negatives 
for each modality compared with the gold 
standard (IADSA) on a per patient and per 
aneurysm basis. Sensitivity, specificity, positive 
and negative predictive values, and accuracy 
were calculated and compared on a per patient 
and a per aneurysm basis for the following 
investigative strategies: (a) C[TA alone, (b) MRA 
alone, (c) TCD alone, (d) CTA +TCD, (e) 
MRA +TCD, and (j CTA +MRA. Per patient 
basis means the ability to correctly discriminate 
a patient as true $iositive or true negative for 
possession of at least one intracranial aneurysm 
and per aneurysm basis the ability to correctly 
identify all aneurysms. Exact 95% confidence 
intervals (95% CIs) based on binomial prob- 
abilities were calculated :1ó Unweighted K statistic - 
w.. 1.4 , LI, w 
was used to assess the level of intermodality and 
interobserver agreement." A x value of -0.20 
implies poor agreement, of 0.21 -0.40 fair agree- 
ment, of 0.41 -0.60 moderate agreement, of 
good agreement." 
Results 
Three patients experienced minor complica- 
tions from IADSA (one groin haematoma and 
two nausea and vomiting); one had a moderate 
delayed contrast reaction after CTA (that 
responded rapidly to oral antihistamine and 
steroid); two patients experienced claustropho- 
bia during MRA but were able to complete the 
examination and five patients were unable to 
tolerate the MRA examination; one patient 
reported mild scalp discomfort from the TCD 
probe. 
The diagnostic performance of both observ- 
ers (for CTA and MRA) was similar and there 
was good interobserver agreement for CTA 
and MRA, with x values of 0.69 (95% CI 0.56- 
0.83) and 0.73 (95% CI 0.60 -0.87) respec- 
tively. Overall, observer B had slightly better 
results with an accuracy per patient of 0.87 
(95% CI 0.79 -0.92) for both CTA and MRA 
compared with 0.81(95% CI 0.72 -0.87) for 
CTA and 0.84 (95% CI 0.76 -0.90) for MRA 
for observer A. The results of observer B were 
used to evaluate further the different possible 
non -invasive imaging strategies. 
The sensitivity and specificity of the different 
imaging strategies are given in full on a per 
patient basis in table 1. The sensitivity for 
CTA +TCD was 0.83 (95% CI 0.66 -0.93); for 
MRA +TCD it was 0.76 (95% CI 0.59 -0.88) 
and for CTA +MRA it was 0.79 (95% CI 0.64- 
0.91). Table 2 relates the performance of the 
non -invasive tests on a per aneurysm basis to 
the aneurysm size and shows that CTA and 
MRA performed substantially better than 
TCD forlarger aneurysms and that each non- 
invasive method performed much worse in the 
detection of small aneurysms. Table 3 indicates 
the effect on sensitivity on a per aneurysm basis 
from combining non -invasive tests together. 
Sensitivity was reduced on a per aneurysm 
basis by combining tests together, the methods 
frequently disagreed on the presence of an 
individual aneurysm or on the precise location 
and size of aneurysm (as indicated by the 
number of cases falling into the "uncertain" 
category). 
Despite the trend demonstrated for a combi- 
nation of tests to improve the sensitivity and 
overall accuracy of non -invasive imaging on a 
per patient basis, the extent of improvement 
did not reach significance. The statistical 
parameters for the increase in sensitivity of 
adding TCD to CTA, TCD to MRA, and 
MRA to CTA were respectively p =0.55 (x: 
0.37), 0.50 (xz 0.46), and 0.95 (x2 0.004) and 
for the improvement in accuracy were 0.16 (x' 
1.95), 0.18 (x' 1.75), and 0.18 (x2 1.75). 
The level of agreement for each method with 
the reference standard and with the other non- 
invasive tests was determined using the x value 
(with 95% CI calculated in all cases). This 
method was also-used-to determine the level =of 
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Sensitivity (95% CI) 
(TPITP+FN) 
Specificity (95% CI) 
(TNITN +FP) 
tam 1.11 1,11 1, 1 1 
(64 "uncertain ") 3 -5 tim 0.43 (0.23 -0.66) (10/23) 
5.1 -10 mm 0.71 (0.29 -0.96) (5/7) 
>10mm 1.00 (0.59 -1.00) (7/7) 
All 0.47 (0.32 -0.62) (22/47) 0.95 (0.86-0.99) (58/61) 
MRA+TCD* <3 tam 0.00 (0.00 -0.22) (0/15) 
(55 "uncertain") 3 -5 mm 0.26 (0.10 -0.48) (6/23) 
5.1 -10 mm 0.63 (0.24-0.91) (5/8) 
>10nm 1.00 (0.54 -1.00) (10/10) 
All 0.38 (0.25 -0.51) (21/56) 0.97 (0.89 -1.00) (61/63) 
CTA+MRA <3 mm 0.20 (0.04-0.48) (3/15) 0.98 (0.91 -1.00) (61/62) 
(34 "uncertain") 3 -5 mm 0.50 (0.31 -0.69) (15/30) 1.00 (0.94 -1.00) (61/61) 
5.1 -10 mm 0.89 (0.52 -1.00) (8/9) 1.00 (0.94 -1.00) (61/61) 
>10mm 1.00 (0.69 -1.00) (10 /10) 1.00 (0.94 -1.00) (61/61) 
All 0.56 (0.43-0.69) (36/64) 0.98 (0.91 -1.00) (61/62) 
"Uncertain" indicates that the tests disagreed about the presence of an aneurysm. 
*For TCD, size categorisation was not available for all the false positive cases, therefore specificity 
and accuracy could not be determined by aneurysm size category. 
Table 4 Level of agreement between modalities (singly 
and in combination) and the reference standard and with 
each other determined using unweighted x statistic 
Modalities compared tc (95% CI) 
CTA with IADSA per patient (PP) 0.72 (0.59 -0.85) 
MRA with IADSA PP 0.71 (0.58 -0.85) 
TCD with IADSA PP 0.66 (0.52 -0.81) 
CTA with MRA PP 0.73 (0.59 -0.86) 
CTA with TCD PP 0.60 (0.45-0.75) 
MRA with TCD PP 0.66 (0.51 -0.81) 
CTA with MRA per aneurysm 0.69 (0.56-0.81) 
CTA with TCD per aneurysm 0.44 (0.27 -0.61) 
MRAwith TCD per aneurysm 0.50 (0.32 -0.68) 
CTA+TCD with IADSA PP* 0.84 (0.72 -0.95) 
MRA+TCD with IADSA PP* 0.79 (0.69 -0.94) 
CTA +MRA with IADSA PP* 0.83 (0.71 -0.94) 
Table S 
size 
íc50.20 indicates poor agreement, of 0.21 -0.40 fair agreement, 
of 0.41 -0.60 moderate agreement, of 0.61 -0.80 good agree- 
ment, and of >0.80 very good agreement. 
*These results apply where the non -invasive tests agreed with 
each other. Where they disagreed the result was classified as 
"uncertain" and not included in the calculation of st. 
agreement for the combinations of non- 
invasive tests with IADSA. These results are 
summarised in table 4. The agreement be 
tween non -invasive modalities and IADSA on a 
per patient basis (PP) was good. The agree- 
ment of the non -invasive tests with each other 





Size of subjects'largest Sensitivity) (95% CI) 
aneurysm (TPITP+FN) 
CTA+TCD 
(20/114 "uncertain" and 
10/20 had aneurysm on IADSA) 
MRA +TCD 
(16/114 "uncertain" and 
8/16 had aneurysm on IADSA) 
CTA +MRA 
(14/114 "uncertain" and 

























0.25 (0.03-0.65) (2/8) 
0.82 ( 0.57-0.96) (14/17) 
0.89 (0.52-1.00) (8/9) 
1.00 (0.72-1.00) (11/11) 
0.125 (0.00-0.53) (1/8) 
0.71 (0.44-0.90) (12/17) 
0.89 (0.52-1.00) (8/9) 
1.00 (0.72-1.00) (I1/11) 
0.25 (0.03-0.65) (2/8) 
0.59 (0.33-0.82) (10/17) 
0.56 (0.21-0.86) (5/9) 
0.82 (0.48-0.98) (9/11) 
117 (0.00-0.64) (1/6) 
92 (0.62-1.00) (11/12) 
1.00 (0.59-1.00) (7/7) 
1.00 (0.69-1.00) (10/10) 
0.14 (0.00-0.58) (1/7) 
0.75 (0.43-0.95) (9/12) 
1.00 (0.63-1.00) (8/8) 
1.00 (0.69-1.00) (10/10) 
0.14 (0.00-0.58) (1/7) 
0.85 (0.55-0.98) (11/13) 
1.00 (0.63-1.00) (8/8) 
1:00 (032-1.0) (11/li) 
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was also -good except forCTA and TCD where 
agreement was only moderate. In comparison, 
agreement between the modalities was poorer 
on a per aneurysm basis, particularly between 
TCD and either CTA or M . e improve- 
ment in x was substantial for all combination 
strategies with an improvement to a "very 
good" level of agreement with the reference 
standard for the CTA +TCD and CTA +MRA 
strategies. 
In table 5, sensitivity results are again given 
on a per patient basis but stratified according to 
the largest sized aneurysm that each patient 
had (whether or not the non -invasive test(s) 
detected it). The results on a per patient basis 
for the combination strategies were excellent 
for aneurysms larger than 5 mm in maximum 
angiographic diameter with a sensitivity, spe- 
cificity, and accuracy of 1.0 for all three combi- 
nation strategies. Of course a certain number of 
cases where the non -invasive tests disagreed 
were classed as "uncertain" and were therefore 
excluded from these analyses -on the basis 
that if this disagreement occurred in clinical 
practice, confirmatory IADSA would be man- 
datory to resolve the discrepancy. For aneu- 
rysms between 3 and 5 mm in maximum 
diameter, the results for the combination 
strategies were good, in particular for the CTA 
and TCD combination_ For aneurysms less 
than 3 mm in size the sensitivity was very poor 
for all strategies (table 5). 
Questionnaires were returned by 88% (100/ 
114) of subjects. The mean discomfort scores 
recorded on the visual analogue scale (with 
95% CI) were: for IADSA 4.5 (3.9 -5.1); for 
CTA 1.6 (1.2 -2.0); for MRA 2.9 (2.3 -3.5), and 
for TCD 0.5 (0.3 -0.7). Nine patients expressed 
no preference between any of the non -invasive 
modalities, four patients ranked CTA and 
TCD equally, and three MRA and TCD 
equally.,Twenty four preferred CTA, 12 MRA, 
and 48 TCD. Trancranial Doppler was pre- 
ferred to both the other non -invasive modali- 
ties by significantly more subjects (p <0.001 (f 
39.76)) and the preference for CTA over MRA 
was also significant (p <0.025 (x2 7.88)). 
Discussion 
In the context of aneurysm detection by 
non -invasive imaging, the most important per- 
formance criterion is sensitivity. This is be- 
cause there is a confirmatory reference stand- 
ard method available for the non -invasive 
tests - namely IADSA, which carries a rela- 
tively low risk in this group of subjects (0.07% 
rate of permanent neurological deficit°). Miss- 
ing an aneurysm (false negative) is potentially 
disastrous for a patient whereas an unnecessary 
angiogram resulting from a false positive study 
is likely to be of much less consequence for the 
patient. Moreover, because it is likely that 
IADSA will be performed after a non -invasive 
test has shown a positive finding, the result on 
a per patient basis is more crucial for the non- 
invasive modalities than that on a per aneurysm 
basis. For example, not detecting one out of 
three aneurysms with a non- invasive test (true 
positive per patient and for two aneurysms but 
false negative for one aneurysm) is a much less 
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important mistake than missing -all -the aneu- 
rysm(s) in a particular patient (FN per patient) 
because in the first scenario the reference 
angiographic standard would be subsequently 
a 
performed anyway, whereas in the second sce- 
nario it would not. 
The results presented are based on the "bet- 
ter" of the two observers. This observer (B) had 
lower sensitivity but greater specificity and 
slightly higher accuracy than observer A (see 
second paragraph of results). However, the 
results of the two observers were very similar 
with good interobserver agreement (0.69 for 
CTA, 0.73 for MRA). In fact, as can be seen in 
the footnote to table 1 that combination 
strategies using the "poorer" observer's results 
had a better sensitivity than those for the "bet- 
ter" observer. Therefore using the most 
accurate observer's results has not biased the 
sensitivity results upwards at all, rather the 
reverse. 
As outlined in the methods section, for vari- 
ous reasons not all patients underwent all three 
non -invasive imaging tests. However, the final 
114 subjects included had a similar age /sex 
distribution and aneurysm prevalence as the 
original 200 subjects recruited. All the non- 
invasive tests were well tolerated with TCD 
causing the least discomfort and being pre- 
ferred to the other modalities. Interestingly, 
CTA also caused less discomfort than MRA 
and was preferred by significantly more sub- 
jects despite the fact that CTA involved an 
injection of contrast and MRA did not (in the 
imaging protocol used for this study). 
There are no other previous similar studies 
to compare with this one, where it has been 
possible to determine the effects of combining 
non -invasive tests. Combining power TCD 
with either CTA or MRA can produce a 
non -invasive imaging strategy that, compared 
with any single test, has improved sensitivity- 
and level of agreement with the reference 
angiographic standard (on a per patient basis). 
This is at the cost of some subjects falling into 
an "uncertain" category in whom confirmatory 
IADSA would be required. The combination 
of CTA and pow ̀TCD had the greatest sen- 
sitivity (0.83) annroduced the highest level of 
agreement with IADSA (x 0.84). None the less 
this strategy would have led to 20/114 (18 %) of 
subjects being classified as "uncertain and 
requiring IADSA. Furthermore in the true 
positive and false positive cases, IADSA would 
also have been necessary (29 subjects and one 
subject respectively). Thus in the population 
we studied, to achieve optinaal sensitivity on a 
per patient basis with a combination of CTA 
and power TCD, almost half the subjects 
would have undergone IADSA (50/114, 44 %). 
The combination of MgA and CTA did not 
improve sensitivity over either examination 
alone, because they tended to detect or miss 
the same aneurysms. By detecting or missing 
different aneurysms, TCD did seem to corn- 
plement CTA and MRA. Figure 1 indicates an 
example of this difference between modalities 
in practice. The CT angiogram in this 44 year 
old woman presenting with subarachnoid 
haemorrhage was correctly interpreted by both 
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observers as demonstrating a 4 mm anterior 
communicating artery aneurysm (ruptured 
according to blood distribution on earlier plain 
CT) and a 3 mm right middle cerebral artery 
(MCA) aneurysm. The MR angiogram was 
erroneously interpreted as demonstrating only 
the right MCA aneurysm by both observers, 
whereas the power TCD demonstrated the 4 
mm anterior communicating artery aneurysm 
but the ultrasonographer did not detect the 
right MCA aneurysm. The quality of the non- 
invasive imaging in this example, particularly 
the MRA, is limited, but this reflects the 
difficulty in obtaining good quality imaging in 
sick, anxious, and often restless patients, and 
the fact that in routine clinical practice not all 
examinations can be performed on state of the 
art equipment using the very latest imaging 
sequences. 
All three of the combination strategies had a 
very similar overall accuracy per patient, and all 
had increased accuracy over the result of any 
single non -invasive method, but the improve- 
ment did not reach significance. However, con- 
tinuing technical improvements in all the non- 
invasive technologies studied mean that we can 
expect the diagnostic performance to improve 
further in the near future. Combining tests 
together did not improve performance on a per 
aneurysm basis probably because in many 
instances the modalities disagreed on the exact 
location and size of an aneurysm as well as 
disagreeing about the presence or absence of 
an aneurysm in other cases. This is indicated 
by the many aneurysms falling into the "uncer- 
tain" category in table 3. 
It is relevant to comment that we did not use 
contrast enhancement for either MRA or TCD 
studies. This study deliberately sought. to 
examine the effect of combining modalities 
that used the standard clinical imaging proto- 
cols available to most neuroscience centres. 
After the research started evidence began to 
become available that suggested contrast en- 
hancement might improve the diagnostic 
performance of both MRA and TCD. How- 
ever, as the evidence was early, limited, and not 
yet established as standard clinical practice, we 
decided not to alter our examination protocols 
part way through the study, which would not 
have been sound scientific practice anyway. 
There is considerable data now available on 
the accuracy of contrast enhanced (CE) MRA - 
in the investigation of cervical carotid, thoraco- 
abdominal, and peripheral vasculature.1e There 
is evidence from in vitro models that CE 
contrast enhanced MRA improves aneurysm 
detection." However, the evidence in vivo for 
aneurysm detection is still very limited. It 
should also be remembered that the technical 
complexities of obtaining a good quality 
contrast enhanced MRA study are consider- 
ably greater than for conventional 3D TOF 
MRA. The timing of data acquisition and K 
space filling needs to be precisely timed to the 
contrast bolus to gain the benefits of improved 
signal to noise ration and reduced signal from 
adjacent venous structures. Metens et al 
recently published the only prospective, 
blinded study of aneurysm detection by 
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contrast enhanced MRA to date.20 They exam- 
ined 32 patients and found that contrast 
enhanced MRA had an improved sensitivity of 
100% compared with 96% for 3D TOF MRA 
but a lower specificity-94% versus 100 %. The 
results in this small series are very impressive 
although- this -- may- be-due in part to-using-a- - 
consensus result of MRA review and to the 
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Figure 1 (A) LIDSA examination of a patient presenting 
with subarachnoid haemorrhage. A 4 mm ruptured anterior 
communicating artery aneurysm is demonstrated (long 
arrow) along witk an unruptured additional 3 mm right 
MCA aneurysm (short arrow). (B) CTA axial collapsed. 
MIP (maximum intensity projection) projection of the circle 
of Willis. Both aneurysms are demonstrated (arrows). (C 
and D) MRA axial collapsed MIP projection of circle of 
Willis. The MCA aneurysm is subtly demonstrated (short 
arrow) but neither observer detected the anterior 
communicating artery aneurysm (long arrow), possibly 
because the base MRA image at this level (D) does not 
confirm the presence of an aneurysm. (E) TCD image of 
the terminal left ICA segment, MCA and anterior cerebral 
arteries. The anterior communicating artery aneurysm was 
demonstrated (short arrow) but the right MCA aneurysm 
was not detected. 
aneurysm size -mean aneurysm size was 6 mm 
and only 39% (9/23) of aneurysms were 5 mm 
or less compared with 72% (59/82) in our 
study. Nevertheless detection of all small aneu- 
rysms (compared with 31% for MRA in our 
study) does indicate the potential improvement 
that-contrast- enhanced/ARA may offer_ Recent_ 
evidence has also become available to indicate 
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that contrast enhancement also improves the 
sensitivity of power TCD." 21 One large series 
found that contrast enhancement significantly 
improved sensitivity from. 40% to 55 %, al- 
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combination cannot yet replace IADSA in the 
detection of small and very small aneurysms. 
Non -invasive imaging tests performed and 
interpreted in neuroscience centres are a 
rr 
though again specificity was reduced -from 
91% to 83 %.11 Another much smaller series 
combined 3D power TCD with contrast 
enhancement although the ultrasonographer 
was not fully blinded. Klotzsch et al found that 
sensitivity was 87% with 100% specificity.' In 
summary, both contrast enhanced MRA and 
power TCD look promising on the limited data 
available so far. It should be borne in mind, 
however, that the cost, invasiveness, and 
complexity of the examinations are increased 
by the use of contrast. 
Increasingly there is a desire for screening 
tests to be carried out in general hospitals. The 
procedures in this study (and virtually all of 
those referred to in the literature) were carried 
out under the direct supervision of a specialist 
neuroradiologist in a neuroscience centre. It is 
doubtful whether better or even equivalent 
results could be achieved if the examinations 
were performed outside a specialist neuroimag- 
ing department. It is our view on the present 
evidence that these non -invasive procedures 
are best performed and at the very least 
interpreted in specialist neuroradiology depart- 
ments. 
Although the ISUTA data on risk of aneurys- 
mal rupture and surgical morbidity require to 
be confirmed by prospective data, they provide 
a strong indication that most incidental aneu- 
rysms should not be considered for treat- 
ment." In a young asymptomatic patient with 
no history of subarachnoid haemorrhage, only 
those aneurysms larger than 10 mm would be 
regarded as possibly requiring treatment; for 
aneurysms smaller than this, the risks of 
treatment -with an overall combined surgical 
morbidity and mortality rate of 15.8% -seem 
to outweigh the risk of rupture (0.05% per 
year)." For older patients, the risks of treat- 
ment probably outweigh the rupture risk what- 
ever the size of an incidental asymptomatic 
aneurysm. Table 5 indicates the performance 
of the non- invasiv gists on a per patient basis 
stratified by maximum size of aneurysm. In 
practice, failing to detect small aneurysms in 
patients with no history of subarachnoid 
haemorrhage may not matter very much due to 
their very low risk of rupture, but whether 
asymptomatic patients should undergo any 
"screening" examination for intracranial aneu- 
rysms at all is highly questionable in view of the 
ISUTA data. Furthermore, there is a need for 
counselling any person considering screening 
regarding the diagnostic performance of avail- 
able tests, the potential implications of a 
positive result (for example,in insurance, driv- 
ing, and employment), as well as the manage- 
ment options available. 
In conclusion, the combination of transcra- 
nial power Doppler ultrasound with either CT 
angiography or MR angiography did improve 
the detection of intracranial aneurysms com- 
pared with either modality alone on a per 
patient basis. Non-invasive tests even in 
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reliable method of detecting or excluding 
aneurysms greater than 5 mm in diameter on a 
per patient basis -particularly when used in 
combination (table 5). Compared with the use 
of a single modality alone, employing a strategy 
combining two non -invasive tests would de- 
crease the number of false negative results but 
at the cost of increasing the number of 
confirmatory IADSA studies required where 
the non -invasive tests do not agree. More 
information is still required on the diagnostic 
performance of CE MRA in the detection of 
small intracranial aneurysms. 
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